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Note:  Chemical structure – stereochemistry 
Inside this doctoral thesis, various chemical compounds are presented and depicted in the form of 
molecular or condensed structures. As many of these structures contain stereogenic centres, 
stereochemistry (information on the asymmetry of molecule) is an important aspect of the correct 
representation of these molecules. Especially when focusing on biochemical and biomedical relevant 
applications, as intended within this doctoral research, the use of specific compounds with the proper 
chirality (L, levorotatory or D, dextrorotatory) is of the utmost importance. Naturally occurring proteins 
and other structures composed of amino acids (except glycine which has no stereogenic centre) bear 
stereogenic centres characterized by the L-form.  
H2N C COOH
CH2
CH2
C
NH2
O
H2N
C
COOH
CH2
CH2
C
NH2
O
H
H
glutamine L-glutamine  
Therefore, within this thesis, the aim was to synthesise also L-based polymers (e.g. poly-L-glutamine). 
To simplify the representation, specifically when condensed polymer formulas are in order, the exact 
nature of the stereogenic centre is not specified when depicting the R-group of the poly-L-amino acid 
(oriented away from the reader). Nevertheless, when talking about the polymer and more specifically 
polymer structure further on, the L-form and it’s corresponding representation is always implied. 
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1 The promising rise of gene therapy 
Gene therapy or gene delivery is an approach towards healing a person who is suffering 
from a genetic anomaly. The strength of this application lies in its basic concept, being the 
repair of malfunctioning DNA, the root cause of the illness. To understand this idea, it is 
necessary to comprehend the importance and role of DNA within the body. As many people 
are aware of the fact that DNA consists of the basic building blocks relevant for functioning 
of the body, few know in what way this is achieved. DNA is the carrier of hereditary 
information (a ‘blueprint’), consisting of nucleotides that have a specific sequence which is 
typical for a certain characteristic of the body, often referred to as a gene sequence (e.g. 
brown eyes, the production of insulin, etc.). Each nucleotide consists of a nucleobase 
attached to a sugar (deoxyribose) and phosphate unit, that build up rigidity to form polymer 
strains. There are 4 nucleobases,i.e adenine, guanine (purines), thymine and cytosine 
(pyrimidines) that are endlessly repeated in a specific order, forming the total genetic 
information. Every cell within the body, possesses a complete copy of all the genes, which 
are appearing as chromosomes (densely packed, long coils of DNA). Cells differ in function 
because they use different parts of the chromosomes to produce their typical proteins. This 
is done by a specific process that requires several intermediate agents (Fig. 1.1).   
 
Figure 1.1 – Simplified scheme for the synthesis of a protein. 
In some cases (e.g. genetic mutation) certain gene sequences can become erroneous, 
resulting in defective DNA and might lead to the insufficient or incorrect production of 
proteins which could induce disease patterns. Currently, treatments for these conditions are 
focused on symptoms whereas the ideal cure should address the source of the problem. 
Gene therapy could be an answer to a huge amount of diseases that are affected by 
defective DNA like for instance schizophrenia, cystic fibrosis or age related macular 
degeneration. This way of working could be expanded to the treatment of other diseases like 
AIDS or cancer. The alteration of genes in order to cure diseases was already postulated by 
E. Tatum (1958)1 but since insufficient knowledge on the human genome was available at 
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that time, successful practical experiments could only be executed in the early 1990’s2. With 
increasing biological and medical understanding of genetic mechanisms, this has lead to 
recent applications in clinical trials for cancer3, blindness4 and deafness5.  
Theoretically, the replacement of a faulty gene within the chromosome, is physically possible 
but very challenging and so far not fully understood. The lack of understanding gene 
replacement is not really a drawback since in the majority of therapies, an easier solution 
can be found in the plain addition of a specific gene to the cell. In this way the need for a 
certain protein can be compensated6. Nevertheless, introducing foreign substances into the 
body remains a tricky endeavour since the immune system of mammals has increasingly 
evolved through time. This phenomenon is also applicable for gene therapy and comprises 
the main difficulty this research encounters. DNA is a highly negative molecule (due to 
phosphate residues) which is often very large in size. Together with obvious immunological 
implications, the introduction of DNA to a cell requires consideration on the use of a delivery 
system that could prevent rapid DNA clearance or destruction before reaching its target7. 
Moreover, a carrier would ideally facilitate the cell internalisation by encompassing  the cell 
membrane barrier. 
  
At current, gene delivery can be classified in 3 categories. 
 
Ex vivo: Prior to incubation with DNA and a delivery system, cells are removed from 
the body, after which the cells are readministered. This is mainly applied for blood 
cells (due to the ease of withdrawal and subsequent administration). 
In situ: A delivery system containing DNA is put directly into the target tissue. 
In vivo: The delivery system is brought into the bloodstream and is presented 
throughout the body (systemically). 
 
One of the main application domains for gene therapy is obviously hereditary diseases. To 
treat these disorders, the insertion of a correct version of a defective gene into the genome 
of stem cells is attempted. These methods primarily target easily accessible tissue8 (muscle, 
lung, blood) and also make use of delivery systems9. Another area of interest, on which a 
huge amount of genetic research is focussed, is cancer. Since this is the number two cause 
of death in the world, it is not surprising that the highest amount of clinical tests in gene 
therapy are aimed at curing cancer or cancer related issues10. Cancer therapy can be 
addressed in several ways: 
Immunotherapy: using this approach, the immunogenicity towards tumours is 
increased by locally producing immune-stimulating substances (interleukins, 
lymphokines) so that the body is prompted to take action against the malignant 
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tumours. In this way the immune system can reach tumour cells that were not 
covered by the initial therapy (systemic advantage)11,12. 
Repair of original cell function: to treat cancer there is generally a need to affect 
genes that are involved in the cell cycle. Therefore, the oncogenes should be 
deactivated and tumour suppressor genes activated. Upon oncogene mutation, the 
gene that causes proliferation of tumour cells is rendered useless by antisense 
therapy (introduction of single stranded RNA that caps a part of the mRNA, coding for 
the mutated protein). The activation of suppressor genes is achieved by bringing 
genes into the cell that recover the tumour suppressing ability of the cell13,14. 
Use of suicide genes: via this dual therapy, an enzyme-coding gene is introduced, 
followed by the administration of a harmless pro-drug. The added enzyme is capable 
of converting this pro-drug into a highly cytotoxic drug that destroys the tumour cells 
(for instance, brain tumour cells)15. 
Anti-angiogenesis therapy: tumours induce blood vessel growth (angiogenesis) by 
secreting various growth factors (VEGF) and basic fibroblast growth factor (bFGF). 
To disrupt nutrient supply and metabolite activity, the suppression of angiogenic 
factors or the reinforcement of angiogenic inhibitors (endostatin, angiostatin) is the 
start of tumour isolation and eventually death16,17.  
 
Furthermore, gene therapy can be employed to treat AIDS18. There are two main strategies 
used for this, avoiding that the HIV replicates or preventing the infection of healthy cells. The 
first strategy is achieved by introducing genes that code for ribozymes, capable of destroying 
the viral DNA whereas in the second approach genes are added to healthy cells that 
consider HIV as a foreign entity and which is followed by antibody production19,20,21. Many of 
these investigations already reached clinical trials22,23. Recently, a new intervention strategy 
has surfaced enabling the treatment of AIDS related diseases based on genetically 
engineered hematopoietic stem cells that possess the capacity for prolonged self-renewal 
and which are able to continuously produce protected immune cells to fight against HIV24,25. 
Finally, one of the other appealing applications of gene therapy is the recovery of bone 
defects26. Instead of stabilising the defect and minimalising the pain, genes are added to the 
cells that code for specific cytokines or hormones that are implicated in the remineralisation 
(bone morphogenic proteins, BMP-4 or growth factors).  
Besides DNA, alternative approaches were developed over the last 20 years making use of 
RNA interfering strategies27 (RNAi, a cellular mechanism). RNAi is a potent and specific 
gene silencing event in which small interfering RNA (siRNA) degrades target mRNA by 
mediation at the posttranscriptional level, for instance in the case of HIV-1 virus-related 
 
Chapter 1: Introduction & objective  4 
 
conditions28,29. The first clinical trials were reported to use lentiviral gene therapy30 and has 
rapidly grown31. 
 
Despite the tremendous advances in antiretroviral combination therapy over the last decade, 
eradication of HIV from the infected organism is still an elusive goal. Lifelong therapy is 
associated with potential long-term toxicity, adherence problems, and development of drug 
resistance. Current approaches were mainly limited by a low number of transduced cells and 
genotoxicity32. The use of new vector systems and the right choice of target cells and 
improved transduction protocols may overcome these obstacles. Over the last decade, the 
emphasis of gene delivery research has been on finding these suitable delivery systems that 
can aid in targeting the proper tissue, protecting the DNA from destruction and promoting the 
transport to the nucleus once inside the cell. In combination with significant advances in 
molecular understanding of bioactive processes, it is believed that gene therapy holds a 
considerable promise for treating thousands of human genetic diseases for which there is no 
adequate treatment at present33. Because of that, the rise of gene therapy could very well 
become a milestone in medical history enabling higher life quality and reducing costs for 
extravagant treatments that up to now, have only focussed on symptoms.  
 
2 Gene Delivery systems 
There are different types of delivery systems that can be divided in two groups, the viral and 
the non-viral delivery systems. Each of these has certain advantages and drawbacks. Viral 
systems generally show the highest activity but most are more prone to mutation and 
secondary toxicity (inflammatory response) whereas the non-viral systems appear to be less 
potent but display better biocompatibility. Additionally, there are also methods for introducing 
DNA into the body using physical techniques. Only a limited amount of delivery systems 
express properties that are sufficient to continue the investigation up to the level of clinical 
trials. In figure 1.2, the number of delivery systems that was used in clinical trials so far is 
listed and confirms the superior importance of viral research which accounts for almost 70% 
of the total amount of delivery systems applied in clinical trials25. Not counting the use of 
naked (plasmid) DNA, the application of non-viral systems, both synthetic and natural, barely 
exceeds 10% of the total amount used in clinical trials. When looking at the different phases, 
the amount of trials in phase III is < 1% of the total34. Below, a table with a list of examples of 
both viral vectors (including plasmids) (table 1.1) and non-viral vectors (table 1.2) that 
reached clinical trials is shown. The number of clinical trials using polymeric synthetic 
vectors is at this moment very low, yet it’s use for clinical trials is strongly increasing during 
the last years35.  
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Figure 1.2 – breakdown of delivery systems used in clinical trials
25,36
. 
 
Non-viral vector Disease Status 
DMRIE:DOPE (1:1) i. Melanoma 
ii. Melanoma and renal cell 
cancer 
i. Phase III 
ii. Phase II 
DOPSA:DOPE (3:1) Solid tumours Phase I 
DC-Chol:DOPE (1.5:1) i. Head and neck cancer 
ii. Ovarian cancer 
iii. Cystic fibrosis 
i. Phase II 
ii. Phase I 
iii. Phase I 
DC-Chol:DOPE (3:7) Glioblastoma multiforme Phase II 
DOTAP Cystic fibrosis Phase I 
GL-67:DOPE (1:2) Cystic fibrosis Phase I 
In vivo jet PEI Bladder cancer Phase IIb 
PEG-PEI-Chol Ovarian cancer by radiation 
induced promoter 
Phase I 
PEI mannose and dextrose HIV Phase II 
PEGylated 30mer PLL Cystic fibrosis Phase II 
Cyclodextrin based polymer Solid tumours Phase I 
Naked DNA Liver, breast and colorectal 
cancers, leukemia 
Phase I/II 
Electroporation Melanoma, glioma,  renal cell 
cancer 
Phase I 
Table 1.1 – Overview of non-viral vectors used for clinical trials
35
.  
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Type of virus Therapy Indication Phase 
Retrovirus ADA-SCID GT: CD34+ cells 
transduced with Moloney murine 
leukemia virus carrying ADA gene 
Primary 
immunodeficiencies 
1/2 
CD34
+
 cells transduced with 
retrovirus vector with multiple 
ribozymes 
Non-Hodgkin's lymphoma, 
HIV/AIDS 
2 
Toca-511: replication-competent 
retrovirus with prodrug activator 
cytosine deamidase gene injected 
into tumor 
Glioma 1/2 
Lentivirus LentiGlobin: introduces globin 
gene into patient hematopoietic 
stem cells 
-thalassemia and sickle 
cell anemiaPhase 1/2 
1/2 
 LG-740: T cells treated ex vivo with 
lentivirus with chimeric T-cell 
receptor gene 
740: T cells treated ex vivo 
with lentivirus with 
chimeric T 
1 
 ProSavin: lentivirus with three 
genes required for dopamine 
biosynthesis injected into striatum 
of brain 
Parkinson's disease 1/2 
Adenovirus Adenoviral mediated interferon-β Pleural mesothelioma  
Colon cancer, glioma 
1 
1/2 
 TNFerade: replication deficient 
adenovirus with TNF-a controlled 
by radiation induced promoter 
Esophageal cancer 2 
 rAd-p53: replication deficient 
adenovirus encoding hu 
recombinant p53 
Advanced thyroid tumors, 
oral, maxillofacial tumors 
4 
Adeno-
associated 
virus 
AMT-101: AAV with human 
lipoprotein lipase (LPL) gene 
LPL deficiency 3 
AAV2-sFLT01: AAV with anti-VEGF Wet macular degeneration 1 
tgAAC94: AAV2 with TNF-α-IgG1 
fusion gene 
Arthritis 2 
(completed) Plasmids Allovectin-7: plasmid with gene for 
HLA-B7 and β-2 microglobulin 
genes, injected into tumors 
Melanoma 3 
 Hepatocyte growth factor plasmid Arterial disease 2 
Table 1.2 – Examples of viral vectors used in clinical trials
35
. 
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2.1 Physical methods 
2.1.1 Direct gene delivery using plasmid DNA 
The simplest and safest approach of delivering DNA is transfection using naked plasmid 
DNA. Transfection is referred to as the total process of introducing DNA into a host cell and 
its consequent expression of a protein. In 1990, it was first demonstrated that upon 
intramuscular injection, naked plasmid DNA was efficiently expressed in myofibers37. This 
observation is due to, on one hand the slow turn-over of myofiber nuclei and on the other 
hand the unusual high access of DNA into the nucleus of myocytes. This muscle transfection 
ability opened doors for DNA vaccines38,39,34. Later on, it was shown that the efficiency of this 
gene transfer was improved by using precursors of delivery systems with polymers such as 
polyvinyl pyrrolidone (PVP) that weakly interact with DNA40,41. It is assumed that these 
polymers protect DNA from enzymatic degradation and that they provide a sort of storage 
system allowing DNA to be released over a prolonged period. In addition to muscles, the 
skin, some tumours and certain immune cells are also susceptible to naked DNA-mediated 
gene transfer. However, it should be noted that the levels of expression after intra-tumoural 
injection are much lower compared to intramuscular injection.  
 
Intravascular injection of plasmid DNA generally results in limited gene expression in all 
major organs42,43. Research has been performed to discover the causes of this observation. 
It was observed that the hepatic clearance of naked DNA was very close to the plasma flow 
rate through the liver and decomposition traces were found in the skin and intestine due to 
the possible binding to serum components like albumin44. In addition, it was also found that 
DNA is rapidly degraded by plasma nucleases45. The incorporation of polysaccharides into 
non-viral gene delivery systems, on the other hand demonstrated a reduced toxicity and 
greater stability into biological fluids46. Furthermore, it has been demonstrated that 
intravascular injection may result in high levels of gene expression when the injection occurs 
under high hydrostatic pressure47. It is believed that this pressure enhances expression by 
facilitating the passage of the plasmid DNA out of the blood vessels48.  
 
Introduction of plasmid via microinjection has led to successful delivery of genes including 
GFP, interleukin (IL)18, Flt23k, endostatin, MMP14, and vasohibin into various cells of the 
cornea (ocular applications)49,50,51 by targeting different layers performed at various anatomic 
locations including intrastromal, subconjunctival, and directly into the anterior chamber. For 
example, successful transgene delivery in the cornea in vivo was reached using intrastromal 
lamellar implantation of a partially dried p-bFGFeSAINT-18 complex composed of SAINT-18 
(non-liposomal delivery device52) and plasmid vector encoding reporter or FGF2 gene. 
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Intra-nuclear injection results in a high efficiency of DNA transfer into the nucleus. This 
procedure which can only be used in vitro and ex vivo, however, is laborious because each 
cell needs to be treated separately but is able to overcome some drawbacks associated with 
naked DNA delivery to tissue, such as the size and negative charge density of the plasmid 
that can prevent the crossing of cellular boundaries53.  
 
2.1.2 Gene gun 
This particle-mediated gene transfer is achieved by a physical force. A gene gun accelerates 
DNA coated gold particles to high speeds by means of a high pressure (5-8 bar) stream of 
helium gas. This force is sufficient to allow the penetration of physical barriers such as plant 
cell walls and cell membranes. An improved transfection efficiency is obtained due to the 
induction of micro-traumas within the treated tissue54, which increases DNA uptake. The 
introduction of foreign particles (gold) on the other hand, is a disadvantage as well as the 
depth that can be reached by the particles. This technology has been widely used for gene 
transfer to the skin55.  
For ocular applications, the use of a gene gun reported successful delivery in the cornea for 
genes such as IL4 and IL10 plasmid DNA and opioid growth factor receptor, introduced into 
the corneal epithelium56,57,58.  
 
2.1.3 Electroporation 
Electroporation is a technique in which cells are exposed to intense electric fields that induce 
a transmembrane potential59. A sufficiently high potential will trigger a dielectric breakdown 
of the membrane which results in formation of transient breaks (e.g. pores in the plasma 
membrane) allowing DNA and other molecules to enter the cytoplasm. Both in vitro as well 
as in vivo gene delivery using electroporation have been reported60. In the latter case, cell 
electro-permeabilisation is achieved by means of electrodes for example in electro-
chemotherapy, to facilitate cellular entry of anticancer agents. However, several drawbacks 
are associated with this method. To begin, it’s effective range within the tissue is limited 
which results in reduced transfection efficiency for large tissue areas. Secondly, a surgical 
procedure is needed to place the electrodes into the organ of interest. Finally, the thermal 
heating generated by the high voltage applied may irreversibly damage tissue61. For In vitro 
applications, cells and DNA are combined in a recipient which is placed between electrodes. 
When voltage is applied, a small incubation time is needed to allow the membrane passage. 
Hereafter, the cells are restored to normal culture conditions62. Compared to in vivo, higher 
charges can be applied which results in the cell-crossing of larger DNA molecules (larger 
membrane breaches). Most reports show a 10 to 1000-fold increase in transfection when 
DNA injection was followed by electroporation63. It should be noted that different tissues may 
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respond differently to electroporation due to biological differentiation. Amongst the key 
parameters to optimise this technique are the electric field strength and the pulse length64. 
An advantage of this technique is also the large DNA constructs that can be transported into 
cells, although specialized equipment is necessary65.  
Few studies have been performed during last years which target ocular applications. 
Electrically assisted gene delivery to the endothelium of ex vivo human corneas was recently 
described66. 
 
2.1.4 Gene transfer by ultrasound radiation 
Another physical method used to enhance tissue penetration is via ultrasound (US) 
radiation67. US waves render the membrane permeable by creating small cavitations that 
allow the delivery of DNA into the cytoplasm through passive diffusion. This is in contrast to 
electroporation where the DNA is moved along the electric field. The transfection efficiency 
is determined by several factors such as the frequency, the output strength, the irradiation 
time and the DNA dose. The efficiency can be enhanced by using contrast agents like air-
filled micro-bubbles that readily expand or shrink under ultrasound treatment or by 
combining DNA with cationic liposomes68. In the first approach, local shock waves are 
generated to induce transient corridors that permeate the cell membranes in close 
proximity69. It was shown that US could enhance transfection efficiency of DNA both in vitro 
and in vivo70. The benefit of US assisted technique was proven for both viral and non-viral 
vectors in tissue like cardiac muscle71, the pancreas72 or even tumours73. 
Also for the cornea, ultrasonic radiation waves enhance transfection efficiency of several 
vectors applied (e.g. liposomal gold particles74). For a specific type of adeno-associated 
viruses; efficient transfection was achieved in vitro for human RPE cells and even in vivo for 
rat retina75.  
Combining plasmid DNA with cationic lipids (lipoplexes) or cationic polymers (polyplexes) 
may overcome problems associated with the previously mentioned methods. The 
subsequent particle formation effectively reduces the size of DNA and creates a less 
negative surface charge. Additionally it protects the DNA against degradation and facilitates 
intracellular trafficking. Furthermore, the cationic lipids and polymers that form the DNA 
complexes can be designed to target specific processes such as receptor binding, nuclear 
localization or modulation of immune response76.  As a final note, the use of the above 
mentioned techniques can be combined and even extended with other newly emerging 
methods (e.g. combining US microbubbles and magnetic particles77). 
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2.2 Viral vectors 
Due to natural invading mechanisms, viruses are suitable candidates for delivery of DNA into 
targeted cells. Currently the use of viral vectors is the most efficient method known for gene 
transfer in vivo. The process that introduces a gene of interest into a host cell is referred to 
as viral transduction. Viral particles are composed of a nucleic acid genome surrounded by a 
capsid of proteins. They efficiently gain access to host cells where the genetic information is 
replicated by the host’s machinery. In the ideal case, these viral vectors utilise the viral 
infection pathway but avoid the subsequent expression of viral genes as this may lead to 
self-replication and potential toxic effects. Optimally, the gene must be incorporated into a 
virus that is replication-deficient78. This is achieved by deleting all of the coding regions from 
the viral genome except for sequences that provide functions such as packaging of the 
therapeutic gene into the virus capsid or the integration into the host’s genome. The 
previously mentioned deletion of the coding regions creates space for the incorporation of 
the therapeutic gene into the viral backbone. The deleted genes are subsequently utilised in 
a separate packaging construct to provide helper functions. This construct contains viral 
genes derived from the parental virus that encode structural proteins and proteins that are 
required for vector genome replication. Finally, packaging cells are transfected with the 
vector genome and the packaging construct, which results in production of recombinant 
vector particles (Fig. 1.3)79. 
 
 
 
 
 
 
 
 
 
 
 
A 
(A) a generic viral vector including structural proteins, (B) a packaging cell construct with 
vector genome that contains the therapeutic gene flanked by inverted terminal repeats 
and cis-acting sequences required for genome encapsulation 
Figure 1.3 - Viral vector modification
54
. 
 
 
B 
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The most frequently used viruses as gene delivery vectors include adenoviruses, adeno-
associated viruses, retroviruses (incl. Lentivirus) and herpes simplex viruses.  
 
2.2.1 Adenovirus 
This type of virus was one of the first viruses to be investigated80. More than 50 human 
serotypes from six different groups are known (Fig. 1.4). Their genetic material consists of 
double stranded DNA and they are divided in two groups dependent on the time of genetic 
expression (early and late)81. Generally, certain genes are deleted in order to render the 
virus replication deficient. Adenoviruses (Ad) are able to transfect both dividing and non-
dividing cells. The mechanism of cell-entry is well known and initiation of the cell binding 
usually occurs through the coxsackie- and adenovirus-receptor82. Subsequent interaction 
with cell integrins allows internalization of the virus through clathrin-mediated endocytosis83. 
Inside the endosomes, a part of the virus particle is removed, followed by transport to the 
nucleus. The virus replicates episomal (outside the chromosomes) in the nucleus and is 
consequently not inserted in the hosts genome84.  
As a result, adenoviruses are only used when temporarily expression is sufficient to obtain 
the desired therapeutic effect. On the other hand, these vectors have a large loading 
capacity (up to 36 kb) for insertion of therapeutic DNA and are very efficient in transducing 
cells85. One of the main side-effects is (mild) flue and occurs in healthy persons which 
means that a large amount of the population possesses antibodies against Ad. This implies 
neutralisation of the infection in the long run and limits the time of expression. Because of 
that, extensive research was performed to design vectors that combine Ad with non-viral 
vectors86. In 1999, a 18-year-old patient died in of the first clinical trials due to direct 
administration of an adenoviral vector into the liver through the hepatic artery87. An autopsy, 
however, showed that substantial amounts of this vector were distributed into the circulation 
and had accumulated in the spleen, lymph nodes and bone marrow. 
 
Figure 1.4 - Adenovirus composition
86
. 
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The systemic delivery of the vector triggered a massive inflammatory response which 
resulted in death within 4 days. Subsequent studies in monkeys demonstrated that the 
adenoviral capsid proteins were responsible for the cause of an early inflammatory cytokine 
cascade. To avoid these safety issues, recent research has been focussed on gutless 
viruses88, a type of Ad of which large parts of the viral genome are removed. When these 
viruses are used, the expression in the transduced cells lasts longer because of the lack of 
immune response. Due to the rise of other viral research domains, the investigation of Ad 
viruses has drastically decreased, yet focus on hybrid Ad systems remains89.  
 
2.2.2 Adeno-associated virus   
An adeno-associated virus (AdAV) is non-pathogenic when applied in humans but requires 
co-infection of a helper virus (Ad or herpes virus) to be efficient90. There are more than 8 
serotypes available of which AdAV serotype 2 is commonly used. The viral genome is 
composed of single stranded DNA that codes for two genes (rep and cap). This first gene is 
known to code for proteins that control the viral replication and promote integration into the 
host genome. The other one codes for structural proteins that form the capsid and is usually 
replaced by the therapeutic gene, but restricts the length of the gene to 4.7 kb. A huge 
advantage of AdAV is the ability to offer permanent expression of the delivered genes and its 
capability of infecting dividing as well as non-dividing cells. Additionally, there’s a minimal 
immunogenic response related to AdAV use and this virus also doesn’t produce viral 
proteins, allowing repeated administration91. Limitations of AdAV include their small 
packaging capacity and possible production issues due to increased chances of 
contamination. The AdAV has been one of the most studies viral vectors and resulted in over 
a 100 models explored, yet very few actually reached clinical phase trials92. Recent 
advances with clinical application were made using AdAV in the treatment of lipoprotein 
lipase deficiency93, muscle desease94 or rheumatoid arthritis95.  
Ocular approaches focussing on Leber congenital amaurosis have confirmed the potential of 
AdAV’s for retinal96 and corneal97 applications 
 
2.2.3 Retrovirus 
Another type of frequently investigated viruses are retroviruses. Most of them are mainly 
based on the murine leukemia virus, a cancer inducing virus for mice. Their genetic material 
appears as single stranded RNA that replicates by reverse transcriptase via a DNA 
intermediate. The retroviral genome contains three regions, ‘gag’, ‘pol’ and ‘env’, which 
encode for the capsid proteins, the viral enzymes (reverse transcriptase, integrase and 
protease) and the envelope proteins, respectively98. Given removal to avoid replication, they 
create space for the loading of therapeutic genes99. Notable is that genome integration 
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occurs and this establishes a sustained gene expression100. Unfortunately, the integration in 
the genome of the host cell is only possible in dividing cells because the nuclear membrane 
has to be fragmented to allow entry into the nucleus. This drawback on the other hand could 
play a major role in transduction of tumour cells, which are located between slowly dividing 
tissues such as brain tissue. Other drawbacks include the random insertion into the host 
genome, which can result in activation or inactivation of a host gene. Finally the capacity for 
insertion of therapeutic DNA is limited to 8,5 kb which is rather small for elaborate 
applications. Several types of retroviruses have been developed for gene therapy including 
lentiviruses such as HIV-1101,102,103 (Fig. 1.5). Moreover, they are currently the focus of 
considerable other viral gene therapy research  like for instance in Parkinsons disease104, 
treatment of melanoma105 or retinal disorders106,107. 
 
Figure 1.5 – Structural formation of a lentivirus (HIV-1)
98
. 
 
2.2.4 Herpes simplex virus  
A final, major group of viruses widely investigated in gene therapy research are herpes 
simplex viruses (HSV). As main advantage they have the ability to infect a broad range of 
dividing as well as non-dividing cells. Replication-defective HSV-type 1 vectors are produced 
by deleting all, or a combination of, five immediate-early genes (ICP 0, 4, 22, 27 and 47), 
which are required for infection and expression of all other viral proteins coded by dsDNA. 
Despite the ICP0 gene product is cytotoxic, it is required for high levels of sustained 
transgene expression. Recent research solved this problem by substituting ICP0 by a protein 
which facilitates efficient transgene expression without cytotoxicity51. Moreover, due to its 
large genome, about 30-50 kb of therapeutic gene can be introduced into the vector. 
Furthermore, HSV’s do not insert their DNA into the host’s genome thus avoiding the 
deleterious effects that may occur by random integration7. HSV replicates in epithelial cells 
and establishes a life-long latent infection in neuronal cell bodies within the sensory ganglia, 
where the latent viral genome is maintained in an episomal state50,54. This has led to quite a 
 
Chapter 1: Introduction & objective  14 
 
lot of studies and clinical trials in the field of tumours (e.g. melanoma108, carcinoma109, etc.) 
but in many cases clinical trials are not progressing due to the possibility of adverse 
effects110. 
 
2.2.5 The viral future? 
Viral vectors derived from natural viruses are still actively investigated and used in clinical 
gene therapy due to their inherent high transduction capabilities. It has been demonstrated 
that one viral particle is already sufficient to induce a measurable effect36. These high 
efficiencies are to a large extent due to the excellent cell-membrane rupture mechanisms111. 
However, several limitations have reduced their use in clinical settings, such as the induction 
of cancer by insertional mutagenesis. Because of random transgenic insertion into the host’s 
chromosome, the normal expression of a critical gene that regulates cell growth and division 
gets often disrupted112. The lack of cell or tissue specificity of these vectors is also a major 
drawback. Another adverse factor is the pre-existing or acquired immune responses that are 
experienced when viral vectors are applied. With these immune responses neutralising 
antibodies will quickly clear viral vectors from circulation and this results in a reduced 
efficacy and hampered repeated administration. Finally, various viral vectors fail to transfer 
high levels of genes which are required to achieve therapeutic effects in several cell types.  
 
These issues along with devastating results of viral gene therapy induced death of patients 
have motivated the exploration for safer, less pathogenic and less immunogenic gene 
delivery alternatives including genetically modified viruses and lipid or polymer based 
delivery systems113. Extensive research has been performed in the field of combining viruses 
and polymers to overcome the aforesaid drawbacks. In this approach, the role of the 
polymer is passive. It facilitates the delivery of the virus, whereas the active gene transfer 
function is carried out by the viral part114. Polymers are very well suited for this task since 
macromolecules are composed of multiple active sites which enable interaction with the 
virus. This results in an efficient protection and can additionally allow controlled release 
when biodegradable polymers are used. In these polymer-based viral gene delivery 
approaches four categories can be distinguished30. At first method, a polymer matrix 
encapsulates viral vectors to allow delivery into the body through surgical implantation or 
injection. Polymers used for this approach can be natural as well as synthetic. Secondly, 
positively charged polymers (polycations) can form complexes with negative viral vectors 
resulting in viral complexation. Additionally, polycations such as polylysine and 
polyethylenimine also neutralize the negatively charged cell. A third series of polymers are 
hydrophobic, biodegradable polyesters that form microspheres that entrap viruses and 
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release the virus continuously when degrading. In the last approach, the polymer is 
anchored chemically to the surface of the virus34. 
 
From the information given above, it is safe to state that viruses form very potent and 
attractive delivery systems for genetic, therapeutic purposes. Nevertheless, since the 
inherent toxic effects of the viral pathway still comprise too much danger, alternatives are 
imposed on gene therapy research. Because the incubation of a viral vector can provoke a 
cascade of replications within the host cells (Fig. 1.6) and as long as the understanding of 
viral vector methods is not adequate, the need for non-viral systems will exist and gain 
increasingly more interest.    
 
Figure 1.6 - The viral pathway
115
. 
 
2.3 Non-viral vectors 
2.3.1 Inorganic based delivery systems 
In the beginning, research on inorganic materials that could aid in the delivery of genes into 
tissue and cells was focused on the use of divalent cations like calcium. This method was 
precedingly used for bacterial transformation and a similar strategy was reasoned to 
enhance the uptake of DNA into mammalian cells far before the time of gene therapy 
started116. A frequently used material is Ca3(PO4)2 which has an excellent biocompatibility 
due to its chemical similarity to human hard tissue (bone). In nano-particle dispersed form, it 
can be used as a carrier in biological systems117. This is basically achieved by allowing co-
precipitation of a diluted DNA solution in the presence of a low concentration of phosphate 
ions. In subsequent steps, Ca2+ ions (CaCl2), are graduately added to the solution until 
precipitation of DNA occurs118. The formed calcium phosphates protect DNA from nucleases 
such as those present in serum. Finally, the precipitated DNA is taken up by cells by means 
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of endocytosis23. Some of the benefits include a stable and sustained expression of the 
gene, ease of use and a low cost. However precise control over the pH is required and large 
amounts of DNA are needed to obtain efficient precipitate formation. Unfortunately, the 
sustained expression is often low and difficult to apply in vivo60.  
Recent research is for a large part focused on magnetic based materials like 
hydroxyapatite119 or iron(oxide) containing compounds120,121,122. Additional to packing DNA, 
these structures are susceptible to magnetic force. This benefit is exploited by applying a 
magnetic field after injection in order to facilitate tissue and cell entry. Other natural minerals 
that are increasingly evaluated as biomaterials to be applied as delivery systems are layered 
double hydroxides, a family of anionic clay materials, exemplified by the natural mineral 
hydrotalcite [Mg6Al2(OH)16CO3x4H2O]. They were found to be efficient in the delivery of 
siRNA to cells (HEK293T)123. Also in combination with organic systems, inorganic based 
materials such as silica containing bioceramics or alginate hydrogels loaded with Ca3(PO4)2 
nanoparticles are successfully applied124,125. Finally, quite some research is emerging in the 
domain of gold nanoparticles due to good biocompatibility, monodispersity and ready 
functionalisation126,127.  
 
2.3.2 Liposomal based delivery systems 
Many different systems based on lipids have been developed as vectors for gene therapy in 
vitro and in vivo. Early studies made use of neutral and anionic liposomes because they are 
less toxic and better compatible with biological fluids and therefore more appropriate for 
systemic gene delivery128 (Fig. 1.7). However due to the previously mentioned 
characteristics of DNA, such as the large hydrodynamic diameter and the negative charge, 
the encapsulation efficiency was limited. Other drawbacks of these anionic and neutral 
liposomes include insufficient cell interaction and lack of endosome disruption. Therefore, at 
present, most of the research is performed in the field of cationic lipids27,54. 
 
Figure 1.7 - DNA-encapsulated (neutral) liposome
128
. 
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All cationic lipids possess a hydrophobic group, which is often one or two alkyl-containing  
C12-18 chains or a cholesterol unit, as well as a charged group like an amine or phosphate 
group67. In some cases, this amphiphilic molecule contains also a linker group (e.g. ether or 
ester). Single chain hydrocarbon-anchored lipids, such as cetyltrimethyl-ammonium bromide 
(CTAB), tetradecyl-trimethylammonium bromide (TTAB) and dodecyltrimethylammonium 
bromide (DTAB) form micelles and can be classified as detergents. Lipids with a double 
chain like 1,2-dioleoyl-3-trimethylammoniumpropane (DOTAP) and N-(1-(2,3-
dioleoyloxy)propyl)-N,N,N-trimethylammonium chloride (DOTMA) are more efficient in 
transfection compared to the single chain lipids27 (Fig. 1.9). The presence of cholesterol in 
the lipoplex results in an increased stability. The hydrophobic moiety of these compounds is 
of a slightly different nature since it contains cyclic groups. An example of such a lipid, is 3b-
[N-(N,N-dimethylaminoethane)-carbamoyl]cholesterol hydrochloride (DC-Chol.HCl)6,27,63 (Fig. 
1.8).  
Above a certain concentration and when dispersed in an aqueous environment, hydrophobic 
moieties are responsible for the rearrangement of cationic lipids into bilayer vesicles. This 
assembling process effectively shields the hydrophobic portion of the molecule and exposes 
the charged heads to the aqueous medium. Cationic groups are required for the electrostatic 
interaction with DNA and its subsequent, spontaneous condensation. This results in a 
considerable, reduced size of the anionic DNA which is residing within those liposomes or is 
often trapped between individual liposomes, referred to as lipoplexes61. Lipoplexes have 
sizes that can cover a range from 50 nm to over 1 µm67 and it has been demonstrated that 
there is no size limitation in the complexation of DNA129. Additionally, depending on the pKa 
of the used lipid (charged group), the pH can also affect the interaction of cationic lipids with 
DNA and the structures of the complexes27. Lipoplexes are prepared in such a way that a 
residual positive charge remains to allow interaction with the negatively charged cell 
membrane. The main property of the charged groups is to complex with DNA. This 
phenomenon occurs continuously by liposomes in order to stabilize the cationic charge. 
Unfortunately, this process renders lipoplexes limitedly usable since continuous aggregation 
forms aggregates that become too large for cellular uptake. Other structural parameters that 
influence the transfection efficiency are the length of the aliphatic chain, the degree of 
saturation and the addition of neutral lipids. Neutral lipids induce a conformational change 
from double-layer to hexagonal structure when applied and promote endosomal escape130. 
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Figure 1.8 - Structure of DC-Chol. 
 
R = H (DTAB), R = CH3CH2 (TTAB) and CH3(CH2)3  (CTAB) 
Figure 1.9 - Structure of liposome forming compounds. 
For a long time spontaneous fusion of the liposome with the cell membrane was accepted as 
main route for the uptake of lipoplexes in the cell19. The advantage of this fusion would have 
been the introduction of DNA into the cytoplasm instead of the endosomal uptake, where 
DNA is more prone to degradation24. However, recent studies, demonstrated that this way of 
internalization only accounts for a minor percentage and that generally cationic liposomes 
bind to the cell surface via ionic interactions and are taken up by non-receptor mediated 
endocytosis7,72. Proteoglycans (PG) present on the cell membrane seem to play an essential 
role in these interactions as cells deficient in PG synthesis are more difficult to transfect27. 
O
O
N
H
N
R
N+
CH3
CH3
CH3
O
O
O
O
N+
CH3
CH3
CH3
O
O
N+
CH3
CH3
CH3
O
O
O
O
O P
O
O-
O
NH3
+
DTAB, TTAB, CTAB
DOTAP
DOTMA
DOPE
 
Chapter 1: Introduction & objective  19 
 
When lipoplexes are taken up via endocytosis they are introduced in the endosomal pathway 
but need to be effectively liberated (‘endosomal escape’) to deliver their contents into the 
cytoplasm. This endosomal release is thought to occur by interaction and following fusion of 
the lipid layer with the membrane layer of the endosome vesicle. In turn, this fusion creates 
membrane destabilization and release of DNA into the cytoplasm131. This assumption was 
supported by the observed enhancement of transgene expression when 1,2-
dioleoylphosphatidyl-ethanolamine (DOPE) was included within the complexes. DOPE can 
be catalogued under the group of neutral lipids that promote transfection efficiency by 
enhancing the endosomal escape due to membrane fusion and disruption. This molecule is 
neutral, yet internally charged, containing a dipolar head (one positive and one negative 
charge) and two bulky fatty acyl chains67. The fusion of lipid bilayers is often pH-dependent, 
a quality that is eagerly exploited inside the late endosomes where the pH drop catalyses the 
fusion of the lipid bilayers of liposome and endosome.  
  
In recent approaches, more attention is given to the incorporation of fusogenic agents in 
lipoplexes with the intent of further destabilising the endosomal membrane. Successfully 
utilised fusogens include adenoviral particles, peptides of viral origin and subunits of 
toxins132,133.  
The use of lipids as gene delivery systems offers some advantages, such as their lack of 
immunogenicity which makes repeated delivery in vivo possible134. Another advantage is the 
ability to deliver large amounts of DNA while ensuring sufficient protection of DNA against 
physical forces and enzymatic degradation. Even so, certain limitations like degree and 
duration of expression remain79. Present studies demonstrate higher transfection efficiencies 
when lipid gene delivery systems are combined with cationic polymers50,135,136. Gene delivery 
in cultured human epithelial cells and in rabbit corneal epithelium in vivo has also been 
reported with DOTAP/DOPE transfection mixture137. Recently, a new domain of lipid-based 
materials is explored, making use of combinatorial methods to create large family’s of lipids, 
termed lipipoids127. Studies deploying such a strategy proved successful in the treatment of 
ovarian cancer with siRNA138 or could be even used for liver gene silencing by one single 
shot addition139. 
 
2.3.3 Delivery systems based on peptides 
The discovery that certain molecular structures have the ability to readily move across the 
cell-membrane (translocation) was made already in the late 1980’s140. In that experiment, a 
living cell could easily internalise a peptide consisting of 86 amino acid units (part of the HIV-
1 Tat protein). Some years later, a similar compound was identified derived from the 
Drosophilia Antennapedia protein, capable of translocating along the cellular boundary141. 
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Further research uncovered that small parts of these sequences (often 10-30 amino acid 
residues) were responsible for these excellent translocation properties and because of that 
were categorised as cell-penetrating-peptides (CPP). This opened possibilities for the 
introduction of the model amphiphilic peptide MAP142 and other well known peptides like 
Penetratin143 and Tat144 (Fig. 1.10). Up to now, a limited number of CPP’s is known and they 
consist of different primary and secondary structures145. 
 
Figure 1.10 – Amino acid sequence of two known cell-penetrating peptides. 
One important feature of CPP’s is their amphiphilic nature. Both hydrophilic/cationic and 
hydrophobic amino acids are incorporated in a peptide sequence. It is this combination that 
facilitates cell-internalisation and the transport of active molecules like for instance DNA. 
This groups of peptides is also referred to as protein transduction domains (PTD’s).  
The mechanism of cell-internalisation consists of two steps146. Initially, interaction is 
established between the CPP and the cell surface based on electrostatic forces. This 
process induces already to a certain extent, membrane de-stabilisation (due to a 
conformational transition) but complete translocation only occurs after membrane disruption 
by both hydrophobic and hydrophilic units (often present in an -helical structure)147. A 
thorough or precise idea of the internalisation mechanism is still the topic of many 
discussions but generally it is believed that most of the CPP’s are internalised by different 
forms of endocytosis148. The fact that different forms of endocytosis are applicable can be 
correlated with the composition of the peptide. Sequences containing a number of guanidine 
functional groups for instance are inclined towards receptor mediated endocytosis since 
guanidine is a bidentate ligand that can form two adjacent H-bridge connections with 
proteoglycanes149. An example of a prominent proteoglycan is heparin sulphate which is 
capable of binding the Tat sequence by its whole length and initiate translocation89. A 
considerable disadvantage of CPP’s is noticeable once the peptide and cargo are 
internalised and reside inside an endosome. Release from the vesicle seems restricted since 
CPP’s do not possess qualities that provoke cell-rupture, hence eventual degradation inside 
the lysosome is likely to occur (including its cargo)90.  
Delivering DNA can in principal be achieved by CPP’s in two ways150. Utilising the cationic 
charges and hydrophobic groups present on CPP’s, a complex could be formed with DNA 
(co-incubation method). Additionally, the DNA and CPP could be covalently linked to each 
other. This latter method however, is difficult to execute since it requires certain purification 
TAT
Penetratin NH2-lys-lys-trp-lys-met-arg-arg-asp-gln-phe-trp-ile-lys-ile-gln-arg-OH
NH2-arg-arg-arg-gln-arg-arg-lys-lys-arg-gly-tyr-OH
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steps that endanger the DNA integrity but on the other hand creates well-defined structures. 
Moreover, larger amounts of DNA seem to be needed to obtain significant results. Although 
CPP’s transport macromolecules through the cell-membrane in an excellent way in vitro, the 
in vivo translocation is limited by a low cell-specificity151. Certain studies showed that if Tat--
galactosidase was introduced in mice, the produced peptide was recovered all over the body 
(including the brain)152. Because of this, higher doses are required which could evoke 
secondary, adverse effects (random insertion). Therefore, recent investigation is devoted to 
CPP’s that address specific cells and tissue to minimise side-effects153. This was achieved 
by for instance a drug or a vector154. 
An accepted solution is found in the use of cell-interactive peptides (CIP’s)155. These 
peptides are similar to CPP’s (specific sequences of amino-acids that perfectly match 
chemical structures on the outside of particular cells) but have a strong affinity for a fixed 
cell-type. In combination with CPP’s, this leads to a considerable higher and clear expressed 
gene delivery. One of the best known CIP’s is the RGD-peptide (arginine – glycine – aspartic 
acid) that interacts with integrin receptors (V3) which play a major role in angiogenesis of 
tumours, hence the active investigation in cancer treatment in recent years87,156,157. Its affinity 
towards these receptors is even increased when cyclisation or multimerisation is applied, 
mainly because the conformation of the cyclic RGD peptide is spatially better suitable for 
interaction with receptors than the linear counterpart158. 
Combining CPP’s and CIP’s is promising yet not all problems are addressed. Endosomal 
escape and DNA shielding for in vivo applications remain weak links. A better approach 
would consist of the combination of CPP’s (and CIP’s) with a suitable polymer carrier. 
 
2.3.4 Polymer based delivery systems 
2.3.4.1 Polymers 
A final group of delivery systems that is gaining increasingly more attention during the last 
decade are polymers. Vectors based on polymer systems have the advantage that they can 
be tailored to address specific needs in for instance DNA protection, cell internalisation and 
nuclear transduction. This is achieved by synthesizing multifunctional polymers containing 
particular functional groups and ligands that enhance the transfection efficiency. The 
interaction between cationic polymers and DNA was already known in the 60’s because of 
research on condensation methods for genetic material159. The outcome of this investigation 
led to the rational selection of histone-like materials (e.g. poly-L-lysine or poly-L-arginine) but 
its potential use as delivery system was not successfully exploited at that time160,161. 
Polysaccharides like dimethylaminoethyl-modified dextran162 or chitosan163 (Fig. 1.11) where 
the real first type of polymers that were explored as gene delivery systems.  
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Parallel with an improved understanding of cellular processes over the last two decades, a 
wide variety of polymers has been studied as synthetic vector. Up to now, one of the 
polymers which displays the highest potential in transfecting cells is polyethyleneimine 
(PEI)164,165. Extensive research of this polymer has elucidated the importance of certain 
structural parameters on the success cell transfection and research on modified versions is 
still ongoing, like coupling to chitosan166 or other ligands (e.g. RGD167 or albumin168). A first 
parameter is the pH-dependence. Dependent on the type of functional groups (pKa) present, 
polymers bear charges when dissolved in a physiological environment (pH ≈ 7.2). This is 
necessary for DNA complexation, cell-membrane interaction and buffering of the endosome. 
One of the unique properties of comblike (branched) PEI is its buffering capacity169. The 
optimal range of buffering is situated between pH 4-11 which is due to the combination of 
primary, secondary and tertiary amines, the 3D-structure as well as the proton-neighbouring 
effect170. Furthermore, the importance of molecular weight and spatial rearrangement 
(branching) was determined in the case of PEI (Fig. 1.11). Branched PEI has an apparent 
advantage over linear chains in transfection efficiency171. Moreover, for linear derivatives the 
transfection efficiency was proportional to the molecular weight whereas the cell-viability on 
the other hand was inversely related. This problem was partially solved by introducing 
biodegradable crosslinks (disulfides) between low MW PEI units172,173. Chemically modifying 
PEI with polyethyleneglycol174,175 (PEG) chains or lactose units176 also improves both in vitro 
and in vivo transfection. Tuning the chemical structure of polymeric vectors with PEG (Fig. 
1.11) is a general trend for improving in vivo application since PEG is known for its excellent 
biocompatibility177. Additionally, it shields the negative presence of high amounts of charge 
that lead to membrane stabilization of cell-organelles178,179,180. PEI was successfully used in 
in vivo gene delivery for human corneal epithelium tissue181. 
 
Other types of polymers that have been subjected to frequent examination are poly--
aminoacids (Fig. 1.11 – polylysine or polyarginine). Considering the discovery of efficient 
complexation of DNA and histone-like polymers, the use of poly-L-lysine was 
straightforward182. Other polymers within this class are often based on amino acids, for 
instance, L-aspartamide183,184 or L-glutamic acid185. One of the notable downsides is the 
clear lack of buffering capacity when compared to PEI86. In some case, the use of imidazole 
was suggested as a possible solution since this molecule exhibits buffering properties which 
are suitable for endosomal escape (pKa of conjugated acid  ≈ 7)
186,187. Additionally, the 
excessive presence of charges demonstrated high toxicity. Again, attempts to circumvent 
this disadvantage were found in the coupling of PEG188. On the other hand, poly--amino 
acids (as well as other polyamides or polyesters) have the huge advantage of being readily 
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metabolised (degraded) by the cell (peptidase enzymes), a beneficiary effect when 
acceptable cytotoxicity is desired189,190. 
 
 
In combining two of the above mentioned advantages, branching and biodegradability, a 
series of dendrimers, of which the most widely studied is based on polyamidoamine 
(PAMAM)191,192, were explored as potential delivery system. Dendrimers are synthetic193, 
hyperbranched polymers that are produced via a so called ‘diverging’ strategy in which by 
stepwise addition more functionality (higher number of functional end-groups) and branching 
is introduced to the system (Fig. 1.12). The end-groups of these branches are covered with 
primary amines that allow complexation with DNA (high density of primary amines provokes 
a strong interaction). Internal amine groups are largely shielded from interacting with large 
anionic molecules and contribute only to the buffering ability of the polymer. Dendrimers are 
ideally used for their high solubility and ability to release their cargo constantly85. 
Additionally, dendrimers demonstrate good shielding properties for enzymatic attack of DNA. 
Regrettably, few polyplexes based on dendrimers are able to transfect DNA and most exhibit 
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a substantial toxicity (due to considerable haemolysis and high charge densities)194. To 
improve the transfection efficiency and to reduce the cytotoxicity, several modifications were 
attempted. For instance, coupling to the amphiphilic ‘GALA’-peptide (30-units long peptide 
with EALA repeats)195, to PEG or by introducing disulfide bonds in individual PAMAM 
units196,197. Also arginine modification of PAMAM was proven to have a positive effect198,199. 
Some PAMAM derivatives (4th generation) proved to possess anti-tumour regulating 
properties when combined with oligodeoxynucleotide complexes, applicable in breast cancer 
treatments (in vitro & in vivo)200.  
 
Figure 1.12 - PAMAM dendrimer (2.0 = Generation 2 = 2
nd
 expansion addition). 
 
Within the group of polymer gene delivery systems, an important class are methacrylate 
based polymers. Due to their simple (often one-pot) synthesis and commercial availability of 
monomers, these systems have been the subject of extensive research201,202. A commonly 
accepted transfection-efficient vector is poly(dimethylaminoethyl)methacrylate (pDMAEMA) 
which contains tertiary amines for DNA interaction and appears to have sufficient buffering 
properties for endosomal escape174,203,204. To reduce the inherent cytotoxicity and protein-
interaction, coupling to PEG or internal modification (copolymerisation) with 
ethoxytriethyleneglycol or N-vinylpyrrolidon was successfully carried out205,206. Upon in vivo 
application in nude mice, pDMAEMA showed even better transfection results than PEI207. 
Many copolymer derivatives (also block copolymers) containing DMAEMA were as a result 
investigated and reported interesting properties when combined with poly--caprolacton 
(PCL) for cancer treatment208,209 or SiRNA delivery210. Other types of interaction between 
DNA and the polymeric carrier were explored such as hydrophobic (coupling to N-
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vinylpyrrolidon204, butylmethacrylate211, methylmethacrylate233, etc.) or primary amine 
coupling, introduced as an intermediate for ligand coupling212. This family of methacrylate-
based polymers was even expanded with thermo- and pH-sensitive derivatives. 
Copolymerisation with respectively pNIPAAm233,213 and monomers containing imidazole or 
pyridine functional groups214,215 expressed such properties. More recently, polymethacrylates 
were adopted as gel-based materials for matrix-based gene delivery216,217 (see paragraph 
2.3.4.2) which becomes an increasingly more potent research field.  
Finally, there are also delivery systems known that react to external stimuli like temperature 
or pH218,219,220. Dependent on the external environment, these polymers undergo a reversible 
transition from random coil to DNA-complexed globule. In the case of thermo-responsive 
polymers, a critical solution temperature (and concentration) can induce this transition221. 
With regard to the nature of the material this temperature provokes a rearrangement of the 
material from two to one phase (LCST, lower critical solution temperature) or the other way 
around, from one to two phases (UCST, upper critical solution temperature)222. When DNA 
and polymer are randomly dissolved (relaxed, hydrophilic, coil conformation), this is seen as 
a two-phase system whereas the DNA-associated particle (collapsed, less soluble or 
hydrophobic globules) is considered as the one-phase stage (Fig. 1.13). The driving force for 
this phenomenon can be either thermodynamic or entropic (G = H – T.S). Given this 
information, materials possessing LCST behaviour close to the body temperature possess 
unique characteristics that can be used in gene delivery since polymer-DNA complexes 
could be formed above LCST, remain as a particle inside the body  but become unstable 
upon local temperature decrease and dissociate223,224. 
 
Figure 1.13 - Thermo-responsive behaviour of pNIPAAm. 
Poly(N-isopropylacrylamide) (pNIPAAm) is a clear example of a thermo-responsive polymer 
with an LCST value just below body-temperature (± 32 °C)225,226. They can be used to deliver 
tightly condensed DNA complexes to cells (globule complexes at 37 °C)227,228,229. Once 
inside the cells, an externally applied temperature reduction to below the LCST induces the 
relaxed, extended-chain conformation (DNA dissociation)230. Other benefits of pNIPAAm in 
biomedical applications include its simple chemical structure and sharp phase-transition 
DNA
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behaviour, necessary to prevent extreme temperature reduction231,232. The LCST of 
pNIPAAm (Fig. 1.14) can be altered by copolymerization with hydrophilic monomers like 
acrylamide (LCST increase) and hydrophobic monomers, such as n-butyl acrylamide (LCST 
decrease)233. 
Adding hydrophilic, charged monomers such as DMAEMA into the polymeric structure can 
make the resulting copolymer both temperature and pH responsive188,234. In general, a pH-
sensitive material consists of both hydrophilic and hydrophobic moieties. Changes in pH and 
therefore also in net charge cause certain phase-transitions which are induced by protonated 
functional groups235. Copolymers of methylmethacrylate and methacrylic acid can undergo 
phase transition at low pH since carboxylic groups become protonated and render the total 
polymer highly hydrophobic. Dependent on the environment, this can result in precipitation 
or solubilisation or the loss or gain of interaction with other solutes. A similar result can be 
obtained with copolymers of methylmethacrylate and DMAEMA (Fig. 1.14), where the use of 
a high pH can turn a hydrophilic polymer into a hydrophobic one108.  
 
Figure 1.14 - Structure of methacrylate-based compounds for gene delivery. 
 
2.3.4.2 Application of biomaterials as gene delivery platforms 
An alternative strategy to delivering DNA to tissue or cells via polymer carriers is the use of 
3-dimensional structures that can encapsulate or immobilise DNA and polymer-DNA 
complexes236. These biomaterials (or tissue engineering scaffolds) should ideally mimic the 
extracellular matrix (ECM) and are therefore mostly composed of highly biocompatible 
materials (often naturally occurring polymers). This concept gave rise to the use of gene 
activated matrices (GAM) for therapeutic purposes64. To satisfy fundamental requirements of 
the ECM, the scaffolds should meet certain design criteria such as mechanical strength, cell 
adhesion, infiltration and migration140,237. Especially these last requirements turn out to be 
somehow complex in attaining due to the need for a construct of a vascular and metabolite 
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network, essential for cell proliferation. It is important that cells from the surrounding tissue 
are capable of infiltrating the engineered scaffold to allow integration as well as development 
of a vascular network to supply necessary metabolites for continued cell proliferation238. 
Gene delivery from those scaffolds may represent a versatile approach to manipulating the 
local environment for directing cell function239. Using this technique, several approaches can 
be employed to increase the expression of tissue inductive factors or block the expression of 
factors that would inhibit tissue formation240. Utilising gene therapy enables localised 
expression due to site-specific implantation. Additionally the scaffold can protect the vector 
(when applied) from degradation by serum nucleases, increase the residence time and 
minimise the inflammatory response241. Furthermore, a major advantage of scaffold-based 
delivery is the sustained release of the vector, which enhances gene transfer242.  
In most cases natural materials like gelatin, collagen and chitosan are applied but also 
synthetic materials like PEG or Pluronics® are promising candidates or can assist in fine-
tuning the properties of natural compounds202. Naturally occurring materials have been 
widely used in tissue engineering for their innate cellular interactions and cell mediated 
degradation. Biodegradable polymers are developed to avoid a second surgical procedure. 
The release pattern can be controlled by influencing the biodegradable part of the polymers 
(in time). GAM’s are categorised according to the mechanism by which DNA is incorporated, 
via scaffold encapsulation or surface immobilization88 (Fig. 1.15).  
 
Figure 1.15 – GAM for DNA delivery: (A) Scaffold encapsulation; (B) Surface immobillisation
88
. 
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2.3.4.3 Scaffold encapsulation 
In the case of scaffold encapsulation, the main attention is focused on scaffold fabrication. 
Critically in the design is the presence of DNA that could be easily affected by external 
stimuli243. Even when the DNA is enveloped by a vector, high temperature, the use of 
organic solvents, the presence of free radicals and the occurrence of shear stresses could 
readily affect DNA integrity. There are two types of scaffolds that are frequently described, 
being hydrogels and some hydrophobic polymer structures244. 
Hydrogels are highly hydrophilic polymeric networks that can absorb a huge amount of water 
(up to 99%). In the formation of these structures, mild processing conditions are applied, 
favourable for encapsulated vectors. The hydrogels can be constructed ex vivo before 
implantation or in situ245 and are divided into natural and synthetic polymers. Early work in 
the field of gene therapy explored natural polysaccharides like pullulan246, chitosan247,248 or 
collagen249,250,251 often in combination with hyaluronic acid (HA)252. Also agarose253 and 
alginates254 are successfully used as base polymers in the design of scaffolds. They can 
possess different morphologies and geometrical structures ranging from films over sponges 
to pellets and microtubular networks2451.  
Soon focus was also put on synthetic polymers because of their ease of production and 
versatility in structure modificiation. One of the most studied polymers is poly(lactic-co-
glycolic acid) (PLGA) which was used as polyplex reservoir. The importance of the scaffolds 
geometries receives increasingly more attention (scaffolds presented as films251, 
microspheres255, fibrous scaffolds256 or even foams257). Varying the process parameters of 
these structures allows the scaffold to be uniquely designed for each required purpose, e.g. 
degradation rate, pore size and mechanical stiffness. In vivo trials have revealed the 
potential of such delivery devices for bone regeneration in nude mice258,259 and for tumours 
in rats260,261. Other studied polymers which contain biodegradable ester links are for instance 
poly(D,L-lactide) (PDLLA) and derivatives thereof but just as for PLGA, acidic scaffold waste 
products may provoke an inflammatory response262.  Hydrogels composed of PEG100,263 or 
pegylated polymers264 are also of high interest as they are highly biocompatible and produce 
very flexbile geometries. Block-copolymers containing PEG/PEO (e.g. Pluronics265,266,267) or 
PEO in combination with other synthetic polymers like PLA268 or PCL269, prove to be versatile 
delivery devices (many are characterised by thermo- and pH responsive properties). Within 
the group of polyesters also the use of PET270 and PCL271  for designing degradable 
constructs was reported. 
Finally, combining natural and synthetic polymers seems logical in cumulating the 
advantageous properties (maximising biocompatibility and degradability272,273) of both groups 
yet, limited research has appeared in literature274. Mainly PEG based copolymers were 
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retrieved (e.g. with HA and Chitosan275 or for pluronics with cyclodextrins276) but also 
matrices composed of collagen and PGA277 or GAM’s formed by crosslinked dextran-glycidyl 
methacrylate polymers278.   
The release of the vector and subsequently DNA occurs through diffusion and in the case of 
biodegradable polymers, also by structural disintegration279. Hydrophobic polymers don’t 
possess the quality of attracting water280 but can be interesting as gene delivery device due 
to the facile release of weakly surface-bound DNA-vector complexes. Nevertheless, diffusion 
of these complexes in a non-hydrophilic environment is somehow hampered. This process 
can be sped up by introducing hydrophilic, biodegradable linkages (e.g.PLGA) that are prone 
to enzymatic hydrolysis281,282. Alternatively, in non-biodegradable materials (e.g. 
poly(ethylene-co-vinylacetate), water-penetration can be increased by incorporating a pre-
existing network of pores through which diffusion can be facilitated283.  
 
2.3.4.4 Surface immobilization 
Another approach to deliver DNA via matrices makes use of coupling DNA or polyplexes 
covalently to the scaffold surface structure. In this way, immobilized vector DNA can be 
transfected if target cells adhere to the substrate which averts the limitations related to mass 
transport. The coupling of the polyplex is achieved post scaffold fabrication. Cells cultured on 
the substrate can internalise DNA either directly from the surface or by degrading the linkage 
between the vector and the biomaterial284. Alternatively, specific interactions between the 
cell and the vector/scaffold can be introduced by using complementary functional groups, 
such as antigen/antibody reactions. On the other hand, the integrity of the DNA is more 
susceptible to surrounding interaction when it’s not protected within a matrix, therefore the 
proposed approach consists of coupling of vector/DNA complexes rather than DNA as 
such285.  
In this way, localised gene delivery can be obtained, for instance in gene-eluting stents for 
vascular applications making use of polyallylamine bisphosphonate matrix286 or 
gelatine/collagen impregnated with PEI287,290. VEGF and angiopoietin-coupled collagen 
scaffolds proved to exhibit advantageous properties for revascularisation purposes. For bone 
regeneration, suitable scaffold candidates were found in poly(lactide-co-glycolide) 
derivatives immobilised with viral vectors288. In general, similar scaffold structures (and 
materials) as for encapsulation are used but with an extra coupling step in the total design 
that allows attachment of the DNA/vector to the polymer network, either through traditional 
chemical coupling strategies (e.g. EDC coupling or disulfide linkage289 or by means of a bio-
relevant couple (e.g. avidin/biotine290).   
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3 Overcoming general limitations in human gene delivery 
Up to now, gene therapy could not redeem the expectations that were initially considered as 
revolutionary. Considering that the concepts that were put forward are well engineered and 
supported by substantial in vitro and ex vivo evidence, the limited success for in vivo 
applications should be mainly attributed to the body and its natural defence system. This is 
especially the case for non-viral delivery systems that encounter numerous barriers between 
administration and nuclear activity. Since it’s very unlikely that therapeutic DNA passes 
these hurdles passively, vectors with an optimised design are needed to meet the criteria for 
DNA interaction, protection and cell-internalisation. In an ideal scenario, vector-associated 
DNA complexes target specific cells or tissue, become internalised and escort the DNA to 
the cell-nucleus where transcription can result in the production of a therapeutic molecule 
(protein)100. The transfection process can be divided in several subcategories (Fig. 1.16): 
 ► DNA interaction (condensation) and protection  stage I 
 ► Cell-interaction and internalisation   stage II 
 ► Cytoplasmic release     stage III 
 ► Polyplex dissociation     stage IV 
 ► Nuclear translocation and entry    stage V 
 ► Gene-expression (protein production)   stage VI 
 
 
Figure 1.16 - Overview of the transfection process
202
. 
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3.1 DNA interaction and packaging 
At the start of the transfection process, carefully selected therapeutic DNA plasmids need to 
be protected by synthetic vectors. Non-condensed DNA is a vast molecule that is unable to 
cross the nuclear membrane. The dimensions of plasmids of just a few kbase easily reach 
several hundred nanometers which implies the need for a condensed state to ensure swift 
uptake291. Similarly to natural DNA condensation into chromosomes by cellular proteins like 
histones, synthetic vectors can undergo an electrostatic interaction with cationic polymers 
which yields an inter polyelectrolyte complex (IPEC) also referred to as polyplex. This self-
assembly is the result of charge neutralisation and polyelectrolyte bridging followed by 
hydrophobic condensation292 (Fig. 1.17).  
 
Figure 1.17 - Self-assembly of IPEC's (polyplex). 
The extent to which polyelectrolytes adhere, is not only dependent on the charge. Many 
other facets like chain length, chain stiffness, ionic salt concentration and surface charge 
density have been recognised as being key parameters for IPEC formation293. Charge by 
itself can be imputed to the structure of the polyion and is mostly pH-dependent (for weak 
polyelectrolytes)294.  The key parameters of theories that reveal the mechanism of charge-
mediated forces for polyelectrolytes become overwhelmingly large so that usually 
simplifications are required295. Geometrical constrains of the different polyelectrolytes 
involved in complexation highly affect the spatial arrangement of the complex which in turn 
can influence the cell-interaction and internalisation behavior (Fig. 1.18)296. Complexes with 
DNA occur most often as geometrical form C and F or a combination (but this is subject to 
the rigidity of the DNA).  
Because of the need for cationic vectors, polymers are equipped with functional groups that 
bear positive charges in a physiological environment (pH ≈ 7.2). That is why for instance 
amine functional groups (and derivatives) are frequently used (pKa of R-NH3
+ ≈ 10).  
Besides electrostatic interaction, the packaging shields DNA from nucleases and other blood 
components. An excess of vector on the other hand implies the presence of a surplus of 
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-
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cationic charges which is often correlated with increased cytotoxic effects. A beneficial 
consequence of excess charge is the prevention of aggregation. The strength of the 
electrostatic bond is also important for the polyplex stability but can hamper the dissociation 
of polyplexes inside the cytoplasm.  
 
Figure 1.18 - Various combinations of macroion complexes: (A) globular + globular, (B) flexible 
linear + globular, (C) flexible linear + flexible linear, (D) semi-flexible linear, (E) rodlike linear + 
globular, (F) rodlike linear + flexible linear
296
. 
 
3.2 Cell internalisation (endocytosis) 
If small DNA-containing particles are available, they have to get past the first physical barrier 
which is the cell membrane. Firstly, targeting specific cells and initiating the interaction with 
the cellular exterior is a requirement that partially can be met by the vector. Predominantly 
positively charged particles can be attracted by negatively charged glycoaminoglycans to 
start negotiating possible entry mechanisms. Moreover the vector can be embedded with 
certain cell-specific sequences (peptides for integrin receptors) that target well-defined 
tissues. Passive diffusion is not possible due to size restrictions of regular transmembrane 
pores (1-5 nm). Strategies used to surmount this physical barrier are based upon processes 
by which cells naturally internalise macromolecules like nutrients and bacteria from the 
extracellular space, a process better known as endocytosis297. This cellular entry is tightly 
regulated to avoid uptake of undesirable or unnecessary particles and can occur by at least 
5 pathways (clathrin-mediated endocytosis, caveolae-mediated endocytosis, phagocytosis, 
macropinocytosis and clathrin- and caveolae-independent endocytosis) of which the first two 
represent the most plausible entry mechanism for linear polymers with side-chain charges298. 
The internalisation of polyplexes may occur by means of a clathrin-mediated endocytosis 
pathway. This is the best characterised and kinetically most effective route for various 
polyplexes299. The first step in this pathway is the binding of certain molecules to clathrin 
related structures on the plasma membrane. After binding to the plasma membrane, a 
clathrin coated pit is formed at the basolateral side of the cell membrane. This pit ensures 
the formation of a membrane invagination which is pinched off from the plasma membrane 
by dynamin to form intracellular clathrin-coated vesicles with diameters ranging from 100-
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150 nm. Hereafter, the clathrin coat is rapidly depolymerised and individual vesicles fuse to 
form the early endosome291. During this internalisation pathway, the polymer-gene construct 
undergoes a pH drop from 7.4 at the cell surface to approximately 5.5 in the lumen of the 
endosome. When the endosome fuses with the lysosomes the pH is further decreased to 4.5 
and the DNA becomes susceptible to degradation by hydrolytic enzymes present in the 
lysosome which emphasises the need for endosomal escape. Caveolae-mediated 
endocytosis is similar to its clathrin counterpart and starts with the formation of invaginations 
on the cell surface which are lined by caveolin-1300. The buds are formed from hydrophobic 
membrane micro-domains rich in cholesterol and sphingolipids (lipid rafts). Once internalised 
the polyplex resides inside caveosomes that in a later stage may fuse with the early 
endosomes but avoid direct trafficking to the more acidic late endosomes and 
lysosomes301,302. Determining which internalisation mechanism will be involved, depends on 
various factors like polymer structure, polyplex composition and size, cell type and cell 
stage. Since caveosomes do not always experience a significant pH-drop this could explain 
why some polycations with considerable proton buffering capacities are not effective in gene 
transfection. 
 
Figure 1.19 - Illustrations of targeted and non-specific uptake
186
: I – pinocytotic uptake 
(endocytosis), II – polyplex internalisation via phagocytosis, III – interaction of cationic 
polyplexes and proteoglycans , IV – internalisation via lipophilic ligand coupling, V – CPP 
mediated internalisation
202
. 
The formerly discussed entry mechanisms are classified as forms of pinocytosis, processes 
that internalise mostly particles up to 200 nm (although in some cases particles up to 500 nm 
were reported)303. Larger particles, in general, are internalised via phagocytosis, a process in 
which extra-cellular particles are engulfed by membrane segments that get detached from 
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the membrane to form a phagosome. Via this method molecular structures up to 1 µm can 
be taken up by the cell. Besides forms of targeted uptake, there are also several non-specific 
internalisation mechanisms. These occur through interaction with negatively charged 
proteoglycans, present within the membrane or by the coupling of lipophilic ligands and cell-
penetrating peptides. This latter method is the topic of much recent work, yet the 
internalisation mechanism is not fully known (Fig. 1.19).  
 
3.3 Cytoplasmatic release (DNA release) 
When polyplexes are internalised (using a variety of entry-mechanisms), they most likely 
reside within a vesicle. Several subsequent processes can follow the vesicular 
internalisation. The vesicle can be recycled at the cell-surface or can be delivered to cell-
organelles like the Golgi-apparatus. The most feasible follow-up action however is the fusion 
with lysosomes188. These cellular entities are responsible for cellular waste and destruction 
of foreign material since they contain a wide range of hydrolytic enzymes (sulfatases, 
phosphatases, nucleases, etc.) situated in a acidic environment (pH ≈ 4.5). Obviously, the 
polyplex needs to escape from the endosome before fusion with the lysosome occurs. 
Different theories exist on how polyplexes can be released from the endosome but the most 
widely accepted theory is the proton-sponge theory as stated by J.P Behr304. This theory 
suggests that high concentrations of protonable groups effectively buffer the endosomal pH 
drop which occurs when endosomes mature. If carefully selected polymers with suitable 
buffering properties are presented to such an environment, the resulting protonation of the 
polymer will destabilise the endosomal pH. Endosomal ATPases however, try to keep the 
endosomal pH constant by coupling the proton influx to the influx of the counter anion 
chloride33,159. This causes a huge increase in ionic concentration within the endosome 
resulting in osmotic swelling and finally bursting of the vesicle with release of its contents188 
(Fig. 1.20). Moreover, it is also believed that protonation of the polymers increases the 
dimensions of the polyplexes, thereby putting more pressure on the endosomal membrane 
while also inducing increased interaction with the endosomal membrane. To cover the 
continuous pH decrease during maturation of the endosome, polymeric vectors are equipped 
with considerable buffering functional groups (like imidazole and pyridine of which the 
conjugated acids have pKa values around 7 and 5 respectively). Also amine and to a lesser 
extent, guanidine groups, can be used for this when present in a polymer chain due to the 
proton-neighbouring effect. In general, synthetic vectors that should be capable of escaping 
the endosomal pathway have to buffer efficiently between a pH of 5.5-7.5. When expanding 
the buffering capacity of vectors, there’s a higher chance for endosomal escape since the 
time before reaching the lysosomal stage is extended305.  
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Although this hypothesis is still being contested, it is backed up by the fact that viruses, such 
as the influenza virus, make use of a similar mechanism. They efficiently use the previously 
described decrease in pH, to induce a conformational change in proteins306. These proteins, 
called endosomal release proteins, undergo a structural transformation from a random coil at 
neutral pH to an α-helical conformation at lower pH. The α-helical conformation is believed to 
induce membrane interaction and disruption, leading to release of the endosomal content 
into the cytosol307. Examples of such release proteins are melitin, influenza virus 
hemagglutin, diphtheria toxin, GALA, KALA and JTS-1188. Specific for these compounds, is 
the presence of both carboxyl functional groups (for pH control) and hydrophobic alkyl 
chains (for membrane disruption)308.  
 
Figure 1.20 - Mechanism of the 'Proton Sponge' theory
304
. 
 
3.4 Polyplex dissociation and intracellular trafficking 
Following endosomal escape, polyplexes are exposed to the cellular environment (cytosol). 
One final barrier remains before replication of the genetically engineered protein can be 
attained, which is the directing of the polyplex to the nucleus where it should be taken up. It 
is not fully clear weather the polyplex should dissociate before nuclear internalisation or 
when present within the cell core299. There is evidence that migration of polyplexes (or DNA) 
to the nucleus periphery through the cytoplasm is an active (not diffusive) transport process 
mediated by the microtubule network309,310. This process is typically not a rate-limiting step in 
intracellular trafficking of polyplexes (or DNA). However, the entry of polyplexes (or DNA) 
into the nucleus typically imposes a huge barrier to transgene expression because of the 
small functional size of the nuclear pore complex in the nucleus (≈ 10 nm or about 30 nm 
even under the inclusion of a nuclear localization signal/sequence311) of a non-dividing 
(“postmitotic”) cell. Therefore, the association of DNA and its vector remain beneficiary312.   
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Polyplexes entering the cytosol, either directly or upon escaping the endo-lysosomal 
pathway are faced with a hostile environment containing nucleases that are able to degrade 
unprotected nucleic acids. It was demonstrated that microinjection of DNA into the cytoplasm 
resulted in degradation of DNA with a half-life of 50 to 90 minutes313. These enzymes are 
interspersed in a dense network of microtubules, intermediate filaments and microfilaments 
which form the cytoskeleton that maintains cell shape and enables cellular motion as well as 
intracellular transport314 (Fig. 1.21). The microtubuli network impedes the passive diffusion of 
naked DNA greater than 80 nm thus imposing an active transport mechanism on polyplexes 
(50 - 150 nm), using molecular motors associated with the microtubule network or actin 
microfilaments315. Movement is mediated by two classes of motor proteins, namely kinesins 
(outward direction) and dyneins (inward direction). Therefore, kinesins are linked to the 
secretory pathway while dyneins regulate perinuclear transport316. It is worth to mention that 
the polyplex may not escape the endosomes too early as this may prevent the arrival at 
deeper regions of the cell (the nucleus). Directing a polyplex to the nucleus may also be 
performed by an appropriate ligand (nuclear localisation signals, NLS)317. Also this aspect 
can to some extent be fulfilled by the delivery system as NLS contain several cationic 
sequences that can be mimicked by the carrier (e.g. arginine or lysine containing). 
Established NLS-containing compounds are for instance histone318 and protamine319 
(proteins) as well as viral compounds like the SV40-large tumour antigen320. 
 
Figure 1.21 - Intracellular trafficking of polyplexes/DNA
202
. 
In order to initiate the delivery of DNA cargo for transcription and gene expression, the 
vector/DNA complex should dissociate safely and effectively. This phenomenon however, is 
 
Chapter 1: Introduction & objective  37 
 
in contrast with the previously described complex formation needed to allow cell uptake. 
Ideally, a polyplex strongly interacts with DNA before cell-internalisation after which the 
attraction graduately diminishes under influence of environmental stimuli (pH, temperature, 
ionic concentration or electric fields) until dissociation occurs at nuclear entry. Intelligent 
polymers are able to exhibit large changes in their physical state or properties due to small 
changes in environmental stimuli. Structural adaptions for vectors often comprise of 
cleavable disulfide bonds (via glutathione) or hydrolysable groups like esters. Typically, the 
strength of the polyplex is related to the amount of charge present on a vector. Replacing by 
or adding other types of attractive forces like Van der Waals and H-bonding can initially 
create a similar binding pattern to DNA but in a later stage facilitate the intracellular 
dissociation of the polyplex. Once the DNA cargo is released, the polymeric carrier has 
served its purpose and is considered a ‘waste’ product of the gene delivery cycle. Ideally, the 
carrier is fully biodegradable and can be metabolized by the cell.  
 
3.5 Nuclear uptake & gene expression 
The nuclear membrane is a barrier that prevents uptake of the majority of macromolecules 
into the nucleus, unless they are able to interact with the nuclear active transport system. 
This system consists of nuclear membrane proteins that form the nuclear pore complex 
(NPC) as well as soluble proteins present in the cytoplasm. These NPCs are gateways for 
export and import of proteins and nucleic acids. Each NPC is an assembly of at least 30 
distinct proteins, is cylindrical in shape and has pores that span the inner and outer nuclear 
membrane with a diameter of about 125 nm. These channels allow free movement of 
molecules (< 10 nm)321. It has been demonstrated that although the pore occupies a 
diameter larger than 10 nm, passive movement is restricted to that size due to the presence 
of a central granule322. This granule is able to change conformation when a suitable NLS is 
coupled to the relevant particles. Cytosolic import of large molecules is therefore regulated 
by import proteins (e.g. importunes) which actively transport them through the NPC. 
 
A second method by which DNA may gain access to the nucleus is during mitosis, when the 
nuclear envelope is disintegrated. It has been proven that DNA is localised in the perinuclear 
region of the cell where it remains until breakdown of the nuclear membrane. Therefore, 
gene expression may be considerably enhanced if transfection occurs shortly before cell 
division323. This method however is clinically limited as most cells in the body are in 
postmitotic state. 
 
After dissociation and upon arrival into the nucleus the genes must be transcribed into 
mRNA before they can be translated into therapeutic proteins, produced in the cytosol (Fig. 
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1.22). As mentioned earlier, the expression of these proteins can be sustained or transient. 
Ideally, DNA is permanently inserted into the genome by means of DNA transposons. This 
renders the use of additional DNA administrations obsolete but has the main drawback that 
the integration could be random and lead to gene disruption with undesired side-effects. 
Dependent on the desired therapeutic effect, specific plasmid DNA (or sequences) can be 
developed and delivered via a vector in order to cure illnesses and genetic disorders.  
 
 
Figure 1.22 - DNA transcription into mRNA and translation of a protein. 
 
4 Objective of the doctoral thesis 
In order to meet the current needs on finding suitable synthetic vectors for gene delivery, this 
thesis has the aim to synthesise and characterise biodegradable and non-biodegradable 
vectors for ocular and cardiovascular applications. Biodegradable compounds are derived 
from poly--amino acids (polyamides) whereas the non-biodegradable compounds are 
derived from methacrylate-based polymers. The properties of the synthetic vectors will be 
evaluated both at a physico-chemical level as well as for biological applications. In addition, 
the advantage of coupling cell-penetrating peptides to cationic polymers in terms of 
transfection enhancement will be examined for several peptides. Furthermore, a selection of 
polymer compounds are provided with fluorescent molecules to enable mechanistic 
elucidation of the intra-cellular trafficking and inter-polyelectrolyte formation. Moreover, 
immunological and haemo-compatible considerations towards in vivo uses will be monitored. 
Finally, the activity and toxicity will be assessed for most vectors on relevant cells such as 
ARPE19, HEK 293 or COS cells. 
Within the polymer & biomaterials research group (PBM – Ugent), earlier work was 
performed on (cationic) polymers for gene delivery/therapy on which this doctoral thesis 
continues. In the work of Luc Dekie185,324, the use of poly-L-glutamine derivatives containing 
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amine, pyridine and carboxylic acid functional groups was investigated as potential gene 
carriers. The multifunctional polymers were further derivatised with reagents such as 
agmatine and fluoresceine. Transfection efficiency studies elucidated that only the agmatine-
containing polymers expressed biological activity. Analogue research was done for 
polymethacrylate compounds by Peter Dubruel201,206,325, in which specific functional groups 
like amines, pyridine and carboxylic acids were evaluated as gene carriers. The most 
optimal transfection results were obtained for pDMAEMA with a high MM. Furthermore, there 
was also research performed by Kathleen de Winnie on pHEG-PAMAM dendrimers which 
confirmed the positive effect on the cell viability compared to regular PAMAM while 
maintaining the high DNA load possible (due to the high surface charge density)326. 
 
4.1 Treatment of age-related macula degeneration (ARMD) 
In the framework of a European project (EU-STREP, PolExGene – Nr. 019114), the 
synthetic vectors, developed in this doctoral thesis, will amongst others have the aim to 
deliver therapeutic DNA for the treatment of ophthalmological disorders. An important 
syndrome that is expressed in up to 30 % of the older adults (> 60 years), is age-related 
macular degeneration (ARMD)327. In the US alone, 200.000 new cases are discovered every 
year328. This is a medical condition that results in the loss of vision in the center of the vision 
field (macula) due to retinal damage. It occurs in ‘dry’ and ‘wet’ form, dependent on the 
cause of the deficiency (Fig. 1.23). Dry ARMD results from atrophy to the retinal pigment 
epithelial layer (natural abrasion of photoreceptors) and cannot be treated at current while 
wet ARMD is caused by unregulated, abnormal blood vessel growth (choroidal 
neovascularisation). Eventual blood and protein leakage can damage the photoreceptors 
which rapidly causes fading of vision quality. For wet ARMD, there are certain treatments 
available like photodynamic therapy (stops blood vessel growth) or laser therapy (destroys 
leaking blood vessels) but they inflict surrounding tissue with scarring as a result (Fig. 1.24). 
Recenlty also commercially available drugs (antibodies, Ranibizumab329 or Bevacizumab) 
have emerged in this field which act on VEGF suppression. Gene therapy is one of the 
promising alternative approaches330 and solutions can be found in the use of DNA that 
encodes for anti-angiogenesis or anti-VEGF331 proteins that should prevent the proliferation 
of blood vessels and as a result induce a reduction of the unregulated blood vessel 
growth332. Ocular applications are ideally suited for gene therapy. One obvious advantage is 
that therapy on the genetic level addresses the source of the problem, not just the 
symptoms, and the option for local delivery may improve effectiveness without systemic 
toxicity. Animal models containing loss-of-function and gain-of-function mutations are 
available, as are models containing mutations in structural, functional, and developmental 
genes, and models for testing the effects of genetic therapies on wound healing and surgical 
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interventions enabling researchers to test therapies designed to target a variety of disease 
categories333,334. 
     
Figure 1.23 - ARMD disorders: dry and wet macular degeneration
332
. 
 
Figure 1.24 – Laser therapy for wet ARMD: destruction of leaking blood vessels and the 
occurrence of scarring as a result
332
. 
 
4.2 Development of biodegradable, synthetic vectors 
The production of biodegradable poly--amino acids, applicable as synthetic vector starts 
with the synthesis of the base polymer. For poly--benzyl-L-glutamate (pBG) or poly--
benzyloxycarbonyl-L-ornithine (pZO), the corresponding N-carboxyanhydride (NCA) 
Dry macular
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macula
fovea centralisoptic disc
Wet macular
degeneration
Normal retina
Atrophy of
photoreceptors
Unregulated
angiogenesis
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derivative of -benzylglutamate and -benzyloxycarbonyl-ornithine is polymerised with a 
primary or tertiary amine as initiator, dependent on the desired molecular mass (MM). 
Therefore, the ratio of monomer to initiator is varied to obtain polymers with a broad range of 
MM’s (Fig. 1.25). The MM of these polymers will be investigated with viscometry (Mv). 
 
 
 
 
 
Figure 1.25 - Synthesis of base polymers (L-derivative). 
 
In order to acquire multifunctional vectors, the base polymers will be converted to cationic 
polymers (amine or guanidine side-groups). For pBG this will be done by means of an 
aminolysis reaction with bifunctional reagents that possess a primary amine on one side and 
the desired functional group on the other side (hydroxyl, protected primary amine, tertiary 
amine, imidazole, etc.), each with specific properties in DNA complexation (Fig. 1.26). In 
case of pZO, an intermediate polycation (poly-L-ornithine) is initially generated after 
deprotection of the Z-group. Afterwards, the primary amine side-groups can be (partially) 
converted into a guanidine functional group via a specific reagent (Fig. 1.27).  
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Figure 1.26 – Synthesis of multifunctional poly-L-glutamine derivatives. 
 
All chemical structures of the polymers will be verified for the degree of purity and the MM 
will be regulated by the initiator type and quantity. The properties and behaviour of these 
polymers in DNA-complexation will be extensively studied using ethidiumbromide 
fluorescence measurements, agarose gel-electrophoresis tests, zeta()-potential and 
dynamic light scattering experiments in order to obtain a more complete insight on the 
interaction with DNA. 
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Figure 1.27 – Synthesis of L-arginine based vectors. 
 
4.3 Development of non-biodegradable, synthetic vectors 
Genetic vectors based on non-degradable methacrylates (MA) will be produced by radical 
polymerisation using thermal initiators (AIBN or APS). Various monomers, both commercially 
available, as well as modified compounds, will be combined to yield multifunctional polymers 
with various MM. Certain monomers require protective groups before polymerisation can 
occur. Hence, additional protection and deprotection steps will be required. The polymer 
composition and MM will be validated and the physico-chemical properties of the polymers 
related to DNA interaction will be assessed using analogue methods as before mentioned.  
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Figure 1.27 – Monomers for non-biodegradable vectors (AEMA, DMAEMA, HEMA, GuAEMA). 
 
 
 
 
 
Chapter 1: Introduction & objective  43 
 
4.4 Biological evaluation of multifunctional vectors 
The final step in the development of suitable synthetic vectors includes the investigation of 
the biocompatibility and the efficiency of delivering DNA, including transfection of the cell. 
From a range of synthetic vectors of which the physico-chemical properties were screened, 
candidates that show the most promising results will be selected to undergo different 
biological tests. In a first test, the ability to protect its DNA cargo from degradable enzymes, 
will be tested using a model nuclease (DNAse I). The interaction of the polymer and polyplex 
with blood can be derived from haemolysis and haemo-agglutination studies using human 
erythrocytes. In the case of biodegradable polymers, their property to degrade inside the 
body can be tested using protease like enzymes (papaine). Furthermore, polyplexes will be 
subjected to cytotoxicity tests. More importantly, the efficiency to transfect cells will be tested 
using a RucHA model plasmid (Renilla Luciferase coding for green fluorescent protein, GFP) 
on COS and ARPE19 cells335,336.  
 
4.5 Optimisation of vectors by the incorporation of cell-penetrating peptides 
Given the added value of incorporating CPP’s into a delivery system in terms of enhanced 
cell-internalisation, synthetic vectors are expected to show an increased transfection 
efficiency when combined with a CPP (penetratin or octa-arginine). Therefore, certain 
polymers will be covalently coupled to CPP’s. Additionally, modified CPP’s with variable 
spacer lengths and composition will be tested. Finally, CPP’s will be physically combined 
with polyplexes by mixing them in an attempt to compare the influence of CPP and polyplex 
formulations. These optimised compounds are also examined on both their physico-chemical 
and biological properties. Mechanistic studies on the preferred internalisation route will be 
established for a selection of relevant polyplexes by providing the polymers with fluorescent 
tags to enable detailed investigation by confocal microscopy. 
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1 Introduction 
For polymers, considered as possible delivery systems for DNA into a cell or cellular 
structure, a whole range of qualifications needs to be met. As was mentioned in the 
introduction, polymer structures can be tailored to fulfil these requirements. This starts with 
the selection of a base polymer that has a specific composition and structure. From literature, 
several polymer systems are known to be suitable for gene delivery including 
polysaccharides 1 , vinyl-based polymers 2 , poly(-amino esters)3 or polyphosphoric ester 
derivatives3. One of the most actively studied polymers in gene delivery is (branched) pEI4, a 
highly active polymer that unfortunately expresses a high degree of cytotoxicity5. In many 
cases, toxicity issues result from non-biodegradable properties, preventing for instance 
intracellular degradation. Repeated administration can result in accumulation within the 
lysosome, a condition labelled as lysosomal storage disease6. Keeping these considerations 
in mind, this work has the aim to synthesise and apply biodegradable polymers with superior 
DNA interaction and protection properties as well as minimal cytotoxic implications or 
haemolytic effects while being highly efficient in transfecting the cell. A class of synthetic 
polymers that has high potential for these applications is poly--aminoacids. Due to their 
natural occurrence, excellent biocompatibility is presumable as well as their ability to be 
degraded within the body (enzymatic degradation of amide bonds). Furthermore, there are 
numerous approaches that allow control of the composition and the MM (by introducing or 
modifying functional groups located on the side chains). 
Derivatives of poly-L-lysine have been explored before as gene delivery system because of 
their presence in histones, the natural packaging material for DNA and chromosomes. 
However unsuccessful results were obtained by severe toxicity7,8. Also L-arginine, which is 
substantially present in the histones, was proposed but only a few actual try-outs were 
achieved9. In some cases, arginine residues were incorporated into or combined with other 
structures like pNIPAAm 10  or poly-L-leucine 11  to reduce its toxic behaviour. A similar 
approach was applied for poly-L-lysine, such as the coupling to PEG 12  or with poly-L-
ornitine13 in order to improve the cell-viability. Alternative strategies were found in the use of 
polyaspartamide14,15 and L-glutamic acid derivatives16. Based on this latter research, initial 
promising results (e.g. positive transfection for polyagmatine-containing derivatives) 
suggested further exploration of this starting material using new synthesis approaches. 
Preparing multifunctional polymers based on L-glutamine is a multistep process in which 
starting polymers (poly--benzyl-L-glutamate, pBG) are prepared from L-glutamic acid and its 
corresponding NCA. After that, various functional groups can be introduced during the 
subsequent modification steps in order to yield synthetic vectors with desired properties for 
gene delivery (e.g. buffering, DNA complexation, charge separation), as shown in fig. 2.1. 
 
Chapter 2: Synthesis of biodegradable polymer vectors 62 
HN
O
O
O
(CH2)2
C O
O
CH2
H2N CH COOH
CH2
CH2
COOH
H2N CH COOH
CH2
CH2
C
O
O
CH2
CH2
C O
O
CH2
CHNH C
O
n
CH2
CH2
C O
NH
R
CHNH C
O
n
CH2
1 2
4 3
 
Figure 2.1 – Different steps in the synthesis of poly-L-glutamine derivatives. 
1. Protection ; 2. Cyclisation ; 3. Polymerisation ; 4. Aminolysis 
Additionally, poly-L-arginine is selected to be combined with poly-L-glutamines in an attempt 
to mimic the biological behaviour of DNA condensation in the cell. Poly-L-arginine and 
derivatives can be synthesised via a similar strategy. The formation of a cyclic arginine 
compound is not straightforward due to the nucleophilic nature of the side-group17  and 
because of that, the use of a precursor (L-ornithine) is chosen. In an subsequent step, poly-
L-ornithine can be converted into poly-L-arginine by using an appropriate reagent 
(‘guanidylating agent’). Moreover, a protected derivative of this precursor (N-
carbobenzyloxy-L-ornithine) is commercially available, eliminating the need for a preceding 
protection step. The total process for poly-L-arginine is shown in figure 2.2. 
All individual reaction steps influence different aspects of the total synthetic pathway and will 
be discussed accordingly.  
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Figure 2.2 – Different steps in the synthesis of poly-L-arginine derivatives. 
1. Cyclisation ; 2. Polymerisation ; 3. Acidolysis ; 4. Guanidylation 
 
2 Synthesis of poly-L-glutamine derivatives 
2.1 Synthesis of protected L-glutamic acid (-benzyl-L-glutamate) 
To be able to form a cyclic monomer, required for subsequent ring-opening polymerisation of 
the intermediate pBG, the functional group located on the side chain of L-glutamic acid 
needs to be protected18. If not, side products (6-membered NCA derivative) can hamper the 
cyclisation of the correct NCA molecule17. The starting reagent, L-glutamic acid is selectively 
esterified by reaction with benzylalchohol in diethylether catalysed by sulphuric acid at room 
temperature (as was described before by R. Vercauteren19). The final product -benzyl-L-
glutamate (BG) was obtained in a moderate yield (50-60%) as shown in fig. 2.3. 
 
Chapter 2: Synthesis of biodegradable polymer vectors 64 
OH
H2SO4/H2O
H3N CH COO
-
CH2
C O
O
CH2
CH2
H2N CH COOH
CH2
COOH
CH2
 
Figure 2.3 - Synthesis of -benzyl-L-glutamate. 
 
2.2 Monomer synthesis (-benzyl-L-glutamate-N-carboxyanhydride) 
Cyclic derivatives of amino acids (N-carboxy--anhydride or NCA) have already been 
described long time ago and are often referred to as ‘Leuchs’ anhydrides20. They  have the 
significant advantage that neither the synthesis nor the polymerisation induce racemisation if 
conducted under appropriate conditions21. The versatility of their polymerisation reactions, in 
particular the ability to incorporate a large variety of amino acid monomers, both natural and 
synthetic, results in unprecedented flexibility of molecular design (giving rise to the formation 
of homo, co, block or graft-polypeptides)18,22,23. 
The simplest way of achieving ring formation is the reaction of an amino acid and 
phosgene21. Via this reaction, N-chloroformyl-L-glutamic acid is formed which undergoes 
intramolecular cyclisation to form its corresponding NCA (Fig. 2.4). An excess of HCl is 
produced during this reaction and needs to be readily removed from the reaction mixture 
since the presence of HCl can cause side reactions like the reverse ring opening that can 
subsequently be phosgenated into an -isocyanate acid chloride (Fig. 2.5).  
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Figure 2.4 - NCA formation by phosgene mediated cyclisation. 
The use of phosgene represents hazardous implications due to its toxic nature. Therefore, 
alternative reagents can be applied by using phosgene precursors like  
trichloromethylcarbonate 22  (diphosgene) or di-(trichloromethyl)carbonate 23  (triphosgene) 
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which naturally occur in a liquid and solid state respectively at room temperature. Because 
residual triphosgene is difficult to remove from the reaction mixture (can eventually 
decompose with new HCl production as a result), priority is given to the use of diphosgene 
which demonstrates better handling properties and can be more easily removed (although 
HCl production is still possible).  
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Figure 2.5 – Unwanted side reaction during NCA synthesis. 
 
Despite the use of diphosgene, several recrystallisations of the final product remain 
necessary to achieve a sufficient level of purity24. An important aspect of this purity is the 
amount of free chlorine present, generated by the production of HCl and can be checked 
using an AgNO3 test which results in precipitation of insoluble AgCl (due to the extremely low 
solubility, Ks = 1.77x10
-10), followed by visual comparison to standardised solutions. In this 
case, pure tapwater is put forward as a sufficiently ‘chloride free’ solution (10-100 mg/l).  
The reaction is carried out by heating a suspension of -benzyl-L-glutamate in dry 
ethylacetate (EtOAc) to 60 °C. A portion of diphosgene, dissolved in EtOAc (15 v/v %), is 
added dropwise to the mixture and allowed to react for 20 minutes. After that, Ar is used to 
degas the mixture in order to remove any formed HCl and prevent the occurrence of side 
reactions. This portionwise addition and degassing is repeated until all diphosgene has been 
consumed (visible by the transition of suspension to solution). At that moment no additional 
diphosgene should be added (to limit side reactions) and the mixture is thoroughly degassed 
(using He or N2) for about 1 hour at elevated temperature and additionally for 30 minutes at 
room temperature. Subsequently, the product is precipitated in cooled pentane and 
recrystallised in EtOAc until the amount of free chlorine is acceptable according to the AgNO3 
test. Generally, yields up to 80-90 % can be obtained via this method. The final product, -
benzyl-L-glutamate-N-carboxyanhydride (BG-NCA) is verified using 1H-NMR (CDCl3) and 
FTIR spectroscopy (Fig. 2.6 & 2.7).  
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Figure 2.6 - 
1
H-NMR of BG-NCA (with peak assignment). 
 
 
Figure 2.7 – FTIR spectrum (KBr) of BG-NCA with characteristic peaks: ester (1715 cm
-1
), 
anhydride peak 1 (1780 cm
-1
) and anhydride peak 2 (1870 cm
-1
). 
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2.3 Polymerisation 
In order to synthesise a long peptide chain, one of the most convenient methods, both 
practical and economical, is a ring-opening polymerisation (ROP) of NCA (BG-NCA). Five-
membered -NCA rings possess 3 reactive centers that can be employed (Fig. 2.8), 2 
carboxyl groups and an NH-group. Due to the presence of the nitrogen atom, the C2 
carboxyl is less electrophilic than carboxyl C5. Both the NH-group as well as the -CH don’t 
exhibit nucleophilic behaviour but can form strong nucleophilic anions upon deprotonation. 
Since the NH-group is distinctly more acidic than the -CH, the latter will only be 
deprotonated if the NH-group is substituted25. 
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Figure 2.8 - Reactive centres & initiation of an -NCA. 
 
2.3.1 Reaction mechanism 
Because of the availability of different reaction centres the initiation of the ROP can be 
classified in two groups (Fig. 2.8), a nucleophilic attack on the C5-carbonyl and the 
deprotonation of the nitrogen (N3) referred to as the activated monomer mechanism. The 
extent to which a certain initiation will be preferred is dependent on several parameters like 
solvent, ionic strength26, nature of the R-group, monomer concentration and most importantly 
the type of initiator used 27 . The most important aspect of an initiator is its ratio of 
nucleophilicity/basicity which is determined by the electrondensity, polarisibility of the the free 
electron pair and steric hindrance. Initiators can be divided into protic and aprotic systems 
and subjected to the choice of initiator, their corresponding propagation mechanisms are 
variable (activated monomer mechanism28, amine mechanism or carbamate mechanisme24). 
Two major groups of initiators are used in nearly all polymerisations used, amines and 
alcohols/alkoxides of which only the first group was employed herein. 
 
Initiation by use of primary amines   
Primary amines demonstrate a high nucleophilicity/basicity ratio and because of that the 
polymerisation occurs nearly exclusively by nucleophilic attack on the C5-carbonyl. Unstable, 
intermediate carbamic acids are formed due to the ring-opening reaction but a stable peptide 
compound is rapidly generated by spontaneous decarboxylation. The resulting molecule 
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retains a free amine that is able to start a new ring-opening reaction. This procedure lasts 
until all reactive monomer is consumed and polypeptides are formed (Fig. 2.9)29.  
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Figure 2.9 – “NCA-polymerisation” cycle using primary amines as initiator. 
The course of polymerisation is determined by the nucleophilic character of the initiator and 
the monomer to initiator ratio. Because both the initiator as the formed peptide contain a free 
amine that can induce ROP, control over the molecular weight can only be established if the 
initiator is considerably more nucleophilic than the active chain-end (amine). This implies that 
the initiation is faster than the propagation and because of that the amount of active chains 
can be directly related to the initiator concentration (every initiator molecule is the start of an 
active chain). The degree of polymerisation (DP) can be calculated from the following 
equation: 
   
 
 
  
            
   
 
This formula is applicable for a living polymerisation. In practice, small deviations of this 
value are observed due to decreased solubility (and increased viscosity) of large polymer 
chains that invoke a physical ‘death’. Alternatively, intra-molecular termination is possible 
when free amine react with a benzyl ester to form undesired and non-reactive pyrrolidon-
rings30  (Fig. 2.10). These termination reactions are mainly noticed for high NCA/initiator 
concentrations and are responsible for a MW limitation of about 40.000 Da when using 
primary amines as initiating systems while maintaining sufficient polydispersity control.  
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Figure 2.10 - Intramolecular termination (pyrrolidone formation). 
When the propagation is faster than the initiation, polymers with a DP higher than calculated 
are obtained, hence the loss of control as a side-effect.  
 
 
Chapter 2: Synthesis of biodegradable polymer vectors 69 
Initiation by use of tertiary amines 
Tertiary amines display much lower nucleophilic behaviour than primary amines, especially 
when alkyl chains with a considerable length are used (e.g. tributylamine). Consequently, a 
tertiary amine will deprotonate the NH-group of the NCA molecule and form a highly reactive 
anion that will attack a second NCA molecule yielding a dimer with an N-acyl-NCA part and a 
carbamate anion. Since the N-acyl-NCA is more electrophilic than a non-substituted NCA, 
chain growth is achieved by reaction of anions with N-acyl-NCA chain ends. Moreover, 
nucleophilic attack will predominantly be carried out by the charged anion rather than the 
intermediate primary amine. This process is labelled as activated monomer mechanism27 
(Fig. 2.11).  
The polymerisation of an NCA by a tertiary amine occurs seemingly through a living-like 
reaction since the propagation speed is much higher than the initiation speed31. Additionally, 
termination or chain transfer processes were not abundantly reported. This allows for the 
production of polymers with a very high MW (up to 300.000 Da)17. 
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Figure 2.11 - Activated monomer mechanism: initiation and propagation steps. 
Polymerisations using alkoxides or alcohols make use of similar initiation steps 
(deprotonation and activated monomer mechanism respectively) and propagation 
mechanisms (mainly carbamate).  
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2.3.2 Synthesis of poly--benzyl-L-glutamate 
2.3.2.1 Application of primary amines as initiator 
The polymerisation of BG-NCA using an appropriate initiator yields poly--benzyl-L-glutamate 
(pBG) after 40 hours of stirring at room temperature in a mixture of DCM/EtOAc (6/1 v/v)32. 
The polymer is purified by precipitation in a methanol/diethylether mixture (2/1 v/v). In the 
case of high MW pBG, the mixture is diluted with DCM prior to precipitation. This is due to 
the molecular association of pBG in non-hydrogen bonding solvents like DCM which greatly 
enhances the viscosity (end-to-end associations). For low MW compounds, the portion of 
methanol in the non-solvent is reduced to 1/1 or 1/2 to decrease the polarity of the mixture in 
order to preferentially keep oligomeric peptides and low MW pBG dissolved while 
precipitating the high MW compounds (Fig. 2.12).  
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Figure 2.12 - Synthesis of pBG. 
The reaction can be followed by FTIR since specific peaks disappear (NCA, C=O stretch 
vibrations at 1780 and 1870 cm-1) and new peaks arise (formation of the amide bond, 1650 
and 1550 cm-1) during polymerisation (Fig. 2.13 & table 2.1). The values of the amide I and II 
peak are indicative for the formation of an ordered -helical structure (H-bonding of the 
amide backbone) in solution, which was proven prior in literature 33 . In dipolar, aprotic 
solvents like DMF, the -helix end can be dissolved by the solvent and there’s no resulting 
molecular association. To prove the helicity, circular dichroism measurements were executed 
as was reported by Reinaudo et al38. 
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Peak value (cm-1) Corresponding structure 
3.300 Amide N-H stretch 
2.800-2.950 C-H stretch (-CH2/-CH3) 
1.730 O=C-O (carbonyl) stretch 
1.650 / 1.550 Amide I + II bend 
Table 2.1 – Peak assignment of the FTIR spectrum of pBG (KBr). 
 
Figure 2.13 – FTIR spectrum (KBr) of pBG with characteristic peaks (table 2.1). 
The use of n-butylamine as an initiator generated pBG of a rather low MW (determined by 
the monomer to initiator ratio). Additionally, the -CH3 unit of n-butylamine can easily be 
observed in the 1H-NMR spectrum and can also be used to calculate the MW (Fig. 2.14). The 
number of repeat units can be derived by integrating the surface of this peak and comparing 
to the integration value of the -CH peak of pBG. From NMR analysis, it could be concluded 
that excellent control over the MW was possible (table 2.2). 
Calculated MW (Da) Experimental MW (Da) 
5.000 5.700 
10.000 9.900 
20.000 19.700 
30.000 29.600 
Table 2.2 – MW of pBG produced via primary amine initiaton.  
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Figure 2.14 - 
1
H-NMR spectrum of pBG - 10.000 Da in TFA-d as a solvent. 
 
2.3.2.2 Application of tertiary amines as initiators 
When tributylamine is applied as initiator system, pBG with high MW can be achieved. Since 
in this case the initiator is not covalently linked to the polymer, it can not be traced in the 1H-
NMR spectrum and used for calculation of the MW (Fig. 2.14). The initiator is removed during 
purification and because of that the MW can only be determined using traditional methods 
like viscosimetry (Ubbelohde apparatus) and is therefore difficult to compare with other MW-
determination techniques (e.g. light scattering). 
 
2.3.2.3 Viscosimetry 
Viscosimetry was used to determine the molecular mass of polymers (Mv) based on the 
viscosity of polymer solutions. With increasing length of polymer chains, an increase in 
viscosity can be detected (while concentration and temperature are given and kept constant). 
The molecular weight can be acquired by approximation using the following formula: 
            
              (Mark-Houwink relation)     (1) 
With  being the intrinsic viscosity, Mw the molecular weight and K and  Mark-Houwink 
parameters, specific for a certain polymer dissolved in a known solvent at a given 
temperature (25 °C).  
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The intrinsic viscosity can be derived using an approximation method for polymers at low 
concentration (0.1-0.2 w/w%)34. In practice, this comes down to a measurement of the time, a 
polymer solution (t) or a blank (pure solvent, t0) needs to flow through a predetermined 
volume. From these results the specific and relative viscosity can be calculated: 
     
    
  
              
 
  
 
Using these parameters, the intrinsic viscosity is given by the equation: 
                 
  
 
                    (2) 
Combining both formula’s allows for the molecular weight to be determined. Determination of 
the Mv by viscosimetry gives rise to a specific molecular mass that is situated in between Mw 
and Mn. This is due to the higher importance of long polymer chains in the contribution to the 
total viscosity (Fig. 2.15). Dependent on the method to analyse the MM of a polymer, the 
resulting value is given as either Mn (number-average molecular mass), Mp (peak-value 
molecular mass), Mv (viscosity-based molecular mass) or Mw (weight-averaged molecular 
mass). The ratio of Mw/Mn is described as the polydispersity (or PD) of the polymer. 
 
Figure 2.15 - Molecular weight as a function of the polymer distribution. 
 
2.3.2.4 Set-up of a mastercurve (ratio M/I) for MW determination of poly--amino acids 
In general, the amount of initiator (in case of deprotonation) added to start a polymerisation, 
is expressed in terms of M/I ratio. As the polymerisation appears to have an upper limit in 
MM, a deviation of the living polymerisation course is to be anticipated. Because of that, 
prediction of the final obtained MM was difficult. For that reason, a series of pBG’s with 
various MM was synthesised and analysed for MM via viscosimetry in an attempt to 
determine a relation between the initiator amount (M/I) and the obtained Mv.  
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The polymers were measured in a solution of dichloroacetic acid (CHCl2COOH) at a 
temperature of 25 °C and a concentration of 0.2 % (w/w). This solvent was chosen due to the 
unusually strong secondary bonding with pBG allowing full dissolution and a random coil 
configuration33. The Mark-Houwink parameters,  and K for pBG in CHCl2COOH (25 °C) are 
0.87 & 2.78.10-3 g/ml respectively35. Because the polymerisation of tertiary amines occurs via 
the highly reactive activated monomer mechanism, polymers with a high MM can easily be 
obtained but control of the propagation is limited and can cause an increase in polydispersity 
(PD)36. Theoretically, termination reactions are not readily expected, nonetheless, a decline 
in MW is observed with increasing M/I ratios. When the initiation step is fast, compared to the 
propagation, the concentration of active centres is equal to the initiator concentration, hence 
the simultaneous propagation of the polymer chains. The degree of polymerisation should 
therefore augment proportionally with the degree of conversion: 
    
    
   
 
This relation was not found for the ROP of BG-NCA which implies that termination reactions 
still occur. They can be attributed to the increased viscosity and lack of surrounding 
monomer needed for further propagation37. Intra or intermolecular cyclisation reactions are 
rather limited and mainly regulated by the geometrical arrangement of the polymer, that 
forms -helices (starting at lengths of 10 structure units) which puts a considerable restraint 
on the chain mobility (macromolecular stiffness) and propagation capability 38 . From the 
viscosity measurement, the Mv (and DP) and the M/I ratio prove to be logarithmically 
connected (Fig. 2.16).  
 
Figure 2.16 - Mastercurve for pBG (using Bu3N as initiator) as obtained by viscosimetry. 
At first, for low DP’s, the relation appeared linear but was graduately deviating from this 
relation with increasing M/I ratio. A living polymerisation displays first-order kinetics which 
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implies that the monomer concentration is decreasing linear in time. Due to the logarithmical 
relation observed, this value was more inclined towards a second-order kinetic approach 
(especially for higher M/I ratios).  
              
 
 
          
 High MW pBG was synthesised in a range from 70.000 – 300.000 Da.      
 
2.4 Aminolysis 
During the polymerisation of pBG, the MM of the compound is determined. These polymers 
need to be further derivatised if they need to exhibit DNA-interacting functional groups (for 
complexation, buffering, etc.). This can be achieved by modifying the functional group of the 
side chain while preserving the integrity of the backbone (and its correlated MM). By 
selecting a suitable reagent, the desired functional groups can be introduced and at the 
same time, the protective benzyl ester can be removed. This modification is carried out by an 
aminolysis reaction (carbonyl substitution) in which an ester is transformed into a 
thermodynamically stronger amide-bond by an amine-containing reagent. To extend the 
length of the side chain in order to optimise flexibility towards interaction, reagents with a 
spacer length of two CH2-moieties were chosen (Fig. 2.17). 
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Figure 2.17 - Synthesis of multifunctional cationic polymers via aminolysis. 
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2.4.1 Aminolysis reaction mechanism 
Initial modificiation experiments of pBG revealed that the MM of the polymer after aminolysis 
reached maximum 70% of the original weight and that the polydispersity was substantially 
increased39. This drop in MM can be attributed to transamidation or chain cleavage of the 
amide backbone. Hence these reactions complicate the development of well-defined 
polymers. Optimisation procedures (e.g. solvent and temperature40) for this modification were 
carried out but were not deemed successful until the use of a bifunctional catalyst was 
proposed 41  (previous investigation performed in the research group by K. Hoste). The 
addition of an excess of 2-hydroxypyridine was able to speed up the reaction time and 
simultaneously prevent chain scission at the same time42.  
2-hydroxypyridine (Fig. 2.18) contains a nucleophilic (pyridine) and electrophilic group 
(phenol), oriented in such a way that they can provoke the selective elimination of 
benzylalcohol from the substrate, pBG. Substitution was reported to occur through a 
concerted mechanism in which a cyclic transition state favours the reaction on the side chain 
rather than on the polymer backbone (with the assistance of H-bonding)43,44. However, this 8-
membered-ring transition state (Fig. 2.18) can only be achieved by have 3 molecules 
interacting simultaneously, an entropically unfavourable state. An alternative strategy could 
exist in the consecutive reaction of 2-HP with pBG forming a reactive ester that subsequently 
can be transformed in the amide by means of the amine reagent. The catalyst is present as 
one of 2 tautomeric forms of which the N-protonated form (lactam derivative) is the most 
likely one in polar solutions (like DMF), yet the energy difference between both is low 
(theoretically 8.9 kJ/mol) 45 . Dimerisation can take place and would imply that higher 
concentration of the product are required to reach the same level of efficiency as without the 
presence of dimerisation but this effect is mainly predominant in non-polar solvents46. To 
optimise the speed of conversion and to limit backbone scissoring, the amount of catalyst 
added, was set to 5 equivalents (relative to the # moles benzylester)41. 
Besides the obvious importance of temperature, also the solvent was found to exhibit a 
distinct influence on the reaction. When pBG is dissolved in dichloroacetic acid or 
trifluoroacetic acid (TFA), polymer chains are present as random coils (parameters similar to 
-solvent) which is the reason for using this solvent in viscosimetry. Most organic solvents 
(DCM, THF, etc.) induce the formation of -helices as secondary structures, followed by the 
aggregation of these structures. In dipolar aprotic solvents (DAS) like DMF or DMSO, -helix 
formation still occurs but aggregation is prevented due to the H-bonding with the solvent 
instead. On the other hand, the presence of a solvatation layer inhibits aminolysis at the start 
but when a few side groups are modified, the layer is fragmented and the reaction speed 
drastically increases.  
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The final products were verified using FTIR and 1H-NMR. Due to the solubility of these 
compounds in water, the molecular weight was determined by gel-permeation 
chromatography (GPC) in a NaH2PO4/CH3CN buffer (pH = 4) using dextran standards.  
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Figure 2.18 – Tautomeric forms of the bifunctional catalyst 2-hydroxypyridine and the 
representation of the possible TS-mechanism versus the reactive intermediate compound  
strategy during aminolysis reaction of pBG & reagent
42
. 
2.4.2 Synthesis of poly(dimethylaminoethyl)-L-glutamine (pDMAEG) 
Similar to well-studied polymers like pEI and pLL, the presence of charged groups in L-
glutamine derivatives is a necessity for obtaining DNA packing into small, well-defined 
structures. For that reason, the incorporation of tertiary amines was applied and expected to 
yield polymers which possess functional groups with proper pKa behaviour (≈ 10.5)
16,47. The 
Lactam derivative 
Reactive intermediate: 
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reaction was carried out in DMF (pBG concentration of 10 w/v %) at a temperature of 50 °C. 
Five equivalents of 2-HP were added to prevent transamidation of the backbone as well as a 
20-fold excess of dimethylaminoethylamine (DMAEA) to ensure complete conversion of the 
benzylester. The amount of amine reagent added, is determining for the conversion rate. Too 
few product can only reach partial conversion, too much equivalents can enhance backbone 
scissoring. The conversion was followed via FTIR. After 48 hours, another five equivalents of 
DMAEA were added and allowed to react for 2 hours to ensure complete conversion. The 
final product was purified and isolated by precipitation in cooled diethylether and 
subsequently dialysed. The product was verified by 1H-NMR (D2O) as shown Fig. 2.19.  
Several polymers with different MW were prepared (Table 2.3). For pDMAEG based on low 
MW pBG, the polydispersity was not determined experimentally but is expected to be close 
to one (like its base polymer pBG) as the backbone cutting is minimised by the catalyst.  
 
 
Figure 2.19 - 
1
H-NMR of pDMAEG (obtained in D2O). 
MW (Da) polydispersity () 
10.000 - 
29.000 - 
80.000 1,24 
242.000 1,36 
Table 2.3 – Overview of the MW of various pDMAEG prepared 
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2.4.3 Synthesis of poly(dimethylaminoethyl-co-aminoethyl)-L-glutamine (p(DMAEG-AEG)) 
For certain applications, polymers need to be functionalised using bioactive molecules (cell-
penetrating peptides, glycoaminoglycans, etc.). Coupling to a tertiary amine, present in 
pDMAEG, is not straightforward due to the limited nucleophilic properties for coupling 
reactions. Therefore, primary amines were introduced as an extra functional group. Since a 
small quantity of active molecules is traditionally sufficient to induce an obvious effect, a low 
amount of primary amines was built-in during aminolysis (in combination with tertiary 
amines). To a solution of pBG in DMF (10 w/v %), both DMAEA (15 equivalents) as well as 
mono-protected diamine, N-tritylaminoethylamine (TrAEA, 5 equivalents) and 2-HP (5 
equivalents) were added and reacted for 48 hours at 50 °C. Another 5 equivalents of DMAEA 
was reacted for 2 more hours to ensure full conversion. The resulting product was isolated in 
cooled diethylether, dried and redissolved in pure TFA in order to cleave the trityl protective 
group. The final product was again precipitated in diethylether, dried and dissolved in water 
to be purified finally by dialysis. Confirmation of the polymer structure and purity was proven 
by 1H-NMR (Fig 2.20 – detail, other peaks equal to the 1H-NMR of pDMAEG, Fig. 2.19).  
   
Figure 2.20 - Structure of p(DMAEG-AEG) as determined by 
1
H-NMR. 
Regarding the amount of primary amines required, consideration was given to the lower 
reactivity of the voluminous trityl (triphenylmethyl-) group and the equivalents used for the 
aminolysis reaction. Preliminary experiments showed that a degree of 15 % primary amines 
could be obtained with a ratio of 15/5 equivalents DMAEA/TrAEA. Continued synthesis led to 
the conclusion that for shorter polymer chains, the degree of primary amines was slightly 
reduced (to 10 %) using the same ratio of reagents. Several compounds of various MW were 
produced with a nearly constant degree of primary amines (10-15 %) (Table 2.4). 
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MW (Da) Composition (NMe2/NH2) polydispersity () 
5.500 90 / 10 % - 
27.000 90 / 10 % - 
91.000 85 / 15 % 1,51 
242.000 85 / 15 % 1,43 
Table 2.4 - Overview of the MW of the various p(DMAEG-AEG). 
2.4.4 Synthesis of poly(dimethylaminoethyl-co-hydroxyethyl)-L-glutamine (p(DMAEG-
HEG)) 
Besides the evident interaction properties with DNA, a synthetic vector must also be able to 
introduce DNA into the cytoplasm of a cell. Therefore it is believed that DNA should 
dissociate from the vector when it has escaped the endosomal pathway. Polyplexes which 
exhibit attractive forces that are too strong, can experience difficulties in releasing the DNA 
and accordingly hamper the transfection process. To anticipate this problem, a series of 
polymers was developed using neutral groups (hydroxyl groups) that are not charged at 
physiological pH. These functional groups can easily be incorporated during the final 
aminolysis step by applying a suitable reagent (2-aminoethanol, AE). To synthesise an L-
glutamine derivative with both neutral and charged groups, pBG is dissolved in DMF and 
heated to 50 °C. Five equivalents of 2-HP, together with a combined amount of DMAEA and 
AE (relative ratio equal to the desired polymer composition and considering the difference in 
reactivity, see 2.4.7) totalling a 20-fold excess  were added and the mixture was stirred for 48 
hours followed by the addition of another 2 equivalents (reaction of 2 hours). The reaction 
was purified by precipitation in cooled diethylether, filtered off, washed and redissolved in 
water for purification by dialysis. The formed compounds are displayed in table 2.5. 
Compared to TrAEA, the reactivity of the AE reagent was higher and resulted in polymers 
composed of less tertiary amines. 
MW (Da) Composition (NMe2/OH) polydispersity () 
11.100 40 / 60 % - 
11.900 61 / 39 % - 
179.000 62 / 38 % 1,19 
Table 2.5 - Overview of the MW of various p(DMAEG-HEG) prepared. 
Structure elucidation and composition was obtained via 1H-NMR analysis (Fig 2.21 – detail 
other peaks equal to pDMAEG, Fig. 2.19). 
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Figure 2.21 - Structure of p(DMAEG-HEG) as obtained by
 1
H-NMR (D2O). 
 
2.4.5 Synthesis of poly(aminoethyl-co-hydroxyethyl-co-imidazolethyl)-L-glutamine (p(AEG-
HEG-ImEG)) 
Another crucial aspect of the transfection process lies in the ability of a polyplex to be 
released from endosome vesicles, once internalised in the cell. As mentioned before, the 
generally accepted mechanism for this escape, is the proton sponge theory. Consequently, 
the use of functional groups that can buffer during this endosomal stay, increase the chance 
for release. One of the chemical structures that displays acid-base properties in the range of 
the endosomal pH is imidazole (pKa of conjugated acid ≈ 7). Also pyridine could be selected 
for this task (pKa conjugated acid ≈ 5) but priority was given to the more natural resembling 
imidazole moieties (e.g. histidine). These functional groups can be introduced by using 
histamine (NH2-CH2-CH2-Imidazole) as an aminolysis reagent (in combination with other 
aminolysis reagents in a relative ratio corresponding with the desired polymer composition 
and considering the reactivity properties). Dependent on the amount of imidazole required, 
an excess is used. A similar reaction course and purification method as before was carried 
out. The composition of the polymer was determined using 1H-NMR of which the structure 
and corresponding distinct peaks are displayed in Fig. 2.22. The synthesised compounds are 
given in table 2.6.  
MW (Da) Composition (NH2/OH/Im) polydispersity () 
26.000 12 / 79 / 9 % - 
9.900 15 / 49 / 36 % - 
Table 2.6 - Overview of the MW of the various p(AEG-HEG-ImEG): MW & composition. 
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Figure 2.22 -  Structure of p(AEG-HEG-ImEG) as obtained by 
1
H-NMR (D2O). 
 
2.4.6 Synthesis of poly(hydroxyethyl-co-guanidylethyl)-L-glutamine (p(HEG-GuAEG)) 
In an attempt to produce synthetic vectors which display optimal, biocompatible properties, 
an alternative functional group for DNA interaction was considered. Due to the natural 
resemblance with histones, guanidine functional groups are believed to interact strongly with 
DNA and can additionally assist in the cellular uptake (see chapter 1 – 3.2)16. The distribution 
of the charge for a guanidine group is more diffuse than for a tertiary or primary amine which 
results in a different interaction behaviour and the ability to target different types of anionic 
ligands present on the cell surface (e.g. glycoaminoglycans) via bidentate bridges (Fig. 2.23). 
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Figure 2.23 – bidentate bridging for a guanidine functional group. 
Because of the nucleophilic nature of guanidine (pKa conjugated acid ≈ 12.5), the functional 
group needs to be protected or introduced during a separate modification step. Two 
pathways were compared and achieved equal final products (Fig. 2.24).  
 Guanidine conversion: in a first approach, the polymers are functionalised with 
 primary amines (including other functional groups) during aminolysis. After 
 deprotection, the primary amine can be converted into a guanidine using 
 3,5-dimethyl-1-guanylpyrrazole (DMGP) via a nucleophilic substitution reaction50,51.  
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Protected guanidine: commercially available, BOC-protected derivatives of 
 guanidinethylamine are used during aminolysis. In a next step the BOC group 
is removed via acidolysis (TFA/CH2Cl2).  
              Conversion mechanism                Protection mechanism 
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Figure 2.24 – Overview of two alternative reaction strategies for the introduction of guanidine 
functional groups: conversion or protection strategy. 
 
The practical synthesis of p(HEG-GuAEG) using the protection strategy is similar to the 
aminolysis and acidolysis of p(DMAEG-AEG). For the use of the conversion method, an 
additional reaction step is required. Once the production of p(HEG-AEG) is completed (post 
dialysis), the polymer is dissolved in H2O (5 w/w %) and KI is added to a total concentration 
of 6 M. In a separate recipient, 16 equivalents (relative to corresponding # of moles –NH2) of 
DMGP are dissolved in H2O and the pH is adjusted to 9.5 using KOH (4 M). The 2 mixtures 
are combined and allowed to react overnight. Next, neutral pH is restored and the solution is 
dialysed against pure water. The side product, 3,5-dimethylpyrazole, is poorly soluble in an 
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acidic environment and needs to be removed prior to protonation of the guanidylated polymer 
(achieved via acidic dialysis, 0.1 M HCl). The composition was again confirmed by 1H-NMR 
(Fig. 2.25). 
Since guanidine-containing compounds are expected to yield promising results in biological 
testing, a series of polymers was produced (table 2.7). 
MW (Da) Composition (OH/Gua) polydispersity () 
9.600 63 / 37 % - 
10.200 75 / 25 % - 
11.400 85 / 15 % - 
26.900 87 / 13 % - 
146.000 87 / 13 % 1,79 
Table 2.7 – Overview of the MW of the various p(HEG-GuAEG). 
 
Figure 2.25 -  Structure of p(HEG-GuAEG) as obtained by
 1
H-NMR. 
 
2.4.7 Synthesis of multifunctional poly-L-glutamines 
As was already mentioned during the introduction, diverse functional groups are required to 
form a synthetic vector which possesses all the properties that ensure the appropriate 
functioning as a delivery device. In the previous sections, the synthesis of polymers with 
different types of functional groups was reported and by combining one or more of these 
modification reactions, poly-L-glutamine derivatives with multifunctional properties were 
prepared. Table 2.8 gives an overview of the composition (% molar ratio) and MW (Da) of 
these compounds .   
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MW (Da) -guanidine -NMe2 -NH2 -OH -imidazole polydispersity () 
59.700 11 % 13 % - 76 % - 1.37 
9.300  27 % 23 % - 50 % - - 
63.200 - 13 % 11 % 76 % - 1.40 
50.400 - 23 % 21 % 56 % - 1.24 
23.000 21 % - 16 % 63 % - - 
23.000 32 % - 5 % 63 % - - 
12.000 50 % - 7 % 43 % - - 
9.700 26 % - 32 % 42 % - - 
9.600 11 % - - 32 % 57 % - 
12.800 20 % - - - 80 % - 
13.000 35 % - - - 65 % - 
Table 2.8 - Overview of multifunctional vectors: composition (% molar ratio) and MW (Da). 
 
In all cases, polymers containing a substantial amount of neutral functional groups (non-
charged) were synthesised. Furthermore, a combination of charged moieties was 
incorporated as well as primary amines that allowed subsequent coupling. All polymers were 
verified by 1H-NMR analysis. The presence of two or more functional groups gave rise to 
overlapping signals but did not hamper the identification since one reference signal always 
remained.  
The numerous modification reactions (aminolysis) allowed the subdivision of the reagents in 
terms of reactivity. The trend could be fully attributed to the degree of spatial volume of the 
reagent and the steric hindrance. A qualitative ordering is given in Fig. 2.26. 
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Figure 2.26 - subdivision of reagent reactivity. 
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3 Synthesis of poly-L-arginine derivatives 
The synthesis of poly-L-arginine is not straightforward due to the high basicity of the 
guanidinium group that exhibits specific nucleophilic properties. To circumvent the laborious 
methods of protecting all nitrogen containing functional groups so that cyclisation of an NCA 
becomes feasible 48 , the use of a precursor polymer was considered (poly-L-ornithine). 
Moreover, the use of protected L-arginine derivatives does not ensure success since the 
cyclisation of such a compound is seriously hampered by the competing intra-molecular -
lactam formation49. The use of this precursor requires an additional modification step but on 
the other side, initial protection is not required since this compound is commercially available.  
3.1 N-carboxyanhydride derivative of N-benzyloxy-L-ornithine (ZO) 
Producing the -NCA derivative of protected N-benzyloxy-L-ornithine (ZO) occurs in the 
same way as for BG-NCA (mentioned in section 2.2). The reaction is carried out by reacting 
with diphosgene in EtOAc at elevated temperature until the suspension becomes a solution. 
Thorough degassing remains a crucial step to prevent side-reactions and to minimise the 
presence of chloride ions inside the final product. The product is recrystallised from EtOAc 
and precipitated in cooled pentane. The product was again confirmed by 1H-NMR and FTIR 
(Table 2.9). Seeing that the R-specific group of the NCA has no influence on the carbonyl 
stretches of the anhydride, the absorption peaks have the same value. Only the urethane 
carbonyl stretch is slightly different. Characteristic peaks of the 1H-NMR are shown in the 
image below (Fig. 2.27). A slight contamination of EtOAC can be observed (peaks a, b, c). 
Peak value (cm-1) Corresponding structure 
3.300 amide N-H stretch 
3.020 C-H stretch (benzyl) 
2.800-2.950 C-H stretch (-CH2/-CH3) 
1.870 anhydride I (-N-C=O) stretch 
1.780 anhydride II (-C-C=O) stretch 
1.740 O=C-NH (carbonyl) stretch 
1.520 O=C-NH (amide II) bend 
730 C-H bend (benzyl) 
Table 2.9 – Diagnostic FTIR signals for ZO-NCA (KBr). 
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Figure 2.27 – Structure of ZO-NCA as obtained by 1H-NMR (in CDCl3). 
 
3.2 Polymerisation: synthesis of poly(N-CBZ)-L-ornithine 
In a corresponding way to the previous ring-opening-polymerisation of BG-NCA (section 
2.3.), the formation of poly(N-carbobenzyloxy)-L-ornithine (pZO) occurs through a similar 
reaction mechanism. Dependent on the type of initiator used, different propagation 
mechanisms are realised. Also the MW is controlled by the amount of initiator added (low 
MW polymers via R-NH2 and high MW polymers by the use of R3N). Viscosimetry (in 
CHCl2COOH) was used to determine the MW of the intermediate compound.  
 
3.3 Deprotection: synthesis of poly-L-ornithine 
Following polymerisation, the intermediate poly(N-CBZ)-L-ornithine is immediately converted 
into poly-L-ornithine by removal (cleavage) of the protective group (acidolysis in HBr). 
Poly(N-CBZ)-L-ornithine is first dissolved in CHCl3 (20 w/v%) and 10 ml of HBr (33 % in 
CH3COOH) is gently added. The mixture is allowed to react for 1 hour and is subsequently 
precipitated in cooled diethylether and filtered off. The final product, poly-L-ornithine (pORN) 
is neutralised in NaHCO3-containing water (4 w/v %) and further purified by liquid extraction 
with diethylether. The water phase, containing the polymer is isolated and dialysed against 
NaCl (0.5 M) followed by HCl (0.1 M) and ultrapure water (analysis via 1H-NMR, Fig. 2.28).  
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Figure 2.28 – Structure of pORN as obtained by 
1
H-NMR. 
 
3.4 Guanidine conversion: synthesis poly-L-arginine 
Once the precursor (pORN) is available, poly-L-arginine (pARG) can be obtained via a 
guanidine modification. To realise this, a guanidylating agent (3,5-dimethyl-1-guanylpyrazole 
or DMGP) was allowed to react with a solution of pORN.HCl in water (at pH = 9.5)50. The 
conversion of an amine into a guanidine functional group is a straightforward reaction but 
converting all functional groups located on side-chains of (high MW) polymers has sterical 
implications51. As a first measure, a substantial excess of guanidylating agent is added (15 
equivalents). Additionally, initial testing has pointed out that no more than 70 % of the amines 
were converted using this method. To improve this modification, the use of high ionic 
concentrations was suggested and was tested for KI (6M)52. It appears that the addition of 
these ions was able to increase the conversion to nearly quantitative yields (Fig. 2.29). Since 
the addition of KI to the conversion reaction of L-ornithine into L-arginine has no apparent 
influence, it is believed that the effect is exclusively macromolecular (conformational), most 
likely due to the large atomic ratio and corresponding lower surface charge of the iodine 
anion which is able to interact better with the macromolecule (which is at that time 
deprotonated and can undergo only hydrophobic/hydrophilic interactions rather than 
dispersion forces)53. As a result, the degree of conversion can be controlled in time which 
was confirmed by the observed decrease when the MW of pORN was lowered (table 2.10). 
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Figure 2.29 – Influence of KI (6M) on the conversion of pORN in pARG. 
Given this information, it is possible to select the degree of conversion by adjusting the 
reaction time. In this way, the pARG derivative still contains primary amines available for 
subsequent coupling reactions.  
Practically, pORN is dissolved in water (5 w/w %). A solution of 15 equivalents DMGP, 
dissolved in water and adjusted to a pH of 9.5, is added to the polymer solution. Finally, KI is 
mixed in to attain a total concentration of 6M. The reaction is allowed to continue overnight 
after which the pH is neutralised using 0.1 M HCl and dialysed against ultrapure water. After 
24 hours, the polymer solution is acidified (pH ≈ 5) and further dialysed against ultratpure 
water.  
Confirmation of the product was obtained by 1H-NMR (Fig. 2.30). In the past, the presence of 
guanidine functional groups was predominantly demonstrated by the Sakaguchi reaction54. In 
this reaction, the specific and exclusive coloration interaction between the guanidine group 
and -napthol/NaOBr was determined using VIS-spectroscopy (and a calibration curve)55. 
Because of the extensive procedure and time-consuming nature in combination with the 
relative error margin that is inherent to coloration methods, this experiment was only applied 
as a proof of principle. More reliable results can nowadays be obtained by improved NMR 
techniques with high magnetic fields (e.g. 700 MHz)56. The chemical structure of pORN and 
pARG is very similar and the conversion can only be determined by comparing the -CH2 
peak of both components which displays triplet-coupling at 2.9 ppm for pORN that undergoes 
a shift to 3.1 ppm in the case of pARG. The detailed part of the spectrum indicates that the 
remaining amine signal is not higher than 1 %. 
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Figure 2.30 – Structure of pARG as obtained by 
1
H-NMR (in D2O) 
As was performed for poly-L-glutamines, pARG derivatives with a broad range of MW were 
synthesised as well as polymers still possessing primary amines (pORN-ARG). Gel 
permeation chromatography experiments (relative to dextran standards) also confirmed the 
lower degree of conversion for low MW compounds (less quantitative) up to 90-95% 
suggesting the macromolecular effect of KI addition.    
MW (Da) Presence of –NH2 polydispersity () 
6.000 7 % - 
13.000 5 % - 
22.800 3 % - 
78.800 1 % 1,16 
187.000 1 % 1,49 
71.100 18 % 1,63 
Table 2.10 - Overview of pARG and p(ORN-ARG) compounds prepared. 
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4 Synthesis of L-glutamine and L-arginine copolymers 
Seeing that the polymerisation conditions of both BG-NCA as ZO-NCA are nearly identical, 
initial tests to form copolymers of L-(hydroxyethyl)glutamine (HEG) and L-arginine were 
applied. Synthesising pBG-pZO was readily achieved by ROP of a mixture of the 
corresponding NCA’s in DCM/EtOAc. To prevent intra-molecular coupling, the primary amine 
of pZO needed to remain protected during aminolysis. Carbobenzyloxy (Z) is reported to be a 
stable protective group under nucleophilic conditions57. Hence, aminolysis can be performed 
prior to Z-deprotection (by acidolysis). Finally, guanidine conversion can be easily carried out 
without compromising the L-glutamine side-chains (both the amide bonds as well as the 
chain-end functional groups) followed by purification via dialysis. Two compounds were 
produced to verify the feasibility of the reaction (using a primary amine and tertiary amine 
respectively) as shown in table 2.11. The identical composition moreover, validates the 
precise practical execution of the reaction as well as the highly controllable nature of the 
aminolysis reaction.  
MW (Da) % HEG % ARG 
11.200 58 % 42 % 
56.000 58 % 42 % 
Table 2.11 – Overview of p(HEG-ARG) compounds. 
5 Biodegradable graft-copolymers 
It is generally accepted that cationic charges are important for DNA interaction and delivery. 
Besides the fact that the amount of charges and the combination with other functional groups 
needs to be controlled, there’s also a substantial influence of the spatial arrangement of 
those charged units. Since the guanidinium group is believed to yield optimal interaction 
properties, several orientations of this functional group were examined. Charged groups can 
for instance be located on the backbone, within side chains, at the end of a side chain or on 
grafts starting from side chains (Fig. 2.31). The way charges are positioned within a polymer 
has an influence on the formation of polyplexes and the interaction with cellular entities. 
Finding the most advantageous charge orientation is relevant in order to minimise the 
amount of charge and the related toxicity. 
Examples of polymers with charged guanidine groups present in side chains were shown in 
afore mentioned paragraphs. A special type of polymer, which bears charges in its backbone 
structure is pEI. Via commercial synthetic pathways, branched pEI is obtained with a  ratio of 
primary, secondary and tertiary amines equal to about 1-2-1. Grafted (co)polymers can be 
produced by specific coupling reactions or by using a pre-polymer as an initiator for graft 
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polymerisation. Such a graft-copolymerisation was carried out using an amine-containing 
pre-polymer and a particular NCA (Fig. 2.32). Since primary amines are used, nearly perfect 
control over the MW of the grafts (living-like polymerisation) can be achieved. Unlike 
previous polymerizations of R-NCA, the reaction is performed in DMF which is one of the few 
solvents suitable for dissolving both reagents. Because the H-bonding influences the 
dissolution and molecular association of the formed polymers, small deviations of the MW 
(higher) are observed as well as a change in polydispersity58. 
Prior to the grafting process, polymers containing primary amines need to be available. 
Because the polymers are isolated as hydrochloride salts (-NH3
+Cl-), they need to be 
deprotonated. Therefore, an equivalent of KOtBu is added to a solution of the pre-polymer in 
DMF and reacted for 15 minutes. Next, an NCA of choice is added, followed by the standard 
reaction pathway required for the synthesis of multifunctional polymers as described above.  
Different types of pre-polymer were tested (Fig. 2.32). Glutamine (GLN) derivatives were 
provided with ARG-grafts whereas for PEI, grafts composed of GLN-derivatives 
(hydroxyethyl, HEG and guanidine-ethyl, GuAEG) were used. A large number of neutral 
hydroxyl groups was introduced since it is expected to be advantageous for the cytotoxicity 
(sufficient charge remains due to the secondary and tertiary amines present on branched PEI 
(table 9)). Moreover, as a result of the re-orientation of charged groups towards the outer 
environment, an enhanced interaction with DNA is expected.   
 
Figure 2.31 - Position of cationic charges within a polymer 
It is also possible to incorporate guanidine groups onto branched PEI by converting the 
primary amines of PEI in a similar reaction as for the guanidine modification of pORN (Fig. 
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2.32). The degree of modification (up to 25 %) can be controlled in time and verified by a 
ninhydrine test or Sakaguchi test. By controlling the quantity of reagent or the reaction time, 
PEI-Guanidine derivatives containing 14 and 20 % of guanidine groups were prepared.  
 
Figure 2.32 – Schematic representation of the structure of grafted-NCA (using -NH2 pre-
polymer); PEI modification via NCA grafting or guanidine conversion. 
Pre-polymer MW (Da) Graft type Graft MW 
p(DMAEG-AEG) 91.000 pARG 5000 (± 25 units) 
p(HEG-AEG) 27.700 pARG 1500 (± 8 units) 
pEI 25.000 pGLN (OH63%, Gua37%) 3500 (± 17 units) 
Table 2.12 – Overview of graft copolymers (composition determined by 
1
H-NMR). 
 
6 Conclusion 
In this chapter, several methods were discussed that led to the synthesis of an elaborate 
series of multifunctional, biodegradable polymers. Various linear polymers based on L-
glutamine and L-arginine, composed of different functional groups and with MW’s ranging 
from 5.000 to 250.000 were obtained. Every different functional group is relevant for certain 
properties related to the vector requirements. Additionally, a well-established polymer (PEI) 
was subjected to guanidine conversion to assess if the positive effect of guanidine functional 
groups in terms of reduced toxicity and increased DNA interaction could be extended to other 
polymer families. Finally, also graft copolymers were produced to allow the study on charge 
orientation within a polymer and the implications towards polymer-DNA formation. 
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1 Introduction 
In the previous chapter, the synthesis of biodegradable systems was discussed. It is 
believed that these compounds would ideally be non-toxic because of their biodegradable 
backbone (polyamide) which can be digested by enzymes within the body and are therefore 
put forward as outstanding delivery systems. As could be noticed before, the total synthesis 
of such a polymeric vector can be quite comprehensive (up to 6 individual synthesis steps).  
In literature, many non-biodegradable based delivery systems were already positively 
evaluated1. An important class of synthetic vectors explored for genetic delivery is based on 
methacrylate derivatives2,3. The presence of an aliphatic backbone renders these polymers 
more hydrophobic and excludes the process of enzymatic degradation 4 . In addition, 
corresponding polymers can be easily produced in one-pot reactions given the availability of 
suitable monomers.  
A possible solution for the requirement of a straightforward reaction when possible industrial 
applications are kept in mind as well as for the validated use in terms of transfection 
efficiency, methacrylate-based synthetic polymers were also explored as potential delivery 
systems. Moreover, specific trends and correlations (for the MW or composition of functional 
groups) that are existing for biodegradable compounds could consequently be compared to 
non-biodegradable systems (or vice-versa). In this chapter, polymethacrylates will be 
synthesised with functional groups similar to poly-L-glutamine and poly-L-arginine derivates 
discussed before. Comparing the MW proved to be less simple since one of the main 
drawbacks of polymethacrylate synthesis is the limited control over the MW due to the 
unregulated nature of free radical polymerisations.  
 
2 Free radical polymerisation of methacrylates 
Unlike the nucleophilic ring-opening-polymerisation of NCA, the polymerisation of 
methacrylates occurs most conveniently via a radical mechanism. The double bond (-bond) 
of a monomer can be disrupted by radicals originating from initiators which are capable of 
forming new C-C bonds. If this process is continuously repeated, long polymer chains 
(aliphatic) are developed. Traditionally, this mechanism occurs in three steps (Fig. 3.1). 
Initiation: generally, an initiator molecule (In) is required to produce radicals needed for 
the homolytic cleavage of the double bond. In a first step, the initiator is split in several 
parts, yielding one or more radicals that are transferred to the monomer in a next step. 
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Propagation: once a radical containing monomer is generated, new monomers can be 
consecutively adhered. This process can be continuous until all monomer is consumed 
or interference reactions arise. 
Termination: Several mechanisms can restrict or end polymerisation. The most 
frequently occurring reactions are transfer of the radical onto a non-reactive species 
(transfer agent), disproportionation and combination between two active chains.  
C
C
O
R
n
CH2
CH3
In
O
CH3
O
O
R
In +
+ monomer
C
C
O
R
CH2
CH3
O
C
C
O
R
n
CH2
CH3
O
termination
 
Figure 3.1 - Schematic stepwise process of a free radical polymerisation. 
 
It is obvious that the synthesis of these materials needs to be carried out in clean conditions 
in order to limit termination reactions and accordingly have as much control as possible over 
the polymerisation process. A frequently encountered inhibition phenomenon is the presence 
of O2 within the monomer solution. Oxygen is a unique molecule since it’s one of the few 
molecules which has a triplet di-radical as ground state due to its electronic structure5 (Fig. 
3.2). 
 
Figure 3.2 - Oxygen inhibition: electronic & chemical structure. 
If the radical required for propagation is transferred to oxygen, the resulting peroxide (Fig. 
3.2) intermediate is much less reactive towards the coupling of additional monomers. 
Moreover, when making use of photo-initiators, the excited state of the sensitizer can be 
transferred to oxygen (which induces triplet  singlet transition) thereby decelerating the 
polymerisation6. Due to the omnipresence of this molecule, most radical polymerisation 
reactions undergo one or more degassing steps. This can involve the set-up of a vacuum or 
the extensive bubbling through of inert gasses (Ar/He/N2). 
singlet triplet
Degeneracy = 2S + 1
C + O O C O O
Oxygen radical transfer
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Free radical polymerisations are difficult to control and because of that, regulating the MW is 
difficult and reproducibility moderate. This limited control is often expressed in a high 
polydispersity (). The occurrence of transfer and termination reactions is numerous and can 
only be minimised by working in clean conditions with pure reagents and solvents while 
carrying out thorough degassing procedures. To determine the MW, certain approximations 
are carried out. To simplify the calculation, the appearance of chain transfer (to reagent, 
solvent, etc.) is disregarded. Furthermore, termination of the propagation chain is believed to 
occur via disproportionation rather than by combination. Finally, a steady-state (dynamic 
equilibrium) is put forward which claims an equal rate of initiation and termination. The 
equation for relating the MW (degree of polymerisation = DP) to the amount of initiator and 
monomer required is as follows:  
   
      
              
 
With kp, kd and kt being the propagation, dissociation and termination constants respectively, 
f being the initiator efficiency, [M] = monomer concentration and [I] = initiator concentration. 
Other important aspects that influence the outcome of a radical polymerisation are related to 
viscosity (e.g. Trommsdorff effect), the temperature, the solvent and type of initiator used.  
 
3 Polymethacrylate derivatives as synthetic vectors  
Just like for biodegradable synthetic vectors (chapter 2), a whole list of requirements and 
conditions are to be considered for the synthesis of non-biodegradable polymeric vectors. In 
order to compare both classes of polymers, methacrylates possessing similar types and 
amounts of functional groups are prepared with a MW of comparable size according to 
methods from literature1,2, 7 , 8 , 9 , 10 . Dependent on the desired polymer structures, 
polymerisations were carried out in aqueous or organic environments using correspondingly 
soluble initiators. 
3.1 Description of a free-radical polymerisation 
As is traditionally used for free radical polymerisations, thermal initiators were adopted as 
radical producing compounds. Upon heating, generally to temperatures of about 60-80 °C, 
the initiator dissociates (with a dissociation constant, kd) in one or more radicals. For 
polymerisations carried out in organic solvents, 2,2′-Azobis(2-methylpropionitrile) (AIBN) was 
used whereas for polymerisations in the aqueous phase, ammoniumpersulfate (APS) was 
applied (Fig. 3.3). Both compounds undergo a homolytic cleavage of the weakest bond when 
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energy is provided whereby two identical radicals are produced (optionally with a by-product, 
N2 in the case of AIBN)
11. The dissociation speed of APS is also pH-dependent. 
N N CC
CH3 CH3
CH3
CN
CH3
CN O O SS
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O
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NH4NH4
 
Figure 3.3 - Chemical structure of initiators: AIBN and APS. 
 
To set up a polymerisation, a two-neck flask is equipped with a septum and a reflux cooler 
with a tap. Via this tap, the whole set-up can be put under vacuum with a pump. A degassing 
procedure then consists of repeated steps of stirring under vacuum to remove air from the 
solution with the introduction of an inert N2 atmosphere afterwards. This action is repeated 
three times after which the initiator (from a stock solution) is added through the septum and 
degassing is carried out for the last time in order to allow start of the polymerisation by 
temperature increase.  
3.2 Chain transfer agents regulate polymerisation for low MW’s 
In some cases, very small polymers are required but given the highly reactive nature of a 
radical polymerisation, short polymer chains are difficult to obtain. By using AIBN, it 
appeared to be difficult to produce polymers with a MW smaller than 40.000 Da without the 
use of a chain transfer agent (CTA or regulator). A well known regulator is 2-
mercaptoethanol (EtSH), which can absorb the active chain radicals and accordingly lower 
the expected MW. The decrease in obtained MW is due to the higher stability of the radical 
EtS and the corresponding lower reactivity towards radical combination (Fig. 3.4). With a 
decreasing M/CTA ratio (or increasing CTA concentration), shorter polymer chains were 
obtained while keeping the amount of initiator constant (typically 1-10% of the monomer 
concentration)12.  
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Figure 3.4 - Chain transfer mechanism for the production of low MW methacrylate compounds. 
 
3.3 Synthesis of poly(dimethylaminoethyl)methacrylate (pDMAEMA) 
In accordance with its biodegradable counterpart, a polymethacrylate homopolymer 
containing only tertiary amine functional groups (located on the side chain) was synthesised. 
Poly(dimethylaminoethyl)methacrylate (pDMAEMA) could be readily obtained in a one-step 
synthesis from its commercially available monomer, dimethylaminoethylmethacrylate. 
Polymerisation is carried out in solution with monomer concentrations of 10-20 % (v/v) at 
elevated temperature (75  °C) and is allowed to react overnight to increase the degree of 
conversion. The purification and isolation is subject to the type of initiator and solvent used. 
In the case of AIBN, the polymerisation is performed in toluene. After the reaction, the 
polymer is isolated by precipitation in ice-cooled pentane, filtered off, washed and re-
dissolved in water to be further purified by dialysis. When APS is used (typically 0.1-4 
mol%), the polymerisation is carried out in water (pH ≈ 5) and precipitated in ice-cooled 
acetone, filtered off, washed and re-dissolved in water to be further purified by dialysis. For 
AIBN, MW’s up to 300.000 Da could be achieved while the use of APS yielded polymers up 
to 1.000.000 Da13. As the results in table 3.1 confirm, the polydispersity of APS initiated 
polymers is lower (compared to AIBN) due to the precipitation in more polar non-solvents 
that are able to retain low MW fractions better and artificially improve polydispersity (closer 
to 1). This effect is also more pronounced for low MW compounds (AIBN initiation). The MW 
of these compounds was checked via GPC measurements using an aqueous buffer (5 % 
NaH2PO4, 3 % CH3CN, pH = 4) whereas the degree of purity (disappearance of vinyl 
protons) and confirmation of the structure was given by 1H-NMR (Fig. 3.5). 
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Figure 3.5 – Structure of pDMAEMA as obtained by 
1
H-NMR (D2O). 
Several homopolymers with different MW were produced to investigate the relation between 
the MW and the properties related to the delivery of DNA (table 3.1).  
MW (Da) Initiator M/CTA polydispersity () 
11.900 AIBN 9/1 1.54 
29.200 AIBN 20/1 1.61 
62.900 AIBN - 2.01 
121.000 AIBN - 1.90 
310.000 APS - 1.38 
658.000 APS - 1.49 
Table 3.1 – Overview of various pDMAEMA compounds. 
The polydispersity of the final products was susceptible to the type of initiator system used. 
Polymers with a low MW showed tendency for having a correspondent lower polydispersity 
compared to high MW compounds. In contrast, the use of APS generally yielded final 
products with a considerable narrower polydispersity (range = 1.3 – 1.7) than for AIBN.  
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3.4 Amine-containing methacrylates 
Having a polymer at its disposal that contains numerous functional groups for both 
complexation and continued coupling is of high interest to obtain multifunctional polymers. 
The production of poly(aminoethyl)methacrylate (pAEMA) can be used as such but can also 
be utilised for coupling to peptides or as a precursor for the formation of guanidylated 
compounds. The polymerisation of the corresponding monomer (aminoethylmethacrylate 
hydrochloride) is complicated due to the high occurrence of side-reactions (Fig. 3.6).  
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Figure 3.6 – Overview of possible side reactions during the polymerisation of AEMA. 
The occurrence of these side reactions can alter the final products completely. The presence 
of hydrolysed methacrylic esters (D) can turn solutions into hydrogels (high polarity and 
water absorption) or even worse in the case of intermolecular amidation (C), initiate the 
formation of covalently crosslinked networks. The chances of intra-molecular amidation II (B) 
happening are rather low due to the entropically unfavourable formation of 9-membered 
rings (or larger if the ester bond is not positioned on the adjacent unit). Because of the 
exclusive solubility in water, copolymerisation with other monomers is limited. Therefore the 
monomer needs to be protected during polymerisation. This can be achieved in two ways. 
By applying the proper pH, the amine functional group can be protonated, thereby 
eliminating its nucleophilic property. Fine-tuning the pH is of the utmost importance given the 
need for a pH that can quantitatively protonate primary amines (pKa ≈ 9.5) while at the same 
time prevents the hydrolysis of the ester14. A pH close to 5 proved to fulfil both requirements. 
An alternative solution for this problem is the use of a protected amine derivative. A urethane 
protection (tert-butoxycarbonyl - BOC) was proposed to reduce the nucleophilic capacity 
through its electron withdrawing ability as well as the sterical hindrance15. Additionally, the 
synthesis of BOC-AEMA rendered the monomer less polar, allowing the subsequent 
dissolution in organic solvents and the correspondent copolymerisation with other 
monomers. Recovering the original functional group can be achieved by swift cleavage 
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under strongly acidic conditions (TFA or HF). The application of polymethacrylamides could 
solve this problem due to its thermo-dynamical stability but forms a drawback towards 
degradability of the chemical bond (esters degrade better via enzymatic hydrolysis) although 
the polymer backbone remains non-degradable for both. Its use was not further considered. 
3.4.1 Synthesis of (N-tert-butoxycarbonyl)aminoethylmethacrylate 
The production of BOC-AEMA was achieved by reacting a cooled suspension of AEMA.HCl 
in DCM (0.3 M) which was mixed with 1.1 equivalent of triethylamine (TEA) with a solution of 
bis(tert-butyl)dicarbonate (1.1 eq) in DCM. The reaction was acclimatised to room 
temperature and stirred overnight. Purification of the formed BOC-AEMA was carried out by 
liquid extraction, firstly with 0.5 M HCl (repeated 2x) to remove remaining AEMA.HCl and 
TEA.HCl, followed by 0.5 M NaHCO3 to remove remaining tert-butoxycarboxylic acid and 
finalised by extraction with 0.1 M NaCl. The organic phase was collected an dried over 
MgSO4 and filtered after which it was concentrated by rotary evaporation. The solution was 
then crystallised in a cold mixture of pentane/diethylether (1/1 v/v). The final product was 
isolated by decantation and dried in vacuo. Structure validation was obtained via 1H-NMR 
(Fig. 3.7) and FTIR. The overall yield proved to be around 75 %. 
 
Figure 3.7 – Structure of BOC-AEMA as obtained by 
1
H-NMR (CDCl3). 
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3.4.2 Synthesis of poly(aminoethyl)methacrylate (pAEMA) 
In order to obtain guanidine-containing polymethacrylates, primary amine-containing 
derivatives are required. Since the protection of AEMA is a time-consuming step, BOC-
AEMA was only used for copolymerisation using different monomers. The production of 
homopolymers was performed using AEMA.HCl. Therefore AEMA.HCl was dissolved in 
water and adjusted to pH = 5 after which it was thoroughly degassed. Ammoniumpersulfate 
was added as an initiator (10 mg/ml stock) in concentrations ranging from 0.1 to 4 mol %. 
The final product was purified by dialysis and isolated by freeze-drying followed by structure 
confirmation via 1H-NMR (Fig. 3.8).  
 
Figure 3.8 – Structure of pAEMA and pGuAEMA (detail) as obtained by
 1
H-NMR (D2O). 
 
3.4.3 Synthesis of poly(guanidylethyl)methacrylate (pGuAEMA) 
In accordance with previously described guanidine conversion reactions (section 2.3.4) 
pAEMA was converted into pGuAEMA during a one-step reaction. Nearly quantitative 
modification was observed from 1H-NMR (Fig. 3.8 – peaks 3’ and 4’). A detailed spectrum of 
the guanidine derivative revealed a peak shift of 0.5 ppm for C4-H and 0.1 ppm for C3-H. An 
overview of the synthesised pAEMA and pGuAEMA compounds is given in table 3.2. The 
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low MW pAEMA was used for the guanidine conversion, hence the modest increase in MW 
and polydispersity. The GPC analysis of pGuAEMA was next to the phosphate buffer also 
performed in a 0.5 M NaCl buffer to see the possible effect of elution retardation (due to 
sticking or blocking of the GPC column pores) but the resulting MW proved to be in the same 
MW range.  
Polymer MW (Da) polydispersity () 
pAEMA 61.200 1.34 
pAEMA 176.300 1.83 
pAEMA 841.200 1.54 
pGuAEMA 63.000 1.49 
Table 3.2 - pAEMA & pGuAEMA overview. 
  
3.4.4 Synthesis of poly(aminoethyl-co-dimethylaminoethyl)methacrylate (p(DMAEMA-
AEMA)) 
To allow additional coupling reactions (e.g. fluorescent tags), primary amines are required to 
enable straightforward coupling to a methacrylate polymer. Moreover, the addition of primary 
amines is expected to influence the complexation in a different way as for L-glutamine 
containing polymers since H-bonding with the polymer backbone is not possible. To prepare 
this polymer, the reaction can be performed in both organic and aqueous environments but 
due to the additional practical work caused by AEMA protection, all polymerisations were 
carried out in water (pH ≈ 5) using reaction parameters described above (section 3.1 & 
3.4.2). APS was used as initiating system in high concentrations (2-4 wt %) to yield polymers 
with sufficiently low MW. The composition was verified by 1H-NMR and is shown below in 
figure 3.9 and table 3.3. 
MW (Da) -NMe2/-NH2 polydispersity (PD) 
51.000 79 / 21 1.69 
191.000 82 / 18 1.44 
135.000 54 / 46 1.42 
132.000 23 / 77 1.29 
Table 3.3 - overview of p(DMAEMA-AEMA) compounds. 
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Figure 3.9 – Structure of p(DMAEMA-AEMA) as obtained by
 1
H-NMR (D2O). 
 
3.5 Hydroxyl containing polymethacrylates 
Similar to biodegradable synthetic vectors, also polymethacrylates were assumed to 
experience a positive effect when incorporating neutral hydroxyl groups into the structure 
since these functional groups can dissipate the excess of cationic charge and consequently 
improve cell-viability. Making use of the generally-known and commercially available 
hydroxyethylmethacrylate (HEMA) would be natural but side-reactions of the same nature as 
for pAEMA derivatives are inhibiting its use (intermolecular trans-esterification which can 
result in crosslinking, Fig. 3.10). For that reason and also to minimise to occurrence of chain 
transfer reactions by the free hydroxyl group, an alternate form of this monomer containing 
the trimethylsilyloxy (TMS) protective group is used 16 . Due to the presence of TMS, 
polymerisation can only proceed in organic solvents and additional deprotection (acidic 
cleavage) was required (Fig. 3.9). This latter step was completed under cooled conditions (0 
°C) to prevent intermolecular transesterification of the cleaved hydroxyl groups (which is 
increased at elevated temperature). The possibility of crosslinking for HEMA-containing 
compounds (e.g. into ethyleneglycoldimethacrylate type of compounds) always remains and 
should therefore be contained by keeping temperatures low and limit the time in solution. 
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Figure 3.10 – Side-reactions related to the use of non-protected HEMA and structure of the 
protected TMS-HEMA and final pHEMA. 
 
3.5.1 Synthesis of poly(dimethylaminoethyl-co-hydroxyethyl)methacrylate (p(DMAEMA-
HEMA)) 
Creating a polymer with only hydroxyl functional groups was not expected to yield a vector 
capable of sufficient DNA interaction and complexation. Therefore, TMS-HEMA was only 
used in combination with charged monomers like DMAEMA. The production of these 
copolymers was carried out in toluene and their composition and MW were chosen to be 
similar to their biodegradable equivalents (chapter 2). Both monomers were dissolved in 
toluene (20 wt % monomer combined) and according to the desired MW, initiator (AIBN) was 
added while performing the required degassing steps. The reaction was accomplished 
overnight at elevated temperature (75 °C) and was finished by precipitation in cold 
pentane/diethylether (1/1 v/v) and dried in vacuo. Next, the intermediate polymer (containing 
TMS-protected HEMA) was dissolved in CHCl3 (20 w/v %) and TFA was added to remove 
the TMS-group. After precipitation in cold pentane, the product was re-dissolved in water 
(0.1 M HCl) for further purification by dialysis. The composition and purity of the polymers 
was checked by 1H-NMR (Fig. 3.10). Polymer compounds with a desired number of charged 
groups, around 25, 50 and 75 % respectively, were calculated prior to polymerisation.  An 
overview of the produced polymers is given in table 3.4. 
MW (Da) -OH/NMe2 polydispersity () MW (Da) -OH/NMe2 polydispersity () 
9.800 45 / 55 1.60 187.500 20 / 80 1.43 
218.000 44 / 56 2.26 14.900 69 / 31 2.46 
22.800 23 / 77 1.69 241.900 66 / 34 2.85 
Table 3.4 – overview of p(DMAEMA-HEMA) compounds. 
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Figure 3.11 – Structure of p(DMAEMA-HEMA) as obtained by
 1
H-NMR (D2O). 
 
3.5.2 Synthesis of poly(guanidylethyl-co-hydroxyethyl)methacrylate (p(GuAEMA-HEMA)) 
In order to produce a polymer with both primary amines (the precursor of guanidine) and 
hydroxyl functional groups, protected derivatives of the respective monomers are to be used. 
In this way, polymers containing a hydrophobic backbone and also a biologically highly 
relevant guanidine group can be compared to biodegradable vectors of similar composition 
and MW. Because of solubility reasons, polymerisation of such monomers can only be 
carried out in toluene using identical parameters as described above (20 wt % monomer 
concentration). Post precipitation, both protective groups can be removed using TFA. After 
purification and isolation, the primary amines can be converted into guanidine groups (as 
specified above, section 2.1.6). The composition and structure are verified by 1H-NMR (Fig. 
3.11 & table 3.4). 
MW (Da) -OH/Gua polydispersity () 
29.500 60/40 1,54 
Table 3.5 - Composition and MW of p(GuAEMA-HEMA). 
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Figure 3.12 – Structure of p(GuAEMA-HEMA) as obtained by
 1
H-NMR (D2O). 
 
4 Conclusion 
In this chapter, the production of non-biodegradable polymers based on methacrylate 
monomers that bear different functional groups was discussed. Similar to the biodegradable 
counterparts, every functional group was introduced to possess specific physico-chemical 
properties. The composition and MW was controlled in such a way that trends related to the 
more hydrophobic polymethacrylates could be compared and if necessary implemented in 
biodegradable derivatives without carrying out its corresponding complexer synthesis. 
Synthetic vectors of a desired composition (functional groups) were accordingly produced. 
Due to the different nature of polymerisation (free radical versus controlled living-like), 
anticipated lower control of the MW was observed. Moreover, the copolymerisation of 
monomers with variable functional groups seemed to have almost no effect on the acquired 
polymer composition which suggested that the reaction kinetics are nearly equal. The 
conversion degree of the polymerisations revealed that in most cases yields up to 50% were 
possible. Despite the more hydrophobic nature of these polymers, the solubility in water was 
still high (although not always confirmed in NMR spectra because of the broad peaks 
observed with lack of coupling identification, a result of the average shift value of the 
different repeating units).  
C
C
O
CH2
CH3
O
C
C
O
CH2
CH3
O
CH2
CH2
NH
CH2
CH2
OH
NHNH2
3
4
5
11
1
2 2
2
3
4
5
6
6
D2O
 
Chapter 3: Synthesis of non-biodegradable polymers 111 
5 References 
                                                          
1
 Dubruel, P. and E. Schacht (2006). "Vinyl polymers as non-viral gene delivery carriers: Current status and 
prospects." Macromolecular Bioscience 6(10): 789-810. 
2
 van de Wetering, P., J.-Y. Cherng, et al. (1998). "2-(dimethylamino)ethyl methacrylate based 
(co)polymers as gene transfer agents." Journal of Controlled Release 53: 145-153. 
3
 P. Dubruel, (2003) “Studie van synthetische polymeren als vectoren voor gentherapie”, Ghent 
University, Doctoral research 
4
 Verbaan, F. J., G. W. Bos, et al. (2004). "A comparative study of different cationic transfection agents for in vivo 
gene delivery after intravenous administration." Journal of Drug Delivery Science and Technology 14(2): 105-
111. 
5
 Hanrahan, M. J. (1992). “Overcoming the effects of oxygen on cured and uncured UV formulations.” Journal of 
Radiation Curing 19 (40). 
6
 Wight, F.R. and Numez, I.M. (1989). ““Oxygen inhibition of acrylate photopolymerisation.” Journal of Radiation 
Curing 16(1): 3-7.. 
7
 Dubruel, P. and E. H. Schacht (2000). "Effect of polyethylene oxide blocks or grafts on the physicochemical 
properties of poly(2-N-(dimethylaminoethyl) methacrylate) DNA complexes." Journal of Bioactive and Compatible 
Polymers 15(4): 279-296. 
8
 Dubruel, P., V. Toncheva, et al. (2000). "pH sensitive vinyl copolymers as vectors for gene therapy." Journal of 
Bioactive and Compatible Polymers 15(3): 191-213. 
9
 van de Wetering, P., J.-Y. Cherng, et al. (1997). "Relation between transfection efficiency and cytotoxicity of 
poly(2-(dimethylamino)ethyl methacrylate)/plasmid complexes." Journal of Controlled Release 49(1): 59-69. 
10
 Cherng, J. Y., H. Talsma, et al. (1999). "Long term stability of poly((2-dimethylamino)ethyl methacrylate)-based 
gene delivery systems." Pharmaceutical Research 16(9): 1417-1423. 
11
 Vorsina, I. A. and Y. I. Mikhailov (1996). "Kinetics of thermal decomposition of ammonium 
persulfate." Russian Chemical Bulletin 45(3): 539-542. 
12
 Boyer, C., G. Boutevin, et al. (2004). "Study of the telomerization of dimethylaminoethyl 
methacrylate (DMAEMA) with mercaptoethanol. Application to the synthesis of a new 
macromonomer." Polymer 45(23): 7863-7876. 
13
 Layman, J. M., S. M. Ramirez, et al. (2009). "Influence of polycation molecular weight on poly(2-
dimethylaminoethyl methacrylate)-mediated DNA delivery in vitro." Biomacromolecules 10(5): 1244-
1252. 
14
 Thompson, K. L., E. S. Read, et al. (2008). "Chemical degradation of poly(2-aminoethyl 
methacrylate)." Polymer Degradation and Stability 93(8): 1460-1466. 
15
 Dufresne, M.-H. and J.-C. Leroux (2004). "Study of the micellization behavior of different order 
amino block copolymers with heparin." Pharmaceutical Research 21(1): 160-169. 
16
 Hirao, A., H. Kato, et al. (1986). "Polymerization of monomers containing functional groups 
protected by trialkylsilyl groups." Macromolecules 19: 1294-1299. 
  
Chapter 3: Synthesis of non-biodegradable polymers 112 
 
  
 
 
 
 
 
 
 
 
 
Chapter 4 
 
Physico-chemical characterisation of multifunctional 
synthetic  vectors  
  
  
 
 
Chapter 4: Physico-chemical characterisation of multifunctional synthetic vectors 113 
1 Introduction 
One of the primary requirements of a synthetic polymer that needs to be applied as a vector 
for gene delivery, is the ability to engage in an associative way with DNA, RNA or a 
sequence of nucleotides. As was mentioned earlier, this can be achieved in the most 
straightforward way by electrostatic attractions, hence cationic polymers were synthesised. 
Regarding restrictions of the body on a cellular and systemic level, certain aspects of the 
polymer-DNA interaction are considered essential for the proper functioning as a delivery 
device. Among these critical conditions are the size of the formed particles, their ability to be 
taken up by the cell and the capacity to protect the DNA from external stimuli. Moreover, the 
interaction between DNA and the vector should be stable (in time and in saline buffered 
environments) to allow prolonged results and the delivery system should ideally be non-toxic 
afterwards, in other words: be metabolised by the body down to basic structures. 
A whole range of analytical techniques exists, allowing the investigation of certain physical 
and chemical properties that can be correlated with the conditions described above. In this 
chapter, several properties and conclusions derived from every individual characterisation 
method will be discussed. The focus of the physico-chemical analysis of polymer-DNA 
complexes is therefore on the formation of these particles, their size and size-distribution 
and their stability in solution. The capacity of delivery systems to protect its DNA cargo from 
enzymatic degradation as well as the extent to which the polymer can be degraded after 
dissociation was investigated as well. Throughout the characterisation, structure-related 
properties of polymers were interpreted to result in the discovery of specific trends. One 
important quality that is not covered by these characterisation tests but which should be 
mentioned as an additional parameter in the total evaluation of a vector, is the buffering 
capacity of the polymers. From previous doctoral research1,2, the buffering range of polymers 
with similar functional groups (and compositions) was found to be in the range of pH = 5.5-
7.5, which is in good correspondence with the pH-drop that is realised during cell-
internalisation using the endocytotic pathway (endosomes).  
In order to fully comprehend the way polyplexes are prepared, the theory of polyelectrolytes 
(mutual association) will be clarified first as will their method of preparation. Before polymers 
can be used as synthetic vectors they need to be completely, chemically characterised 
(structure, composition and MW).  
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2 Polyelectrolyte complex formation theory 
It is imperative for polymers that have to interact with DNA, to posses cationic charges that 
can induce an electrostatic interaction with the negatively charged sugar-phosphate 
backbone of DNA (polyanion). Therefore, during synthesis the polymers were provided with 
functional groups that are positively charged in a physiological environment (to become 
polycations). Upon physical mixing, these two macro-ions form self-assembling inter-
polyelectrolyte complexes (IPEC’s or polyplexes) that drastically change the properties of the 
individual components (Fig. 4.1). A polyplex is thus composed of a certain ratio of polymer to 
DNA (cation to anion), which is better known as the charge ratio (CR).  Many facets 
influence this formation, such as charge density, salt concentration, order of mixing and 
polymer chain flexibility3. In order to have a reproducible way of forming these polymer-DNA 
complexes, it is essential to have a well established protocol. 
 
Figure 4.1 – Simplified representation of the IPEC formation between DNA and a polymer. 
2.1 The concept of mass per charge and the calculation of polyplex composition 
The charge of a macro-ion at physiological pH depends on its structure (type and amount of 
functional groups). Every charge on the polymer, corresponds with a certain molecule mass, 
defined as the mass per charge (M/C). This value is often the molecular mass of one 
structure unit (in case of fully charged polymers) and is needed for all macro-ions involved in 
the formation of the polyplex.  For DNA, this value is fixed since it consists of a sugar unit 
(deoxyribose), a phosphate group and the average weight of nucleic acids according to the 
Chargaff rule4,5. It is of great importance that the calculated M/C of polyelectrolytes can be 
mutually compared so that uniform conclusions can be drawn from experimental analysis 
between polyplexes composed of different vectors. Because of that, the M/C was put 
forward as the value corresponding with 100% of the polyelectrolyte being charged. This 
definition is specifically relevant for polymers with neutral groups since a correction needs to 
- -
-
polyplex
polycation
DNA
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be made for the lack of cationic charges. Even though the assumption that a polymer is fully 
charged, is not entirely correct (proton neighbouring effect), it allows for a simple and swift 
way of calculating the M/C. The M/C of a cationic polymer is calculated by determining the 
mean molecular weight of the different structure units of the polymer (including counter-ion if 
present) and dividing it by the relative amount of charged structure units (in %).  
In a polymer-DNA complex, the CR is defined using the mutual relation of mass/charge 
between the macro-ions, expressed in the following equation: 
      
 
 
     
X  = mass/charge of polycation (g/mol) 
Y  = mass/charge of polyanion (g/mol) 
y  = amount of polyanion added (g) 
x  = amount of polycation added (g) 
z  = integer multiple of the excess of polycation over polyanion (where z  
       equals 1 for a charge ratio of 1/1).  
Given these parameters, polyplexes at different CR can be calculated from the amount of 
DNA that needs to be effectively delivered. In typical characterisation experiments, 
concentrations of 20 µg/ml DNA are used. The order of compound addition and mixing is 
critical as will be demonstrated later. Firstly DNA is added to water and subsequently 
polymer is added, followed by briefly vortexing the entire mixture. 
 
2.2 Standardised protocol 
For reasons of uniform experimental testing (standardisation) as well as to respect the need 
for harmony within a partner-based project, a standard protocol was established that 
describes the preparation of polyplexes in solution. Prior to practical execution, the desired 
CR of the polyplex is calculated using the formula given above and a polymer (1 mg/ml) and 
DNA stock (2.5 mg/ml) are prepared. All polyplexes were prepared in a total volume of 2 ml 
and need to be dissolved in ultrapure water to prevent precipitation. Mixing with a buffer can 
only be carried out after polyplex formation in water (via dilution). Calf Thymus DNA (sodium 
salt) of about 23,000 basepairs was used as standard DNA (Sigma). Polyplexes based on 
plasmid DNA (pDNA) were in certain cases also applied. It is imperative that the order of 
mixing is carried out as described. It appeared that the vortex time and speed play a big role 
in the size and distribution of the particles (determined by DLS).  
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Practical execution 
 16 µl of a DNA stock solution (= 40 µg) is brought into a vial 
 Water is added after which the solution is gently shaken (manually). 
 An amount of polymer, corresponding with the desired CR is added (µl range) 
 The mixture is vortexed for 5 seconds at medium speed (≈ 1500 rpm) 
 
2.3 One-step versus multi-step polymer addition 
Dependent on the method of characterisation applied, polyplexes with the same CR can be 
achieved in a different way, that is by single-shot addition or by multi-step addition. For EtBr 
displacement assays, a CR of 2/1 is reached by repeated additions of 0.2 CR units (multi-
step) in order to determine the condensation point of the polyplex. On the other hand, when 
the size of a 2/1 polyplex needs to be measured, a single addition of polymer to DNA is 
performed to get to the desired CR (single-shot addition). Therefore, these two methods of 
polyplex formation were compared to verify weather similar conclusions could be drawn from 
different characterisation techniques. The use of small polymer additions to a DNA solution 
(including a vortexing step of two seconds between each addition) allows a better orientation 
of polymer around DNA so that the most optimal interaction can be achieved 
(thermodynamically favourable). Adding the total required amount of polymer at once, 
induces polyplex formation which is largely kinetically driven. The extent to which the way of 
polymer addition has an influence on the final polyplex formation was investigated by UV 
spectrometry for p(DMAEG) 80 kDa (Fig. 4.2 & 4.3). 
In figure 4.2, the UV absorbance as a function of polymer addition (stepwise / multishot 
increase of CR) displays a sudden increase in UV intensity until a maximum value is 
reached (CR 0.8/1) which corresponds with the CR for polyplex formation. The 
conformational change from free dissolved DNA to collapsed complex (particle) induces a 
absorbance increase which is most likely due to attenuation (scattering) as the UV 
absorption of DNA is shielded by the polymer. Afterwards, the absorbance declines (only 
limitedly) as a result of the larger amount of polymer which is gradually added around the 
preformed polyplex (adding up to the shielding effect). A clear difference between 
uncomplexed DNA and complexed DNA remains and the observed difference pre- and post-
polyplex formation confirms the use of UV spectrometry as an alternative in case EtBr 
fluorescence measurements would be excluded. Additionally, UV analysis is able to produce 
smaller standard deviations compared to EtBr fluorescence (< 1%, the standard deviation is 
not shown when < 0.1%). When the formation of a polyplex based on pDMAEG is subjected 
to a single shot addition (i.e. all polymer is added at once), the maximum value measured, is 
situated close to the value for a multishot addition (A = 0.4356 instead of 0.4203) which is a 
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negligible difference (Fig. 4.3). Moreover, the discrepancy between free DNA and complexed 
DNA is also here apparent and remains clear as the CR is further increased (here shown up 
to a CR of 6/1).  
 
Figure 4.2 - UV absorbance profile ( = 260 nm) for polyplex formation using p(DMAEG) 80 kDa 
(formed by multishot addition). 
 
Figure 4.3 – UV absorbance profile ( = 260 nm) for polyplex formation using p(DMAEG) 80 kDa 
(formed by single-shot addition). 
 
2.4 Polyplex mixing sequence 
A final topic that needs to be dealt with in order to attain a comprehensive understanding of 
polyplex formation is the order of mixing. As was stated in the standard protocol, the 
sequence in which polyelectrolytes are added and the capacity in which they are present (in 
solution, solid, etc.) can have far-reaching consequences on the polyplex composition. 
Principally, DNA is dissolved in water prior to the addition of polymer. This method was 
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mainly chosen for arbitrary reasons, more specifically because the dose of DNA used in 
polyplex formation is kept constant (20 µg/ml) while the polymer content is varied. Working 
in reversed order for instance, that is adding DNA to a polymer solution, should theoretically 
result in equal polyplex formation if both components are thoroughly dissolved and if the 
mixing process could stimulate optimal polyelectrolyte contact and arrangement. This is 
practically not always applicable due to the nature of the polyelectrolytes involved (e.g. the 
dimensions of the polymer coils). If these components possess sufficient flexibility and 
mobility the order of mixing is assumed to be irrelevant but when the structural integrity limits 
one of these properties, exceptions are observed. When using plasmid DNA (pDNA), an 
obvious difference between the two sequences of addition was noticed as was determined 
by fluorescence fluctuation spectroscopy based on EtBr intercalation (see also chapter 5, 
section 2.4). Plasmid DNA (pDNA) is a specific, mostly circular type of DNA (with different 
variants in configuration) of over a 1000 base pairs long and double stranded. Regular (or 
lineair) double stranded DNA on the other hand, is not expressed as a supra-molecular 
structure  (e.g. circle). Figure 4.4 demonstrates that mixing sequence I (addition of polymer 
to dissolved pDNA) exhibits slightly less fluorescence, which indicates a somewhat stronger 
polyplex interaction but with clear spikes at random times observed. Mixing sequence II 
(addition of pDNA to a polymer solution) displays a little higher fluorescence than sequence I 
but is far more constant (no spikes visible). 
 
Figure 4.4 - Fluorescence yield as a function of time for 2 mixing sequences (addition of 
polymer to DNA (I) and DNA to polymer (II)). 
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A hypothesis was proposed on what happens on a molecular level when both components 
are mixed (Fig. 4.5). If polymer was added to a solution of pDNA, the initially concentrated 
polymer drop blends into the medium (solvent), thereby searching possible interactions with 
oppositely charged entities. As the first molecules they encounter and associate with, not 
readily disperse away from the more concentrated polymer area (due to their lower mobility 
or reduced Brownian motion), they keep on attracting additional polymer and form even 
tighter complexes. In this way, most of the polymer is consumed before reaching other parts 
of the solution, hence a significant part of the pDNA remains weakly bound or simply 
uncomplexed. The solution is then composed of a combination of heavily interacting 
polyplexes, medium interacting polyplexes and free DNA, which explains the variable 
fluorescence values which exhibit a considerable amount of spikes. These spikes should 
probably be attributed to weak or non-complexed DNA that passes the laser when 
measuring the fluorescence (by EtBr intercalation). 
 
Figure 4.5 – Hypothetical model of the interaction between polymer and DNA related to the 
difference in mixing-order. 
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To confirm this latter statement, fluorescence measurements of highly diluted DNA (in an 
EtBr solution) should be carried out to verify the occurrence of random peak spikes (data not 
available). 
On the other hand, when pDNA was combined with a polymer solution, a more evenly 
distributed appearance of equally tight polyplexes can be observed. Since the polymer is 
now homogenously spread, no excess is present when the first molecules of pDNA start 
interacting. Gaining additional cationic charges, can only occur when the pDNA moves on 
through the solution, gradually taking up more polymer, consequently generating a more 
equal distribution of polyplex composition. 
Although the polymer-to-DNA method could generate less homogenously composed 
polyplexes this problem is only of importance when the DNA or polymer (or both) are 
voluminous (less mobile), poorly soluble or too much or less concentrated.  
3 Characterisation of polyplex formation properties 
To start with the development of a full, physico-chemical profile of a polymer that can be 
adopted as vector for gene delivery, the ability to associate with DNA is the first parameter to 
be investigated. If a polymer does not fulfil this basic condition, further experimental analysis 
is rendered useless. As an important result from these tests, the amount of polymer required 
to obtain a stable and well defined polymer-DNA complex, can be deduced. The amount of 
positively charged polymer is a crucial factor for the toxicity of the polyplex which, in case of 
toxicity, generally rises with an increased amount of polymer (and positive charge, e.g. 
higher CR). It is therefore recommended to develop synthetic polymers that require small 
quantities to ensure full interaction with DNA into an associated complex.  
There are two characterisation methods that are often used for facile screening of the 
polymer’s DNA-interactive properties. The first one, fluorescence spectroscopy based on 
EtBr intercalation, makes use of light to distinguish complexed and free DNA. A frequently 
used alternative to this method is gel-electrophoresis based on agarose. Differentiation 
between a polyplex and uncomplexed DNA is here based on the migration of free DNA 
through a gel matrix stimulated by an electric field. 
 
3.1 Ethidium Bromide Fluorescence 
Ethidium Bromide (EtBr) is a planar, aromatic molecule with a particular tendency to 
specifically interact with DNA. This process is called intercalation and can be described as 
the realization of non-specific bonding (VDW and - stacking) between the bases of the 
DNA and the EtBr molecule. In other words, the EtBr molecule slides in between the base-
 
Chapter 4: Physico-chemical characterisation of multifunctional synthetic vectors 121 
pairs of the minor groove part of the helix and causes a deformation of the DNA strand which 
is countered by the rigidity of the phosphate-sugar backbone 6 . The intercalation 
phenomenon can be detected by fluorescence measurements originating from the EtBr 
molecule. Upon irradiation, the EtBr molecule absorbs light (UV or VIS, see excitation curve 
Fig. 4.6) and emits correspondingly light of 590 nm by means of fluorescence. When DNA is 
brought into a solution of EtBr, abundant intercalation will cause a considerable increase in 
fluorescence (> 20 times). If polymer is added to this solution, intercalation is inhibited 
because the electrostatic attraction forces between DNA and the polymer are multiple times 
stronger which is accompanied by a loss in fluorescence, hence the use of the term EtBr 
displacement assay7. The stepwise addition of polymer to an EtBr-intercalated DNA solution 
enables the set-up of a condensation profile (in which the fluorescence yield is correlated 
with the amount of polymer added, expressed in CR).  
Since EtBr intercalation substantially stabilizes the DNA, the concentration of EtBr used 
should be carefully selected. An optimum is to be reached between opposite needs that on 
one hand require a sufficient amount of EtBr present in order to detect a clear signal 
whereas on the other hand the quantity of EtBr should be kept as low as possible to allow 
inhibition of the intercalation process by cationic polyplex formation. From literature, this 
value was found to function best within the range of 0.2-0.4 µg/ml8. The spectrum of EtBr 
(excitation and emission pattern) as well as the structure are shown below (Fig. 4.6).  
 
Figure 4.6 - Fluorescence wavelength spectrum of EtBr and its structure 
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polyplex. Prior to this collapse, the fluorescence signal generally increases modestly, a 
phenomenon which can explained by the presence of small quantities of polymer that 
promote the stability of DNA and allow an even higher level of intercalation. Polymers can be 
mutually compared by plotting the fluorescence as a function of polymer added. Several 
interpretations are given to these graphs of which the MinF (relative fluorescence at a CR of 
2/1) and the CRminF (lowest CR that represents the steepest fluorescence drop), derived from 
the intersection of the tangent and the X-axis, are considered the most relevant. This latter 
value is often referred to as the complexation or condensation point.  
3.1.1 One-step versus multi-step polyplex formation 
Conform the data presented in section 2.3 of this chapter, the use of EtBr fluorescence 
spectroscopy was likewise applied to confirm the similarity in polyplex formation between 
one-step and multi-step polymer addition. A comparison between these two methods (up to 
polyplexes with a CR of 2/1) led to the conclusion that after 30 minutes of stabilisation, MinF 
fluorescence values did not differ more than 5 % (Fig. 4.7). Unlike for UV analysis, the 
decrease in fluorescence yield is a measure for the formation of a polyplex and corresponds 
with a loss of EtBr intercalation (described in section 3.1) rather than being the result of 
higher level of shield (and DNA absorbance decrease). These results validate the possibility 
to apply both methods, yet preference is given to the more sensitive fluorescence analysis.  
 
Figure 4.7 – EtBr Fluorescence data (MinF) in which multi-step and single-shot polyplex 
formation are compared for different polymers (MW ≈ 10.000 Da, PEI = 25.000 Da). 
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3.1.2 Polyplex formation: kinetics and stability in time 
Besides the obvious capacity to attract DNA, a polymeric vector needs to preserve this 
interaction for a sustained time. A simple way to check this feature can be accomplished by 
measuring the fluorescence intensity of polyplexes for a prolonged time. Additionally, from 
this experiment, a basic idea on the rate of polyplex formation can be deduced by focusing 
on the time required to obtain stable polyplexes. This investigation was carried out at a CR 
of 2/1 so that for all polymers tested, polyplex formation could be reached. 
Figure 4.8 demonstrates the EtBr fluorescence yield for several polyplexes as a function of 
time. In general, polymer-DNA complexes already experience more than 90 % of their total 
fluorescence decrease 30 seconds past polymer addition (single-shot) after which the value 
reaches a plateau (Fig. 4.8 – zoomed rectangle). The formation of polyplexes based on PEI 
deviated considerably from previous conclusion and demands an incubation time of 1 hour 
to reach a stable value. Initial confirmation of the ability for polymers to condense DNA is 
already apparent from this experiment but will be discussed further on (section 3.1). 
Nevertheless, this experiment proved that polyplexes were able to interact with DNA for a 
prolonged time and were ready to be used after 10 min of incubation (except for PEI). A fully 
substantiated kinetic approach in understanding polyplexes and polyelectrolyte mediated 
forces was not within the scope of this doctoral research.  
 
Figure 4.8 - EtBr fluorescence of different polyplex compositions prepared using single shot 
addition (CR 2/1): stability as a function of time.  
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3.1.3 Biodegradable polymers 
In chapter 2, the synthesis of biodegradable poly--aminoacids was discussed and several 
derivatives with potential use as synthetic vectors were produced. As a useful tool EtBr 
displacement assays were carried out and these results were analysed in a systematic 
approach including a correlation with structural properties. 
3.1.3.1 p(DMAEG) 
At first, the influence of the MW on the condensation ability was verified. This test was 
carried out on pDMAEG derivatives and is accepted to apply for all poly-L-glutamines. The 
MW appeared to have a small influence on the DNA-binding capacity and there seems to be 
a trend that favours the use of short polymer chains since DNA complexation occured at 
lower CR’s (Fig. 4.9). This is advantageous for the in vitro viability because the lower the 
amount of polymer presented inside cells, the lower the toxicity of these delivery systems is 
expected to be. A lower requirement for cationic polymer to induce a total collapse of DNA 
into a small particle (CRminF) can be ascribed to an optimal polymer rearrangement due to 
the increased mobility of smaller polymer chains compared to larger ones. Moreover at a CR 
of 2/1 (MinF), a similar trend was noticed. With decreasing MW, lower fluorescence values 
were observed which indicated reduced intercalation which corresponds with a tighter DNA 
interaction. An indication of the CRminF value (= 0.9) and MinF value (25%) for p(DMAEG) 10 
kDa is indicated by dashed lines. 
 
Figure 4.9 – EtBr fluorescence assay of pDMAEG: Influence of the MW. 
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3.1.3.2 The main effect of functional group replacement 
The base polymer pDMAEG, which contains tertiary amines, displays intense interaction 
behaviour with DNA due to its corresponding pKa and predominantly positive charge when 
incorporated into a polymer. Because of biological requirements, polymers possessing other 
functional groups were synthesised and consequently could affect the interaction qualities 
compared to pDMAEG (MW = 10.000 Da). If a small amount of tertiary amines in the side 
chain was replaced by primary amines, there appeared to be almost no difference noticeable 
in complexation behaviour. For p(DMAEG90%-AEG10%) with a MW of 6 kDa, the MinF 
remained the same and the CRminF increased no more than 5 % (Fig. 4.10). When a non-
charged functional group was introduced (-OH) a clear decrease in fluorescence was noticed 
at a CR of 2/1 (approx. 20%). The importance of the type of cationic group was also here 
observed, given the fact that the MinF of p(DMAEG61%-HEG39%) is higher than the one of 
p(DMAEG23%-GuAEG27%-HEG50%) while the latter one contains less cationic charges, 
indicating the stronger attraction force derived from guanidine functional groups. 
 
Figure 4.10 - EtBr fluorescence assay: effect of functional group replacement (MW = 10 kDa): 
pDMAEG, p(DMAEG90%-AEG10%); p(DMAEG61%-HEG39%) & p(DMAEG23%-GuAEG27%-HEG50%). 
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charge required for convenient DNA complexation. As can be noticed in figure 4.11, the 
condensation capacity of the polymers is logically increasing with higher quantities of charge 
present on the polymer. Optimal condensation is reached when the complexation coincides 
with a large, sharp drop in fluorescence. This appeared to be the case for the polymer 
possessing 55 % of guanidine groups while for the derivative containing 35 % (or less) of 
charges, this drop was smaller in size and smoother. Accordingly, the critical guanidine 
concentration to induce swift and intense polyplex formation at a low CR is assumed to be 
between 40 to 50 %. 
 
Figure 4.11 – EtBr fluorescence assay for p(HEGx-GuAEGy) 10 kDa: effect of guanidine (% y). 
3.1.3.4 Imidazole-containing polymers 
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the presence of functional groups that can be protonated and the neighbouring effect typical 
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need even further, derivatives containing imidazole moieties were developed on account of 
their pKa value (pKa of conjugated acid ≈ 7, partially charged at physiological pH). The 
fluorescence assay of these derivatives reveals that the contribution of imidazole functional 
groups in DNA interaction is less than that of the guanidine group. As demonstrated in figure 
4.12, a derivative with a substantial higher amount of imidazole (80%) displays a weaker 
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into account when discussing non-charged imidazole groups. Certain hydroxyl-containing 
variants appear to have lower CRminF values than certain higher charged polymers like 
p(ImEG80%-GuAEG20%)) and comparable MinF values. This confirms that the DNA interaction 
based on imidazole is not so intense and suggests that the presence of hydroxyl groups 
demonstrates a stronger association with DNA than anticipated based on the net charge (for 
instance by means of H-bonding)9. For non-charged imidazole moieties, the quality of H-
bridging is much lower than for hydroxyl groups which partially explains the observed effect.  
 
Figure 4.12 - EtBr fluorescence assay: Imidazole incorporation to enlarge the buffering 
properties (poly-L-glutamines with a MW of about 10,000 Da). 
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this suggests that the collapse into a small particle is much less intense and happens at a 
slower pace. Hence, particles of lesser quality (i.e. larger, more weakly bound) are expected 
although this assumption is not confirmed by DLS measurements (section 4.4). Because all 
the polymers used for this experiment have an equal MW, the CR at which condensation 
starts, is similar (ranging from 0.6-1.0). Furthermore, the superior interaction ability of 
guanidine functional groups as opposed to tertiary amines is apparent when comparing MinF 
of p(HEG-GuAEG) and p(HEG-DMAEG) derivatives. On the other hand, the slightly more 
voluminous guanidinium group (with different charge density) induces a particle formation at 
a higher CRminF (also confirmed in Fig. 4.10). 
 
Figure 4.13 - EtBr fluorescence assay: poly-L-glutamines (MW ≈ 10 kDa), high charge (≈ 60%). 
 
Figure 4.14 - EtBr fluorescence assay: poly-L-glutamines (MW ≈ 10 kDa), low charge (≈ 25%). 
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To finalise, it can be concluded that fully charging a polymer is not required to obtain a fluent 
and strong complexation between a polymeric vector and DNA. Moreover, the use of 
guanidine functional groups can induce the most optimal polyplex profile (strong interaction 
and swift complexation). Imidazole moieties express a lower interaction with DNA (due to 
partial protonation) than guanidines, yet when present in sufficient quantity (> 40%) or 
combined with additional charged functional groups, this does not negatively interfere with 
the complex formation. As a result, they can be involved in the polymer synthesis when 
considered biologically relevant (e.g. enhanced buffereing). Additionally, neutral hydroxyl 
functional groups can be used to dissipate charge over the entire polymer and further 
complete the total composition of the side chain (to influence the desired charge density). 
Whether a polyplex should be strong and tight or more loose can only be confirmed by 
biological transfection studies, yet the requirement for intra-cellular polyplex dissociation and 
the need to protect the therapeutic DNA until the cell nucleus suggests that a little of both 
approaches is in order. 
3.1.3.6 Arginine-based polymers 
Besides poly-L-glutamine based biodegradable vector systems, also poly-L-arginine (pARG) 
and other L-arginine derivatives were subjected to a physico-chemical characterisation. 
Considering that the homopolymer, pARG (MW ≈ 80.000 Da) bears solely guanidine 
functional groups (that represent a pKa of 12.5 for the conjugated acid), the polymer 
comprises a high amount of charge as marked in the corresponding EtBr fluorescence assay 
(Fig. 4.15). Both a low MinF value (16%) as well as a low CRminF (1.0) are noticed with a very 
sharp transition upon complex formation. The profile for p(ARG82%-ORN18%) of the same MW 
largely resembles the homopolymer. Hence, the amount of primary amine required for 
further coupling does not exert a significant influence. A copolymer that contains both a 
hydroxyetlyglutamine (HEG) and arginine part as backbone, p(HEG58%-ARG42%) was 
likewise prepared and its structure was compared with other arginine derivatives as well as 
with its glutamine-based counterpart, p(HEG-GuAEG). The small difference in its structure 
lies in the distance between the charge, located on the side-chain, and the backbone, a 
parameter which is often not considered and that could have serious biological implications 
(for instance in receptor communication)10. The p(HEG58%-ARG42%) vector has a MW of 
about 56.000 and displays a fluorescence pattern similar to p(HEG-GuAEG) which indicates 
that there is still sufficient mobility to induce an optimal orientation around DNA despite the 
shorter side-chain (when compared to GuAEG). When the arginine residues are 
incorporated in another way, that is by grafting pARG onto an L-glutamine based polymer 
containing primary amines that can act as an initiator, for instance p(HEG87%-AEG13%) with a 
MW of about 10.000 Da, a very pronounced influence is perceived. More specifically, 
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condensation occurs at a lower CRminF(0.9) and tighter polyplexes are obtained (lower MinF, 
22 %) than for p(HEG58%-ARG42%) although the effect of the smaller MW should be taken 
into account as well. The effect of charge position and orientation will be discussed later on. 
 
Figure 4.15 – EtBr fluorescence assay: p(ARG) 80 kDa; p(ARG82%-ORN18%) 80 kDa; p(HEG58%-
ARG42%) 56 kDa; p(HEG87%-AEG13%)+p(ARG) grafts (10 + 2 kDa). 
3.1.4 Non-biodegradable polymers 
In the framework of developing synthetic vectors that demonstrate a high level of biological 
activity and to substantiate structure-property relations of polymers applied as gene delivery 
systems, a group of non-biodegradable polymers based on a methacrylate backbone was 
likewise evaluated and compared to biodegradable compounds. Since these compounds 
have a more hydrophobic nature, varying results were expected.  
3.1.4.1 p(DMAEMA) 
The basic polymer suitable for comparison to biodegradable counterparts is p(DMAEMA), a 
polymer containing exclusively tertiary amines. Several compounds with a variable MW were 
synthesised and their ability to interact with DNA was checked by an EtBr displacement 
assay. In contrast to glutamine-based polymers,  p(DMAEMA) (Fig. 4.16) indicates an 
optimum existing in the formation of polyplexes. Both high and low MW polymers show 
complexation at higher CR’s (CRminF deviates up to 0.4 CR units) than the intermediate 
polymer of 121 kDa. The optimal MW also exhibits the strongest interaction with DNA (at 
MinF) although the difference with other MW’s is limited. Seeing that mobility is not the 
decisive parameter, secondary effects (like the influence of hydrophobic backbone in an 
aqueous environment) could play a role in explaining the essential function of chain length.  
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Figure 4.16 - EtBr fluorescence assay of p(DMAEMA): influence of the MW. 
To facilitate the interpretation of the influence of the MW, the CRminF values of a range of 
different DMAEMA-polymers with various MW were compared (Fig. 4.17). From these 
results, the optimal MW appeared to be situated in the range of 100-150 kDa. To validate 
this assumption, experiments with more polymers having a MW close to the ‘optimum’ 
should be carried out. Confirmation of this trend could partially be inferred from previous 
doctoral research for p(DMAEMA) by Dubruel et al2.  
 
Figure 4.17 – CRminF of various p(DMAEMA): influence of MW on the condensation ability2.  
3.1.4.2 The effect of functional group replacement 
Replacing functional groups in p(DMAEMA) has a more explicit influence than for 
p(DMAEG). Whereas for glutamine-based polymers only the introduction of a substantial 
amount of hydroxyl groups provoked a decreased interaction with DNA, for 
polymethacrylates a minor change of the composition has considerable consequences for 
0,0 
20,0 
40,0 
60,0 
80,0 
100,0 
120,0 
0 0,2 0,4 0,6 0,8 1 1,2 1,4 1,6 1,8 2 2,2 
Fl
u
o
re
sc
e
n
ce
 (
%
) 
Charge ratio 
12 kDa 
29 kDa 
121 kDa 
310 kDa 
658 kDa 
0,5 
0,6 
0,7 
0,8 
0,9 
1 
1,1 
1,2 
1,3 
10 100 1000 
C
R
m
in
F 
MW (kDa) 
p(DMAEMA) 
Dubruel et al. 
 
Chapter 4: Physico-chemical characterisation of multifunctional synthetic vectors 132 
the capacity to prevent EtBr displacement (Fig. 4.18). Even at small concentrations of 
primary amines present (p(DMAEMA82%-AEMA18%) – 191 kDa), a shift towards a higher 
CRminF value is required for the start of polyplex formation. This is remarkable because the 
difference between p(AEMA) 176 kDa and p(DMAEMA) 121 kDa homopolymers is rather 
small. These unfavourable effects are even more clear when charged groups are replaced 
by hydroxyl groups (p(DMAEMA80%-HEMA20%) – 187 kDa) causing a CRminF shift of nearly a 
full CR unit. The interaction strength at full condensation (when a plateau value is reached) 
is not affected for primary amines but is very pronounced for hydroxyl-based derivatives 
(loss of about 30 % at MinF) because of the obvious loss of charge. Combining tertiary amine 
groups and primary functional groups in one polymer confirms the different nature of the 
methacrylate and amide compounds in polyplex formation (CRminF values). Because the 
extra opportunity for hydrogen bonding with the backbone is excluded for polymethacrylates, 
only side-chain/side-chain H-bonding remain possible. The extent to which primary amines 
are incorporated appears to have a strong effect on the CRminF value and is most likely 
related to the polymer conformation (e.g. limited intra-molecular interaction for small portions 
of primary amines). For poly-L-glutamine compounds on the other hand, H-bonding with the 
backbone compensates the lack of interaction which might be needed to change the polymer 
conformation in such a way that the spatial rearrangement with DNA is different (expressed 
by the different CRminF). This is also revealed when comparing hydroxyl-based copolymers of 
both types, specifically the CRminF value is much less shifted in the case of glutamine 
because backbone H-bonding remains. The MinF value in contrast, is not affect, indicating 
that the DNA interaction remains mainly driven by the electrostatic forces. 
 
Figure 4.18 – EtBr fluorescence assay: influence of functional group for p(DMAEMA) 121 kDa, 
p(AEMA) 176 kDa, p(DMAEMA82%-AEMA18%) 191 kDa & p(DMAEMA80%-HEMA20%) 187 kDa. 
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3.1.4.3 The impact of type of functional group  
The type of functional group on which the charge is located, was proven to be quite relevant 
for glutamine based polymers. For methacrylate polymers on the other hand, the difference 
appeared to be more restricted (Fig. 4.19). The condensation profile of p(DMAEMA) with a 
MW of 29 kDa and p(GuAEMA) with a MW of 63 kDa turned out to be virtually the same 
(equal CRminF and a MinF value differing less than 5 %). For copolymers that also contain 
neutral functional groups, the effect was more pronounced. The apparent resemblance 
between p(DMAEMA55%-HEMA45%) with a MW of 14 kDa and p(GuAEMA40%-HEMA60%) – 
MW 29 kDa is due to the higher amount of charge present on the former. This discrepancy 
masks the actual difference of a derivative possessing an equal amount of charges (with a 
more or less equal CRminF but higher MinF value in the case of tertiary amines). The effect of 
the pKa value is very clear in the case of p(AEMA40%-HEMA60%) – 29 kDa and its guanidine 
modified version that has a weaker ability to attract DNA and a correspondingly higher MinF 
value.  
 
Figure 4.19 – EtBr fluorescence assay: influence of type of charged functional group on 
methacrylate based compounds: p(GuAEMA) 63 kDa; p(DMAEMA) 29 kDa; p(GuAEMA40%-
HEMA60%) 29 kDa; p(DMAEMA55%-HEMA45%) 14 kDa & p(AEMA40%-HEMA60%) 29 kDa.  
3.1.5 PEI  & PEI-derivatives 
Throughout this research, the potential of newly developed synthetic vectors was on a 
permanent basis compared to PEI , a vector that is widely considered as highly active. As a 
consequence of the negative effect it has cellular viability, several research groups started 
the investigation of PEI modification during the last years11,12,13,14,15,16,17. Based on previous 
statements, claiming the beneficiary effect of arginine residues on both the DNA interaction 
and cellular uptake, modified PEI-derivatives were also synthesised and characterised within 
0,0 
20,0 
40,0 
60,0 
80,0 
100,0 
120,0 
140,0 
0 0,2 0,4 0,6 0,8 1 1,2 1,4 1,6 1,8 2 2,2 2,4 2,6 2,8 3 3,2 
Fl
u
o
re
sc
e
n
ce
 (
%
) 
Charge ratio 
p(GuAEMA) 
p(DMAEMA) 
p(GuAEMA-HEMA) 
p(DMAEMA-HEMA) 
p(AEMA-HEMA) 
 
Chapter 4: Physico-chemical characterisation of multifunctional synthetic vectors 134 
this research. Modification was carried out by using similar guanidylation strategies as 
before and which appeared to be applied as well by others as reported in literature later18,19. 
The interesting potential of grafting onto PEI was likewise evaluated in order to maintain the 
excellent buffering capacity while enhancing the DNA-interaction and cell toxicity. Therefore, 
the poly-L-glutamine grafts were modified with both hydroxyl and guanidine functional 
groups. Fluorescence analysis of PEI, PEI-Guan20% and PEI-pGLN (HEG63%-GuAEG37%) is 
shown below in figure 4.20. 
According to expectations, PEI displays a swift complexation with DNA (CRminF around 0.8). 
Converting the primary amines into guanidine functional groups causes a change in MinF 
(about 20% lower) but has a similar CRminF value although a a much steeper drop in 
fluorescence was observed. This contrast is on one hand ascribed to the nature of the 
guanidinium group (higher pKa of conjugated acid) but also to the change in charge 
distribution and corresponding buffering ability. When poly-L-glutamine grafts are introduced, 
the polyplex profile is largely altered. Due to the nature of the glutamine composition (with a 
high hydroxyl content), the interaction force is slightly decreased. Additionally, grafting onto a 
branched molecule, drastically expands the hydrodynamic radius and because of the 
diminished occurrence of charged groups a more diffuse cationic pattern is observed which 
leads to higher values of CRminF (1.6). On the other hand, by increasing the charge density 
on the grafts, the interaction (MinF) can be intensified. The medium MinF value of PEI could 
suggest that the success of this compound is attributed to an optimal interaction with DNA, 
meaning a strong but not inseparable bond with DNA, able to dissociate during endosomal 
escape.  
 
Figure 4.20 - EtBr fluorescence assay of PEI, guanidylated PEI and L-glutamine grafted PEI. 
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3.1.6 Conclusion 
EtBr-based fluorescence experiments in which the formation of polyplexes is proportional to 
the degree of decreased intercalation, proved to be a very suitable characterisation 
technique that provides global information on the interaction strength of polyplexes and the 
quality to start forming these complexes. Fully charged polymers, both biodegradable and 
non-biodegradable readily form polyplexes and do this in strong manner (tight complexes) as 
indicated by the often low values of MinF. The introduction of other functional groups than 
tertiary amines, results in different condensation profiles for these two classes of synthetic 
vectors. If replaced by other charged groups, there was nearly no change observed for poly-
-aminoacids whereas a more distinct influence was noticeable for polymethacrylate-
derivatives (higher CRminF values). In both cases, the introduction of guanidines appeared to 
reinforce the interaction, also for PEI. When neutral functional groups where built-in during 
synthesis, the CR required to induce polyplex formation was increased and the interaction 
strength lowered (higher MinF values). For poly--aminoacids this effect was less 
pronounced than for polymethacrylates where a small quantity of hydroxyl group causes a 
clear CRminF increase and MinF decrease which illustrated the different nature of the polymer 
backbones. In the case of poly-L-glutamines, imidazole functional groups were deemed 
appropriate to be assessed as biological enhancers while preserving the physical behaviour. 
The condensation of DNA was inversely proportional to the MW for biodegradable polymers 
but for polymethacrylates, an optimum was observed that favours vectors with a MW around 
100.000 Da. Grafting onto a polymer via the side-chain generally increases the size and the 
complexation ability of these compounds. Dependent on the type of grafting (highly charged 
or rather neutral), the polymers can be rendered highly interacting or considerably less 
interacting, regardless of the base polymer involved.   
Table 4.1 gives an overview of the different CRminF and MinF values for the tested polymers. 
 
Polymer Mw (kDa) CRminF MinF 
pDMAEG 10 0.9 25 % 
pDMAEG 30 1.0 30 % 
pDMAEG 80 1.2 33 % 
pDMAEG 242 1.3 40 % 
p(DMAEG90%-AEG10%) 6 1.0 30 % 
p(DMAEG60%-HEG40%) 10 1.1 52 % 
p(HEG85%-GuAEG15%) 10 2.6 81 % 
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p(HEG75%-GuAEG25%) 10 2.8 70 % 
p(HEG65%-GuAEG35%) 10 1.7 48 % 
p(HEG45%-GuAEG565%) 10 1.6 26 % 
p(ImEG65%-GuAEG35%) 10 1.2 26 % 
p(ImEG80%-GuAEG20%) 10 1.5 50 % 
p(HEG49%- GuAEG15%-ImEG36%) 10 1.1 47 % 
p(HEG79%- GuAEG12%-ImEG9%) 10 1.5 68 % 
p(HEG50%- GuAEG27%-DMAEG23%) 10 1.2 43 % 
p(HEG76%- GuAEG11%-DMAEG13%) 10 2.2 84 % 
pARG 80 1.0 13 % 
p(ARG82%-ORN18%) 80 1.1 19 % 
p(HEG58%-ARG42%) 56 1.2 42 % 
p(HEG87%-AEG13%)+pARG grafts 10 0.9 22 % 
PEI 25 0.8 33 % 
PEI+Guan20% 25 0.8 14 % 
PEI+p(GLN) 25 1.6 61 % 
pDMAEMA 12 1.2 23 % 
pDMAEMA 29 1.0 20 % 
pDMAEMA 121 0.9 18 % 
pDMAEMA 310 1.0 19 % 
pDMAEMA 658 1.1 20 % 
pAEMA 176 1.0 21 % 
pGuAEMA 63 1.0 19 % 
p(DMAEMA82%-AEMA18%) 191 1.3 21 % 
p(DMAEMA82%-HEMA18%) 187 2.1 53 % 
p(DMAEMA55%-HEMA45%) 14 1.8 49 % 
p(GuAEMA40%-HEMA60%) 29 1.8 42 % 
p(AEMA40%-HEMA60%) 29 1.8 77 % 
Table 4.1 - Summary of CRminF & MinF values (EtBr fluorescence assay). 
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3.2 Agarose Gel-electrophoresis 
In order to substantiate the results derived from EtBr fluorescence analyses, gel-
electrophoresis is applied as a secondary technique in validating polyplex formation. Gel-
electrophoresis based on agarose (AGE), the most suitable matrix to separate large nucleic 
acids, is an easy way to split-up and visualize DNA fragments based on their size, hence its 
classification as size-exclusion chromatography (SEC). Nevertheless, this method is 
differently employed in this experiment: vector-associated DNA (polyplex) is prevented from 
migrating through an agarose gel under the influence of an electric field whereas free DNA is 
not (Fig. 4.21). In such a way, not the degree of migration is considered important but merely 
the inhibition of DNA migration towards the positive anode 20 . Complexation of DNA 
neutralises and shields the negative charge so that migration is prevented. Complete 
condensation leads to retention in the wells of the gel as is visualised by EtBr staining 
afterward (no DNA bands visible). The extent of DNA migration will depend on the quality of 
condensation, determined by the degree of DNA-polymer interaction and in practise, this is 
noticed by a gradual decrease in staining intensity. When the DNA signal has completely 
faded, this value is considered as the condensation CR (CRcond). 
 
Figure 4.21 – Schematic impression of gel-electrophoresis with corresponding DNA migration. 
In AGE, mixtures of DNA and polymer with increasing CR (0.2 step) are injected onto an 
agarose gel (1 %). To prevent diffusion of the compounds into the buffered environment (1x 
TBE buffer), they were mixed with 10% of loading buffer (50 % glycerol, 0,1 % bromophenol 
blue). A voltage of 90 V was applied during one hour and subsequent staining of the DNA 
was carried out by submerging the gel in an EtBr solution (0.5 mg/ml) followed by 
visualisation on a transilluminator using UV-B light ( = 312 nm). Pure, free DNA was always 
checked as well to allow comparison. The corresponding results are shown below. 
3.2.1 DNA-condensation by cationic biodegradable polymers 
The results represented in figure 4.22, confirm the trends derived from EtBr fluorescence 
measurements. PEI (A) and PEI-Guan20% (B) display the same CR values as previous 
established (0.6 / 0.8 units) and in the case of PEI-Guan the DNA band corresponding with a 
wells E
matrix
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polyplex of 0.6/1 is stained weaker since complexation is already starting (analogue to Fig. 
4.20). For p(DMAEG) and p(DMAEG85%-AEG15%) of respectively 80 and 91 kDa, also a 
consistent result was obtained with both polymers demonstrating polyplex formation at a CR 
of 1.0 and a sharp transition from stained free DNA (CR 0.8) to non-visible polyplex (CR 
1.0). Dependent on experimental irregularities and the fact that AGE is a technique which is 
based on a different principle (SEC compared to spectrometry for EtBr fluorescence), small 
deviations of the results obtained by fluorescence are frequently observed (e.g. 0-0.2 CR 
units). This occurred also for p(ARG) as shown in Fig. 4.22 – E where the inhibition of DNA 
is only fully achieved at a CR of 1.2 instead of 1.0 for EtBr fluorescence.   
 
Figure 4.22 - AGE images of PEI (A), PEI-Guan (B), p(DMAEG) 80 kDa (C), p(DMAEG85%-AEG15%) 
91 kDa (D) and p(ARG) 79 kDa (E). 
Similar to fluorescence analysis, general trends concerning the composition could be spotted 
for p(HEG-GuAEG) (Fig. 4.23). With a decreasing amount of charged guanidine functional 
groups, the ability to enclose DNA becomes less pronounced, visualised by the presence of 
a DNA smear that is gradually decreasing towards higher CR’s (compare to Fig. 4.11). The 
values obtained here are substantially lower than those measured with fluorimetry and seem 
to be comparable to the start of the fluorescence drop (starting from the maximum peak 
value at the beginning, section 3.1) and end when a relative value of 80 % is crossed.  
The importance of the nature of the charged group involved as well as the influence of 
combining two or more types of functional groups could also be verified from electrophoresis 
(Fig. 4.24). A sufficiently high amount of charged groups in combination with charge 
separators (hydroxyl groups) is perfectly capable of forming tight complexes at low CR’s 
(0.8), confirmed in image A and B. When smaller amounts of charged groups are applied, 
the minimal CR for full condensation is accordingly augmented (Fig. 4.24 – C to E). The 
importance of hydroxyl groups, which are in the first place applied to diminish the overall 
charge and to induce more charge dispersity, appears from these images. A substantial 
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amount of imidazole moieties is only efficient in helping attract DNA when hydroxyl groups 
are present because the polymer containing both hydroxyl and imidazole (C) has a lower 
complexation point (1.8) despite the lower amount of charged groups on the hydroxyl-
containing polymer. This is confirmed by comparing image 4.24 – D (CRcond > 2.0) with figure 
4.23 – C/D which have a comparable amount of guanidines. 
 
Figure 4.23 - AGE images of (A) p(HEG45%-GuAEG55%), (B) p(HEG65%-GuAEG35%), (C) p(HEG75%-
GuAEG25%) and (D) p(HEG85%-GuAEG15%) with a MW of about 10,000 Da. 
 
Figure 4.24 - AGE images of (A) p(HEG60%-DMAEG40%), (B) p(HEG45%-GuAEG55%), (C) p(HEG49%-
GuAEG15%-ImEG36%), (D) p(GuAEG20%-ImEG80%) and (E) p(GuAEG35%-ImEG65%) (MW ≈ 10,000 Da). 
The hypothesis that imidazole functional groups change the way the polymer interacts with 
DNA is once more proven by mutually comparing imidazole-containing polymers (Fig. 4.25). 
When drawing a parallel between images B and D, the latter polymer contains more charged 
groups and more imidazole groups but has no hydroxyl groups (CRcond = 2.0). Nevertheless 
polymer B, which has about 50% of neutral groups exhibits a more or less equal CRcond 
(1.6). This leads to believe that a higher ratio of imidazole is required to obtain a polymer 
that demonstrates swift polyplex formation. But from image C can be concluded that only 
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weakly associated complexes are formed if the quantity of imidazole groups is raised. 
Therefore, only if the amount of charged groups is increased, will tighter complexes be 
formed and a lower CRcond be obtained. The exclusive addition of hydroxyl groups is 
consequently not sufficient to enhance DNA interaction with imidazole possessing polymers 
(as noted from image A) and therefore the combination of hydroxyl and charged groups 
remains advisable in the case of imidazole-containing derivatives.  
 
Figure 4.25 - AGE images of (A) p(HEG79%-GuAEG12%-ImEG9%), (B) p(HEG49%-GuAEG15%-
ImEG36%) (C) p(GuAEG20%-ImEG80%) and (D) p(GuAEG35%-ImEG65%). MW = 10,000 Da. 
In general, it can be concluded that AGE largely confirms the results given by EtBr 
fluorescence with a margin for the CRcond that corresponds with full condensation (CRminF). 
When the fluorescence intensity is decreasing, there appears to be a tendency within 
corresponding AGE experiments to start observing inhibition of DNA. Roughly stated, the 
CRcond in AGE experiments is reached when the fluorescence intensity of the 
corresponding EtBr experiments drops below 80%.  This indicates that weakly bound 
complexes can not always be distinguished from tighter ones. On the other hand, in nearly 
all cases, a graduate decline in fluorescence correlates with a similar decrease in related 
AGE images, i.e DNA bands that display a shorter run-length and intensity (‘fuzzy smear’). 
Finally and most importantly, the relative ratio for condensation between the different 
polymers remains for both techniques. 
3.2.2 Gel-electrophoresis results of non-biodegradable polymers   
Homopolymers of p(DMAEMA) revealed that the correlation between the MW and the ability 
to form complexes with DNA was resembling the curve of a parabola with a minimum (in 
CRminF) for polymers with a MW around 100.000-150.000 Da. This trend was equivalent with 
the one observed from AGE images. Whereas the extreme values display full condensation 
at the highest CR’s (1.6 for 658 kDa and 1.2 for 11.9 kDa), the derivative of 121 kDa 
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prevents DNA migration already at a CR of 1.0. The closer the MW is shifted to the optimum, 
the lower the CR gets (Fig. 4.26).   
 
Figure 4.26 – AGE images of p(DMAEMA): 11.9 kDa (A), 29.2 kDa (B), 121 kDa (C), 310 kDa (D) 
and 658 kDa (E). 
AGE images of other types of methacrylate polymers are shown below in figure 4.27. For the 
homopolymer of pAEMA with a MW of 176 kDa (A), a similar result was obtained (CRcond of 
1.0 which is similar to pDMAEMA 121 kDa). If copolymers were evaluated, fluorescence 
analyses pointed out that a high increase in CRminF and/or MinF was readily observed. 
Nevertheless, the electrophoresis result of p(DMAEMA82%-AEMA18%) did not show an 
increase but rather a decrease in CRcond needed to inhibit DNA migration. Mainly the 
presence of hydroxyl-containing HEMA in copolymers demonstrated clear deviations, both 
for CRminF and MinF. Images C – E show a p(DMAEMAx%-HEMAy%) derivative with increasing 
HEMA content (20, 44 and 66 % respectively) and their correspondent augmentation in CR 
required for the prevention of DNA migration. Despite the analogous trend, lower CRcond-
values are displayed with gel-electrophoresis (1.2, 1.4 and 1.6) compared to EtBr 
fluorescence. The incorporation of neutral hydroxyl groups turned out to affect the interaction 
with DNA differently for methacrylate compounds and poly--aminoacids, especially for 
small quantities of hydroxyls. At higher amounts of neutral groups, this reduced attraction 
was compensated by the lack of cationic charges that induced a general decline in DNA 
attraction as these forces are evidently of a much higher degree than the inter-molecular 
forces H-bonding is based on. Briefly, it could be stated that supplying polymethacrylates, 
which already have a non-polar backbone, with neutral functional groups is disadvantageous 
since all polarity and charge is ascribed to the presence of protonable side-chains whereas 
for poly-L-glutamines, sufficient polarity remains provided by the backbone, hence the 
positive effect of H-bonding neutral groups (in case of charge surplus).   
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Figure 4.27  – AGE images: p(AEMA) 176 kDa (A), p(DMAEMA82%-AEMA18%) 191 kDa (B), 
p(DMAEMA80%-HEMA20%) 187 kDa (C), p(DMAEMA56%-HEMA44%) 218 kDa (D) and p(DMAEMA34%-
HEMA66%) 242 kDa (E). 
3.2.3 Influence of DNA concentration on polyplex formation 
As the main function of a gene delivery system is to supply DNA to cells of interest, the dose 
of DNA provided is preferably as large as possible (unless other specific requirements would 
contradict) to prevent the need for repeated administration. Therefore, the influence of the 
amount of DNA used for complexation with a cationic polymer was examined for two typical 
polymers via AGE (Fig. 4.28). In general, when the standard protocol is applied, a dose of 20 
µg/ml of DNA is delivered along with the polymer load. With increasing DNA amount, little or 
no change in complexation behaviour was perceived. Only for doses of 60 µg of DNA, a 
small decrease in CRcond could be noticed (of about 0.1-0.2 CR units). For PEI (Fig. 4.28 – 
upper row), this is only visible when focusing on the last DNA band (CR = 0.4) that is 
appearing as a smear rather than a well-defined line, of which the former is consistent with a 
higher amount of free DNA. In the case of p(DMAEG) – 80 kDa, the decrease is better 
identifiable (Fig. 4.28 – lower row) as well as the change in appearance of the DNA-band 
(vertical line representing a certain MW of DNA rather than a smear).  Higher quantities of 
DNA led to polyplexes that were insoluble or that precipitated shortly after preparation. 
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Figure 4.28 – AGE images of PEI (upper row) and p(DMAEG) (lower row) polyplexes loaded 
with an increasing amount of DNA. 
Table 4.2 gives an overview of the different CRcond values for the tested polymers. 
Polymer Mw (kDa) CRcond Polymer Mw (kDa) CRcond 
PEI 25 0.6 p(HEG40%-DMAEG60%) 10 0.8 
PEI-Guan20% 25 0.8 pDMAEMA 12 1.2 
pDMAEG 80 1.0 pDMAEMA 29 1.2 
p(DMAEG85%-AEG15%) 91 1.0 pDMAEMA 121 1.0 
pARG 79 1.2 pDMAEMA 310 1.2 
p(HEG85%-GuAEG15%) 10 > 2.0 pDMAEMA 658 1.6 
p(HEG75%-GuAEG25%) 10 2.0 pAEMA 176 1.0 
p(HEG65%-GuAEG35%) 0.8 1.7 p(DMAEMA82%-AEMA18%) 191 0.8 
p(HEG45%-GuAEG55%) 0.8 1.6 p(DMAEMA80%-HEMA20%) 187 1.2 
p(ImEG65%-GuAEG35%) 10 2.0 p(DMAEMA56%-HEMA44%) 218 1.4 
p(ImEG80%-GuAEG20%) 10 > 2.0 p(DMAEMA34%-HEMA66%) 244 1.6 
p(HEG49%- GuAEG15%-ImEG36%) 10 1.8 p(HEG79%- GuAEG12%-ImEG9%) 10 > 2.0 
Table 2 - overview of CRcond values for various tested polymers. 
 
4 Polyplex size and distribution 
4.1 Dynamic light scattering (DLS) 
Not only the ability of a polyplex to be taken up is dependent on its size but also the 
mechanism of cell internalisation is highly influenced by the dimensions. Since the formation 
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of a (tight) complex diminishes the overall spatial occupation of free DNA when collapsing 
into a nano-sized particle, the presence of tiny complexes is an ideal way to confirm the 
association between DNA and a cationic polymer. Moreover, an idea on the distribution of 
the particles can be obtained and the most-likely corresponding cellular uptake mechanism 
can be derived thereof. Photon correlation spectroscopy (PCS) is an ideal technique to 
obtain a basic idea of the size and size-distribution of polyplexes in solution21. Due to thermal 
energy and solvent interference, particles in solution move at random (Brownian motion) and 
the speed at which they do, can be linked to their size. This means that when particles are 
illuminated with a laser, the monochromatic light that gets scattered is fluctuating in a similar 
way as the speed of movement of the particles. This constructive and destructive 
interference of light scattered by moving neighbouring particles gives rise to the intensity 
fluctuation at the detector plane22. Analysis by means of algorithmic correlation of the time 
dependent intensity fluctuations yields the diffusion coefficient (D) of the particles and allows 
for the hydrodynamic radius (rD) to be calculated via the Stokes-Einstein equation:  
   
  
    
 
  k  = Boltzmann constant (1.38 x 10-23 J/K) 
  T  = absolute temperature (K) 
    = dynamic viscosity of the solvent (cP or centiPoise) 
  D  = diffusion coefficient (m²/s) 
This measuring technique enables a fast and sensitive way to detect particles in solution in a 
theoretical range of 1-5000 nm at low concentrations (up to 0.1 ppm)23 . The diameter 
obtained via this method corresponds with that of a sphere possessing an equal diffusion 
coefficient24.  
The time dependence of the intensity fluctuation is analyzed using a digital correlator which 
determines the intensity of the autocorrelation function. At short delay times, correlation is 
high but as particles diffuse, the correlation diminishes to zero. The exponential decay of the 
correlation function is characteristic for the diffusion coefficient of the particles. A 
monodisperse sample gives rise to a single exponential decay to which fitting a calculated 
particle size distribution is relatively straightforward. For polydisperse particles, the 
autocorrelation function is a sum of contributions from the various particle sizes and 
diffusional modes, and the interpretation of D becomes more complex. Many algorithms exist 
for fitting autocorrelation functions to particle size distributions. 
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For DLS experiments, polymer-DNA complexes (20 µg/ml DNA) of various CR (1/1, 2/1 and 
4/1)  were measured in PS cuvettes (2 ml content) at a scattering angle of 90° using light of 
488 nm (Argon laser). All results were integrated using the CONTIN algorithm and measured 
in triplicate. When measuring the size of a particle via DLS, the algorithm is able to produce 
a certain value based on the correlation data. Since random (Brownian) motion is at the 
base of this measurement and the fact that the polymers used for DNA complexation are 
disperse the outcome of an individual measurement always produces values (peaks) that 
demonstrate a certain width (distribution). Additionally, more than one distribution is often 
observed. 
4.2 PEI and modified PEI derivatives 
One of the reasons that PEI is performing exceptionally well as synthetic vector for gene 
delivery could be explained by the size of the formed polyplexes. As was mentioned earlier, 
the process by which external particles are taken up by a cell are amongst others related to 
the size and charge. It appears that PEI shows an uneven distribution (bimodal) that could 
suggest the requirement for different internalisation mechanisms such as caveolae or 
clathrin mediated endocytosis25 (Fig 4.29 – A). At low CR’s, polyplexes display an almost 
identical distribution of which one part (< 200 nm) is within the (theoretical) requirements for 
receptor-mediated endocytosis. When the CR is increased, the diameter of the particles 
becomes more uniform and lower in value (table 4.3, size in nm). If PEI is modified with 
guanidine groups, the size-distribution demonstrates a clear discrepancy with PEI (Fig. 4.29 
B), more specifically, unimodal at all CR’s and decreasing in size with increasing CR. The 
decrease in size is attributed to the stronger interaction originating from cationic guanidinium 
groups. Grafting a copolymer of p(HEG63%-GuAEG37%) of about 3.5 kDa onto PEI (= 
PEI+pGLN), on the other hand results in exclusively monomodal distributions with low 
values already at a CR of 1.0 even when full condensation had not occurred according to 
EtBr fluorescence results (Fig. 4.29 – C). It is not fully clear why already small particles are 
occurring at a CR of 1/1 but two possible hypotheses could explain this: on one hand, there 
is probably still a significant part of the total amount remaining as free DNA and polymer that 
causes sufficient fluorescence observed via an EtBr displacement assay. On the other hand, 
given the non-specific separation of MW during the purificiation process, there’s a big 
chance that some non-coupled PEI and poly-L-glutamine derivative exist that are able to 
form complexes separately at lower CR’s than the CR which corresponds to complexation 
for the PEI+pGLN graft polymer.    
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Figure 4.29 – Size distribution (signal intensity) as a function of complex diameter (nm): (A) 
PEI 25 kDa, (B) PEI-Guan20% 25 kDa, (C) PEI+p(HEG63%-GuAEG37%) grafts (25 + 3.5 kDa). 
Polymer 1/1 2/1 4/1 
PEI 149 (47%) / 320 (53%) 128 (50%) / 323 (50%) 62 (98%) / 295 (2%) 
PEI-Guan20% 104 ± 9 47 ± 5 - 
PEI+GLN grafts 47 ± 12 33 ± 7 30 ± 3 
Table 4.3 – Size of polyplexes expressed in nm at different CR’s. PEI 25 kDa, (B) PEI-Guan20% 
25 kDa, (C) PEI+p(HEG63%-GuAEG37%) grafts (25 + 3.5 kDa). 
 
4.3 Polyplexes based on biodegradable polymers 
In a similar way as for PEI, a series of p(DMAEG) with various MW was investigated. It 
appeared that all particles possessed particles sizes within typical requirements for 
endocytosis at every CR measured (except 1/1 of the high MW) with values reaching as low 
as 30 nm. Moreover, there seems to be an influence of the MW on the particle size which is 
in accordance with the previously performed fluorescence results. High MW compounds 
display an incomplete formation of complexes because the diameter of the particles 
decreases with increasing CR. Also, the occurrence of bimodal distributions at a CR of 1/1 is 
observed. For complexes assembled by low MW polymers, the smallest complexes seem to 
be formed already at a CR of 1/1 and increasing this ratio negatively affects the complex 
formation (by creating larger diameters). Additionally, the particles formed using low MW 
polymers form complexes with a more narrow distribution (Fig. 4.30 & table 4.4).  
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Figure 4.30 - Size distribution (signal intensity) as a function of particle diameter (nm) for 
p(DMAEG) compounds: (A) 10 kDA, (B) 30 kDa, (C) 80 kDa and (D) 242 kDa. 
Polymer 1/1 2/1 4/1 
10.000 Da 32 ± 5 66 ± 12 104 ± 8 
30.000 Da 34 ± 2 29 ± 2 30 ± 3 
80.000 Da 543 (65% )/ 184 (35%) 94 ± 2 87 ± 7 
242.000 Da 533 (18%) / 77 (82%) 24 ± 3 62 ± 4 
Table 4.4 – Effect of MW on size (in nm) of polymer-DNA complexes using p(DMAEG). 
When different functional groups were introduced, the particle size and distribution was 
limitedly affected for pDMAEG (table 4.5). Primary amine containing derivatives have 
polyplex sizes in the same range as the homopolymer and become smaller with increasing 
CR whereas the hydroxyl-based polyplexes tend to increase slightly with increasing CR, 
except for the copolymer that contains also guanidine functional groups. Furthermore, the 
influence of the MW remains clearly visible for all copolymer types and favours low MW 
compounds for obtaining the smallest polyplexes. For polyplexes with a CR close to the 
CRcond, the presence of (extra) distributions that are marked by a higher value is also 
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observed since the polyplexes are not yet strongly interacting and are therefore subjected to 
kinetic phenomena (local increases in electrolyte concentrations can temporarily form denser 
complexes with higher sizes until thermodynamic stability takes the upper hand).  
Polymer 1/1 2/1 4/1 
p(DMAEG85%-AEG15%) 91 kDa 48 ± 4 34 ± 4 30 ± 2 
p(DMAEG85%-AEG15%) 242 kDa 75 ± 9 35 ± 13 39 ± 1 
p(DMAEG61%-HEG39%) 11.9 kDa 31 ± 6 30 ± 2 39 ± 4 
p(DMAEG61%-HEG39%) 179 kDa 47 ± 5 61 ± 16 68 ± 11 
p(HEG50%-DMAEG23%-GuAEG27%) 9.3 kDa 302 (29%)/162 (71%) 37 ± 2 33 ± 1 
Table 4.5 - Size of polyplexes (in nm) of DMAEG-based copolymers. 
In previous sections, the potential of p(HEGx%-GuAEGy%) that contain guanidine side-groups 
in combination with neutral groups for charge separation was cited (table 4.6). These 
derivatives already form tiny particles at a CR of 1/1, even when condensation appeared to 
be incomplete (e.g.  EtBr fluorescence). At these low CR’s, distributions with a large 
diameter were also detected but disappeared with increasing CR. The polymers that 
possessed the lowest amount of cationic charges strangely enough yielded the smallest 
polyplexes and the influence of the MW was not markedly established. A high CR (4/1) the  
polymers were able to produce small, uniform and monomodal particles in all cases while 
this was not confirmed at an intermediate CR (2/1).  
Polymer 1/1 2/1 4/1 
p(HEG45%-GuAEG55%) 12 kDa 64 ± 6 67 ± 3 42 ± 5 
p(HEG65%-GuAEG35%) 10 kDa 90 (73%)/299 (27%) 72 ± 2 51 ± 3 
p(HEG75%-GuAEG25%) 10 kDa 93 (92%)/302 (8%) 70 (95%)/284 (5%)  
± 2 
82 ± 11 
p(HEG85%-GuAEG15%) 11 kDa 360 ± 23 64 (97%)/ 96 (3%) 36 ± 2 
p(HEG87%-GuAEG13%) 27 kDa 305 (42%)/659 (58%) 43 ± 24 29 ± 3 
p(HEG87%-GuAEG13%) 146 kDa 54 ± 11 30 ± 13 29 ± 8 
Table 4.6 – Size and distribition of polymer-DNA complexes based on p(HEGx%-GuAEGy%). 
When extending these trends to other types of guanidine-containing polymers, the  results 
can be largely correlated (table 4.7). The outcome of the particle size is the same but the 
presence of secondary and larger size-distribution was not perceived. In general, with 
increasing polymer to DNA ratio, the formed complexes get smaller and the diameter 
narrower. If imidazole groups were incorporated, a different polyplex formation occurred. 
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Due to the lack of cationic groups, more diffuse particles were generated at a low CR (1/1) 
which corresponds with partial condensation and is characterised by secondary distributions. 
The addition of more polymer eventually created smaller particles but the degree of collapse 
remained proportional to the amount of charge present on the polymer (limited charge 
equals limited decrease in diameter).   
Polymer 1/1 2/1 4/1 
p(ARG) 187 kDa 57 ± 5 30 ± 1 31 ± 2 
p(HEG58%-ARG42%) 11 kDa 64 ± 4 41 ± 8 36 ± 2 
p(HEG87%-AEG13%) 28 kDa 
+ ARG grafts (1.5 kDa) 
48 ± 3 56 ± 2 35 ± 1 
p(GuAEG20%-ImEG80%) 13 kDa 160 (46%)/489 (54%) 
? 
67 ± 8 42 ± 2 
p(GuAEG35%-ImEG65%) 13 kDa 119 (35%)/530 (65%) 46 ± 8 29 ± 4 
p(HEG32%-GuAEG11%-ImEG57%) 
 9.6 kDa 
145 (19%)/325 (81%) 92 ± 15 52 ± 21  
Table 4.7 – Size and distribution of several guanidine containing polymer-DNA complexes. 
  
4.4 Size & distribution of polymethacrylate-DNA complexes 
For non-biodegradable compounds like pDMAEMA that have a more hydrophobic backbone, 
polyplex sizes could possibly be affected by the change in behaviour in a water-based 
environment when compared to more polar poly-L-glutamines. In excellent accordance with 
fluorescence results, polyplexes based on p(DMAEMA) are readily formed and undergo 
nearly no difference in particle dimensions when increasing the CR (table 4.8). For all CR’s, 
starting at 1/1, particles with sizes within endocytotic requirements were obtained. The 
influence of the MW is due to the limited difference in absolute value not really detectable. 
Except for high MW pDMAEMA (658 kDa), with a larger particle size close to the CRcond, the 
DLS graphs were virtually identical (Fig. 4.31).  
Polymer 1/1 2/1 4/1 
11.900 Da 42 ± 5 31 ± 4 31 ± 2 
29.200 Da 39 ± 5 35 ± 2 31 ± 3 
121.000 Da 30 ± 3 20 ± 5 27 ± 2 
310.000 Da 34 ± 8 28 ± 3 30 ± 7 
658.000 Da 145 ± 14 55 ± 9 25 ± 6 
Table 4.8 - Size and distribution of DMAEMA-based polyplexes 
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Figure 4.31 - Size distribution (signal intensity) as a function of particle diameter (nm) for 
pDMAEMA compounds: (A) 11.9 kDA, (B) 121 kDa and (C) 658 kDa. 
The extent to which copolymerisation influences the interaction with DNA in forming 
complexes was obvious and considerable from fluorescence and electrophoresis 
measurements. DLS results of polyplexes formed by methacrylates containing other than 
tertiary amine functional groups are shown in table 4.9. Similar to pDMAEMA, pAEMA forms 
small complexes at a low CR but increasing the polymer content yields larger particles (that 
remain low in absolute value). For copolymers of tertiary and primary amines, a variation in 
the size of the polyplexes can only be seen at a CR of 1/1 since AEMA slightly increases the 
complexation point, yet all CR’s tested, generated particles with sufficiently low diameters. If 
hydroxyl groups are built in, the resulting change in complex formation and size is better 
observed. The appearance of higher size distributions for copolymers with a high amount of 
hydroxyl groups is detectable and confirms insufficient complexation. When there is less 
than 50% charged groups remaining, particles with a broader diameter are seen, 
corresponding with a reduced DNA-interaction.  
Polymer 1/1 2/1 4/1 
pAEMA 61 kDa 29 ± 9 34 ± 3 43 ± 2 
p(DMAEMA82%-AEMA18%) 191 kDa 64 ± 7 39 ± 3 31 ± 1 
p(DMAEMA54%-AEMA46%) 135 kDa 54 ± 5 32 ± 2 27 ± 4 
p(DMAEMA23%-AEMA77%) 132 kDa 36 ± 4 34 ± 1 31 ± 1 
p(DMAEMA80%-HEMA20%) 188 kDa 88 ± 2 31 ± 2 25 ± 4 
p(DMAEMA56%-HEMA44%) 218 kDa 51 (37%)/258 (63%) 35 ± 2 31 ± 1 
p(DMAEMA34%-HEMA66%) 242 kDa 102 (66%)/390 (34%) 93 ± 8 48 ± 6 
p(GuAEMA40%-HEMA60%) 29 kDa 48 (58%)/262 (42%) 27 (78%)/189 (22%) 
± 2 
25 ± 1 
Table 4.9 – Polyplex sizes of methacrylate copolymers (in nm) at 1/1, 2/1 and 4/1 CR. 
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This is not the case when the charges are present as protonated guanidines like in 
p(GuAEMA-HEMA). The influence of functional group replacement seems generally limited 
and tends to disappear completely because the size at high CR is comparable for all.    
4.5 Parameters that influence particle size 
4.5.1 Time (stability) 
One of the aspects, important for correct interpretation of particle sizes when measuring a 
polyplex via DLS, is time. Polymer-DNA complexes are constantly in motion (thermal 
agitation) and realise numerous collisions with other molecules. As a consequence, the 
integrity of the complex can be affected. Mostly, aggregation and spontaneous dissociation 
of weakly-interacting species are responsible for the change of particle diameter in time. The 
impact of this parameter was determined via a DLS measurement at different time-points 
(table 4.10). In case of multiple distributions, only the presence of the new distributions is 
noted (the other distribution remains in the same range as for the reference point, 0h). For 
PEI, measured at 0h, the larger distributions are not shown. As a general trend, it can be 
concluded that the stability of polyplexes close to the CR at which condensation starts to 
occur, is limited. More specifically, due to aggregation of inadequately condensed 
complexes, the total diameter of a particle can increase and even exceed the upper limit 
boundaries for cellular uptake. It seems that all 3 polymers exhibit this behaviour. Only for 
pDMAEMA after 24h, a part of the complexes falls out of the specifications for receptor 
mediated endocytosis. To a certain extent, also pDMAEMA-DNA formed at a 2/1 CR 
experiences aggregation up to a value that is outside of the endocytotic uptake range. At a 
high CR, the complexes remain equally small or even produce smaller particles in the case 
of PEI. Based on these results, polyplex stability is expected to be longlasting when high 
CR’s are applied.  
Polymer 
0h 5h 24h 
1/1 2/1 4/1 1/1 2/1 4/1 1/1 2/1 4/1 
p(DMAEG) 34 ± 9 29 ± 3 30 ± 2 89 (42%) 33 ± 5 35 ± 1 113 (32%) 40 ± 7 34 ± 4 
p(DMAEMA) 30 ± 7  20 ± 3 27 ± 1 156 (45%) 108 (9%) 25 ± 3 307 (45%) 149 (15%) 33 ± 2 
PEI 142 ± 5 128 ± 2 62 ± 4 138 (37%) 75 (25%) 50 ± 4 167 (60%) 65 (98%) 41 ± 2 
Table 4.10 – Stability of polyplex size in time via DLS measurement: p(DMAEG) 30 kDa, 
p(DMAEMA) 121 kDa and PEI 25 kDa after 0h, 5h and 24h. Value in nm, partial distribution 
between brackets. 
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4.5.2 Temperature 
Another important parameter that appears to exhibit influence on the size of particles is 
temperature. Because at elevated temperature, molecules posses more energy (and 
correspondingly an increased mobility), the formation is expected to occur either faster or 
slower (and also at higher or lower CR). It is noteworthy to mention that a difference exists 
between stability of polyplexes at 37 °C if the complexes were prepared at 37 °C instead of 
at 25 °C. Table 4.11 lists DLS values at both temperatures for complexes of selected 
polymers. 
Polymer 
25 °C  37 °C 
1/1 2/1 1/1 2/1 
PEI-Guan20% 104 ± 9 47 ± 5 118 ± 11 45 ± 4 
p(HEG65%-GuAEG35%) 90 (73%)/299 (27%)  72 ± 2 113 (51%)/284 (49%) 48 ± 5 
p(GuAEG20%-ImEG80%) 160 (46%)/489 (54%) 67 ± 8 111 ± 12  38 ± 7 
Table 4.11 – Polyplex sizes (in nm) of selected polymers at different temperatures (DLS). 
A temperature increase leads to better polyplexes in terms of size. For every example, the 
resulting size at a 2/1 CR is smaller. For low CR’s close to CRcond, the influence could alter 
the dimensions in both a negative (e.g. the hydroxyl variant) and positive way (like for the 
imidazole-based polymer), especially when an additional time stability is taken into account. 
Rougly speaking, it could be stated that 37 °C is an environmentally, beneficiary parameter 
for higher CR’s but potentially could destroy the complex (by aggregation or electrolyte 
dissociation if loosely bound) at CR’s corresponding with the start of DNA-condensation 
(CR-values outside of the MinF plateau in EtBr fluorescence). 
 
4.5.3 Buffer medium 
Up to now, as was standardised by implementation of the universal protocol, polymer-DNA 
complexes were prepared in ultrapure water in order to maximise the interaction between 
the polyelectrolytes. If DNA-containing vectors would be administered to the body, the 
influence of the fluid it resides in during the stay inside the body must be considered. Mainly 
salts and proteins which contain charges can destabilise the complexes (by electrostatic 
interaction) 26 . Even more, when polyplex formation is performed in a salt-rich buffer, 
immediate precipitation is observed. Therefore, polyplexes were to be prepared in ultrapure 
water prior to buffer mixing. In the test below, polyplexes were combined with cell culture 
medium, a buffer with a large mixture of salts but without serum27.  
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Polymer 
Ultrapure H2O Cell culture medium 
1/1 2/1 4/1 1/1 2/1 4/1 
p(DMAEG) 30 kDa 34 ± 9 29 ± 3 30 ± 2 155 (42%)/973 (58%) 134 (59%)/328 (41%) 57 ± 4 
PEI 142 ± 5 128 ± 2 62 ± 4 349 ± 22 150 (25%)/304 (75%) 67 ± 3 
Table 4.12 – Polyplex sizes and distributions for PEI & pDMAEG in cell culture medium as 
measured by DLS (results in nm). 
Similar to the previous section, the presence of an excess of salts has a proven influence on 
the size of the particles. As they tend to form aggregates, the stability in time will only be 
sufficient (e.g. within requirements for endocytosis) for high CR’s while it leads to 
precipitation for complexes at lower CR’s (table 4.12). 
4.5.4 DNA concentration 
Because of the elaborate research that is put into the development of synthetic polymers 
with appropriate functions, the focus on the actual purpose (that is delivery of DNA) is 
sometimes lost. In order to obtain reproducible, predictable and solid polyplexes, a fixed 
amount of DNA (20 µg/ml) was implemented for the standardised protocol. As it would be 
practical to deliver as much DNA as possible in a single dose given the lower exposure to 
toxic delivery systems and the need for less repeated administrations, delivering higher 
amounts of DNA seems logic. A comparison in terms of polyplex sizes was made for 
pDMAEMA 121 kDa and PEI and their corresponding polyplexes containing 20, 40 or 60 
µg/ml for typical CR’s tested (table 4.13).  
Polymer 
20 µg/ml DNA 40 µg/ml DNA 60 µg/ml DNA 
1/1 2/1 4/1 1/1 2/1 4/1 1/1 2/1 4/1 
p(DMAEMA) 30 ± 7  20 ± 3 27 ± 1 45 ± 7  23 ± 5 22 ± 1 48 ± 8 36 ± 5 19 ± 4 
PEI 142 ± 5 128 ± 2 62 ± 4 303 ± 12 144 ± 14 59 ± 7 519 ± 45 321 ± 20 121 ± 4 
Table 4.13 – Influence of DNA concentration (20, 40 , 60 µg/l) on the polyplex distribution of 
pDMAEMA 121 kDa & PEI 25 kDa: analysis of the size (in nm) via DLS measurements. 
For pDMAEMA, increasing the DNA dose had no clear influence. At a lower CR, the 
polyplexes experience a slight size-increase but without repercussions towards cellular 
uptake. In the case of PEI, the effect of an augmented DNA dose was more outspoken with 
possibly limiting effects for endocytosis, specifically for a low CR and high DNA dose. When 
preparing polyplexes with higher amounts of DNA incorporated, solutions turned 
proportionally more turbid although this phenomenon was dependent on the type of base 
 
Chapter 4: Physico-chemical characterisation of multifunctional synthetic vectors 154 
polymer (hydrophobic polymethacrylates versus hydrophilic polyaminoacids, data of this 
latter not shown). DNA concentrations higher than 60 µg/ml resulted in precipitation upon 
mixing with polymer. An similar comparison was also made to study the influence of DNA 
concentration on the complexation behaviour (see section 3.2.3). 
 
5 Polyplex stability 
In previous sections, the stability of polymer-DNA complexes was already to some extent 
discussed but only for specific properties (complexation with DNA) and with respect to the 
nature of the polyplex (either shape or size). When looking more to the thermodynamic 
implications of charged particles (polyplexes) in solution, a better and more general 
understanding of the electronic behaviour and stability can be derived from zeta()-potential 
measurements. 
5.1 Zeta-potential 
A relatively unknown but very useful way to study the behaviour of a charged particle in 
solution is by performing zeta-potential measurements. When charged surfaces such as 
those from polymer-DNA complexes are brought in an aqueous solution, an electric double 
layer forms at the particle-liquid interface (Fig. 4.32)28. This electric double layer consists of 
two parts. Firstly a uniform, immobile layer of oppositely charged ions (Stern layer) is formed 
which are tightly bound to the surface. Secondly, an outer layer rearranges which is diffuse 
and whose composition is driven by electrostatic balance and random thermal motion29. The 
potential in this region therefore decays with increasing distance from the surface until it 
reaches the bulk solution value (conventionally fixed at zero). If an electric field is applied to 
a polyplex solution, each particle and its most closely associated ions move through the 
solution as one unit. The potential at the surface of shear between this unit and the 
surrounding medium is called the zeta-potential. In other words, this potential is a measure 
for the layer of solvent (water) which is moving along with the charged particle and is 
associated to the polyplex in an electrostatical way.  
 
Parameters that influence the formation of such an electrical double layer are one hand 
attributed to the particle itself (for instance the ionisation potential of the chemical structures, 
e.g. pKa or the morphology) but on the other hand also influenced by the environment for 
which the type of ions present, the concentration and the temperature appear the most 
dominant factors. The overall charge of a polyplex particle is not only important for the 
behaviour related to solution stability (tendancy to form aggregates) but plays an equally 
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important role in interaction with other (charged) structures of the body (e.g. proteins 
containing charged residues or the outside of the cellular membrane)30.   
 
Figure 4.32 – Schematic representation of the electrical double layer model according to 
Stern
31
. 
The measurement of the zeta-potential is performed by determining the electrophoretic 
mobility (µ) of a charged particle which is obtained by Laser Doppler Velocimetry. The 
velocity (v) and electrophoretic mobility (µ) are related by the following equation (with E 
being the magnitude of the electric field):  
   
 
 
 
By applying the Henry-equation the zeta-potential can be calculated using the following 
formula:           
   
   
     
  
 
 
 
       
 
 
With μ = the electrophoretic mobility  
  
   
  
 = zeta-potential (V) 
 = viscosity of the medium (cP) 
 ε = (relative) permittivity of the dielectric constant (r = medium, 0 = vacuum) 
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A practical measurement is in that sense closely related to DLS because accordingly a 
similar laser set-up is applied to retrieve the electrophoretic mobility. Polymer-DNA 
complexes at various CR (0.5/1, 1/1, 2/1 and 4/1) and dissolved in (filtered) water are 
injected into a thermostatic measuring chamber of the zeta-potential device to be measured. 
The absolute value of the resulting -potential represents the degree of stability according to 
conventional rules32. Typical, sufficiently high values that corresponds with an adequate level 
of colloidal stability start from 30 mV (sufficient) and can go as high as 60-70 mV for 
excellent surface potential23. 
5.2 Colloidal stability of biodegradable polyplexes 
When evaluating the zeta-potential of the polyplexes, a basic idea on the stability (prevention 
of aggregation) can be derived via the magnitude of this parameter. Also the composition of 
the surface can, to a certain extent, be deducted from this value. Furthermore, if for 
measurements with increasing CR, the polarisation is reversed, the corresponding complex 
formation is additionally proven. This validates the use of zeta-potential as a useful, 
additional tool for assessing polymers as delivery devices in gene therapy. In general, both 
the L-glutamine as well as the methacrylate-based polymers yielded polyplexes with a good 
(> 30 mV) to excellent (> 50 mV) zeta-potential at high CR (4/1). 
Fully charged poly-L-glutamines exhibit a high stability with values close to +60 mV (Fig. 
4.33 – p(DMAEG)). Moreover, there appears to be hardly any influence of the MW on the 
zeta-potential value. With increasing CR, a growing number of layers composed of cationic 
polymers arrange around the preformed complex, proportionally augmenting the surface 
charge and leading to a continuous rise in zeta-potential. A similar explanation can be given 
for PEI which demonstrates analogous values despite the lower charge concentration 
present on the polymer (estimated 25 % at physiological pH). Despite the small or even non-
existing difference between the lowest CR tested (1/1) and the CR representing 
condensation (according to AGE), the zeta-potential values mark the presence of stable 
polyplexes. 
The trends seen for p(DMAEG) can be correlated to copolymers that also possess 100% 
charged groups (or close to it) like in the case of p(DMAEG-AEG), (Fig. 4.34, A & B). 
Derivatives that contain non-charged units, like p(DMAEG-HEG) have a considerable lower 
potential (Fig. 4.34, C & D) at all CR’s as could be anticipated2. Taking the large standard 
deviations into account, no real effect of the MW is observed. For the imidazole-containing 
polyglutamine, the zeta-value was surprisingly higher (Fig. 4.34, E). When comparing results 
with partially charged p(DMAEG-HEG), an equal, if not higher value is obtained with less 
charged groups (excluding imidazole groups, not fully charged at physiological pH). 
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Figure 4.33 – Zeta-potential of complexes prepared from pDMAEG with variable MW (10, 30, 80 
& 242 kDa) and PEI (25 kDa). 
 
Figure 4.34 - Zetapotential values corresponding with polyplexes from (A) p(DMAEG85%-
AEG15%) 91 kDa, (B) p(DMAEG85%-AEG15%) 242 kDa, (C) p(DMAEG61%-HEG39%) 11.9 kDa, (D) 
p(DMAEG62%-HEG38%) 179 kDa and (E) p(HEG49%-AEG15%-ImEG36%) 9.9 kDa. 
In cases where the polyplex was not formed at a CR of 1/1 a negative zeta-potential was 
obtained (Fig. 4.35). The different experiments revealed a sharp transition from a negative to 
positive potential close to the CR of complexation which indicates that once a polyplex is 
formed a limited addition of polymer is sufficient to induce adequate particle stabilisation. 
Remarkably, the potential of pARG (Fig. 4.35 - A) was negative for a 1/1 CR what might be 
the result of small deviations possible in the production and measurement process since the 
CR for full complexation is located around 1/1. Other polymers possessing guanidine 
functional groups in combination with a sizeable amounts of neutral hydroxyl groups (50% or 
more) resulted in zeta-potential values in the order of 30-40 mV (at CR 4/1) which 
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represented good to very good stability. Most of the polymers showed, in accordance with 
fluorescence measurements, a negative potential at a 1/1 CR since condensation did not yet 
occur (except for E, which has about 50% charged groups). For really low amounts of 
charged groups (F), the detected, low values were in line with the expectations. Noteworthy 
is also the diminished stability of the grafted PEI-derivative (grafts = p(HEG63%-GuAEG37%)) 
(D) where the introduction of neutral groups shields the core polymer, transforming the 
behaviour of the total polymer by adopting the stabilizing properties of its graft.       
 
Figure 4.35 – Zeta-potential values corresponding with polyplexes from (A) p(ARG) 22.8 kDa, 
(B) p(DMAEG23%-GuAEG27%-HEG50%) 9.3 kDa, (C) p(HEG58%-ARG42%) 11.2 kDa, (D) pEI + 
p(HEG63%-GuAEG37%), (E) p(HEG43%-GuAEG50%-AEG7%) 12 kDa and (F) p(HEG85%-GuAEG15%) 11.4 
kDa. 
For methacrylate-based polyplexes, the effect of MW was in contrast to previously derived 
analysis techniques not really detectable in the case of the homopolymer p(DMAEMA) (Fig. 
4.36). Although the polyplexes derived from polymers with the highest MW’s displayed zeta-
values which were considerably higher than the low MW derivatives. The maximum values 
of these compounds were rather low, especially when comparing with the homopolymers of 
their biodegradable counterparts (p(DMAEG) > 50 mV). This could be most likely attributed 
to the difference in polymer backbone structure, which has in this latter case less affinity for 
polarity (ion-charge).  
Copolymers based on p(DMAEMA) exhibited similar values as the homopolymer itself (Fig. 
4.37). This is not surprising for copolymers that remain fully protonated as is the case for 
p(DMAEMA-AEMA) in graphs A & B but is not expected for p(DMAEMA-HEMA) compounds 
(graph C & D) which have nearly half the amount of charge per polymer chain. Because the 
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zeta-potential seems to be quite low for fully charged polymers, the nature of the polymer 
backbone must be a much more important parameter than originally anticipated, hence the 
small difference observed with non-fully charged polymers. This theory is again confirmed by 
the values of pGuAEMA, a homopolymer that has a nearly identical zeta-value distribution 
as pDMAEMA (for different CR’s) as shown in graph E.      
 
Figure 4.36 – Zeta-potential values for pDMAEMA with variable MW measured at various CR. 
 
Figure 4.37 – Zeta-potential values corresponding with polyplexes from (A) p(DMAEMA79%-
AEMA21%) 51 kDa, (B) p(DMAEMA82%-AEMA18%) 191 kDa, (C) p(DMAEMA55%-HEMA45%) 10 kDa, 
(D) p(DMAEMA56%-HEMA44%) 218 kDa and (E) p(GuAEMA) 63 kDa prepared at variable CR. 
6 Influence of charge: geometrical orientation on a polymer 
Throughout the entire course of polyplex characterisation, the importance of functional group 
orientation has been several times proposed. To come to a better understanding and to 
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check the influence of this phenomenon on the formation of polyplexes, EtBr fluorescence 
data of several guanidine-containing compounds were collected and assembled in the 
following graph (Fig. 4.38). A curve representing PEI is incorporated to allow comparison 
and to check the possibility to correlate fluorescence with biological transfection efficiency, 
based on the fluorescence values obtained by PEI  (see also chapter 6). 
The composition of each polymer in terms of guanidine groups is described in table 4.14. 
The number of guanidine functional groups per polymer depends both on composition and 
MW. To compare these values for polymers with variable MW, the relative ratio of guanidine 
groups per Da is also calculated. When looking at the series of p(HEG-GuAEG), it is clear 
that an increasing number of guanidines, proportionally improves the ability to complex DNA 
(as was described before in section 3.1.1.3) and which is in compliance with the relative 
ratio. If guanidine-incorporation was carried out by grafting, not only the amount of functional 
groups can be more easily extended but also the position of the charged groups is altered. 
Charged groups are now located further away from the backbone and because of that the 
flexibility to rearrange around opposite charges (e.g. DNA) is optimised. This is especially 
the case for macromolecules that are limited by their inherent (backbone) stiffness. As a 
result the fluorescence profile of the grafted equivalent shows a fast and strong 
condensation ability towards DNA (CRMinF = 0.8 & MinF = 22%). In comparison to p(ARG), a 
homopolymer corresponding with a 100% of guanidine functional groups, the profile 
demonstrates a faster condensation, despite its lower relative molar ratio. This effect is even 
more expressed in the case of the Arg8-coupled polymer. Not only displays this polymer the 
highest DNA affinity but it also achieves this at the lowest CR while its relative ratio is 
substantially lower than the other guanidine-rich components.      
Polymer MW (Da) Mol (Gua)/ Mol (pol) Rel. Ratio (mol/1000 Da) 
p(HEG87%-GuAEG13%) 26.950 19.3 
 
0.71 
p(HEG75%-GuAEG25%) 10.200 13.4 1.31 
p(HEG45%-GuAEG55%) 12.000 30.8 2.56 
p(HEG87%-AEG13%) + 
pArg grafts 
27.700 152 5.48 
p(HEG87%-AEG13%) + 
Arg8 4.5% 
27.700 56.5 2.04 
p(ARG) 22.800 145 6.36 
Table 4.14 - Guanidine-containing compounds: composition, MW and guanidine/polymer ratio. 
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Figure 4.38 – EtBr Fluorescence yield of several guanidine-containing polymers as a function 
of increasing CR. 
Another advantage of grafting or coupling of Arg8 (which is a form of grafting but with a fixed 
amount of guanidine residues) is the larger amount of guanidine that can provided per 
polymer chain. Since for polymers where the functional groups are located on the side-chain, 
the maximum guanidine concentration is limited by the number of side-chains (representing 
100% occupancy). For the relative ratio of moles of guanidine per MW, this comes down to 
the MW of a full structure unit. When expressed as mol/1000 Da, the maximum values for 
p(GuAEG) and p(ARG) is 4,71 and 6.36 respectfully. By extending the grafts on a polymer 
these values can be readily multiplied (e.g. the relative ratio for p(HEG87%-GuAEG13%) + 
p(ARG) grafts is multiplied by 8 compared to regular p(HEG87%-GuAEG13%)). 
To conclude, it can be stated that the charge density, present on a polymer,  is still a very 
decisive parameter to interact with DNA but the position and orientation of these charges 
highly influence the condensation properties. In this way, it is possible to develop synthetic 
vectors that require a minimum of charge (e.g. relative ratio ≥ 2) to induce sufficient complex 
formation which is accepted as a mandatory property for minimal toxicity. Consequently, the 
hypothetical, dual influence of both the amount of charge and its position (distance from 
backbone) can be visualised in an abstract way by means of a density graph (Fig. 4.39). In 
this graph, the extent to which a polymer can form a strong polyplex in a fast (at low CR) 
way is expected to be represented by the intensity of the shades of dark. This means that an 
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efficient vector composition is situated in the white region and that how darker a region is, 
the less efficient a vector will be in attracting DNA to eventually form a polyplex. 
 
Figure 4.39 – Hypothetical graphic representation for determining efficient vector 
compositions in terms of charge and corresponding DNA interaction (dark region = suitable). 
 
7 Summary 
In order to decide if a polymer is suitable as a DNA-carrier in terms of physico-chemical 
qualities, a combination of the aforementioned characterisation techniques is required. From 
the results that were presented in this chapter, several (groups of) candidates remain in the 
scope as potential delivery device. Both for poly-L-glutamines as for polymethacrylates, 
there were several polymers that met all the requirements but they do so at different polyplex 
compositions. While for polyglutamines, the influence of non-charged or partially charged 
functional groups seemed efficient (if sufficient charge remained, about 40%), this was not 
the case for polymethacrylates. Since hydrophobicity (or non-polarity) appeared to be of 
relevance in polyplex formation, the need for additional non-charged groups for p(DMAEMA) 
is deemed unfavourable. Moreover, the added value of guanidine functional groups in the 
case of polyglutamines could not be proven for polymethacrylates. Besides, the optimal MW 
selection was confirmed different for both classes, indicating the need for low MW polymers 
in the case of biodegradable compounds whereas for the non-biodegradable ones, an 
optimal MW was found around 100-150 kDa.  
This led to the conclusion that mainly pDMAEMA or primary amine-containing copolymers 
with small (< 10%) amounts of primary amine and with a MW of around 150 kDa show the 
most potential as non-biodegradable vectors. For biodegradable vectors, the choice is more 
complex. Polymers with a MW < 30 kDa and with a partitioned functional group composition 
(not fully charged) seems the most promising. Although the choice of specific functional 
group is less relevant, there’s a strong preference for guanidines in combination with 
imidazole moieties. Further feasibility of potential vector systems will be verified by 
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biologically relevant experiments that address the biocompatibility issue as well as the 
efficiency/potency in gene therapy applications. 
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1 Introduction 
When a polymer or polyplex is brought into the body, there’s no selective interaction with a 
designated cell or tissue. The extent to which polyplexes interact with certain components of 
the body is amongst others dependent on the polyplex charge, size, hydrophobicity and 
nature of the functional groups present on the polymer. Many studies have aimed to optimise 
these parameters by performing mechanistic studies in an attempt to fully understand the 
relation of biological activity and vector structure1,2,3. A way to improve the selectivity of 
polyplexes can be found in the targeting of receptors that are present on cell surfaces. If 
polymer carriers are modified with ligands or molecules that can interact with the cell, 
enhanced targeting of specific cells and tissue can be reached. These compounds are often 
peptides that are referred to as cell-interacting-peptides (CIP) with specific structures that 
can bind to cell-receptors (e.g. v3-integrins) in order to promote cell adhesion
4 , 5 . 
Moreover, certain cell receptor sequences can be used to induce cell-uptake. As described 
before (chapter 1 – 2.3.3), peptide sequences like TAT or Penetratin are the topic of much 
recent research and have shown great potential in facilitating cellular entry of DNA when 
coupled to polymer carriers 6 , 7 , 8 , 9 . Although much controversy exists on their uptake 
mechanism, the consensus is that a combination of both receptor and non-receptor 
mediated endocytosis is responsible for CPP-regulated internalisation10,11 (Fig. 5.1). 
 
Figure 5.1 - Internalisation of CPP-containing polyplexes via receptor mediated endocytosis
11
. 
So far a large number of CPP-based applications have been reported using either covalent 
or conjugate CPP-based strategies from in vitro to in vivo deliveries12,13,14. The interest for 
CPP’s is mainly due to their low cytotoxicity and to the fact that there seems to be no 
limitation for the type of cargo that can be uploaded. Although CPP’s were shown to favour 
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delivery of cargos that vary greatly in size and nature (small molecules, oligonucleotides, 
plasmid DNA, peptides, proteins, nanoparticles, lipid-based formulations, virus, quantum 
dots, etc.) most applications describe the delivery of oligopeptides/proteins15,16 and nucleic 
acids or analogues17,18. At current, a whole series of CPP families are explored (mainstream 
families shown in table 5.1) with new types still being discovered.    
Organism Protein Peptide sequence 
HIV-1 Transcriptional activator TAT 
Herpes simplex virus-1 Viral protein VP22 
Drosophila Antennapedia homeodomain Penetratin 
Human calcitonin hCT (9-32) 
Maize -Zein SAP 
Synthetic SV40 T-Antigen MPG 
Synthetic Galanin-Mastoparan Transportan 
Synthetic Hydrophobic types Pep-1, MTS, CADY 
 
Table 5.1 - of well-known CPP’s and their origin. 
Almost all CPP’s are characterised by their amphiphilic nature which is a necessity to induce 
receptor mediated cell-crossing of the peptide and its cargo since their mechanisms of entry 
are assumed to occur by both hydrophilic and hydrophobic interactions19,20,21. 
Next to peptides, other compounds can increase the rate of cellular uptake. Amongst these, 
glycoproteins, insulin, antibodies (fragments) and sugar-based products are well known 
examples 22 , 23 , 24 .Other methods of optimising DNA delivery systems are focussed on 
minimising uncontrollable interaction with wild type substances of the body (proteins in the 
bloodstream or extra-cellular matrix). Coupling polyethyleneoxide (PEO) by grafting has 
been investigated with the aim to lower the immunogenic character of substances other than 
those of the body (such as polymer carriers)25,26, yet a loss of transfection efficiency was 
accompanied with the expected gain in viability27. Nowadays, the variety of peptides used in 
gene delivery applications has been further expanded. A recent hot topic is antisense 
RNA/DNA therapy in which specific peptide nucleic acids are used to block the translation of 
proteins within a cell28.  
To be able to perform mechanistic studies on a cellular level, it is necessary to visualise 
polyplexes when present in cells (e.g. via confocal microscopy). This can be achieved by 
fluorescent staining using polyaromatic compounds like fluoresceine that exhibit high 
fluorescence yield upon irradiation with visible light. Both DNA as well as the polymer carrier 
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can be covalently linked to fluorescent labels. Nevertheless, staining of DNA could hamper 
its function and therefore preference is given to polymer conjugation. Moreover, since 
polymers already bear cationic charges for DNA interaction, the addition of hydrophobic 
fluorescent labels can partially mimic the structure and effect of amphiphatic CPP’s 29 .  
Besides the obvious analogy with CPP-structures, the addition of hydrophobic regions to 
vector systems was presumed beneficiary towards transfection efficiency 30 . The 
incorporation of these non-polar domains is not only inducing membrane destabilisation 
during cellular uptake but also during endosomal escape31. 
In this chapter, certain peptides based on penetratin and octa-arginine, which is a TAT-
based derivative consisting of eight arginine units and is assumed to be responsible for 
triggering the actual internalisation of TAT32, will be coupled to multifunctional polymers. 
Since these peptides cannot be readily coupled to polymer vectors, thiol and maleimides 
groups will be introduced along the polymers to allow consequent coupling of the peptides 
(via a reversible disulfide and stable thioether bond respectively). The influence of spacer 
types and lengths on the transfection efficiency will also be investigated. Newly developed 
analysis methods based on impedance measurements will shed further light on the 
interaction between CPP’s and the cell membrane. Besides CPP’s also fluorescent tags 
such as Oregon Green 488 and Alexa Fluor 514 are coupled to allow intra-cellular study of 
polyplexes (in combination with CPP’s). Moreover, fluorescently labelled polymers will assist 
in better understanding the polyplex formation and its kinetics using fluorescence assisted 
measurement methods (FRET/FCS). Finally, the possible effect of covalently coupling CPP’s 
to carrier systems in comparison with physical mixing of CPP’s (within polyplexes) will be 
assessed.    
All peptides used within this research were developed by the Homeoprotein laboratory of 
Prof. J. Martinez (CNRS, Montpellier), partner in the PolExGene EU-project (FP6). 
2 Development of fluorescently labelled polymer carriers 
2.1 Visualising polyplexes 
Trying to unravel the functioning of the body is an essential part of all biomedical based 
research. For concepts that are to be applied on a cellular level, like for instance in gene 
therapy, understanding the mechanisms of cellular uptake, trafficking, DNA  transcription 
and protein translation are critical. Since these processes remain subject to considerable 
doubt, attempting to elucidate them is of huge interest and was therefore also put forward as 
a goal for the polymers used within this research. A well established technique to study 
cellular behaviour and the presence of specific compounds in and around cells in a direct, 
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non-invasive way is confocal microscopy (CM). Laser light of a well defined wavelength is 
used to pass through the sample to induce fluorescence of specifically labelled compounds 
(like polymers or DNA). Specific for this method is the use of focal planes that allow to 
assess a sample in different layers when compared to conventional fluorescent 
microscopes33. The most prominent reason to apply a confocal laser enhanced contrast (by 
filtering non-focussed light). Consequently, certain polymers were provided with fluorescent 
tags. A widely spread fluorescent molecule is fluoresceine that shows a high molar 
extinction-coefficient () for light at a wavelength of 488 nm (and 514 nm). These values 
correspond perfectly with the spectral lines of an Ar-laser, hence its common use. However, 
for coupling reactions performed within this research, priority was given to a fluoresceine 
derivative, namely Oregon Green 488. This fluorinated compound (Fig. 5.2) has several 
advantages over common fluoresceine: 
 No appreciable quenching (even at high labelling degrees) 
 Better photostability (allowing an increased acquisition of photons before 
photodestruction i.e. bleaching) 
 Lower pKa (making the fluorescence essentially pH-insensitive) 
Moreover, highly reactive succinimidyl esters of Oregon Green are commercially available 
and allow swift coupling in buffered environments. Nevertheless, this fluorescent label 
prevents the analysis of polyplex sizes because DLS also applies Ar-based laserlight which 
interferes the measurement. To circumvent this problem, Alexa Fluor 546 (max = 554 nm) 
was selected as a similar fluorescent dye that still possessed the advantage of Oregon 
Green over fluoresceine but with a slightly shifted absorbance wavelength that doesn’t 
interfere with DLS measurements (Fig. 5.2).  
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Figure 5.2 - Chemical structure of succinimidyl ester activated fluorescent tags. 
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Noteworthy is the presence of anionic moieties in the structure of the fluorescent labels. 
Because of this, the interaction with the polymer is possible (which could partially inhibit the 
interaction between the polymer and DNA). Moreover, the M/C value of the polymer needs 
to be corrected for the presence of this negative charge.  
 
2.2 Covalent coupling of fluorescent tags 
Fluorescent groups can only be coupled to polymers containing reactive sites like primary 
amines. Because of the availability of succinimidyl-activated molecules, coupling can be 
readily achieved in a one-step reaction. Since the fluorescent probes were selected for their 
excellent quantum yield (high ), only small amounts need to be coupled to attain a 
considerable fluorescent signal. During synthesis, the reagents are shielded from light to 
limit the loss of activity.   
In a typical experiment, a polymer containing free primary amines is dissolved in a 0.1 M 
NaHCO3 buffer at pH ≈ 8.3 (10 mg/ml). In a separate vial, an amount (0.2 equivalents 
relative to the amount of primary amines) of staining dye is dissolved in DMSO (10 mg/ml) 
and added dropwise to the aqueous polymer solution to allow reaction for one hour at room 
temperature. The reaction is stopped by neutralizing the pH and subsequent purification is 
performed by dialysis. The degree of coupling can be determined by UV/VIS spectrometry 
using a calibration curve (abs = 488 nm) and the following formula: 
            
       
                   
 
With A = absorbance 
c = concentration (mol/l) 
mol = molar extinction coefficient (l/mol.cm),  
MWpol = the molecular weight of a polymer structure unit (g/mol) 
MWfluor = the molecular weight of a fluorescent coupled structure unit (g/mol). 
 
Several newly developed polymers where fluorescently labelled as well as certain reference 
polymers (PEI, PLL) so that the intra-cellular trafficking of polyplexes and polymers could be 
followed by means of CM and mutually compared (table 5.2). The incorporation of negatively 
charged (due to the carboxyl/sulphonate functional group) fluorescent tags has an effect on 
the mass/charge (M/C) of the total polymer. This has to be taken into account when forming 
polyplexes since higher amounts of polymer (differences up to 40%) are required to obtain 
equal amounts of positive charge (when compared to the non-labelled polymers). The 
biological evaluation of the modified polyplexes will be discussed in chapter 6 of this work. 
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Polymer Fluorescent tag % coupled M/C 
PEI Oregon Green 488 2.7 244.7 
PLL Oregon Green 488 2.4 251.2 
PEI-Guan (20 %) Oregon Green 488 1.3 297.6 
p(DMAEG-AEG) 91 kDa Oregon Green 488 6.1 291.3 
p(DMAEG-AEG) 242 kDa Oregon Green 488 5.2 278.8 
P(ORN-ARG) 71 kDa Oregon Green 488 1.3 195.7 
p(DMAEG-AEG) 91 kDa + PEN (1,9%) Oregon Green 488 3.1 264.0 
p(DMAEG-AEG) 91 kDa + Arg8 (1,2%) Oregon Green 488 1.3 263.0 
p(DMAEG-AEG) 91 kDa Alexa Fluor 546 0.6 238.5 
Table 5.2 - overview of fluorescently labelled polymers. 
2.3 Influence of fluorescent tags on the polyplex physico-chemical properties 
The requirement of polymer-DNA complexes to be fluorescently active could have 
implications on the formation of polyplexes. Unless desired (in the case were hydrophobic 
associations would be regarded as significant), the incorporation of non-polar groups 
generally lowers the ability for electrostatic interaction with DNA and the formation of (nano-
sized) particles. Despite the small quantities that are typically coupled, the effect on the 
polyplex formation was verified. Employing traditional EtBr fluorescence experiments was 
not possible since Oregon Green absorbs light of 510 nm (exc used standard) and therefore 
the exc for these experiments was set to 340 nm, a value at which Oregon Green has a low 
absorption capacity.  
The premise that fluorescent coupling should not exert a distinct influence on the capacity of 
a vector to condense DNA, was readily countered by means of fluorescence measurements. 
Apparently, the required CR for full condensation was markedly higher in the case of PEI-
OREG2.1% (1.4 instead of 0.6). This effect was less pronounced for p(DMAEG85%-
AEG15%)+OREG6.1% (CRminF of 1.3 compared to 1.1 without fluorescent tag) which has a 
substantially higher amount of cationic charges remaining per polymer for DNA 
condensation compared to PEI (Fig. 5.3). The hydrophobic effect of the fluorescent groups is 
one of the main causes for the altered DNA interaction (the potential loss in cationic charges 
due to coupling is considered only secondary). Hydrophobic interactions between the 
fluorescent labels could form types of micelles and consequently allow only hydrophobic 
(weaker) interaction with DNA and possible also shield the DNA from the polymer’s cationic 
charge. This effect, which is already considerable from concentrations as low as 1%,  also 
rendered the fluorescent polyplexes less firm as indicated by the corresponding MinF value.  
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Figure 5.3 - EtBr fluorescence spectrum: fluorescence yield as a function of added CR for PEI 
25 kDa, PEI-OREG2.7% 25 kDa, p(DMAEG-AEG) 91 kDa and p(DMAEG-AEG)-OREG6.1% 91 kDa. 
A conclusion of the same kind could be drawn from the agarose gel-electrophoresis 
experiments although a proportionally smaller effect was noticed (Fig. 5.4). Labelled PEI 
displays an increase of 0.6 CR units, required for full condensation while the discrepancy for 
labelled p(DMAEG-AEG) versus the non-coupled polymer is nearly untraceable (weak DNA 
band at a CR of 1/1 visible). This difference could be ascribed to the utilised analysis 
method, thermodynamically-based fluorescence spectroscopy versus entropically oriented 
gel-migration during electrophoresis of which the latter has a much larger sensitivity for 
detecting small differences.  
 
Figure 5.4 - AGE images: determination of polyplex formation via stepwise addition of 
polymers: (A) PEI 25 kDa, (B) PEI+OREG2.1% 25 kDa, (C) p(DMAEG85%-AEG15%) 91 kDa and (D) 
p(DMAEG85%-AEG8.9%)+OREG6.1% 91 kDa. 
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Figure 5.5 - DLS results of polyplexes (in various CR's) derived from (A) PEI 25 kDa, (B) 
PEI+OREG2.1% 25 kDa, (C) p(DMAEG85%-AEG15%) 91 kDa and (D) p(DMAEG85%-
AEG8.9%)+OREG6.1% 91 kDa. 
Concerning the size of polyplexes obtained using fluorescent polymers, various effects could 
be observed. In contrast to native PEI, labelled PEI does not demonstrate a bimodal 
distribution (Fig. 5.5 – A & B). Even more, the distributions appear narrower while the 
dimensions remain more or less of the same order (ranging from 90-35 nm). For labelled, 
p(DMAEG85%-AEG15%), the observed effect is mainly related to size (Fig. 5.5 – C & D). 
Already at a CR of 1/1, tiny polyplexes of 30 nm are formed. Additional polymer (i.e. higher 
CR’s) can now only result in increased dimensions because adding extra polycations 
induces expansion of the particle rather than reinforcing DNA interaction with corresponding 
collapse of the complex.  
In summary, the ideal assumption that the labelling of a polymer exerts no influence on DNA 
interaction was contested by the results shown above. The effect tends to be proportional to 
the degree of positively charged functional groups present on the polymer and should as a 
result be limited. 
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2.4 Formation kinetics of polyplexes 
In addition to the unravelling of cellular uptake mechanisms, fluorescently labelled polymers 
can also be utilised for structural elucidation of the polyplex formation and confirmation of 
previously stated principles. In collaboration with a project partner (Fraunhofer Institute for 
Biomedical Engineering, IBMT, St. Inkbert, Germany), fluorescence correlation spectroscopy 
(FCS) analyses were applied as a feasibility test for retrieving structural and kinetic 
information on the polyplex formation. Optical microscopy is applied to detect fluorescence 
intensity fluctuations which can be analysed using temporal autocorrelation and that can 
provide information of the physics of these fluorescent molecules (mainly through diffusion 
constants). Typically a single wavelength derived from a corresponding fluorescent label is 
used for this34. The presence of fluorescent tags should ideally have no notable influence on 
the formation of polyplexes. To verify this latter statement, UV/VIS spectrometry was 
performed to compare covalently labelled polyplexes with physically mixed labelled 
polyplexes.  
2.4.1 FCS analysis 
Oregon Green 488 (for polymer labelling) and rhodamine (for CPP tagging) proved to be 
suitable for FCS analysis. Two major conclusions with regard to polymer diffusion and 
polyplex formation could be drawn: 
- Diffusion of polymers is detectable and the diffusion times depend on the size of 
the polymer (Fig. 5.6 – A) 
- Polyplex formation (condensation) is detectable and the effect of variable CR and 
concentration of polyplexes is noticeable (Fig 5.6 – B & C).  
The diffusion time of the largest polymers (Fig. 5.6 – A) is not higher than 300 µs and is 
proportional to the size. The difference in diffusion time between the low (27 µs) and medium 
(266 µs) MW compound seem to be much larger than that of the medium and high (291 µs) 
MW polymer. This could indicate that the diffusion time expresses a logarithmic course (with 
horizontal asymptote or plateau) in function of the MW and that from a certain MW on, the 
difference in  diffusion time will no longer be detectable. In contrast to polymers as such, 
polyplexes (Fig. 5.6 – B) display a diffusion time which is considerable higher (1500 µs for 
poyplexes with a CR of 0.6 and 2800 µs for polyplexes prepared at CR 3.0) which is the 
result of the gain in MW by (electrostatically) coupling to DNA. Dependency of the CR is 
shown in figure 5.6 (C) and demonstrates that even the smallest differences (0.1 CR) can be 
detected. Since for this series the concentration of DNA remains constant, this incremental 
progression is the result of the increase in polymer amount, hence the difference between 
the various CR’s will be influenced by the polymer MW. Also the point of condensation can 
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be retrieved via FCS, i.e. by the sudden raise in  (for p(DMAEG) 91 kDa between 0.8 & 1.0 
CR). 
  
Figure 5.6 - FCS measurements: auto-correlation fitting of fluorescence (G = autocorrelation 
function as a function of diffusion time (): (A) polymers, (B) normalized correlation function 
of polyplex & polymer, (C) normalized correlation function, effect of CR. 
The data acquired confirms that FCS measurements can identify complex formation based 
on diffusion times and is able to differentiate between polyplexes with a different CR due to 
the detection ability, both at the level of accuracy and sensitivity (down to a CR difference of 
0.1). Nevertheless, FCS measurements can only be validated if the presence of fluorescent 
molecules do not interfere with the polyplex formation as will be shown below. Moreover, 
due to the sensitivity of FCS, highly fluorescent peaks of complexes (mulitmolecular 
complexes, binding of multiple polymers with one DNA molecule or single polymer 
molecules) are observed and drastically disturbed the analysis of the fluctuation profiles by 
autocorrelation. Consequently, the analysis has to rely on the presence or absence of highly 
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fluorescent peaks in the fluctuation profile as representative data for the majority of the 
polyplexes, namely the baseline (data in between high peaks)35. 
 
2.4.2 UV/VIS absorption tests of fluorescent active polyplexes 
UV/VIS absorbance experiments were carried out to compare the difference between 
polyplexes with covalently coupled fluorescent groups and polyplexes where the fluorescent 
group was physically mixed during polyplex formation. The absorption wavelengths selected 
for labelled polyplexes are 488 nm, which corresponds with the maximum abs of Oregon 
Green and 280 nm which corresponds with the abs of purine and pyrimidine bases of DNA. 
 
Figure 5.7 – Absorbance values (exc = 488 nm) of labeled free polymer as such and upon 
interacting in proximity or collapsed into a particle with DNA. 
At first, there seems to be only a limited difference in detection of  the fluorescent group of a 
polymer when DNA is present at a wavelength of 488 nm (Fig. 5.7). It appears that with 
increasing polymer concentration (and CR), the difference becomes clearer and reaches a 
maximum when condensation into a particle has occurred. Furthermore, no significant 
difference in condensation ability is observed when comparing covalent and physically mixed 
fluorescent groups at a wavelength corresponding with DNA detection ( =280 nm), shown 
in figure 5.8. Since the DNA is now present within the polyplex, a serious decrease in DNA 
sensitivity is noted. Moreover, when complexation has occurred, both absorption values 
remain similar and stable. 
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Figure 5.8 – Absorbance (ex = 280 nm) of polyplexes preformed by polymers with physically & 
covalently mixed fluorescent groups of p(DMAEG85%-AEG15%) 242 kDa. 
 
Figure 5.9 – Absorbance (exc = 488 nm) of polyplexes preformed by polymers with physically 
& covalently mixed fluorescent groups of p(DMAEG85%-AEG15%) 242 kDa. 
On the other hand, a distinct difference can be observed when a covalently coupled dye is 
compared with a dye that is physically mixed during polyplex formation (Fig. 5.9). This allows 
to safely state that the fluorescent tags are partially located inside the polyplex (due to 
shielding from the hydrophilic environment). When physically mixing the dye, a more uniform 
distribution of the fluorescent group can be obtained what is already apparent before full 
complexation was reached. The measured absorbance increase, once the polyplex is 
formed (i.e. CRcond = 1.2), is proportional to the additional quantity of polymer added to the 
solution (and which is electrostatically coupled to the preformed polyplex).  
In conclusion, as stated in section 2.3, the presence of fluorescent labels has a small effect 
on the ability to condense DNA. Moreover, the way of introducing fluorescent groups into a 
polyplex (either by covalent coupling or by physically mixing) appeared indifferent for the 
degree of complexation as was measured at a wavelength of 280 nm. Finally, when using 
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the fluorescent capacity of labelled polyplexes, physical mixing has a clear benefit over 
covalent coupling due to a more homogeneous fluorophore distribution (also at the surface) 
as was measured at a wavelength of 488 nm.  
 
3 Application of Cell Penetrating Peptides in polymeric gene delivery 
3.1 Synthesis of polymer-CPP conjugates 
3.1.1 Coupling strategies 
The ability of cell penetrating peptides to facilitate cellular uptake has been generally 
accepted and reported extensively in literature36,37,38. A wide range of CPP’s have been 
explored and were already used for gene delivery applications as such (without the presence 
of polymers). Most of these compounds show promising results in cell-internalising 
applications but nonetheless, they still possess limited cell-specificity and are complex to 
upscale (time & cost). For that reason, this new class of peptides was examined in 
combination with polymeric carriers in order to reduce the amount of CPP needed while still 
preserving the considerable advantage of their cell-internalising effect39.  
The coupling of a peptide to a polymer can be achieved in different ways. On one hand, the 
peptide can be efficiently incorporated during the aminolysis reaction. Unfortunately, high 
equivalents of peptide are required to obtain sufficient coupling degrees. Therefore, 
preference was given to coupling to the final polymers. An elegant tactic for conjugating a 
macromolecule and a small molecule (e.g. ligand, drug, etc.) is given by thiol-coupling 
chemistry, a process largely executed in nature 40 . Due to the multi-step production of 
synthetic peptides, it is possible to incorporate thiol-containing sequences (mainly by means 
of other amino acids like cysteine) in peptides during the synthesis. Polymers on the other 
hand can only be functionalised with thiol functions when protected thiolating reagents are 
used or by thiol-reactive group modification (post polymer synthesis so to prevent inter-
molecular crosslinking). Because of commercial availability and costs, the latter option was 
selected to obtain polymer-CPP conjugates. 
3.1.2 Coupling protocol 
As was indicated above, thiolated derivatives of poly-L-glutamine and poly-L-arginine could 
not be obtained during polymer synthesis. Since the direct coupling of a peptide to an amine-
containing polymer is not straightforward, the use of a hetero-bifunctional crosslinker was 
mandatory. Two types of crosslinkers were selected. Both an N-(-
maleimidobutyryloxy)succinimide-ester (GMBS), containing a maleimide functional group as 
well as an N-succinimidyl-3-(2-pyridyldithio)propionic-ester (SPDP), characterised by the 
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presence of a disfulfide bond, readily enable coupling to the polymer via the formation of an 
amide-bond41 (Fig. 5.10). In a subsequent step, a thiolated molecule (e.g. cysteine-modified 
CPP) can be reacted with the maleimide group (GMBS) to form a stable thio-ether bond42 or 
a reversible disulfide bond (SPDP).  
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Figure 5.10 - Structure of GMBS and SPDP. 
The modification with a crosslinker and subsequent peptide coupling is carried out in an 
aqueous buffer. N-hydroxysuccinimide esters are relatively sensitive to hydrolysis and are 
therefore dissolved just before mixing with the polymer. Also the pH of this reaction is 
monitored since amine-reactivity is limited to a pH of 7-9. Maleimide functional groups are 
less prone to hydrolysis but reactivity towards thiols is limited to a pH-range of 6.5-7.5. For 
the first modification (polymer-crosslinker), a NaHCO3 buffer (0.1 M – pH ≈ 8.3) was used to 
dissolve the polymer (10 mg/ml). The crosslinker is separately dissolved in DMSO (10 
mg/ml) and added to the polymer solution to react for 45 minutes at room temperature. The 
excess of unreacted crosslinker is removed via size-exclusion chromatography (pd-10 
desalting coloumn – General Electric) in a PBS buffer (pH ≈ 7.2). Subsequent coupling of the 
thiolated CPP is immediately performed by dissolving the CPP in a similar PBS buffer and 
added to the purified conjugate solution followed by stirring (1h at RT). Because it is 
common to use higher excesses of crosslinker than thiolated CPP, it is possible that not all 
functional groups of the conjugated crosslinker are consumed, hence a blocking-reagent 
(EtSH) is added (only in the case of GMBS). The final product is further purified by dialysis 
and isolated by freeze-drying (Fig. 5.11).  
The degree of coupling can be determined via UV/VIS spectrometry, 1H-NMR or a 
combination (dependent on the availibilty of UV-active groups on the peptide). In the case of 
Penetratine, UV absorption (abs = 260 nm) is caused by one tryptophan and two 
phenylalanine units present in the structure. The amount of coupled Arg8 can only be derived 
from NMR measurements. When SPDP is used as a crosslinker, confirmation of the degree 
of coupling can be obtained by measuring the release of thiopyridine, which is a side-product 
of the coupling reaction and has a specific absorption at 343 nm. The disulfide substitution is 
a result of the formation of the thermodynamically favoured thiopyridine (pKa ≈ -1)43. 
 
Chapter 5:  Optimisation & modification of multifunctional vectors 179 
 
Figure 5.11 - Coupling of a CPP to a polymer-crosslinker conjugate (via GMBS & SPDP). 
 
3.2 Overview of the developed polymer-CPP conjugates 
3.2.1 Penetratine (PEN) containing conjugates 
The potential activity increase by coupling Penetratine to biodegradable poly-L-glutamine 
derivatives synthesised in chapter 2, was investigated by applying the coupling protocol 
discussed above. The degree of coupling is kept minimal for reasons of cost per gram CPP 
and to ensure that the polymer properties (e.g. polyplex formation) are not substantially 
affected (table 5.3). All polymers selected have a comparable percentage of free amines 
available (10-20%) and were selected, based on differences in functional groups present 
(guanidine, hydroxyl or tertiary amine) and their corresponding impact on biological 
properties.  
The effect of Penetratin-coupling was investigated by physico-chemical and biological 
experiments (sections 3.3 & 3.4 of this chapter). 
Base polymer Type of crosslinker % coupled M/C 
PEI GMBS 1.4 210.6 
[PEI-Guan] + OREG GMBS 2.0 323.6 
p(DMAEG90%-AEG10%) 10 kDa GMBS 2.9 237.6 
p(DMAEG85%-AEG15%) 91 kDa GMBS 2.8 240.0 
p(DMAEG85%-AEG15%) 242 kDa GMBS 1.8 234.7 
p(ORN18%-ARG82%) 71 kDa GMBS 4.0 209.1 
[p(DMAEG85%-AEG15%) 91 kDa] + OREG GMBS 1.8 264.0 
p(DMAEG85%-AEG15%) 91 kDa SPDP 1.8 236.0 
p(HEG87%-AEG13%) 27 kDa SPDP 3.5 141.8 
Table 5.3 – Overview of developed penetratine-coupled polymers. 
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3.2.2 Octa-Arginine (Arg8) 
Similar to Penetratin, Octa-arginine or Arg8 (the peptide sequence that presumably 
represents the active sequence of TAT) was selected to be coupled to certain biodegradable 
polymers. Unlike for Penetratin, the coupling of a higher charged molecule to a cationic 
polymer appeared to complicate the degree of coupling due to charge repulsion which led to 
lower coupling degrees. The negative influence of the cationic charge (present on the 
polymer) on the CPP coupling efficiency could be noticed when equal reaction parameters 
were applied for polymers containing a substantial amount of neutral groups such as p(HEG-
AEG) with a high percentage of hydroxyl groups (85-90 %) resulting in a higher coupling 
degree (table 5.4). 
Base polymer Type of crosslinker % coupled M/C 
PEI GMBS 1.0 209.8 
p(DMAEG85%-AEG15%) 91 kDa GMBS 1.0 232.0 
p(DMAEG85%-AEG15%) 242 kDa GMBS 1.9 233.8 
[p(DMAEG85%-AEG15%) 91 kDa] + OREG GMBS 1.2 262.7 
p(HEG87%-AEG13%) 11 kDa SPDP 8.0 185.0 
p(HEG87%-AEG13%) 27 kDa SPDP 5.0 140.8 
Table 5.4 – Overview of Arg8-modified polymers. 
 
 
3.2.3 Influence of spacer on CPP activity 
Providing polymeric vectors with CPP’s is expected to be the start of obtaining improved 
polyplex internalisation and correspondent transfection efficiency. Nonetheless, since 
polymers form tightly-condensed particles with DNA, the availability of CPP’s for cell-surface 
negotiation can be seriously restricted due to the fact that CPP’s are partial (PEN) to fully 
charged (Arg8) structures that are equally prone to electrostatic forces of oppositely-charged 
molecules as the polymer. To judge on the importance of this aspect, several Arg8-
derivatives with variable spacer lengths were synthesised. Different types of spacer were 
considered: 1) flexible and rigid ones and 2) short and long ones. Oligo-sized chains of 
ethyleneoxide (PEO) units were applied as flexible spacers. Moreover, PEO chains are 
known to limit protein-specific interactions which could be beneficial for the cell-viability. Also 
regular carbon chains were used with variable length. Specific amino acid sequences were 
able to give rigidity to the spacer. A repeating sequence of proline and glycine units imparts 
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rigidity while a repetition of other amino acids such as for arginine-alanine-aspartic acid-
alanine (RADA) is known to form fibril-like (helical) structures and believed to act as a lineair 
version of the RGD-motive (but with non-integrin mediated adhesion)44. In this way, each 
spacer could provide the polymer-CPP conjugate with a specific geometrical property. The 
spacers were incorporated during peptide synthesis between the active peptide sequence 
and the cysteine unit (used for covalent coupling) as shown in figure 5.12. 
 
Figure 5.12 - Different types of spacers coupled to Arg8. 
The effect of the different spacers was tested with Arg8 on p(DMAEG85%-AEG15%) (MW = 
91.000 Da) using the GMBS crosslinker and the peptide-derivatives by applying the standard 
protocol. A slight influence of the spacer length and type on the coupling efficiency could be 
noticed. Long and flexible chains (PEO) allowed a somehow higher amount of coupling while 
more rigid chains (both -(CH2)- and Pro-Gly) proved to be less efficient. Reactions with short 
spacers or no spacer only reached coupling degrees of about 1 % (table 5.5). Besides 
p(DMAEG-AEG), an initial coupling reaction was performed on PEI with a spacer-containing 
PEN-derivative (-(CH2)7-PEN) which was coupled at a molar concentration of 1%. 
Spacer % coupled M/C 
- 1.0 232.0 
(CH2)3 0.9 231.9 
(CH2)5 1.1 232.1 
(CH2)7 1.8 232.8 
(CH2-CH2-O)2 2.0 233.5 
(CH2-CH2-O)11 3.7 236.1 
(Pro-Gly)3 1.8 233.4 
(RADA)4 2.5 234.7 
Table 5.5 - Overview of Arg8 peptides with variable spacer types and length coupled to  
p(DMAEG85%-AEG15%) 91 kDa. 
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3.3 Physico-chemical characterisation 
It is imperative that cell-penetrating peptides exert a positive influence on synthetic vector 
systems as they are assumed to act upon this by facilitating cellular entry. On the other 
hand, incorporating CPP’s into the polymer-DNA polyplex should not hamper the ability of a 
vector system to interact with DNA. Therefore, the focus of CPP-based polymers and 
polyplexes was, besides biological benefit, also put on improvement (or preservation) of the 
DNA-interacting properties. The outcome of peptide-coupling is checked in terms of polyplex 
formation, size and stability using the characterisation methods described in chapter 4. 
The influence of CPP coupling is already apparent in the calculation of polyplex composition 
because the M/C was altered by coupling peptides (responsible for added molecular weight 
and charge). Dependent on the amount and type of CPP coupled, the M/C can differ up to 
10% from the original value (tables 5.3-5.5).   
Additionally, in collaboration with the Fraunhofer Institute (IBMT) project partner, newly 
developed techniques that are based on the measurement of impedance of single cells, 
were used to help elucidate the mechanism of cell penetration by CPP’s on single cells. In 
this way, the effect of both polyplexes and CPP’s on the cell membrane integrity can be 
assessed.  
3.3.1 Polyplex formation 
In order to decide if CPP-coupled polymers have a different ability to form small particles 
with DNA, EtBr fluorescence and agarose gel-electrophoresis experiments were performed 
to verify the formation of polyplexes and to compare their results with the corresponding non-
coupled polymers. Ideally, CPP addition was expected to enhance the attraction towards 
DNA but in practice, this is only noticeable for systems which don’t possess large quantities 
of cationic charge.  
EtBr Fluorescence 
Via EtBr displacement assays, a rudimentary idea of the complex strength was formed. Both 
the extent to which EtBr intercalation was prevented and the CR at which polyplex formation 
started, allowed for information of the polyplex interacting forces to be derived. In figure 5.13, 
the influence of peptide-coupling to PEI is shown. It appears that the CR for full 
complexation is slightly shifted (0.2-0.4 CR units) towards a higher CR. This could indicate 
that peptides interfere (if only little) with the polyplex formation by hindering the optimal 
orientation of the cationic vector when approaching the polyanion (DNA). All peptide-
derivatives show an equal or small improvement in MinF (lower fluorescence yield) which is 
in accordance with the precluding claim that additional cationic charges (provided by the 
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CPP) should enhance the quality of the attraction force displayed by the basic polymer (but 
due to the limited coupling degree, this effect was rather small).   
 
Figure 5.13 - Fluorescence yield as a function of increasing CR for polyplexes 
based on PEI, PEI+PEN1%, PEI+ARG1% & PEI+spacer+PEN1%. 
Providing biodegradable poly--amino acids with a CPP gives rise to fluorescence results 
which differ from the trend noticed for CPP-coupled PEI derivatives. Moreover, they prove to 
be dependent on the composition of the polymer backbone and functional groups. Similar as 
for PEI, abundantly protonated, poly-L-glutamines (e.g. p(DMAEG-AEG)) display a shift of 
the CRcond towards higher values (0.4 units) when a CPP was coupled to it but the interaction 
forces remain equal (Fig. 5.14 – grey full lines). In the case of a spacer with considerable 
length (i.e. 11 EO-units), an even bigger shift (0.8 CR units) can be observed as well as a 
loss in EtBr exclusion ability (20 %) which could be most likely attributed to a shielding effect, 
induced by the non-charged spacer that possesses sufficient mobility to surround the 
polymer cationic charges. The effect of shielding the cationic polymer is even more 
expressed for derivatives which display an optimal DNA interaction (high EtBr exclusion at 
low CR), observed for p(ORN-ARG). When a substantial amount of PEN is coupled, the 
CRcond is shifted from 1/1 to 2/1 (Fig. 5.14 – grey dotted lines). As opposed to reduced DNA 
interaction, the addition of a CPP can also be the origin of (improved) DNA condensation. 
This is the case for polymers with a low charge density, for instance p(HEG87%-AEG13%) to 
which 5 % of Arg8 was coupled, generates a polymer with excellent condensation properties 
(strong interaction at low CR) and does not demonstrate a negative shielding effect (Fig. 
5.14 – black lines). 
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Figure 5.14 – EtBr displacement assays: influence of CPP addition on DNA condensation by 
p(DMAEG85%-AEG15%) (grey full), p(ORN18%-ARG82%) (grey dotted) and p(HEG87%-AEG13%) (black 
full). 
3.3.2 Agarose gel-electrophoresis (AGE) 
Complementary to the EtBr displacement test, the effects of peptide coupling on DNA 
condensation by polymeric vectors could be verified by AGE. Due to the different principle 
on which both techniques are based (size-exclusion chromatography versus fluorescence 
spectrometry) slight deviations could be observed when compared to EtBr fluorescence 
(generally ≤ 0.2 CR units). A similar trend was noticed based on the retardation of DNA 
when mixed with increasing polymer quantities (steps of 0.2 CR). These results confirm the 
required increase in CR needed for total DNA complexation when making a comparison 
between regular and peptide-functionalised derivatives (Fig. 5.15). 
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Figure 5.15 – Agarose gel electrophoresis experiments of DNA condensation by (A) PEI 25 
kDa, (B) PEI+PEN, (C) PEI+ARG8, (D) PEI+spacer+PEN, (E) p(DMAEG85%-AEG15%) 91 kDa and (E) 
p(DMAEG85%-AEG15%)+PEN. 
3.3.3 Polyplex size and distribution 
Despite the lasting doubt about the cellular uptake mechanisms of polyplexes, a great deal 
of investigations are focussed on obtaining delivery systems with a particular size, 
compatible with the requirements for the endocytotic pathway. Especially for polymers 
containing CPP’s, the necessity to meet certain size restrictions when receptor mediated 
endocytosis is considered, should be kept in mind. Therefore, it is imperative that peptide 
coupling preserves the nano-sized dimensions of vector-DNA particles. With respect to this 
demand, particle sizes were determined by DLS. From figure 5.16 (A), it can be concluded 
that native PEI-DNA complexes show an equal bimodal distribution (130 and 320 nm at CR 
2/1) of which the smallest distribution predominates at higher CR. Polyplexes based on 
CPP-coupled PEI remarkably show almost no particle-sizes above 150 nm and appear 
nearly all as mono-modal peaks. Also, the difference in absolute size between the different 
CR’s is limited. Furthermore, the particles tend to decrease in size with increasing CR and 
can reach values as low as 30 nm but are characterised by broader distributions.  
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Figure 5.16 – Overlay graphs of DLS measurements of polyplexes at various CR (1/1, 2/1 and 
4/1) based on PEI (A); PEI+PEN (B); PEI+ARG (C) and PEI+spacer+PEN (D). 
For poly-L-glutamine derivatives possessing a high amount of cationic charges (Fig 5.17 - 
A), small, uniform particles (≈ 60 nm) are already formed at a low CR (1/1) and can reach 
values as low as approximately 35 nm for a CR of 4/1. It appears that the addition of 
Penetratine (Fig 5.17 - B) does not influence the polyplex size and distribution. Moreover, in 
contrast to EtBr displacement and gel-electrophoresis results, condensation of DNA into 
particles of 30-40 nm appears to occur already at a CR of 1/1. The addition of more polymer 
(i.e. a higher CR) is in this case disadvantageous given the increased particle size as a 
consequence of the optimal particle formation that already occurs at a 1/1 CR and which 
represents a layered expansion of the polyplex particle. In the case of poly-L-glutamines with 
few cationic charges (Fig 5.17 – C), relatively small particles are apparently formed at a CR 
of 1/1 (100 & 300 nm) despite the fact that virtually no EtBr was expelled at this CR. This 
could suggest that the complexation is weaker but sufficient for size reduction (into a 
particle). When augmenting the CR, smaller particles (up to 35 nm) are formed but a 
tendency towards larger size distributions remains. The addition of more cationic charge by 
coupling a CPP (Arg8) proved very successful in fluorescence experiments but the effect on 
size is less pronounced (Fig. 5.17 – D). With the observed new values only half of the CR is 
required to obtain similar sizes compared to the reference (uncoupled) polymer. In general, 
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DLS results are interpreted based on a number-averaged value. If volume or intensity 
averages are taken into account, extra distributions sometimes arise at higher values 
(applicable for polyplexes at low CR, close to the CRcond).    
 
Figure 5.17 - DLS measurements of polyplexes at various CR (1/1, 2/1 and 4/1) for (A) 
p(DMAEG85%-AEG15%) 91 kDa, (B) p(DMAEG85%-AEG15%)+PEN, (C) p(HEG87%-AEG13%) and (D) 
p(HEG87%-AEG13%)+Arg8 based polyplexes. 
3.3.4 Stability of polyplexes in aqueous environment 
To what degree, polyplexes, formed in water, remain stable in an aqueous environment is a 
property that can be revealed by measuring the zeta-potential. The impact of peptide 
residues which should be present at the surface of the polyplex was investigated and found 
to be in accordance with preceding results (fluorescence, AGE and DLS). CPP-containing 
polymers show lower surface charges than their native polymers (or they reach similar 
values only at higher CR’s). Moreover a delay (i.e. higher amount of polymer needed) in 
polyplex condensation can be noted from the CR corresponding with a value of 0 mV. This is 
most likely the result of the geometrical conformation of the polyplex which is more diffuse 
due to CPP extensions which contain also charges and expand the double-layer radius (and 
correspondingly lower the double layer radius. Still, all polymer-DNA complexes exhibit good 
stability (> 30 mV) at high CR’s (4/1) and are highly, positively charged. This implies an 
excess of cationic polymer, capable of protecting the DNA and enabling interaction with 
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anionic cell surfaces. Additionally, when comparing this with fluorescence results, it is clear 
that polyplex formation and the origination of a positive surface charge are reached at 
different CR’s (zeta-potential: usually higher values). 
 
Figure 5.18 – Results of zeta-potential experiments with polyplexes based on several polymers 
at various CR’s (0.5/1, 1/1, 2/1 and 4/1) 
3.3.5 Cell membrane interaction 
An essential, if not the most important, hurdle towards achieving successful gene delivery 
systems, is crossing of the cell membrane, the most notable boundary between cellular 
entities and its surrounding. As was mentioned during the introduction, the cell can exploit 
several processes to take up or excrete substances. Receptor mediated endocytosis can be 
accounted for as one of the major cellular internalisation processes for peptide-based 
delivery to cells. With the aim to help clarifying how CPP’s mediate internalisation, the 
interaction of peptides with the cell membrane was investigated. A possible technique to 
achieve this, is to determine the structural integrity of the cell membrane via impedance 
measurements45. Impedance spectroscopy is a repetitive and non-invasive technique to 
characterise the frequency dependent electrical characteristics of materials like the double 
phospho-lipid layer of cell membranes. To avoid electrode polarisation and consequent 
impedance augmentation (when applying micro-electrodes), a micro-hole based chip was 
developed to optimise sensitivity and eliminate noise-impedance (caused by the electrodes). 
Impedance is a concept that extends resistance to AC circuits whereby not only the ratio (Z) 
of voltage (V) to current (I) is described but also its relative phase-difference (). When put in 
Ohm’s law this becomes: 
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            and                    
 
Figure 5.19 - Impedance measurements of single cells: (A) schematic outline, (B) cavity chip 
and (C) cell position and impedance manipulation (I = current). 
The schematic outline of the experimental set-up is shown in figure 5.19: single cells are 
captured onto a gold-coated electrode with a diameter of about 5 µm. By applying a slight 
vacuum (0,05 mbar), a cell gets positioned into the hole and occupies the complete surface 
of the electrode (A). Up to 4 individual electrodes are incorporated into a cavity chip that 
allows for cells to be cultivated in a controlled environment (B). Electrode coatings 
composed of gold prove additional benefits in coupling CIP’s (thiol-gold affinity). The 
influence of the cell-presence on the electrical signal (impedance, Z) when a voltage is 
applied between the electrodes, is finally measured and interpreted by plotting the values as 
a function of time.  
An example of such a measurement in shown below for Penetratine and PEI (Fig. 5.20). The 
addition of Penetratin shows a disturbance in the membrane (of about 5 kΩ) after 15 minutes 
of incubation. A more severe impact on the membrane is caused by the application of Triton 
X-100, a non-ionic surfactant, which is used here to give an idea on the degree of membrane 
disruption. Because membrane instability is related to the origination of pores, microtunnels 
and other points of entry for extracellular components this confirms interaction of the CPP 
with the membrane but without specifying the mechanism. A similar effect was observed 
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when the addition of PEI to a cell (in culture medium) was measured (Z ≈ 25 kΩ) although 
no incubation period was registered here (similar as for Triton X-100) and could be indicative 
for a difference in internalisation mechanism. 
 
Figure 5.20 - Impedance experiments on single cells: Influence of the addition of Penetratine 
(up) and PEI 25 kDa (down) to single cells positioned onto micro-electrodes.   
These experiments were extended to other polymeric carriers and their corresponding 
polyplexes. The extent to which polyplexes, that are added to the cell medium, can interact 
with the membrane and engage in certain uptake mechanisms is detectable using this same 
set-up. From these results important properties could be deducted when comparing 
(biologically) active with inactive polymers (see also chapter 6). Apparently, the addition of 
active PEI-Guan20% polyplexes showed no noticeable change in impedance, hence the 
conclusion that membrane disruption was not realised (Fig 5.21). This was not the case for 
inactive polyplexes composed of pDMAEG with a MW of 242 kDa or its Penetratine-
containing derivative p(DMAEG85%-AEG15%)-PEN as visualised in figure 5.22. After addition 
of the polyplexes to the cell medium (marked by the black arrow), a drop in impedance was 
detected which was even more pronounced for the penetratine derivative. Also, this effect 
Application of culture medium 50 µM PEI
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continued in time for the penetratine compound whereas for the basic polymer, the 
impedance difference graduately faded in time. Additionally, the increased disruption of the 
penetratine derivative can only be attributed to the coupling of this CPP. In all cases, there 
was a short incubation time required before membrane interaction starts. All the measured 
values (Fig. 5.21-23) were compared with impedance experiments containing only cells 
(reference) or no cells at all (background signal). 
 
Figure 5.21 - Impedance values as a function of time: PEI-Guan polyplex and their influence on 
the membrane destabilisation. Background/noise = signal measured when no cell is present. 
In contrast to polyplexes based on pEI-Guan, which do not seem to interfere with the 
membrane (based on impedance), the pure polymer affects the membrane stability after an 
incubation time of 20 min (Fig. 5.23). This leads again to the hypothesis that an excess of 
cationic charge acts heavily upon the cellular membrane but does not induce membrane 
crossing as such. The incorporation of DNA and the consequent formation of polyplexes 
diminishes the excess charge which suggests that polymeric carriers with reduced positive 
charge (like for neutral or hydrophobic groups) could experience a higher rate of success in 
transduction processes. Because the presence of peptides (e.g. penetratine) has proven to 
facilitate internalisation32 and corresponded with a certain impedance change but this was 
not readily observed for complexes based on PEI-Guan, impedance measurements alone 
are not sufficient in validating the uptake of particles. This is probably the result of different 
internalisation mechanisms used (between pEI derivatives and penetratine) which can’t be 
detected by impedance spectroscopy. 
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Figure 5.22  – Impedance values as a function of time: (up) p(DMAEG) 242 kDa polyplex and 
(down) p(DMAEG-AEG)-PEN 242 kDa polyplex and their influence on the membrane 
destabilisation. Background/noise = signal measured when no cell is present.  
When correlating these impedance spectroscopy measurements with biological activity 
(chapter 6), it is unfortunately not possible to confirm the potential use of a polymer as 
genetic vector by impedance measurements alone. The membrane interaction capacity can 
be readily validated for polymers but as active complexes (PEI-Guan complexes) do not 
display a drop in impedance, additional characterisation is required to assess a vector’s 
ability to transfect a cell.  
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Figure 5.23 - Impedance values as a function of time: (up) PEI-Guan polyplex and (down) PEI-
Guan polyplex and PEI-Guan as such and their influence on the membrane destabilisation. 
Background/noise = signal measured when no cell is present. 
 
4 Comparison of physical versus chemical CPP mixing 
As the interest and the amount of possible applications of cell penetrating peptides is 
graduately increasing, a growing need for CPP’s will originate from this46. Considering that 
the coupling of a CPP onto a macromolecule is a reaction that requires excesses that in 
most cases are accompanied by a substantial loss of the product (when looking at the final 
amount coupled), more efficient ways of incorporating CPP’s into polyplexes are actively 
being pursuit. In combination with the laborious (both time and cost) synthesis of these 
compounds, alternative integration strategies are continuously explored. Since CPP’s act as 
delivery systems as well47, the use of physically mixing polymer and CPP was put forward in 
an attempt to avoid coupling steps and to exploit the most efficient delivery system. In this 
way, the amount of CPP required, can be decreased while still preserving the considerable 
advantage of cell-internalising benefit35 whereas the cell-specificity of CPP’s can be 
enhanced by combining with a polymeric vector.   
The outcome of this optimised procedure can be assessed on both a physico-chemical and 
biological level. The latter will be discussed in the next chapter while the consequences 
related to polyplex formation were interpreted via EtBr fluorescence and gel-electrophoresis 
shown below (Fig. 5.24-25). 
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The result of physically mixing a CPP (e.g. penetratine) with a vector rather than coupling it, 
has a limited significance on the ability to condense DNA. It can be interpreted from figure 
5.24 that a small shift in CR (≈ 0.4 units) represents the need for a higher amount of vector 
(required for full condensation) if the polymer is covalently coupled. The quality of interaction 
seems nearly unaffected as derived from the fluorescence at full condensation. This implies 
that the interaction between CPP-coupled polymer and DNA is slightly hampered and can 
only be the result of changes in orientation or sterical limitation of the cationic charges since 
both pure penetratine and pure p(DMAEG-AEG) display full condensation at lower CR’s. 
 
Figure 5.24 - EtBr Fluorescence yield as a function of increasing CR for polyplexes derived 
from penetratine, p(DMAEG85%-AEG15%) and penetratine coupled to p(DMAEG85%-AEG15%). 
This assumption was confirmed by means of agarose gel-electrophoresis. Physical mixing of 
penetratine and p(DMAEG85%-AEG15%) 91 kDa (Fig 5.25 - B) results in similar retardation 
assays as their individual components (A & D) whereas covalently coupled p(DMAEG-AEG)-
PEN (C) requires a higher CR for full condensation (≈ 0.4 CR units). A similar effect is to be 
expected for polymers coupled with another CPP, i.e. octa-arginine (E). 
With respect to the biological data that will be presented in chapter 6, a procedure based on 
physically mixing of a CPP within a polyplex could lead to a more efficient way of producing 
gene delivery devices since complexation can occur at lower CR which results in less 
reagent consumed. Given the limited amount of CPP that can be covalently coupled to 
polymer carriers, this method enables also the incorporation of relative higher amounts of 
CPP, a condition that was proven to be more efficient in obtaining stronger polyplexes. 
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Figure 5.25 – Gel-electrophoresis images of p(DMAEG85%-AEG15%) (A); physically mixed PEN & 
p(DMAEG85%-AEG15%) (B); p(DMAEG-AEG)-PEN (C); Penetratine (D) and Arg8 (E). 
 
5 Conclusion 
Based on the results of this chapter, it can be concluded that modification of the final 
polymers with small molecules or peptides can be performed using different coupling 
strategies. The effect of the coupling can in most cases already be observed at low coupling 
degrees (e.g. 1-5%) which is a necessity for certain charged peptides as it was proven 
difficult to reach coupling degrees higher than 5%. The interaction with DNA on the other 
hand is slightly decreased compared to non-coupled polymers and was the result of charge 
shielding or the overall increase of the mass/charge ratio. Because of that the CR for full 
condensation is higher, which is a disadvantage in terms of cell viability. Also the zeta-
potential and the size distributions experienced minor changes. Other characterisation 
techniques were presented in this chapter, on one hand as valid alternative to the standard 
methods for assessing interaction with DNA (such as FCS) and on the other hand as a 
useful tool for mapping the interaction of polymers and polyplexes with the cell membrane 
(impedance), although additional methods are required for confirming the obtained results. 
Furthermore, physically mixing of CPP’s with polyplexes was validated as an improved way 
of incorporating CPP’s into polyplexes without loss of DNA-interaction ability.      
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1 Introduction 
Since the ultimate goal of gene therapy is the introduction of a gene of interest into cells and 
enable the subsequent expression of this particular gene inside the cell, the possible effect 
of the carrier system onto processes that assist in realising the corresponding protein 
expression needs to be investigated. An ideal way of delivering polyplexes to cells 
comprises of intravenous administration (in vivo) and calls for the evaluation of the 
interaction between (charged) polyplexes or polymers and blood components. Besides red 
blood cells (RBC) which is the most abundant substance in the blood, also the presence of 
enzymes degrading the DNA, the polymer or both should be taken into account when 
describing the biocompatibility of a polymer. The presence of polyplexes inside the 
bloodstream can mutually affect each other with complex disruption or alteration of the blood 
composition (morphology or lysis) as a consequence. 
In general, issues that are related to global toxicity on a cellular level are interpreted by 
measuring specific characteristics like metabolic activity (MTT test) or cell membrane 
integrity (dye exclusion assays) of healthy cells. Furthermore, it is equally important to check 
whether a polymer can be removed from the body after its task as a delivery system was 
executed. With respect to the natural degrading mechanisms of the cell (lysosomes), 
polymers need to be subjected to a degradation test that simulates the internal composition 
of lysosomes, the waste disposal entities within cells.   
Ultimately, the performance of delivery systems for gene therapy applications is assessed by 
measuring the result of its genetic function. Despite the numerous genetic effects that are 
targeted in gene therapy, the mechanism to obtain therapeutic correction of pathologic 
conditions via DNA is universal, that is the transcription of a genetic sequence and 
production of a protein. Therefore, standard transfection experiments were developed that 
make use of a typical reporter gene that encodes for a chemical structure which can easily 
be detected (e.g. a physical constant like fluorescence yield).   In this part of the work, 
several chemical and biological tests are performed to acquire more information on the 
biocompatibility of the polymers and their corresponding polyplex. In a first approach, the 
use of in-vitro vectors is screened to check the activity and the possibility to exploit the 
potential as a delivery device even further, as for instance by in-vivo relevant experiments.   
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2 Efficiency of polyplexes as in-vitro gene delivery systems 
2.1 Principle of cell toxicity - viability 
For gene therapy to play a leading role in advanced disease and illness control, the use of it 
must result in a proper and efficient solution with minimal side-effects for the patient. 
Because of that, the use of gene carriers that will aid in the delivery of the ‘curing agent’ (e.g. 
therapeutic DNA), should not inflict additional discomfort. On a more basic level, this is 
expressed as cellular damage in which for instance the production of proteins or the capacity 
to continue to divide is negatively altered. It is therefore possible to examine the influence of 
polymer carriers and polyplexes on cells by subjecting them to in-vitro cell viability tests. 
Such experiments assess living cells in a sample and this is accomplished by either directly 
counting the number of living cells (using specialised instruments) or by measuring a 
corresponding indicator for cellular activity (e.g. an assay). In most cases, decreasing values 
of cell survival represent the presence of a toxic effect related to the genetic carrier applied. 
Achieving efficient in-vitro transfection is the basis for proceeding with in-vivo testing. 
Most viability assays are based on one of two characteristic parameters, namely metabolic 
activity or cell membrane integrity of healthy cells. The metabolic activity is usually measured 
in cell populations by incubating the cells with a reagent, such as a tetrazolium salt (MTT test 
– Fig. 6.1), that is converted by metabolic active cells into a compound (insoluble formazan 
crystals) that is readily detectable by for instance UV/VIS spectroscopy1. The second type of 
assay, also termed dye-exclusion assay, makes use of the ability of healthy cells to exclude 
dyes (e.g. trypan blue) from penetrating the cellular membrane due to conservation of the 
structural integrity. As a result, dead cells will be stained with an intensity that is proportional 
to the mortality rate while healthy cells will remain unstained.  
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Figure 6.1 – Reduction process of tetrazolium salt into formazan crystals, catalysed by 
mitochondrial reductase (MTT test). 
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For these in-vitro experiments, the UptiBlue assay is performed. UptiBlue (resazurin) 
consists of a redox indicator that fluoresces and changes color in response to cell growth 
(Fig. 6.2). As cells under investigation grow, the innate metabolic activity causes a chemical 
reduction of UptiBlue which causes the indicator to change from an oxidised, non-
fluorescent, blue form to a reduced, fluorescent, red state2. This indicator was preferred 
above the classic MTT assay because of several reasons. Firstly, the indicator exhibits both 
fluorescence and colorimetric behaviour, allowing intra-cellular visualisation before and after 
substrate conversion by spectrofluorimetry or regular spectroscopy. Also, the required 
irradiation corresponds with traditional wavelengths. Furthermore, this compound is 
minimally toxic to living cells, has a long-term stability and is water soluble which eliminates 
the need for complex extractions (like for formazan crystals). 
 
Figure 6.2 – Chemical structure of resazurin (Uptiblue). 
Practically, cell viability tests are often carried out in combination with transfection 
experiments. After the cells were conditioned for transfection and incubated with genetic 
material by means of a vector with a specific CR (see experimental section), the uptiblue 
product is added (10% v/v) and left for incubation at 37 °C in an atmosphere containing 5 % 
CO2 for about 2 hours. Following incubation, the excitation/emission can be measured for all 
the samples including a positive (Triton X-100) and negative (non-transfected cells in buffer, 
no vector-DNA added) control set to 0 and 100% viability respectively.  
2.2 Transfection efficiency: protein production of modified DNA  
Generally, the ability of genetic vectors to be successful in the elimination of genetic defects 
with corresponding introduction of specific, therapeutic genes into the core of a cell to cure 
pathogens or diseases, is assessed by in-vitro testing using plasmid models. Most plasmid 
models use specific cell-lines and standardized protocols in combination with modified DNA 
that encodes for easy-detectable proteins to produce reliable and reproducible results. The 
total transfection process or efficiency of a (polymeric) vector comprises of cell incubation (in 
buffer medium) with polyplexes. The subsequent uptake in the cell and introduction of the 
genetic material in the cell-core enables it to be used for replication and protein synthesis. 
Traditional assays applied for these kind of tests normally give an indication of the last step 
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(protein production) by providing modified DNA that encodes for proteins that can be 
detected via (VIS light) spectrometry. Unfortunately, when the total process of uptake, 
cellular trafficking and protein expression is for any reason disturbed, no signal can be 
measured. To partially resolve this disadvantage, confocal microscopy was adopted as an 
extra analytical technique that could shed light on the intra-cellular transfection process 
(section 6).  
For the following transfection tests, the activity of polyplexes was measured quantitatively 
and qualitatively by a Renilla Luciferase based assay. These experiments were carried out in 
the framework of the PolExGene project by Dr. Alain Joliot and Dr. L. Tibaldi (Laboratory for 
Homeoprotein Cell Research, Collége De France, Paris, France).  Renilla Luciferase (ReLu) 
is an enzyme (36 kDa) isolated from the marine sea anemone (anthozoa) Renilla 
Reniformis. The substrate on which ReLu can act, luciferine (coelenterazine), can oxidize 
into coelenteramide by emitting light and CO2 when doing so (Fig. 6.3). Specific for this type 
of luciferase, is the close association with a green fluorescent protein (GFP) and a luciferine-
bound protein (which is partially protected). The addition of calcium can readily allow 
decoupling of this protective protein and make the luciferine available for oxidation. 
Furthermore, the (blue) light that is normally emitted when oxidized is now coupled to the 
fluorophore of GFP through resonance energy transfer for corresponding release of a photon 
with a peak value of about 510 nm (green).  When no catalyst (luciferase enzyme) is used, 
this reaction is nearly unexisting. The enzyme does not require post-translational 
modification for its activity and may perform its function immediately following translation3. 
 
Figure 6.3 - Renilla Luciferase oxidation process with corresponding emission of light. 
By introducing the PcRUCHA plasmid, encoding for luciferase, into the cells by means of a 
polymeric vector, the transfection efficiency of these vectors can be obtained quantitatively. 
Only cells which are able to express luciferase will be capable of converting coelenterazine 
and yield the corresponding emission of light. 
Renilla
luciferase
+ CO2 ↗
+ photon
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Experimental transfection tests are always combined with viability tests to minimize the 
laborious cell preparation. The measurement of cell transfection continues with the cells 
utilized for the uptiblue assay. Firstly the supernatant is removed and passive lysis buffer 
(PLB – Promega) is added to each well and left on a plate shaker to induce lysis of the cells 
so that the luciferase is released into the medium. Additionally, the cells are subjected to a 
freezing (-80 °C)/thawing (37 °C) cycle to ensure complete lysis. The coelenterazine 
substrate is added automatically inside the luminometer and the resulting luminescence is 
measured for 10 seconds with a delay of 2 seconds between injection and measurement 
(maximum photon peak a couple seconds past enzyme-substrate mixture). The transfection 
efficiency is expressed in relative luciferase units (RLU) and therefore it’s necessary to 
compare the results with a reference compound (PEI). Furthermore, in the case of weak 
signals a background correction is carried out for the luminescence signal of the cells. 
 
2.3 Results 
2.3.1 PEI & CPP-coupled PEI-derivatives 
The development of new vector-based delivery systems requires a full evaluation and a 
corresponding classification system in order to decide if its use can be promising for 
continued research. Since the use of cell lines for in-vitro research applications is very 
extensive and the combinations of cell types and protocols  are numerous, most experiments 
make use of a reference polymer that is widespread and who’s properties are well known. 
Via this reference compound, it is possible to compare different candidates in variable 
batches mutually and compared to the reference polymer (PEI), even when not always 
displayed in certain graphs. Therefore it is important to test the transfection and toxicity of 
the reference compound prior to evaluation of new candidates. Furthermore, modifications of 
this polymer were also carried out and compared accordingly. 
 It is important to stress that no values are given for the y-axis because of the relative nature 
of the experiment. Also, due to considerable variation that exists for the standard testing 
methods (sensitive behaviour of cells), the obtained results can differ strongly per test, 
hence the high standard deviations observed. A summary of all active components, reported 
in the following results and graphs is compiled at the end to allow comparison mutually and 
with PEI (Fig. 6.20). 
The results for PEI, PEI coupled to Oregon Green (PEI-OREG) and PEI coupled to CPP’s 
like penetratine or arginine8 (PEI-PEN & PEI-ARG8) are displayed in figures 6.4-6.5. Since 
polyplexes composed of PEI give rise to substantial toxicity, these parameters are often not 
tested at CR’s above 2/1. While the viability of PEI steadily decreases with increasing CR, 
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the effect of coupling a molecule appears to keep cells viable at higher CR. On the other 
hand, the efficiency of the PEI-derivatives seems not to influence transfection significantly 
(except for PEI-ARG which can maximally reach half the efficiency of regular PEI). The 
maximum values that were obtained are nearly equal for the modified compound but they 
are only reached at higher CR’s compared to native PEI. This suggests also the importance 
of the condensation value and the corresponding impact on molecular structure. The 
coupled molecules are expected to arrange in a more or less surrounding way around the 
PEI backbone and accordingly shield the cationic charge. Fortunately, the resulting shielding 
effect lowers the toxic nature of the polymer, hence the increased viability values. 
 
Figure 6.4 – Toxicity of cells incubated with polyplexes at variable CR. 
          
   Figure 6.5 - Transfection efficiency of PEI & PEI-derivatives on ARPE19 cells (24 h). 
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2.3.2 Vector efficiency of poly-L-glutamines 
Because of the biocompatibility related to using protein-like biodegradable polymers as 
genetic vectors, the potential of poly-L-glutamine derivatives is high. As was mentioned 
before, a whole range of compounds with different MW and functional groups was prepared 
and characterised in terms of physico-chemical properties. Ultimately, these products need 
to be able to efficiently and safely deliver genetic material to the cell. The first series of 
polymers tested, were based on pDMAEG. Next to the influence of the MW also the coupling 
of a cell-penetrating peptide was checked and mutually compared (Fig. 6.6 & 6.7). When 
looking at toxicity, it is clear that this polymer exhibits a very high biocompatibility with limited 
to no effect on cell survival when applied as vector. Influence of the MW is hardly visible (the 
lowest value is reached for the highest MW compound at 4/1 CR) and also the difference in 
CR has no clear effect on the viability. If a peptide was coupled to the polymer, again limited 
changes were observed, especially for the peptide penetratine (pDMAEG 80 kDa + PEN = 
80k+P, similar for 242k+P). In the case of Arg8 coupling (pDMAEG 242k + Arg8 = 242k+A), 
the resulting decrease was significant, especially with increasing CR and a corresponding 
higher amount of Arg8 present in the polyplexes.  
 
Figure 6.6 – Toxicity results of cells incubated with polyplexes based on pDMAEG with a 
variable MW and CPP-coupled pDMAEG 80 kDa & 242 kDa at variable CR (P = PEN, A = ARG8). 
Unfortunately the transfection efficiency of glutamine-containing homopolymers proved to be 
virtually zero (Fig. 6.7). If focus was put on the different pDMAEG, a higher MW seemed to 
be responsible for increasing efficiency. Nevertheless, compared to PEI, the efficiency 
remained < 1% at all times (see Fig. 6.20). Moreover, polyplexes with a higher CR were 
more active than those composed of a low CR. Strangely, the coupling of penetratine to the 
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polymer caused a (small) decrease in activity rather than an augmentation. The opposite 
result was achieved for Arg8 coupled pDMAEG (242+A) where transfection efficiencies were 
reached that exceeded the pure homopolymer by 10-fold as was anticipated from literature. 
In contrast, while this compound produces the better efficiency, also the highest degree of 
toxicity was detected which confirms again the difficult nature of an optimised vector.  
 
Figure 6.7 - Transfection efficiency of pDMAEG with a variable MW and CPP-coupled pDMAEG 
80 kDa & 242 kDa at variable CR (P = PEN, A = Arg8) on ARPE19 cells (24 h). 
For other polyglutamine derivatives, the toxicity and degree of efficiency was likewise 
evaluated. In figure 6.8, the cell viability of p(HEG-GuAEG) compounds is shown and 
compared to PEI. Again, very high survival rates were displayed (nearly 100%). Importantly, 
the effect of an increasing amount of guanidine did not cause higher toxicity unlike the 
previous result (pDMAEG+Arg8) where the introduction of arginine (and guanidine) residues 
had a negative impact on toxicity. Additionally, the variation in polyplex CR appeared as a 
rather irrelevant factor. Finally also an increase in MW for polymers with similar composition 
kept the overall viability quite constant. 
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Figure 6.8 - Toxicity results of cells incubated with polyplexes based on p(HEGx%-GuAEGy%) 
indicated by the % of GuAEG and the MW (in kDa).  
Based on the transfection results (Fig. 6.8), only one p(HEG-GuAEG) composition was 
revealed as potential vector. It is remarkable that only this specific structure (37% guanidine, 
10 kDa) induced a high transfection efficiency outperforming even PEI. Because it was 
previously demonstrated that the ability to form complexes increased with a higher amount 
of guanidine functional groups, a continuation of high transfection efficiency was to be 
expected for compounds with more than 37% guandines but this was not confirmed. The 
reduced efficiency of p(HEG63%-GuAEG37%) with a MW of 23 kDa on the other hand more or 
less confirms that this specific composition is succesfull in transfection. This suggests on 
one hand that sufficiently charged functional groups need to be present to obtain well-
defined, stable polyplexes with optimal cell interaction but on the other hand reveals that 
charge density cannot be too high because hampered polyplex dissociation leads to 
inactivity. Ultimately this resulted in the survival of one optimal structure. Furthermore, 
activity was only detected at high CR’s which in most cases implies an augmented risk of 
toxicity due to the increased polymer concentration but with limited effect due to the 
excellent biocompatibility. 
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Figure 6.9 - Transfection efficiency on ARPE19 cells (24 h) of p(HEGx%-GuAEGy%) as a function 
of the % of GuAEG and the MW (in kDa).  
As was explained during the introduction, the conclusions above confirm the potential of 
guanidine (and to a certain extent, arginine residues) as a powerful modification to enhance 
transfection activity compared to other cationic functional groups like amines. Because this 
type of modified polymers not always results in an optimised efficiency (e.g. PEI+ARG8), the 
introduction of other functional groups was also checked. Besides different functional 
groups, homopolymers based on guanidines were also als included in these experiments. 
The observed toxicity for some imidazole and arginine modified polymers is shown in figure 
6.10. As a first, clear observation, the large difference in viability between imidazole-
containing polymers (A-C) and the derivatives that possessed arginine residues (D-J) was 
reported. While the increase in CR had only minor effect on imidazole-based polymers, the 
viability of the arginine-based vectors drastically decreased at higher CR’s, often resulting in 
complete cell-death. Grafted copolymers (H & I) display a strong reduction in viability 
compared to the non-grafted base polymer (Fig. 6.8), especially for p(DMAEG85%-AEG15%) 
which has grafted p(ARG) units of about 5.000 Da long. Comparable to the grafting onto 
PEI, the biological properties largely adopt those of the grafted (co)polymer. The copolymer, 
p(ARG82%-ORN18%) (J) that contains a small percentage of primary amines does not provoke 
a notable change in toxicity compared to the homopolymer (F), although this small structural 
difference caused a markedly higher efficiency (Fig. 6.11).  
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Figure 6.10 - Toxicity results of cells incubated with polyplexes from various polymers. 
Code Polymer Code Polymer 
A p(HEG49%-GuAEG15%-ImEG36%) 12 kDa F p(ARG) 78.8 kDa 
B p(GuAEG35%-ImEG65%) 13 kDa G p(ARG) 187 kDa 
C p(HEG32%-GuAEG11%-ImEG57%) 9.6 kDa H p(HEG87%-AEG13%)+pARG 27.7 kDa 
D p(ARG) 13 kDa I p(DMAEG85%-AEG15%)+pARG 91 kDa 
kDa 
E p(ARG) 22.8 kDa J p(ARG82%-ORN18%) 71.1 kDa 
Table 6.1 – Corresponding polymer-code for figures 6.10-6.11. 
Similar to p(HEG-GuAEG) derivatives with a high amount of cationic charges, polyarginine 
does not display considerable transfection activity (Fig. 6.11, D-G). Probably this is the result 
of an excess of positive charge (100% protonation given the pKa of guanidine). An enlarged 
visualization of the transfection efficiency is shown to differentiate between the influence of 
the different MW’s but no conclusion could be derived. In the case of the copolymer 
p(ARG82%-ORN18%) a substantially larger activity was found for a 2/1 CR (compared to 
p(ARG) with a similar MW).  Graft-copolymers, H & I exhibited virtually no efficient 
transfection behaviour. Synthetic vectors that contain a significant amount of imidazole 
moieties on the other hand appeared capable of transfecting a many number of cells (also 
COS cells). Importantly, guanidine functional groups were also present in these polymer 
structures and the highest activity was again established for the polymer containing about 
35% of guanidine functional groups. Since these type of polymers are not fully charged (due 
to the pKa of imidazole or the presence of neutral groups), higher ratio’s of polymer/DNA are 
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required to obtain a clear level of  transfection. The relative ratio of compounds B and J 
compared to PEI is shown in figure 6.20. 
 
Figure 6.11 - Transfection efficiency on ARPE19 cells (24 h) of several polymers (table 6.1). 
For certain applications, specific molecules like fluorescent tags or peptides are coupled to 
polymers. Because the coupling of fluorescent tags brings about an increased level of 
hydrophobicity within the polymer, the consequent change in transfection activity needs to 
be examined. Combining polymers with CPP’s is generally performed to boost the activity of 
certain vectors and and figure 6.12 reports on their performance in transfection. The viability 
tests confirms once more the toxic nature of fully charged guanidine compounds as the PEN 
labelled p(ARG-ORN) becomes increasingly toxic as the CR rises and the coupling of 
penetratine even enlarges this negative effect. All other derivatives, mainly p(HEG-AEG) and 
p(DMAEG-AEG) compounds with small quantities of AEG (< 15%), possess a very high 
degree of viability at all CR’s tested.  
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Figure 6.12 - Toxicity results of cells incubated with polyplexes from various polymers. 
Code Polymer Crosslinker Coupled agent 
A p(ARG-ORN) 71.1 kDa GMBS Penetratine (4 %) 
B p(DMAEG-AEG) 91 kDa SPDP Penetratine (1.8%) 
C p(DMAEG-AEG) 91 kDa + OREG GMBS Penetratine (1.9%) 
D p(DMAEG-AEG) 91 kDa + OREG GMBS Arginine8 (1.2%) 
E p(HEG-AEG) 27 kDa SPDP Penetratine (3.5%) 
F p(DMAEG-AEG) 91 kDa GMBS Penetratine (3%) 
G p(HEG-AEG) 11 kDa  SPDP Arginine8 (8 %) 
Table 6.2 – corresponding polymer-code for figure 6.11-6.12. 
With respect to transfection, the addition of cell penetrating peptides did not provoke the 
expected transfection enhancement (Fig. 6.13). Penetratine demonstrated no real 
improvement since only p(ARG-ORN) showed activity but with a reduced intensity compared 
to the non-coupled polymer. The addition of Arg8 was limitedly successful in the case of 
p(HEG-AEG) which was best at a high CR. A comparable improvement was seen for the 
addition of Arg8 to p(DMAEG) with a MW of 242 kDa in figure 6.6. Based on these resultss 
Arg8 seems to act as the more efficient CPP although its influence was only poor. The 
comparison between with PEI and p(ARG-ORN) 71.1 kDa is summarized in figure 6.20. 
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Figure 6.13 - Transfection efficiency on ARPE19 cells (24 h) of several polymers (table 6.2). 
2.3.3 Guanidylated PEI and other reference polymers 
The positive results of certain guanidylated products like p(HEG-GuAEG) and the (partially) 
beneficiary effect of Arg8 confirmed that the guanidine functional group possesses special, 
advantageous properties towards biological activity enhancement. This led to the believe 
that other active polymers could be modified in such a way as to improve their transfection 
efficiency by introducing guanidine moieties while keeping their toxicity constant. Also the 
results of other important reference vector systems are shown in this paragraph. The degree 
of toxicity for guanidylated PEI (B-E) is shown in figure 6.14 (and table 6.3). It is difficult to 
conclude if modification allows for a statistically improved viability but the conversion 
reaction definitely did not reduce the toxicity. Only in the case of (PEI-
Guan20%)+OREG+PEN, a much lower degree of toxicity was observed. 
Code Transfection agent Coupled agent 
A Lipofectamine 2000 - 
B PEI-Guanidine14% - 
C PEI-Guanidine20% - 
D PEI-Guanidine20% + OREG Oregon Green 488 (3.7%) 
E PEI-Guanidine20% + OREG + PEN Oregon Green 488 (3.7%) 
Penetratine (2 %) 
F Poly-L-Lysine 50 kDa  - 
Table 6.3 – corresponding polymer-code for figure 6.13-6.14. 
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Figure 6.14 - Toxicity results of cells incubated with various transfection agents (table 6.3). 
Charge ratio’s above 2/1 as a result are not advised for PEI-modified compounds. Another 
widespread polymer that was explored already in the early years of synthetic gene therapy 
was poly-L-lysine. This homopolymer contains 100% protonable groups (primary amines), 
hence the limited viability for high CR’s. Lipofectamine, another acknowledged transfection 
agent is a cationic lipid that can achieve extremely high levels of transfection but is linked 
with strong toxicity as visualised in figure 6.14 – A where one equivalent (1x) of 
Lipofectamine 2000 was applied and yielded incredible efficiency but with a low survival rate. 
 
Figure 6.15 – Transfection efficiency on ARPE19 cells (24 h) of several transfection agents. 
It is clear that lipofectamine achieves the highest transfection levels by far (4x higher than 
PEI) but also guanidylated PEI seems to enhance the activity (with about 50%) and because 
of the stronger interaction, this is established at a lower CR than for unmodified PEI. When 
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Oregon Green was coupled to PEI-Guan20%, the resulting efficiency was even higher and will 
most-likely be the result of enlarged hydrophobicity, a phenomenon that was already 
perceived to improve polyplex uptake (and corresponding protein expression). On the other 
hand, no convincing explanation could be given for the substantial decrease observed for 
CPP+OREG coupled PEI-Guan20%. The efficiency of PLL confirmed the rather low results 
shown in literature as well4. 
2.3.4 Polymethacrylates 
As alternative strategy to explore synthetic vectors with a high ranking transfection ability 
that could be applied for direct or non-direct applications in gene therapy, the use of non-
biodegradable polymers was assessed and compared to the biodegradable polymers 
discusses before. Elaborating on previous work by amongst others Hennink et al5 the use of 
poly(dimethylaminoethyl)methacrylates (pDMAEMA) and derivatives there-off were selected 
as delivery systems. By providing these polymers with similar functional groups as for the 
biodegradable polyglutamines (primary/tertiary amine, hydroxyl and guanidine), it was 
possible to examine the influence of the type of backbone (hydrophobic versus hydrophilic). 
The transfection efficiency of all following polyplexes were examined on HEK (Human 
Endothelial Kidney) 293 cells. 
The basic polymer, pDMAEMA, was first analysed as such (homopolymer). The 
corresponding toxicity results are displayed in figure 6.16 for a series of different MW’s. A 
clear trend in terms of toxicity was observed for high CR’s: the viability decreased 
proportionally with increasing MW. For a low CR (1/1 and to a certain extent also 2/1) this 
was less the case. The overall viability was lower than for the biodegradable counterpart 
pDMAEG since a 1/1 CR for pDMAEMA rises in most cases not higher than 80% (except for 
11.9 kDa) while for pDMAEG the viability remained above 80% for all CR’s and MW tested. 
The polymer with the largest MW provoked complete cell death at a CR of 8/1 but even this 
polymer was still able to outperform PEI in terms of viability. Regarding viability, it can be 
concluded that the lowest MW compounds generate the best results and could to be advised 
for optimised gene delivery systems.    
When looking at the corresponding transfection efficiency (Fig. 6.17), all polymers appear to 
be active. Moreover, the levels of transfection are similar to PEI. The most active compound 
is found for the highest MW pDMAEMA because considerable activity is achieved for all 
CR’s whereas for the smaller compounds, transfection efficiency manifests only from high 
CR’s (≥ 4/1) on. Additionally, the viability of this high MW derivative was the lowest, 
especially for high CR’s. As a result, the amount of cells expressing the protein are smaller 
which means that the polymer should be interpretated as being even more efficient in terms 
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of activity per viable cell. The highest MW compound also exhibits the highest level of 
transfection but the difference with smaller compounds (e.g. derivative with a MW of 62.9 
kDa at a CR of 4/1) is not that extreme although these results are relative when taking the 
higher viability into account. 
 
Figure 6.16 - Toxicity results of cells incubated with polyplexes based on pDMAEMA.  
 
Figure 6.17 - Transfection efficiency on HEK cells (24 h) of pDMAEMA complexes. 
In the case of methacrylate copolymers (Fig. 6.18), both the HEMA- and AEMA-containing 
copolymers were analysed. The p(DMAEMA56%-HEMA44%) compound with a MW of 218 kDa 
(DH218) was tested as was done for a compound with a ratio of 55 % DMAEMA and 45% 
HEMA and MW of 9.8 kDa (DH9.8). For p(DMAEMA82%-AEMA18%), a derivative of 191 kDa 
(DA191) together with a compound containing DMAEM54%A/HEMA46% with a MW of 135 kDa 
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was examined (DA135). All 4 polymers exhibit a similar degree of toxicity compared to the 
homopolymer (of comparable  MW) indicating a good viability at low CR but severe to 
complete cell death at high CR.  
 
Figure 6.18 - Toxicity results of cells incubated with polyplexes based on DMAEMA 
copolymers. 
Unfortunately, if transfection efficiency is considered, the least toxic polymer 
(DMAEMA/HEMA 9.8 kDa) showed no activity at all (Fig. 6.19). The other HEMA-containing 
vectors in contrast demonstrated an activity in the range of PEI and were able to achieve a 
comparable level of transfection but with a much higher degree of viability (> 70%) than for 
PEI. Copolymerising primary amine-units into with DMAEMA revealed to have a positive 
effect on the efficiency. Compared to the homopolymer, a small improvement in activity was 
measured for the DMAEMA/AEMA 191 kDa compound. This effect turned out to be even 
more outspoken for p(DMAEMA54%-AEMA46%) with a MW of 135 kDa where protein 
expression levels 3 times as high as PEI were achieved although in contrast the viability 
degree of these polyplexes was not higher than 50%. Nevertheless, there are several 
methacrylate-based vectors that seem appealing for further exploration. The relative 
transfection ratio compared to PEI is depicted in figure 6.20. 
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Figure 6.19 - Transfection efficiency on HEK cells (24 h) of DMAEMA copolymers. 
2.3.5 Summary: activity of vectors compared to PEI 
To conclude, the degree of transfection as well as the viability for all active compounds is 
combined in figure 6.20 & 6.21 (with corresponding codes in table 6.4) to summarise the 
best performing vectors and to compare with PEI. This reference polymer was analysed as 
control for every polymer evaluated (but the data was not always depicted on the previous 
graphs). When focusing on the separate results, reported above, incorrect interpretations 
could be derived for certain cases (A, D, F) since the activity is lower than 1% of the 
maximum activity of PEI. From the biodegradable polymers only the copolymers containing 
about 35 % of guanidine moieties and 65% of less or non-charged units (hydroxyl for B and 
imidazole for E) display significant activity compared to PEI. In contrast, these values can 
only be reached at higher CR’s but due to their excellent biocompatibility (≥ 90%), excess 
amounts of polymer have nearly no negative impact on viability. Additionally, the MW’s 
corresponding with the highest degree of transfection are in most cases of low MW (around 
10 kDa). Polymethacrylates proved to have an even higher transfection efficiency than 
polyglutamines and PEI, especially for DMAEMA copolymers containing hydroxyl or primary 
amines (H & I). The most optimal results were also achieved for polyplexes with a high CR 
which puts certain restraints on the success of polymethacrylate compounds since maximum 
70% of these cells can survive the addition of these polyplexes. Nevertheless, all the 
formentioned polymers still exhibit significantly better viability than PEI which allows then to 
be used as an attractive alternative for gene delivery in-vitro. The modification of PEI with 
guanidine functional groups (J) was also able to enhance the transfection efficiency with a 
comparable level of viability (especially at a CR of 1-1).  
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Figure 6.20 – overview of all active polyplexes compared to PEI (transfection efficiency. 
 
Figure 6.21 - overview of all active polyplexes compared to PEI (cell-viability). 
Code Polymer Code Polymer 
A p(DMAEG)+Arg8 242 kDa F p(HEG32%-GuAEG11%-ImEG57%) 9.6 
kDa 
B p(HEG63%-GuAEG37%) 9.6 kDa G p(DMAEMA) 121 kDa 
C p(ARG82%-ORN18%) 71.1 kDa H p(DMAEMA82%-AEMA18%) 135 kDa 
D p(ARG82%-ORN18%)+PEN 71.1 kDa I p(DMAEMA56%-HEMA44%) 218 kDa 
kDa 
E p(GuAEG35%-ImEG65%) 13 kDa J PEI-Guanidine20% 
Table 6.4 - corresponding polymer-code for figure 6.20 & 6.21. 
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2.4 Physical mixing of CPP’s with vector systems: sequence of addition 
The use of cell penetrating peptides to improve the transfection efficiency has already 
established a solid reputation as a potent method of gene delivery. As was mentioned, in 
most cases, these units are coupled in a chemical way to the polymer backbone in order to 
facilitate the entry of the vector-based delivery system. Because the coupling comprises of 
additional synthesis steps (with unifying loss of material), it’s efficiency was compared to 
vector systems that make use of physically mixed CPP’s as a method to enhance delivery of 
DNA. Since the combination of different compounds to one single solution can be varied and 
the sequence of addition has an important effect on the corresponding transfection 
efficiency, a comparison was made between the addition of CPP’s to a preformed polymer-
DNA complex (PEI+DNA/PEN) and the combination of adding DNA to a premixed CPP-
polymer solution (PEI+PEN/DNA) in order to form a 3-compound ‘multiplex’ (Fig.6.22).  
 
Figure 6.22 – Transfection efficiency of physically mixed Penetratine (varying concentration). 
It appears that the addition of PEN by means of physical mixing has a huge advantage over 
covalent coupling (see Fig. 6.4) which yielded comparable results as non-modified PEI. 
Regardless the higher standard deviation, the addition of PEN in a range of 25 to 100 µM 
can induce a 2- to 5-fold increase of the efficiency. The most optimal sequence of CPP 
addition was not clear from these experiments. 
An analogue experiment was carried out for a broader range of CPP concentrations for both 
Penetratine  and TAT in combination with a DMAEMA-based polymer (CR = 3/1). In contrast 
to PEI, the addition of a higher concentration of peptide is not advantageous (Fig. 6.23). 
Also, the difference in order of addition, is clearer for these tests. Adding a mixture of 
polymer and peptide to DNA, results in a more efficient multiplex compared to the addition of 
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CPP to a preformed polymer-DNA complex. Moreover, combining cationic compounds 
during the multiplex formation results in more stable efficiency which is less influenced by 
the variation in CPP-concentration. Results derived from TAT-based multiplexes showed 
higher (if only very slightly) values than multiplexes composed of PEN. 
In correspondence with the physico-chemical properties (section 5.5) of covalently coupled 
CPP’s, which caused an elevation in the CR representing full condensation, the physically 
mixed multiplex achieved a similar value as the non-coupled vector system. This gives 
preference to the physical combining of peptides and polymer vectors to be selected over 
covalently-coupled polymer derivatives as vectors. Moreover, the total concentration of 
peptide present in the multiplex can already induce a significant effect at low values. 
 
Figure 6.23 – Relative transfection efficiency of multiplexes (CR 3/1) composed of methacrylate 
(MA), DNA (D) and a peptide (Penetratine, P or TAT, T) in variable concentrations. 
3 DNA-protection ability 
3.1 Principle of enzymatic DNA degradation 
Given the preferred route of systemic polyplex delivery (via the bloodstream), it is imperative 
that polyplexes survive this first part of the total transfection process, that is by examining if 
the polymers are capable of adequately protecting the DNA against the hydrolytic activity of 
nucleases6. Nucleases are a class of enzymes that function as regulators of DNA activity 
and can cleave the phosphodiester bonds between the nucleotide subunits of nucleic acids 
(DNA, RNA). Processes under the control of nucleases include DNA synthesis, degradation 
of host cell DNA after viral infections, DNA repair, DNA recombination and protection against 
foreign DNA7. If free DNA is injected in the bloodstream, it is quickly degraded by those 
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nucleases hence the importance of investigating to what extent the (co)polymer prevents the 
degradation of DNA, present within polyplexes. 
Nucleases are classified as exo- or endo-nucleases based on their specificity. Endo-
nucleases cleave the phosphodiester bond within a polynucleotide chain, in contrast to 
exonucleases, which cleave phosphodiester bonds at the beginning or end of the 
polynucleotide. Some nucleases, however possess both endo and exo properties. Most 
nucleases are specialised in either cleavage of single-stranded DNA (ss-DNA) or double-
stranded DNA (ds-DNA) but certain are able to act on both DNA types. Furthermore, some 
exo-nucleases work in a specific direction for phosphodiester cleavage (3' ► 5' or 5' ► 3' 
direction) while others cleave at random8. Additionally, to reach maximum activity, these 
enzymes require the presence of divalent cations like Ca2+ or Mg2+ which are consequently 
added to the buffer or medium. 
The method used to determine if DNA degrades when exposed to a solution of nucleases is 
based on UV-spectroscopy. Free nucleotides absorb more ultraviolet (UV) light than 
nucleotides stacked in a DNA-helix as was proven by Kunitz9 (Fig. 6.24). This is the result of 
both physical limitation whereby the rigid helical structure disturbs optimal exposure to 
incoming light as well as the occurrence of - interactions induced by aromatic stacking that 
transfers previously absorbed energy. Consequently, the quality of a nuclease that is applied 
as degrading enzyme is often expressed in Kunitz units. The increase in the absorption of 
UV light by the degraded DNA can be detected along a wide range of the EM-spectrum 
(225-300 nm) and is most significant at 260 nm (increase of nearly 30 % relative to 
undigested DNA)10.  
For complexed DNA (polyplexes), it is possible that DNA is degraded while remaining 
complexed to the polycation (mainly for high CR’s where considerable interaction exists), 
hence a control using degraded DNA-complexes should be used. Given the complex 
preparation of this latter, this experiment was not carried out. Moreover, it is believed that the 
effect of DNA degradation would still be detectable as the degradation would unambiguously 
result in a conformational change that affects the absorbance values (similar as for free 
DNA, yet to a smaller extent). An indication to substantiate this hypothesis is shown in the 
different results, where at modest CR’s (just above CRcond), there appears to be nearly no 
degradation occurring. 
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Figure 6.24 – UV absorption spectrum of nuclease digested and undigested free DNA
9
. 
3.2 Experimental set-up 
For these experiments, the stability of the polyplexes against the endo-nuclease 
deoxyribonuclease I (DNase I - Bovine) was investigated. DNase I is a nuclease that cleaves 
DNA preferentially at phosphodiester linkages adjacent to a pyrimidine nucleotide, yielding 
5'-phosphate terminated nucleotides. It acts upon ss-DNA, ds-DNA and chromatin. A critical 
concentration of divalent ions such as Ca2+ and Mg2+ are necessary to activate DNase I and 
were accordingly added to the buffer.  
Several polymer-DNA complexes were prepared at different CR’s in a modified version of 
the standard protocol (chapter 4, section 2). Since for these experiments, an appropriate 
buffer is required (40 mM TRIS.HCl, 10 mM NaCl, 6 mM MgCl2, 10 mM CaCl2, pH = 7.9), the 
formation of polyplexes was accordingly disturbed by precipitation phenomena. Therefore, 
initial polyplexes were prepared in 1 ml of ultrapure H2O (concentration DNA = 40 µg/ml) and 
subsequently diluted with 1 ml of TRIS buffer (at double concentration) to obtain polyplexes 
in a buffered solution at a final concentration of 20 µg/ml DNA. Prior to utilisation, the buffer 
was filtered (0.45 µm PTFE membrane) and degassed for 10 minutes. A solution 
representing 40 Kunitz units of DNase I was added to the polyplex solutions in quartz 
cuvettes and the total mixture was correspondingly measured (λ = 260 nm) at given time-
points while maintaining a constant temperature  of 37 °C. 
3.3 Results 
As a first test, the influence of the temperature on the efficiency of nuclease enzymes was 
examined (Fig. 6.25). These results confirmed the importance of using the appropriate 
temperature setting (corresponding with the body temperature of 37° C) and its reflection on 
the kinetics of protein-based reactions. For an equal concentration of DNA and DNAse I, 
nearly maximum absorbance was detected after 120 seconds at 37 °C while at 25 °C, even 
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one hour of reaction was not enough to obtain 90% absorbance increase. Full efficiency 
(100%) was selected to correspond with the absorbance increase after one hour of nuclease 
degradation with free DNA (at 37 °C) since it counts as an ideal benchmark for correlating 
shielding ability (whereby 0% equals perfect shielding and 100% indicates no protection 
towards nucleases). 
 
Figure 6.25 - Influence of temperature on the activity of DNAse I for DNA degradation (% 
absorbance expressed relative to free DNA). 
Because the activity eventually reaches a plateau value, the sample measurements were 
reduced in time and carried out between 0 – 1800 seconds to limit experimental analysis. 
Accordingly, experiments were only tested in 1-fold.  
3.3.1 PEI 
The individual results for PEI, measured at different CR’s (1/1, 2/1 and 4/1) demonstrate 
nearly perfect protection of DNA (Fig. 6.26). This trend is in line with the data obtained 
before and explained by its low condensation CR (≈ 0.6/1). Even a relatively low CR can 
provide adequate protection against enzymatic attack. With increasing time, there seems to 
be no significant change in absorbance so that excellent stability is to be anticipated.  
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Figure 6.26 – Nuclease degradation of polyplexes formed with PEI. 
 
3.3.2 Poly-L-glutamine derivatives 
Several selected polyglutamines were subjected to DNA degradation tests. One of the 
specific compositions examined was pDMAEG with a MW of 29 kDa (Fig. 6.27). The effect 
of complex formation is clearly visible for this compound. With respect to the CR 
corresponding with full condensation (≈ 1/1), a polyplex with a low CR demonstrates no 
protective properties. Moreover, the maximal degradation efficiency appears even higher 
due to the stabilisation effect of the polymer on the DNA (small conformation changes allow 
more and better exposed sites for enzymatic attack). Close to the condensation CR, an initial 
increase in absorbance is noticed. Since particle formation is only partial at this CR 
(equilibrium between polyplexes and free polyelectrolytes), some of the free DNA remains 
exposed for degradation and is responsible for the partial increase. When the degraded DNA 
fragments become increasingly smaller, the non-complexed polymer chains are 
correspondingly better able to rearrange around the small DNA fragments (kinetic effect), 
hence the secondary decrease in DNA absorption. When complexes with higher CR’s are 
prepared, complete protection of the DNA is obtained (starting right at the beginning of 
mixing) without the initial absorption increase noticed (stable value in time).  
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Figure 6.27 - Nuclease degradation as a function of time for polyplexes formed with pDMAEG 
(MW = 29 kDa) at various CR’s. 
In the case of (co)polymers that possess a partial lower amount of cationic functional groups 
(Fig. 6.28), the interaction ability and accordingly the level of DNA protection, is highly 
dependent on the composition. For a weakly charged polymer p(HEG87%-GuAEG13%), 
complete DNA shielding can not be achieved. Burst degradation of DNA is initially noticed in 
all cases which decreases with increasing CR (ranging from 60% at a CR of 0.5/1 to 10% at 
4/1). Only in the case of a 4/1 CR, the secondary complexation effect is capable of 
preventing further degradation of DNA over a prolonged time-range. Initial burst degradation, 
even if only small and rapidly decreasing, can be devastating for the therapeutic function of 
the DNA, RNA or protein sequences  can get seriously disturbed by it. 
Copolymers with a higher amount of cationic charges on the other hand like p(HEG38%-
DMAEG62%) demonstrate a much better DNA-shielding ability (Fig. 6.29). Even at a CR of 
1/1, which is just above the complexation value, burst degradation is small and subsequent 
decline in absorbance over time is short. When compared with the homopolymer, 
p(DMAEG), a better shielding ability is observed for low CR’s, a conclusion which rules in 
favour of the use of hydroxyl groups that act as charge separators. The loss of complexation 
capability (due to the lower strength of H-bonding relative to electrostatic attraction) is here 
corrected by the feasibility to sufficiently cover the DNA in a more homogeneous but diffuse 
way. At higher CR’s, the resulting burst degradation of free DNA is more or less equal to that 
of fully charged p(DMAEG) and can only be avoided at the highest CR (4/1).    
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Figure 6.28 - Nuclease degradation as a function of time for polyplexes formed with p(HEG87%-
GuAEG13%) (MW = 26.9 kDa) at various CR’s. 
 
Figure 6.29 - Nuclease degradation as a function of time for polyplexes formed with p(HEG38%-
DMAEG62%) (MW = 11.9 kDa) at various CR’s. 
As was mentioned above, the properties of vectors are strongly influenced by the 
composition of their charged entities. For a series of p(HEG-GuAEG) with a MW of 10.000 
Da, the decline in degradation rate for a 2/1 CR is shown in figure 6.29. The higher the 
amount of guanidine groups that are present, the better a copolymer is at preventing 
enzymatic degradation due to the more intense attraction forces. In combination with the 
other enzymatic degradation results, it appears again that the minimum amount of charged 
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side groups, present on a polymer, is estimated to be around 50-60%. Moreover, in the case 
of DNA-shielding, the importance of the type of functional group seems less relevant.  
 
Figure 6.30 - Nuclease degradation as a function of time for polyplexes formed with different 
p(HEG-GuAEG) (MW ≈ 10 kDa) at a CR of 2/1 as a function of % GuAEG. 
From figure 6.31, several trends were derived for the protection of DNA (for polyplexes 
containing an equal CR of 2/1). Firstly, the effect of the MW  on shielding ability was only 
modest (15% burst degradation for a MW of 242 kDa compared to 8% burst degradation of 
DNA for a MW of 30 kDa). Additionally, if primary amines are present in the copolymer, no 
significant consequences in terms of shielding effect were observed. Finally, the 
incorporation of imidazole (e.g. 36%) as a typical functional groups that can promote 
endosomal escape does not exert a strong, negative influence on DNA shielding. Taking into 
account that this polymer contains only 15% of guanidine groups, the performance is in line 
with the result of a p(HEG-GuAEG) derivative of equal charge but is better for a derivative 
containing the same amount of guanidines. Again this might be attributed to the more diffuse 
nature of the complexes when less charged groups like imidazole are present in the polymer 
structure. 
Nevertheless, the most important aspects for an acceptable level of protection from 
enzymatic attack, comprise of a substantial amount of charge (> 50%) and the use of a 
polyplex with a CR of at least 2/1 (mostly higher if zero burst-degradation is desired). If for 
other purposes, fully charged polymers are unwanted, the introduction of hydroxyl and 
imidazole (or a combination thereof) comprehends a good alternative since nearly no 
shielding difference can be noticed (when provided with sufficient charged groups). In 
contrast to the effect of chemical composition, the influence of the MW can be neglected. 
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Figure 6.31 - Nuclease degradation as a function of time for polyplexes formed with different 
composition and MW  at a CR of 2/1: pDMAEG 30 kDa, pDMAEG 242 kDa, p(DMAEG85%-AEG15%) 
242 kDa and p(HEG49%-GuAEG15%-ImEG36%) 12 kDa. 
 
3.3.3 Polymethracylate derivatives 
The extent to which DNA could captured by a polymer and induce shielding from degrading 
enzymes was also investigated for a selection of polymethacrylate-based complexes. These 
results were consequent with respect to the conclusions drawn from the EtBr fluorescence 
tests. It should be mentioned that these experiments were performed prior to optimisation of 
the degradation test and were therefore executed at 25 °C instead of 37 °C. As can be 
deduced from figure 6.31, the temperature has a serious effect on the kinetics of an enzyme. 
Nevertheless, the obtained results remain valid but due to the reduced activity at 25 °C, the 
discrepancy between individual results is less explicit. Moreover, some sort of induction 
period (200-300s) was encountered for many samples and as a consequence the 
interpretation of the start and end of the degradation process was performed differently.  
In figure 6.32, the influence of the CR on DNA shielding was studied for p(DMAEMA), a 
homopolymer with a MW of 12 kDa. At a CR below complexation (0.5/1), the polymer was 
unable to protect the DNA from degradation and because of the DNA stabilisation, better 
accessibility for enzymatic attack caused an even higher degradation compared to pure 
DNA. With an increasing amount of polymer, the DNA is proportionally better protected and 
close to the complexation point (i.e CR 1/1), nearly no absorbance augmentation was noted. 
Adding more polymer (CR > 1/1) does not improve the protective ability of the polyplexes. 
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Also the secondary effect (drop in absorbance due to re-complexation of fragmented DNA) 
was not observed.  
 
Figure 6.32 - Nuclease degradation as a function of time for polyplexes formed with pDMAEMA 
(MW = 12 kDa) at various CR’s. 
The effect of the MW was just as for the biodegradable counterparts not traceable at high 
CR’s (2/1) and is shown for different DMAEMA-containing polymers (Fig. 6.33 – full lines). A 
MW influence can only be noticed if the CR is just below or around the CR representing 
condensation since this is the most distinguishable parameter in the case of p(DMAEMA) 
(represented by the dotted lines, CR = 0.5/1, Fig. 6.33). In accordance with fluorescence 
measurements, the optimal MW which complexes at the lowest CR has a MW of 121 kDa. 
The (delayed) burst degradation of DNA is very small (6-7 %) and a secondary complexation 
effect by which uncomplexed, remaining polymer forms polyplexes in a 2nd phase (post-initial 
polyplex formation) is observed. A similar but reduced trend was displayed by p(DMAEMA) 
with a MW of 658 kDa. Given the higher value for condensation, a more pronounced DNA 
burst degradation was measured as was the occurrence of polyplex formation in a second 
phase. The polymer derivative of 12 kDa showed the lowest ability to shield DNA from 
nucleases at this low CR which is completely in correspondence with the requirement for full 
polyplex formation. Furthermore, there was no indication of secondary complexation within 
the measured time-frame. Degradation (burst or delayed) was not visable for higher CR’s 
since a sufficient amount of polymer was present at the initial polyplex formation (due to the 
strong basic interaction between excess polymer and DNA). 
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Figure 6.33 - Nuclease degradation as a function of time for polyplexes formed by p(DMAEMA) 
with different MW at a CR of 0.5/1 and 2/1. 
The application of DMAEMA-based copolymers in which monomers containing different 
functional groups are applied, could affect the shielding ability. Therefore, copolymers with a  
similar MW (≈ 150 kDa), composed of 50% DMAEMA and another functional group were 
examined (Fig. 6.34). At a CR of 2/1, p(DMAEMA) is able to fully protect the DNA from 
enzymatic attack but when the tertiary amines are replaced with primary amines (46%), the 
protective ability is lowered (absorbance increase of about 10%) with no indication of 
secondary complexation. Remarkably, the introduction of non-charged hydroxyl (43%) 
moieties retained full protection behaviour as no DNA-absorption increase could be 
detected. This was not the case for p(GuAEMA40%-HEMA60%) given the occurrence of DNA 
degradation (≈ 15%) although the lower amount of positive charges (40% vs 55%) could 
partly be responsible for the cause of this aberrant result.  
For polymethacrylates, it appeared that comparable trends were derived as for 
polyglutamines. The MW of the polymer showed little to no influence for polyplexes at higher 
CR and was only able to differentiate polymers of variable MW at a CR close to the 
condensation value (where stable polyplexes are not yet formed). Homopolymers of 
DMAEMA display excellent shielding ability and the introduction of other functional groups 
seems not to disturb this quality significantly although maximum CR’s remain the best 
option. Analogous to polyglutamines, hydroxyl-containing derivatives demonstrate excellent 
protection (nearly no DNA burst degradation). Finally, the nature of the polymer (and the 
polyplex) seems to play a role in the occurrence of secondary complexation processes.     
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Figure 6.34 - Nuclease degradation as a function of time for polyplexes formed with 
methacrylate polymers at a CR of 0.5/1 and 2/1: pDMAEMA 121 kDa, p(DMAEMA56%-HEMA44%) 
218 kDa, p(DMAEMA54%-AEMA46%) 135 kDa and p(GuAEMA40%-AEMA60%) 29 kDa.  
 
4 In vitro degradation 
4.1 Principle of enzymatic polymer degradation 
Synthetic poly--amino acids like poly-L-glutamine and poly-L-arginine are often considered 
as suitable candidates for biomedical applications because of their anticipated biocompatible 
behaviour. Besides the fact that they can be tailor-made, they potentially possess low toxicity 
for in vitro or in vivo experiments due to their resemblance with naturally occurring systems 
like proteins. The backbone of poly--amino acids consists of a repetition of amide-bonds 
that can be degraded by proteolytic enzymes which enables the polymers to act as 
biodegradable systems (e.g. in gene delivery), an important asset compared to non-
biodegradable systems (e.g. polymethacrylates or PEI). 
When delivery systems have fulfilled their task (protecting and delivering DNA), they should 
be removed from the body to reduce the possibility of unwanted side-effects. Initially, it was 
believed that the administered vectors were filtered out by the renal system but with 
increasing knowledge of the internalisation pathway, it appeared that a large part of the 
cationic polymers ended up in the lysosomal compartments after endocytotic uptake. This 
could eventually lead to lysosomal storage disease (accumulation of the non-degraded 
polymers)11,12. Lysosomes are cell organelles that are responsible for the degradation of 
nutrients and waste products of the cell. Protein breakdown is carried out within these 
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vesicles and not by the digestive system. Given its resemblance with protein structures, 
poly--amino acids are expected to be degraded inside these lysosomes by proteolytic 
enzymes (proteases). One of the best known, high performance proteases is Cathepsin B 
(Cathepsin family), a lysosomal cysteine-containing enzyme capable of degrading amide-
bonds of peptides13 . The degradation capacity of an enzyme is dependent on several 
parameters like correct environmental conditions (temperature, pH, concentration, 
activators/catalysts) but also on the nature of the target substrate. The hydrophobicity, the 
overall charge, the type of chemical bonds and the macromolecular structure all play a 
considerable role in this process. Other typical enzymes frequently encountered in degrading 
processes include pronase and leucine aminopeptidase (LAP)14. Each degrading enzyme 
has a specific range of substrates and properties it aims to address and in combination with 
others, total breakdown of a entire, large molecule can be achieved down to (single) 
molecular level (e.g. basic amino acids in the case of proteins). Total degradation of waste 
products is necessary to ensure complete recycling of the base components but also to 
allow crossing of the lysosomal membrane that is impermeable for large, polar 
components15.  
In the framework of this doctoral research, the naturally occurring enzyme papaine was used 
to assess the degradability of poly--amino acids. Papaine is a thiol-based endopeptidase 
derived from the papaya tree (latex extract) which is a very potent degrading enzyme16. It 
was already proven that papaine is able to degrade poly-L-glutamic acid and derivatives 
down to oligomer size by a single addition of papaine. Subsequent treatment with other 
endo- or exopeptidases resulted in complete breakdown of the polymer10. To obtain 
preliminary information on the response of the produced polymers, the experiments were 
limited to the single use of papaine.  
4.2 Experimental set-up 
A selection of synthesised polymers was subjected to a degradation test by addition of 
papaine to a buffered polymer-solution to examine the influence of polymer chemical 
structure and MW on the biodegradability. A simulation of the intra-lysosomal environment is 
therefore created by applying polymer samples (10 mg/ml) in an appropriate 
phosphate/citrate buffer (0.2 M, pH = 6) of 2 ml which contains EDTA (4 µM), a highly 
efficient chelating agent and dithioerythritol (DTT, 4 µM), a reducing protein required to 
maintain enzyme function. Next, the polymer solution is incubated at 37 °C and afterwards 
analysed via GPC to determine the MW of the polymer prior to degradation. Degradation 
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was then initiated by adding 40 µg of papaine (5 mg/ml stock solution) followed by GPC 
analysis at different times in a 72 h frame (GPC buffer: 5% NaH2PO4, 3% CH3CN, pH = 4).  
4.3 Results 
To obtain a preliminary idea on the degradation rate of the synthesised and modified 
polymers, a single dose of papaine was incubated with a buffered polymer solution. After 
GPC analysis, the MW decrease could be plotted as a function of time. All polymers 
appeared to be degrading rather fast and reached values as low as 1.500 Da which 
corresponded to nearly complete degradation (oligomer level). For large MW polymers, no 
significant difference in degradation result was noticed since the degradation limit reached 
values of about 2-3 % of the original MW (down to 3000 Da) after 48 h as depicted in figure 
6.35. The influence of the overall charge was only slightly detectable. In the case of 
p(HEG38%-DMAEG62%) about 20% of the initial MW was reached after 120 minutes of 
incubation whereas the MW of the less charged p(HEG-GuAEG) derivatives were reduced to 
7-8%. The starting MW seemed not to differentiate in terms of degradability amongst the two 
guanidine/hydroxyl polymers although minimal MW difference remained between the 
polymers with charges based on tertiary amines and those based on guanidine functional 
groups.  As a secondary effect, the reduced charge density of the functional group applied 
(delocalisation in guanidine groups) could have a (minor) influence on this. 
 
Figure 6.35 – MW decrease of polymers in the presence of papaine: p(HEG38%-co-DMAEG62%) 
179 kDa; p(HEG57%-co-GuAEG43%) 164 kDa; p(HEG63%-co-GuAEG37%) 9.9 kDa. 
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When polymer derivatives with a lower MW were tested, similar trends could be interpreted 
(Fig. 6.36). The denser charged p(HEG49%-GuAEG15%-ImEG36%) degraded slower than in the 
case of p(HEG75%-GuAEG25%) which was again slightly slower in degradation rate than the 
weakly charged p(HEG85%-GuAEG15%) although the discrepancy was minimal, especially for 
the last two. At the end of the experimental time frame, a small but distinct difference in MW 
remained between the guanidine/hydroxyl derivatives and the one containing a substantial 
amount of imidazole. Despite the possibility of delocalizing the charge within the aromatic 
entity, the total amount of charge proved to be of principal interest for the final degree of 
degradation.  
 
Figure 6.36 - MW decrease of polymers in the presence of papaine: p(HEG85%-co-GuAEG15%) 
11.4 kDa; p(HEG75%-co-GuAEG25%) 10.2 kDa; p(HEG49%-co-GuAEG15%-co-ImEG36%) 9.9 kDa. 
When taking into account the mean molecular weight of the structure units present within the 
above mentioned polymers, degradation products of oligomeric size could be achieved (4-8 
amino residues) which was in accordance with literature findings on poly-L-glutamic acid 
derivatives10. High MW compounds degraded down to about 2-3% of their initial molecular 
weight while for low MW compounds the relative ratio of initial to final MW was higher (15%) 
but lower absolute values could be achieved. For all compounds, other types of peptidase 
enzymes (added post-papaine degradation) are required to ensure complete structural 
disintegration of the polymer backbone although not feasible for the applied GPC set-up 
which makes use of SEC columns with a lower limit of 1.000 Da (representing tetrameric 
degradation compounds). Also, to enable clearer distinction of the influence of total charge 
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or type of functional group, studies at decreased enzymatic activity are advised (smaller 
dose of papaine).  
 
5 Blood compatibility 
To investigate the potential use of the synthesized (co)polymers as gene vectors for 
systemic administration they must express an acceptable blood compatibility. Common 
methods to assess this property are the investigation of possible haemolysis (lysis or rupture 
of red blood cells) and haemagglutination (red blood cell clustering). Because polymer-DNA 
complexes are charged components, certain compounds from the blood can induce 
interaction with these polyplexes with potentially harmful implications (for the blood 
components, the polyplexes or both). The blood is mainly composed of plasma, a water-
based liquid in which a wide spectrum of compounds is suspended and of which the most 
abundant are erythrocytes (red blood cells, RBC), leukocytes (white blood cells, WBC) and 
platelets (Fig. 6.37). Erythrocytes vastly outnumber the other types of formed elements 
present in the blood and are shaped like biconcave discs but do not possess a nucleus or 
organelles. Their main function is to collect O2 in the capillary beds of the lungs and release 
it to tissue across other capillaries throughout the body and are accordingly equipped with 
haemoglobin (Hb), a protein molecule that binds respiratory gasses. Since each cell contains 
about 250 million Hb-molecules and every molecule is provided with a Fe2+ ion, it is 
responsible for the characteristic red colour of blood17. 
 
Figure 6.37 - Main cellular structures of the blood and their relative size.
18
 
The interaction between polyplexes and RBC’s is most likely to occur at the membrane of 
the erythrocyte which is composed of a lipid bilayer (40 % w/w), membrane proteins (52 % 
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w/w) and carbohydrates (8 % w/w) 19 . The lipid bilayer is made of cholesterol and 
phospholipids which are asymmetrically distributed, an outer monolayer consisting of choline 
and uncharged phospholipids and the inner monolayer contains charged phospholipids20. 
For the proteins, distinction is made between integral and peripheral proteins. Peripheral 
proteins are located on the cytoplasmic surface of the lipid bilayer and are responsible for 
membrane elasticity and stability while the integral proteins are embedded in the membrane 
via hydrophobic lipid interactions. As a final class of membrane structures, carbohydrates, of 
which the main part (90%) is bound to proteins (forming glycoproteins) and the remainder 
combined with lipids (giving rise to glycolipids). One of the main glycoproteins are the 
glycophorins that comprise 2 % of the RBC membrane proteins and which are rich in N-
acetylneuraminic acid (or sialic acid). This imparts a negative charge to the cell membrane 
and in combination with other membrane proteins, electrostatic interactions with polyplexes 
may emerge from this (leading amongst other to agglutination or lysis)21,22.   
 
5.1 Haemolysis 
5.1.1 Description of haemolytic effect 
As previously mentioned, the energetic implications of electrostatic attraction between 
(oppositely) charged species, like polyplexes and cell membranes can result in a physically 
altering process with one or many consequences. Whereas the formation of polyplexes is to 
a certain extent reversible, the rupture of a cell-membrane is mostly detrimental to the cell 
itself. That is why RBC-rupture or haemolysis forms a good benchmark to check the 
biological viability of polyplexes when used for in vitro or in vivo applications. When a RBC 
lyses, its contents (mainly Hb) is released and can be measured spectroscopically (abs = 
545 nm) and corresponds with the absorption of the Fe2+-porphyrine molecule present in the 
haem group of Hb23. Therefore the haemolytic activity can be quantified by applying the 
following formula: 
% 100
sample blank
triton blank
A A
haemolysis
A A

 

 
With Asample  =  absorbance of a RBC suspension with polymer or polyplex 
 Atriton  =  absorbance of a RBC suspension incubated with Triton X-100 (0.2 %) 
 Ablank  =  absorbance of a RBC suspension in buffer 
A Triton X-100 solution, a non-ionic surfactant able to destabilise cell-membranes, is used as 
a positive control and will be correlated with 100% haemolyis. The negative control is 
checked by applying RBC’s in buffer and calibrating this solution as 0% haemolysis.  
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5.1.2  Experimental part 
Performing experimental tests with RBC’s, derived from human blood, requires careful 
pretreatment in order to achieve pure and well-defined cells. The RBC’s applied for 
haemolysis (and haemagglutination) were extracted from human whole blood (obtained by 
‘Red Cross’ – Belgium) and a concentrate of this suspension was received as such. Further 
purification and isolation of the proper concentration of RBC was achieved by subjecting the 
liquid to a series of centrifuge and rinsing steps as described by the following protocol. 
In a first step, a portion of the concentrate was centrifuged (3700 rpm for 5 min). Remaining 
plasma was removed with the supernatant and the suspension of RBC’s was gently washed 
in HBS buffer (HBS = HEPES Buffered Saline, 20 mM HEPES and 150 mM NaCl at pH 7.4) 
after which another centrifuge step was performed (3700 rpm for 5 min). Again, the 
contaminated supernatant was removed together with the top layer of the RBC mass. 
Following  rinsing of the solid product, a final centrifuge step was carried out (same 
conditions) and both the supernatant and the top layer were once more removed to 
ultimately obtain concentrated, pure, red blood cells. These could subsequently be diluted in 
HBS buffer to a concentration of 2%.   
In order to test the possible lysis effect on RBC’s, a selection of polymers were added to a 
2% RBC suspension prepared prior to experimental analysis and incubated for 24h at 37 °C 
under continuous shaking (100 rpm). The polymers as such were added in a concentration 
range of 1-2000 µg/ml while the polyplexes were tested at a 2/1 CR, sufficient to enable full 
condensation for all polymers applied. Since the test is carried out in a buffered environment, 
polyplexes were prepared in slightly adapted way of the standard protocol (as described in 
section 2.2) which combines a double concentrated RBC-buffer with a double concentrated 
polyplex solution. After incubation, the degree of haemolysis was measured by separating 
the liquid from the solids (via centrifugation at 3700 rpm for 2 min) and subjecting the 
supernatant for a UV/VIS analysis. The values were then compared with the negative (0%) 
and positive (100%) control and plotted as a function of the concentration (not the case for 
polyplexes).  
5.1.3 Results 
5.1.3.1 Vectors based on poly--aminoacids 
The haemolytic activity of cationic polymers is generally proportional to the amount of charge 
present. Nonetheless, this trend was not always observed. As an example when comparing 
highly charged pDMAEG with partially charged PEI (Fig. 6.38). Already at low concentrations 
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(≈ 100 µg/ml), PEI causes about 40% of haemolytic activity while for the other polymers this 
effect is below 10%. With increasing amount of polymer, the haemolytic activity gradually 
rises although at a certain concentration (approx. 1000 µg/ml), nearly no deviation was 
observed. When a copolymer, consisting of hydroxyl and guanidine groups, was grafted onto 
PEI, the resulting haemolysis was decreased up to 50% of its initial value and clearly 
indicates the shielding ability of grafts. Moreover, the PEI-graft-p(HEG-GuAEG) haemolysis 
was comparable ( ≤ 5%) to the graft-copolymer itself which proves that the resulting 
biocompatibility properties could be largely adopted. Claiming that higher amounts of charge 
induce higher haemolytic activity was contested by the low value (≈ 10 %) of p(DMAEG), 
hence the more complex origin of haemolysis-inducing effects.      
 
Figure 6.38 - Haemolysis of RBC’s incubated with increasing polymer amount: PEI 25 kDa; PEI-
graft-p(HEG63%-GuAEG37%) 25 kDa; p(DMAEG) 80 kDa; p(HEG63%-GuAEG37%) 9.6 kDa. 
Although haemolytic activity is not unilaterally connected with cationic charges as confirmed 
for p(DMAEG), a substantial influence of the amount of positive charge is noticed in the case 
of p(ARG) (Fig. 6.39). Already at a concentration of 1 µg/ml, more than 30% of lysis was 
detected and complete rupture of cell-membranes was achieved at polymer concentrations 
relevant for polyplexes (≈ 100 µg/ml). If copolymerization with neutral functional groups (≈ 
50%) was carried out, reduced values of lysis were measured (10% or less). This reduction 
was noticed in case of copolymers containing either guanidine or tertiary amine functional 
groups with a slight preference towards tertiary amines groups as they exhibited the lowest 
values. Additionally, from these results, the effect of guanidine presence on haemolysis can 
be directly correlated (as being negative) but also the influence of the side-chain composition 
on lysis is clear from the difference between ARG & GLN copolymers. Imidazole-containing 
polymers displayed a positive effect on haemolysis (in combination with guanidine groups). 
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Besides cationic charge, secondary effects like hydrophobicity influence haemolysis to a 
certain extent. This is for instance clear, if only limited, for the different haemolytic effect 
between p(HEG-GuAEG) and p(HEG-ARG) where the influence of side-chain plays a role.  
 
Figure 6.39 – Haemolysis of RBC’s incubated with increasing polymer amount: p(HEG39%-
DMAEG61%) 11.9 kDa, p(ARG) 22.8 kDa, p(HEG58%-ARG42%) 11.2 kDa; p(HEG50%-DMAEG27%-
GuAEG23%) 9.3 kDa; p(HEG49%-GuAEG15%-ImEG36%) 12.2 kDa. 
The MW of the applied polymers seems to have little to no influence on the haemolytic 
activity (Fig. 6.40), both at high and low concentrations. Furthermore, the copolymers 
composed of hydroxyl and tertiary amines show again the lowest amount of RBC-rupture 
over almost the entire concentration range. In all cases, the resulting membrane 
destabilisation and corresponding lysis for polymer concentrations that are used in typical 
polyplex compositions remains below 10%.  
 
Figure 6.40 – Haemolytic activity of pDMAEG and p(HEG39%-DMAEG61%), high and low MW. 
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In the above mentioned graphs, results of RBC’s incubated with polymers were shown. 
When polymers are combined with DNA into complexes, reductions in haemolytic behaviour 
are to be expected since cationic charge are partially neutralised by the presence of DNA. In 
contrast to this hypothesis, the measured values appear to be equal or even higher than 
those corresponding with pure polymer (at equal concentration). Besides PEI, the highest 
values are obtained for polyplexes on arginine-rich polymers which confirms the intensely 
charged nature of this functional group compared to p(DMAEG)-based polyplexes. This was 
confirmed if copolymers were analysed. Whenever guanidine functional groups are present, 
the resulting haemolytic activity is proportional to the relative amount present in the polymer 
structure. Polymers that are combined with hydroxyl groups as neutral units exhibit relatively 
low haemolysis. Finally, the positive effect of grafting in terms of decreased haemolytic 
activity is again noticeable for PEI, where  p(HEG-GuAEG) grafts reduce lysis by almost 
50%. The relative ratio of haemolysis for the different type of polymers is reflected in the 
results for polyplexes (Fig. 6.41). 
 
Figure 6.41 – Amount of RBC-haemolysis provoked by polyplexes at a CR of 2/1. 
5.1.3.2 Vectors based on polymethacrylates 
Similar to its biodegradable counterparts, the lysis effect of polymethacrylates was assessed 
and compared to PEI to allow correlation with other polymer classes. As a first analysis, the 
influence of MW on RBC membrane disruption was established for p(DMAEMA) compounds 
of different MW (Fig. 6.42). The variation in observed values gives preference to the use of 
small compounds as the polymer with a MW of 12 kDa gives rise to the lowest increment 
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when applying higher polymer concentrations. With increasing MW, the corresponding 
haemolytic values reaches higher peaks. For all p(DMAEMA) compounds, a plateau value is 
reached at a concentration of about 100 µg/ml and the extent of this value is proportional to 
the MW. Replacing tertiary amines with hydroxyl groups is also for this class of polymers 
beneficiary in reducing membrane disruption. Already 40 % of neutral units are sufficient to 
keep the haemolytic effect below 5% irrelevant of the concentration applied. Guanidine 
functional groups (40%) caused a negative influence at all tested polymer concentrations 
even considering the significant presence of neutral groups and relatively low MW (29 kDa).  
 
Figure 6.42 - Haemolysis of RBC’s incubated with increasing polymer amount: p(DMAEMA) 
with variable MW; p(DMAEMA61%-HEMA39%) 14 kDa and p(HEMA60%-GuAEMA40%) 29 kDa.  
When extending the influence of polymers on RBC’s to polyplexes, the trends visualised in 
figure 6.41 were likewise noticed (Fig. 6.43). For DMAEMA-based polymers with different 
MW, the haemolytic activity displays again a proportional ratio relative to the MW. Also the 
influence of the CR on haemolysis is in general proportional but the discrepancy between 
the different applied CR’s is more pronounced for polymers that already exhibit a significant 
activity at low CR (e.g. 1/1). The low effect of the p(DMAEMA-HEMA) combination on 
haemolysis was again clearly marked in this test with values lower than 10% but this result 
was not better than p(DMAEMA) with an equal MW. If polyplexes based on p(DMAEMA-
AEMA) were used, a rather insignificant increase of lysis was noted. In all cases the effect of 
the MW was obvious and most significant, more specifically where low MW compounds 
display the best behaviour towards RBC haemolysis and a rapidly increasing level of 
membrane disruption is only to be expected for high MW polymers (> 200 kDa). Compared 
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to the reference value of PEI, polymethacrylate-based complexes perform better in terms of 
membrane disruption at any given MW, concentration or composition tested. 
 
Figure 6.43 – RBC lysis induced by polyplexes based on p(DMAEMA) 12–121–658 kDa; 
p(DMAEMA55%-HEMA45%) 9.8 kDa and p(DMAEMA54%-AEMA46%) 135 kDa. 
5.2 Haemo-agglutination 
5.2.1 Description & experimental set-up 
One of the main functions of erythrocytes in the human body, is the delivery of O2 to tissue 
all over the body. For that, RBC’s need to have sufficiently small dimensions so that delivery 
in narrow spaces and poorly accessible places, like for instance via blood capillaries (d ≈ 10 
µm) is achievable. Given the normal size of a RBC (6-8 µm, see also Fig. 6.37), it is clear 
that not much additional space is available to manoeuvre through those channels. If mutual 
interaction of RBC’s would cause aggregation of individual cells (agglutination), the smallest 
capillaries would easily get clogged leading to miniaturised versions of thrombosis24. This 
phenomenon should therefore be carefully considered when applying foreign substances like 
vectors into the body. It has been demonstrated that some polycations induce agglutination 
RBC’s, even at very low concentrations (several µg/ml) while this effect was not observed for 
cationic monomers hence the cause is most likely of macromolecular origin25. Neutral or 
anionic polymers on the other hand do not affect the agglutination behaviour of RBC’s. 
Structural parameters that are important for agglutination effects are amongst others based 
on the amount of charge, the functional groups applied (hydrophilicity) and their 
corresponding conformation.  
Since all polyplexes employed for this research exhibit a positive surface at a CR of 2/1, both 
polymers and polyplexes were subjected to a haemo-agglutination test. For this test, a 2% 
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RBC suspension in HBS was prepared as described above (section 4.1.2) and combined 
with either a polyplex solution or with a polymer solution that represents an equal amount of 
polymer as the amount mixed in a 2/1 CR complex. These solutions were then incubated for 
1 hour at 37 °C, followed by optical microscopy for 2D visualisation. 
5.2.2 Results for poly--amino acids 
Using optical microscopy, the effect of the cationic polymers and their polyplexes on RBC’s 
was studied. As a negative control, RBC’s were also incubated in pure buffer (HBS) to allow 
comparison of the level of agglutination. From figure 6.44 (left), an abundant amount of 
individual cells can be noticed for the negative HBS control without indications of 
agglutination. Lighter coloured shapes represent RBC’s that are oriented orthogonal to the 
incident light beam and appear to partially escape the focal plane, a limitation of this 2D-
visualisation method. When RBC’s were exposed to polyplexes containing pDMAEG, again 
no significant coagulation effect was perceived. The individual cells are clearly 
distinguishable and appear with a shape and size correspondent with the negative standard 
while for pure pDMAEG a considerably higher amount of coagulation is detected. Combining 
the vector with DNA, has in this case a positive effect on the interaction with RBC’s. 
Additionally, small areas in the pictures mark crystallized salt depositions and should not be 
confused with the occurrence of agglutination phenomena.  
 
Figure 6.44 - Agglutination effect of HEPES buffer and pDMAEG - 30 kDa (including polyplex 
CR 2/1) on RBC’s after 1h of incubation (200x). 
In comparison with fully charged polymers, the incorporation of neutral hydroxyl groups (38% 
HEG) demonstrates no agglutination effect as anticipated (Fig. 6.45). Both for low (11.9 kDa) 
and high (179 kDa) MW, individually distributed cells could still be detected. If pure 
p(DMAEG-HEG) was brought into contact with RBC, only the low MW compound showed no 
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coagulation while for the high MW derivative, rather unexpected, severe agglutination was 
observed, an effect for which no unambiguous solution is to be found but which should at 
least find its origin in the different macromolecular size and its inherent kinetics.  
  
Figure 6.45 – Haemo-agglutination of p(DMAEG62%-HEG38%) with a high (179 kDa) and low (11.9 
kDa) MW and their polyplexes (CR 2/1) at 200x magnification. 
The presence of guanidine functional groups, compared to tertiary amines, exerts a higher 
influence on membranes which results in an elevated agglutination degree for polyplexes 
and nearly complete coagulation of the pure p(HEG57%-GuAEG43%) with a MW of 143 kDa 
(Fig. 6.46). This considerably, negative effect is due to both the high MW and the nature of 
the functional group itself. When this polymer, composed of a combination of tertiary amine, 
hydroxyl and guanidine functional groups, p(HEG50%-GuAEG27%-DMAEG23%) – 9.3 kDa, is 
applied, a substantial improvement is observed for the polyplex as well as for the pure 
polymer in terms of haemo-agglutination. In accordance with haemolysis tests, tertiary 
amine-based polyglutamines perform better than guanidine-based ones. On the other hand, 
when guanidine residues were derived from polyarginine and combined with hydroxyl-based 
polyglutamines, the resulting p(HEG58%-ARG42%) and its polyplexes performed better, in 
other words causing almost no agglutination and substantially less than p(HEG57%-
GuAEG43%) allthough an effect of the lower MW should be taken into account as well. In 
addition, the homopolymer p(ARG), was not able to prevent clustering of cells both on the 
level of polyplexes as well as for free polymers and yielded the largest aggregates of all the 
tested polymers (d ≈ 20-50 µm). As a preliminary conclusion, the influence of hydroxyl 
functional groups clearly has a positive effect on haemo-agglutination (and to a larger extent 
on biologically related processes). 
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Figure 6.46 - Haemo-agglutination of p(HEG57%-GuAEG43%) – 143 kDa; p(HEG50%-GuAEG27%-
DMAEG23%) – 9.3 kDa; p(HEG58%-ARG42%) – 11.2 kDa and p(ARG) – 22.8 kDa, including their 
polyplexes (CR 2/1) at 200x magnification. 
Other functional groups (or combinations) like imidazole or a CPP such as penetratine 
(PEN), were likewise subjected to aggregation tests (Fig. 6.47). The covalent coupling of 
PEN to p(DMAEG-AEG) for a total of about 2% did not cause extra clustering when 
compared to pDMAEG as such but the effect remained signifcant. The corresponding 
polyplexes were able to mask the considerable clustering arising from the pure polymer. 
Imidazole-containing polymers can be considered as ideal candidates for blood-related 
applications since both haemolysis and agglutination did not occurr, even in combination 
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with guanidines. Moreover, the agglutination difference between pure polymer and the 
polyplex is minimal, confirming the non-toxic behaviour of imidazole containing compounds. 
 
Figure 6.47 - Haemo-agglutination of p(DMAEG85%-AEG15%)+PEN and p(HEG49%-GuAEG15%-
ImEG36%) – 12.2  kDa (including polyplex CR 2/1) at 200x magnification. 
Reference values were based on the agglutination results of PEI (Fig. 6.48), which were in 
correspondence with previous haemolysis experiments that showed significant, membrane 
interactions. Few individual cells were left and a notable amount of cells were deformed. The 
advantage of grafting onto PEI to compensate for the negative impact of native PEI, was 
established for PEI+p(HEG63%-GuAEG37%). A higher amount of cells as well as a more 
homogeneous occurrence of naturally shaped RBC’s were noticed for the polyplexes. Also 
for the polymer as such, a slight improvement was identified. Contradictory to the effects of 
its separate components (PEI & p(HEG63%-GuAEG37%)) for which both demonstrated high 
levels of haemo-agglutination, the modified conformation and spatial rearrangement of 
charged groups of the complete polymer provokes lower membrane interactions, even when 
incorporated in a polyplex, hence the reduced coagulation. This effect is expected to be 
more outspoken at higher CR’s where increased quantities of polymers will be present at the 
outer boundary of the polyplex particle.     
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Figure 6.48 – Haemo-agglutination of PEI & PEI+p(HEG63%-GuAEG37%) (+ polyplexes (CR 2/1)). 
5.2.3 Results of polymethacrylates 
In general, polymethacrylates tend to exhibit a higher degree of agglutination when 
combined with RBC’s compared to polyglutamines. A striking observation could be derived 
from a MW stud that focuses on the increase in agglutination for pDMAEMA with 
augmenting MW (Fig. 6.49). At the lowest MW (12 kDa), very limited clustering was noticed, 
yet irregularly shaped cells (non-circular) occurred. For polymers with a medium MW (121 
kDa), the degree of clustering was already of such a level that few single cells could be 
observed and mainly clusters of almost 30 µm in size were seen. The highest MW 
compound (658 kDa) induced full agglutination leaving no single cells and thereby formed 
cell-aggregates up to 40 µm. Also for methacrylate-based copolymers, the agglutination 
effect was dominantly influenced by the MW which is clearly marked by p(DMAEMA-HEMA) 
with a low MW that displays limited aggregation whereas a similar polymer structure with 
higher MW (Fig. 6.49) give rise the formation of large cell clusters. The appearance of large 
clusters starts already at a medium polymer MW (100-150 kDa) and was again confirmed for 
p(DMAEMA-AEMA) with a MW of 135 & 176 kDa repsectively. It has to be indicated that the 
best result of the developed polymethacrylate compounds and polyplexes is considerably 
worse than in the case of polyglutamines (and their polyplexes). The reason for the 
importance of the MW can not be readily traced back to physico-chemical properties like 
polyplex size or DNA-interaction as no clear difference amongst them could be derived but 
must be influenced by kinetic (polymer mobility & hydrodynamic radius of the polymer) and 
thermodynamic (intra- and intermolecular forces) differences in polyplex formation. 
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Figure 6.49 -  Haemo-agglutination of pDMAEMA based complexes (CR 2/1) (200x). 
 
Figure 6.50 - Haemo-agglutination of polyplexes (CR 2/1) derived from: p(DMAEMA54%-
AEMA46%) 135 kDa; p(DMAEMA73%-AEMA27%) 176 kDa; p(DMAEMA55%-HEMA45%) 9.8 kDa and 
p(DMAEMA56%-HEMA44%) 218 kDa. 
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5.3 Histologocial data 
Because the final application of gene therapy should comprise of in-vitro and in-vivo 
techniques, the possible influence of genetic vectors and polyplexes on biological aspects 
such as cell-cycle, apoptosis or the survival of whole tissues, has to be assessed. Many of 
these criteria can be investigated by histological experiments that give an basic 
understanding of cell-toxicity, viability, metabolic activity and stimulation of cellular growth. 
Within the PolExGene project this investigation was carried out by the institute of 
microbiology (IMIC, academy of sciences of the Czech republic, Prague). An brief summary 
of their conclusions is shown below.  
 
To assess if a cell remains healthy after addition of a foreign compound, many assays exist 
nowadays that aid in the evaluation. One of such methods that is generally applied to 
determine proliferation of cells and their potential to keep dividing find its origin in 3H-
thymidine incorporation. Tritium-containing thymidine counts as a radioactive label and is 
provided within the buffer medium. When mitosis occurs, the cells will take up this radio-
labelled molecule from its surrounding enabling subsequent detection by a liquid scintillation 
counter. Repeated cell-division cycles incorporate consequently more tritium and increases 
sensitivity, hence longer incubation times need to be respected (24-48 h)26. 
 
The experimental evaluation of polymers and polyplexes in terms of proliferation was 
performed on mouse spleen cells (BALB/c). The standard protocol for polyplex formation 
was applied and tissue culture plates (96FB) were provided with 500.000 cells per well. An 
amount of 600 ng DNA was added to each well and both polymer as well as polyplex 
representing a CR of 4/1, 2/1 and 1/1 were used for incubation with cells. Two hours after 
incubation, the cells were washed and fresh medium (RPMI 1640, glutamine, antibiotics, 2-
ME 0.005 M and 10 % fetal calf serum) was added. One batch of samples was loaded with a 
mitogen, pokeweed mitogen (PWM – 1 µg/ml), an enzyme which stimulates the occurrence 
of mitosis, while the other was left as such. The cells were cultivated after 3 days and the 
amount of 3H-thymidine was measured accordingly.  
The corresponding results for PEI are displayed below (Fig. 6.51). For polyplexes, the 
proliferation was higher than for pure polymers and at a low CR, the activity approached the 
level of the control test which is equal to the distribution of pure DNA among the cells, 
without the presence of a vector. Again the activity increased with decreasing polymer 
concentration (amounts representing a 4/1, 2/1 & 1/1 CR). Moreover, the sensitivity was 
higher for denser populated wells.  
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Figure 6.51 – 
3
H-thymidine assay of PEI on BALB/c cells: level of proliferation 
When pDMAEG with a MW of 80.000 was used, the obtained results demonstrated higher 
biocompatibility (Fig. 6.52). Because at low CR’s, the activity of cells incubated with 
pDMAEG-based complexes was elevated compared to the control, the polyplexes were 
labeled as (limited) stimulators as their value reached as high as 2.5. The stimulation index 
of cell proliferation via the 3H-thymidine assay was determined from the amount of cells 
present for the control signal and set to 1 for further comparison. Whereas the presence of 
pokeweed mitogen has no influence on cellular activity in buffer or DNA-containing solutions, 
the effect on polymer and polyplex incubated cells was positive for all CR’s and is the main 
driver for the increase in stimulation properties rather than the type of polymer used (as 
derived from the result for PEI and pDMAEG). The use of the polymer alone resulted in a 
decrease in viability rather than in a stimulation of the cell proliferation. 
 
Figure 6.51 - 
3
H-thymidine assay of p(DMAEG) on BALB/c cells: stimulation index (ctrl = 1) 
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The compatibility on cell proliferation was also investigated for other polyglutamines and was 
able to confirm the positive effect of the PWM and the advantageous use of polyplexes 
rather than polymers in stimulating cell proliferation although this later effect was always very 
small. The effect of the MW variation is in favour of low MW compounds and the covalent 
coupling of a CPP did not really influence the proliferation behaviour (in-line with previous 
viability experiments). The copolymer, composed of 63% hydroxyl groups and 37 % 
guanidine functional groups and a MW of 9.6 kDa was able to achieve the higher values for 
cell proliferation/stimulation with respect to the control. 
 
6 Confocal microscopy 
A huge drawback in fully understanding genetic manipulation is the behaviour of polyplexes 
once they are internalised within the cell and subsequently move towards the nucleus of the 
cell for genetic transcription. Because this phenomenon is complex, most hypotheses that 
are put forward as feasible solutions on how the polyplex could be taken-up and guided 
through the cytosol focus generally on a specific compound of the polyplex (polymer or 
DNA). As a result, some polymers and polyplexes were subjected to a confocal microscopy 
study in order to obtain extra information on intra-cellular properties. This was done by the 
group of Dr. Alain Joliot as mentioned before. This analysis technique enables the 
identification of specific molecules within the cell by fluorescent spectroscopy. In this way, 
the contents of the cell can be visualised without affecting the integrity of the cell. The 
compounds that will be visualised are to be provided with a fluorescent tag that corresponds 
with the laser detection27. Moreover, only the detection of molecules lying in the focal plane 
can be detected, which allows for the analysis at specific depths of the cell (dividing it in 
layers). As previously mentioned (section 6.2), a list of fluorescently labelled (Oregon Green 
488) polymers were synthesised for this reason. When combined with DNA (with or without 
fluorescent tag), the resulting polyplex can be tracked in-vitro. 
An example of confocal imaging is shown in figure 6.51 where a fluorescently-labelled 
derivative of PEI is visualised and shown to be localised at the borders of HEK 293 cells. 
When different polymer-based DNA complexes are added, different morphologies can be 
detected. PEI-based polyplexes tend to give a more diffuse appearance whereas the 
p(DMAEG) of 80 kDa yields polyplexes that are present as intensily coloured, smaller dots, 
characteristic for the stronger interaction with DNA (as was confirmed by EtBr fluorescence 
exclusion). 
If polyplexes are mixed with cells in-vitro, the first step towards delivery of therapeutic genes 
is achieved by crossing the cell membrane. In order to visualise this process, cells incubated 
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with polyplexes are analysed at different time points to give an idea on the location inside the 
cell. Since fluorescence signals are only detected in a 2D-plane and a perceived signal can 
be the result of more than one fluorescently active compound on the same Z-axis, a specific 
compound is added to the cell medium that enables to distinguish between intra-cellular and 
extra cellular fluorescence.  
 
Figure 6.51 - Confocal images of PEI-OREG, PEI-OREG/DNA and p(DMAEG)-OREG/DNA. 
This product, Tryphan Blue® (TB), is a dye that can not pass the membrane of living cells but 
is able to traverse the membrane of dead cells and consequently stain them blue. Due to the 
addition of TB, the ECM is quenched and accordingly the fluorescent signal of non-
internalised polyplexes is removed which allows only fluorescence of internalized polyplexes 
to be detected. In the case of incubation with PEI-based complex for 4h (Fig. 6.52), diffuse 
polyplex signals are observed as well as small particles (A). When TB is added, the extra-
cellular fluorescence is quenched and the remaining fluorescence can be attributed to a 
considerable amount of internalised polyplexes which appear again in a diffuse state (B). For 
a prolonged incubation (24h) the fluorescence signal seems to be higher and in a more 
evenly spread, diffuse pattern (C). Likewise, the addition of TB demonstrated that the 
polyplexes where taken up by the cells and that they were homogeneously distributed (D) 
compared to 4h incubation. From previous biological tests, it was established that pDMAEG 
expressed no transfection behaviour. If these results are linked to the confocal imaging (Fig. 
6.53), it could be concluded that not only the lack of internalisation lies at the base of its 
failure. Because both after 4h and more specifically after 24h of incubation, a certain amount 
of polyplexes was able to be internalised (B/D), an error or problem in of the intermediate 
PEI polyplex
p(DMAEG) polyplex
PEI
  
Chapter 6: Biological evaluation of polymer-DNA complexes          253 
process steps must still hamper the transfection process. As a result, a substantial group of 
polyplexes are lost due to the take-up incapacity by the cell as revealed by the discrepancy 
in fluorescence before (A/C) and after BT staining (B/D). Furthermore, the internalised 
polyplexes remain visible as small, clearly defined, coloured spots which could be indiciative 
for the incapacity to escape the endosomes (most likely, due to the limited buffering 
properties) or the lack of polyplex dissociation inside the cytosol.  
  
Figure 6.52 – Confocal images of PEI complexes incubated for 4 & 24h, before & after BT. 
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Figure 6.53 - Confocal image of pDMAEG complexes incubated for 4 & 24h, before & after BT. 
 
It is possible to use non-labelled polymers in complexes and still be able to detect the 
resulting polyplexes by using fluorescently tagged DNA. From a therapeutic perspective, this 
could possible limit or even inhibit the function of the DNA involved leading to non-efficient 
transfection. In the following confocal images, pDMAEMA was examined without being 
fluorescently labeled. For DNA, a similar green-fluorescent-protein (GFP) is used to mark the 
molecule and at the same time provide the ability to translate and expresse a protein, which 
emits in this case a cherry red light. After 2h of incubation, it seemed that the pDMAEMA 
121 kDa polyplexes were not yet internalised but could be retrieved at the borders of the 
cells (Fig. 6.54). When displaying only the green detection channel, the imaging is limited to 
visualising the green fluorescent polyplexes. If the cells are treated with wheat germ 
agglutinin (WGA), the cells are stained blue and it can be observed that the polyplexes 
collect at the borders of the cells (to be further internalised) as seen in the RGB (red-green-
blue) picture from figure 6.54. 
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Figure 6.54 – Confocal imaging of a pDMAEMA complex in Green & RGB detection mode. 
A similar explanation can be given for pDMAEMA 12 kDa based polyplexes. The polyplexes 
are situated at the border of the cells after 2h of incubation as visualised in figure 6.55 (RGB 
picture in which the cells are stained by WGA and no internalised fluorescence is detected). 
In contrast to the intensity derived from a DMAEMA polymer of 121 kDa, the polyplexes 
derived from 12 kDa pDMAEMA are considerably more intense, an effect that could be due 
to the higher ability to shield the fluorescently labeled DNA which is entangled by the 
polymer. This hypothesis is strengthened by the weak detection of polyplexes based on 
pDMAEMA with a MW of 658 kDa (visible as light blue spots in RGB detection, again at the 
borders of the cells). Moreover, the high toxicity of this compound is confirmed by the 
significant TB staining, representative of cell death (Fig. 6.56). In conclusion it is proven that 
for this family of amine containing polymethacrylates 2h is not sufficient for internalisation. 
 
Figure 6.55 – Confocal image of polyplexes based on pDMAEMA 12 kDa in Green/RGB mode. 
Green channel RGB – 3 channels
Green channel RGB – 3 channels
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Figure 6.56 - Confocal image of polyplexes based on p(DMAEMA) 658 kDa in Green/RGB mode. 
Successful transfection of cells is also visualised using confocal microscopy (Fig. 6.57). For 
PEI, protein expression is seen in image A after 24h of incubation. In this image the RGB 
detection covers the identification of the cells, marked by WGA (blue), the localization of the 
diffuse polymer pattern (green, indicative for homogeneous spread throughout the cell, most 
likely in combination with dissocation) and the emerging red signal originating from the 
transcribed protein. Once a cell is transfected, strong expression is observed over the entire 
cell volume. In image B, the non-internalised and better-defined polyplexes do not give rise 
to red fluorescence. Positive transfection results were likewise obtained for delivery systems 
that make use of pDMAEMA.  
In figure 6.58, polyplexes based on pDMAEMA 658 kDa are visualised (RGB image). Analog 
to PEI, the protein expression is responsible for the strong discoloration of the cell (red 
fluorescence) while the borders of the cells are stained in blue and remaining green 
fluorescent spots confirm that certain polyplexes dit not yet fully dissociate (A). If the red 
channel detection (B) is isolated, only the signal coming from the produced protein is 
observed. When focusing specifically on the green fluorescence, randomly scattered 
polyplexes are visible as well as the diffuse pattern of dissociated polymer within the 
transfected cells.     
RGB - 3 channels BT staining
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Figure 6.57 – Confocal images of PEI-complexes: protein transcription with red light emission. 
       
Figure 6.58 – Confocal images of p(DMAEMA) complexes after 24h incubation: RGB detection 
(A), exclusive red channel detection (B) and exclusive green channel detection (C). 
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7 Conclusion 
During the extensive biological testing of the polymers and polyplexes developed for this 
doctoral research, several interesting properties of the applied polymers were exposed. 
Many different, individual conclusions could be derived from these results but in several 
cases, it was also possible to draw global conclusions. For instance, it was shown that all 
polymers can protect DNA from being degraded when the charge ratio is sufficiently high. 
The MW appeared to have almost no influence and also the composition was not crucial (as 
long as a minimal amount of charge was present). In the case of poly-L-glutamines, swift 
degradation of the polymer backbone was demonstrated in the presence of papaine as was 
the relevancy of catonic charge in delaying the degradation rate. The compatibility of most 
polymers with red blood cells was largely negative, especially for highly charged polymers 
where haemolytic and coagulation effects proved to seriously hamper the potential in vivo 
usage. The presence of neutral (hydroxyl/imidazole) functional groups on the other hand 
demonstrated high compatibility and in general, low MW compounds perform better in terms 
of biocompatibility compared to high MW polymers. Nearly all polymers that were produced 
during this research exhibited very low toxicity in in vitro cell tests (except high MW 
polymethacrylates and PEI derivatives). Unfortunately, a lot of vector candidates showed no 
sign of transfection  activity. Nevertheless, positive results were retrieved for 
polymethacrylate derivatives that proved to be successfully internalised and able to express 
proteins by gene delivery. Also a few isolated cases of polyglutamines achieved high levels 
of transfection but no general trend could be detected. Finally, PEI modifications could be 
carried out that were able to reduce the inherent toxicity of PEI while preserving or even 
slightly increasing the biological activity. 
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Final Conclusions 
At the beginning of this doctoral research, a concept was proposed that ideally would result 
in the successful development of one or more efficient, biocompatible, synthetic vectors that 
could be applied in gene delivery. Based on existing research and literature, a family of poly-
-amino acids and polymethacrylates was selected to form the basis of what should 
eventually lead to an optimised delivery system. By carrying out a complete & fundamental 
characterisation of the polymer properties in terms of DNA-interaction and biological 
efficiency, establishing a relation between the structure of the vector and its physico-
chemical and biological behaviour was put forward as one the key targets of this 
investigation. Finally, the complete focus of these trends and correlations was aimed at 
obtaining efficient and successful transfection of specific cells (e.g. retinal) to be used in the 
application of related conditions (e.g. ARMD). 
 
1 Synthesis of suitable vectors for gene delivery 
Between both polymer classes employed in this research, a clear difference in synthetic 
pathway exists. Besides the obvious shorter synthetic route, the commercial availability and 
the different polymerisation mechanism, the inherent, higher hydrophobicity of the 
methacrylate counts as the most relevant differentiator compared to poly--amino acids. 
Considering the requirements in overcoming the hurdles related to DNA-protection, cellular 
entry and delivery of the genetic cargo to the nucleus of a cell, specific chemical functional 
groups were selected to be built into the polymer, either via separate modification reactions 
or by selecting the appropriate starting monomer.  
As a first step in the total development process, an extended library of polymers was 
synthesised. For poly--amino acids, two groups of biodegradable polymers were studied. 
Both poly-L-glutamines and poly-L-arginines were derived from their corresponding N-
carboxyanhydride after which one or more modification reactions were carried out. During 
the polymerisation step, intermediate compounds with a predefined MW were obtained for 
both polymer groups (pBG or pZO). Low MW polymers were derived from n-butylamine 
(range: 5.000 – 30.000 kDa) while the higher MW polymer were produced using 
tributylamine yielding molecules of roughly 50.000 to 250.000 kDa. As the polymerisation 
mechanism was different for both initiator types, also the polydispersity of low MW 
compounds was lower (nearly 1) than for high MW compounds (1.2 – 1.8). For poly--
benzyl-L-glutamate (pBG), it was possible to set-up a mastercurve that enabled to select any 
desired molecular weight (MW) based on the monomer-initiator ratio which could 
theoretically reach infinite MW’s but which is in practice limited by the concentration of the 
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monomer and the proximity requirement between two reacting species. Once an 
intermediate polymer of desired MW was available, further modification was performed by 
the aminolysis reaction of pBG with a suitable amine-containing reagent or by deprotection 
followed by guanidine conversion in the case of poly-N-benzyloxycarbonyl-L-ornithine (pZO). 
It was found that full control over the aminolysis reaction was difficult to reach, especially 
when multiple reagents were involved (production of copolymers) because of the number of 
parameters (concentration, MW of intermediate, reactivity of the reagents, temperature, etc.) 
that could influence the conversion reaction. The conversion of poly-L-ornithine into poly-L-
arginine could be more easily tailored by monitoring the reaction time, the reagent excess 
and the concentration of KI.  
Finally, polyarginine derivatives with a broad MW range were obtained as well as 
polyglutamines that contained, besides different MW’s, also a variable composition in 
functional groups. There appeared to be limitations to the composition of certain glutamine 
(co)polymers, dependent on the reactivity of the applied reagent, mainly in the case of 
trityldiethyleneamine. For that reason, it was difficult to produce aminoethylglutamine (AEG) 
or guanidinethylglutamine (GuAEG) containing polymers that contained > 50% 
AEG/GuAEG. Also, full conversion could only be obtained at elevated temperatures (50°C) 
using excess reagents (10-20x) for an extended time (48-72h). The use of the catalyst (2-
hydroxypyridine) was confirmed to be highly efficient since chain-cutting of the backbone 
was minimal and the corresponding polydispersity only limitedly affected . The purity of the 
final products was positively verified by 1H-NMR and the overall yield of the total synthetic 
pathway sufficient (30-40%) given the multiple steps involved.  
The synthesis of polymethacrylates occurred by free-radical polymerisation and proved to be 
difficult in MW control. Moreover, the success of the polymerisation was highly dependent on 
the absence of O2 in the reaction mixture. Obtaining the desired MW was to a certain extent 
possible by varying the M/I concentration and the type of initiator and resulted in polymers 
with a MW as high as 700.000 Da. The use of a chain transfer agent (2-mercaptoethanol) 
was successful and enabled the production of methacrylates with MW’s of 10.000 – 50.000. 
A whole range of polydimethylaminoethylmethacrylate (pDMAEMA) and copolymers were 
prepared from commercially available monomers (e.g. trimethylsillyloxyethylmethacrylate) 
and also copolymers based on aminoethylmethacrylate and guanidinethylmethacrylate could 
be synthesised via a protected monomer. The composition of the copolymers was 
proportional to the monomer composition which indicates that the reactivity of the different 
monomers was virtually equal. In all cases, the polydispersity of the polymethacrylates was 
considerably higher (up to 2.5) than for the biodegradable counterparts but on the other 
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hand, it was possible to reach yields values as high as 60 % (when one-step syntheses were 
applied).  
Besides new classes of polymeric vectors, also certain existing compounds like 
polyethyleneimine (PEI) and poly-L-lysine (PLL) were modified in an attempt to decrease the 
inherent toxicity and increase the efficiency. For both vectors, fully guanidine-modified 
derivatives could be readily synthesised by adopting the guanidine conversion method 
applied for poly-L-arginine. 
 
2 Physico-chemical properties of developed polymers 
In order to decide if a polymer is suitable as a DNA-carrier in terms of physico-chemical 
qualities, they were subjected to a combination of characterisation techniques. From the 
results that were presented, most polymers exhibit good interaction behaviour with DNA and 
this mainly depended on the degree of cationic charges present but also on the orientation 
or position of the cationic charge within the polymer. For poly--amino acids, the best 
interaction was achieved for fully charged polymers consisting of guanidine residues 
followed by tertiary and primary amine-containing polymers. For copolymers, it was 
concluded that a minimal amount of charged groups must remain in order to keep the ratio of 
polymer/DNA (charge ratio or CR) for complexation low. In this way, copolymers with 
hydroxyl and imidazole groups could be synthesised without decreasing DNA-interaction. In 
contrast, polymethacrylate derivatives containing both neutral and cationic functional groups 
displayed worse DNA-interaction properties (e.g. higher CR for full complexation) than the 
homopolymers or copolymers which are fully charged and is believed to be the result of the 
more hydrophobic nature of the polymer backbone. Moreover, the optimal MW was 
confirmed different for both polymer types, requiring low MW polymers (≈ 10 kDa) in the 
case of biodegradable vectors whereas for the non-biodegradable ones, an optimal MW was 
found around 100-150 kDa. The difference in polyplex formation between regular PEI and 
guanidine-modified PEI was validated but no remarkable change in complex size or stability 
was found. Furthermore, the importance of the orientation of the cationic charge onto the 
polymer was proven by comparing several guanidine-modified compounds and it showed a 
clear advantage for polymers possessing cationic functional groups, located further away 
from the backbone.    
The dimensions of the polyplexes were for nearly all cases small enough to ensure easy 
uptake and gradually decreased in size with increasing CR unless the minimal size was 
already reached at low CR’s. In that case, a slight increase was detected. No real influence 
could be derived from the difference in MW and strikingly, also the composition of the 
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copolymers (either low or high amounts of cationic charge) appeared not to induce a 
substantial effect on the size of the complex. 
Regarding the stability of formed polyplexes, the rule of thumb demonstrated a better 
stability (towards coagulation and precipitation) for higher charged vectors which means that 
homopolymers reached higher values than copolymers (with neutral groups), both for 
polyglutamines as well as for polymethacrylates. The effect of MW variation was not readily 
observed. This extensive physico-chemical characterisation led to the conclusion that mainly 
pDMAEMA or primary amine-containing copolymers with small (< 10%) amounts of primary 
amine and with a MW of around 150 kDa show the most potential as non-biodegradable 
vectors. For biodegradable vectors, the selection was more elaborate because several 
polymers with a MW < 30 kDa and with a subdivided functional group composition (not fully 
charged) seem promising. Selection  of the most optimal functional group was less relevant 
but a preference towards guanidine groups in combination with imidazole moieties or 
hydroxyl entities exists, especially when keeping biological implications in mind.   
To be able to create the most optimal polyplexes, the best way to combine polymer and DNA 
was investigated prior to characterisation. From this screening, it was found that the addition 
of DNA could be achieved stepwise or in a single shot without inducing significant 
differences in polyplex behaviour. Also the stability in time and kinetics were to a certain 
extend examined and proved that polyplexes were quickly formed and remained stable (for 
at least a couple of hours). On the other hand, when using non-flexible macromolecules, the 
concentration is critical for obtaining homogeneously dispersed, uniform polyplexes, hence 
the use of diluted solutions is advised. 
 
3 Optimising polymeric vectors 
Due to the continuous advances in research of gene delivery systems, the use of peptides 
has gained additional importance, not only as facilitators of cellular recognition, targeting and 
internalisation but also as a class of compounds fit for DNA delivery and protection. 
Accordingly, two peptides (penetratine & Arg8) were coupled to a selection of vectors to 
examine the benefits in biological and DNA-protective properties. Because vector 
optimisation is not exclusively limited to the structure but also to the mechanism by which 
polyplexes are being guided to the nucleus of a cell, fluorescent tags were required to allow 
investigation of the polyplex position.  
 
As a result, certain key polymers were provided with 1-5 % of Oregon Green 488 via a 
succinimidyl bridge and the effect of incorporating hydrophobic, voluminous molecular 
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structures on the interaction with DNA was examined. The effect on higly charged vectors 
revealed to be rather minimal but for PEI (≈ 25% charged at physiological pH) the 
consequent shielding effect provoked a much higher CR for full condensation, hence the 
influence of fluorescent coupling should be kept in mind when further exploring fluorescent 
vectors. Additionally, fluorescently labelled polymers could be used to confirm certain kinetic 
properties like polyplex formation and mobility based on diffusion experiments (FCS  or 
UV/VIS). These techniques were successfully validated as alternatives for determining the 
CR for condensation.  
 
Coupling of peptides to the polymer backbone was achieved via two different bifunctional 
crosslinkers, N-succinimidyl-3-(2-pyridyldithio)propionic-ester or N-(-
maleimidobutyryloxy)succinimide-ester. Penetratine was coupled to amine-containing 
polymers in 1-4 % whereas Arg8 was coupled with a percentage ranging from 1-8. 
Furthermore, Arg8 was coupled to p(DMAEG) using a variety of spacers which allowed the 
peptide to be further located from the polymer to assess its influence on transfection 
enhancement. One part of the improvement was not fulfilled since for polymers that exhibit a 
clear interaction behaviour with DNA, the coupling of cell-penetrating peptides (CPP) 
resulted in vectors with decreased condensation properties. In general the presence of 
CPP’s induced a certain retarding effect, requiring higher CR’s for condensation to occur but 
while maintaining the same level of DNA-interaction at full condensation. However, for 
certain polymers with a weak ability to condense DNA, transformation into a compound with 
an intense attraction force was feasible if a cationic peptide (like Arg8) was coupled. This 
negative effect was to some extent confirmed by DLS (with a slightly reduced polyplex size 
for CPP-coupled polymers) and zetapotential, where a more significant delay and decrease 
in positive zeta-value was observed when CPP’s where present in the polyplex.  
The ability of Penetratine, which counts as a model CPP, to interact with the cellular 
membrane was proven by impedance spectroscopy and compared to PEI. This latter 
strangely demonstrated a difference in impedance signal (clear membrane disruption for 
penetratine-compounds but not detectable for PEI polylpexes), hence the believe that 
multiple ways of cellular uptake are feasible, was again supported. Finally, incorporating 
CPP’s by physically combining them within polyplexes was suggested as more efficient 
alternative for biological enhancement since the properties of the vector seemed not to be 
affected compared to coupling through chemical linkage.   
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4 Biological properties of improved vector systems 
Because the coupling of additional compounds to vectors, in order to optimise their biological 
activity, proved to have in most cases a (limited) negative effect on condensation properties 
with DNA, the better strategy could be found in the development of a successful polymeric 
vector as such without the need for additional covalent peptide coupling to enhance 
transfection efficiency. During the elaborate biological testing of the developed polymers and 
polyplexes, several interesting properties of the applied vectors were exposed. Apart from  
deductions applicable for each type tested, it was also possible to draw global conclusions. 
For instance, it was shown that all polymers can protect DNA from being degraded when the 
charge ratio is sufficiently high, even when only a limited amount of charged groups are 
present, regardless the MW of the polymer. In the case of poly-L-glutamines, swift 
degradation of the polymer backbone was demonstrated and this was influenced by the 
amount of cationic charge present (slower degradation rate with increasing positive charge). 
The compatibility of most polymers with red blood cells was largely negative, especially for 
highly charged polymers where hemolytic and coagulation effects proved to seriously 
hamper the potential in vivo usage. The presence of neutral (hydroxyl/imidazole) functional 
groups on the other hand demonstrated high compatibility and generally, this tendency was 
more explicit for low MW compounds. Nearly all polymers that were produced during this 
research exhibited very low toxicity in in vitro cell tests (except high MW polymethacrylates 
and PEI derivatives). The coupling or incorporation of peptides did not provoke a decrease in 
toxicity but was unfortunately not able to transform a non-active vector into an active version. 
Improvement of transfection efficiency was noticeable by CPP-addition but only if the base 
polymer was already active. Nevertheless, positive results were retrieved for several 
polymers like polymethacrylate derivatives which proved to be successfully internalised and 
able to express proteins by delivering DNA cargo, irrelevant of the MW. Also a few cases of 
polyglutamines achieved high levels of transfection (even outperforming PEI) but it was 
difficult to identify a general trend related to the structure. However, for poly-L-glutamines, it 
appears that fully charged polymers should be avoided and the incorporation of functional 
groups with a lower pKa is advisable, although a minimum amount of positive charges is 
necessary to keep the DNA-attraction sufficiently high (dependent on the type of cationic 
group but presumably > 30%). The most active compounds were also low in MW which was 
not a requirement for polymethacrylates. For those, it was proven that a higher MW 
corresponded with a higher transfection (but with an equally high toxicity). Therefore the use 
of polymers with an intermediate MW is preferable to extremely high or low MW’s. The 
composition of polymethacrylates favors the presence of completely charged functional 
groups (especially a combination of primary and tertiary amines), given the lower activity of 
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hydroxyl-containing derivatives. Furthermore, PEI modifications were carried out that 
brought about derivatives with a reduced inherent toxicity while preserving or even slightly 
increasing the biological activity, for instance by coupling a fluorescent group or CPP 
Finally, the internalisation process was explored for both polymer classes as well as the 
reference polymer PEI by confocal imaging. Already at the stage of polyplex formation, 
discrepancies were visualised. Whereas polyplexes based on p(DMAEG) formed intensily, 
coloured dots which represent strongly interaction complexes, the appearance of PEI-based 
complexes proved to be much more diffuse, presumed to be the result of weaker 
interactions. Higher success-rates for PEI could be partially attributed to the swift 
internalisation property (already considerable after 3h of incubation) compared to p(DMAEG) 
which was only significantly internalised after 24h. Nevertheless, internalisation was no 
guarantee for positive transfection as the complex still needs to dissociate and move 
towards the nucleus, an additional need that was probably not met and the result of too 
tightly bound polyplexes. 
 
5 Epilogue 
Because the search for the ideal vector is influenced by such a high number of parameters, 
the questions remains if it will ever be possible to identify a general correlation between in 
vitro or in vivo transfection activity and the chemical structure of a synthetic compound. With 
increasing knowledge on a vastly growing group of explored polymers, additional trends and 
properties will hopefully enable the detection of the underlying connections that form the key 
to developing a successful uniform delivery system. With respect to these hypotheses, this 
research has proven the advantages and flaws of a certain class of synthetic polymers and 
based on this information, this knowledge should be part of the global information matrix for 
continued unveiling of the principle that can guarantee success of implementing adequate 
gene therapy in the long run. 
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1 Products 
L-glutamic acid (Bachem), 2-hydroxypyridine (Avocado), diphosgene (Acros) , dry N,N-
dimethylformamide (Aldrich), poly-L-lysine (MW 30.000 – 70.000, Sigma) polyethyleneimine 
(PEI, branched, Mw 25.000 – Sigma), trifluoroacetic acid (Acros), 
aminoethylmethacrylate.HCl (Polysciences), HBr/CH3COOH (33%) (Acros); 3,5-dimethyl-1-
guanylpyrrazolenitrate (Sigma), 2-hydroxypyridine 99% (Avocado), histamine (Sigma), 
diphosgene (Acros), Tris base (Sigma), EDTA (Fischer scientific), boric acid (Acros), 
Bromophenol blue (Acros), Agarose (Fischer scientific), glycerol (Acros), 2-mercaptoethanol 
(Sigma) were used as such. Tributylamine (Acros), ethanolamine (Acros), n-butylamine 
(Acros) and 2-dimethylaminoethylamine (Fluka), N,N-dimethylaminoethylmethacrylate 
(Sigma), trimethylsilyloxyethylmethacrylate (Sigma), triethylamine (Sigma), acetic anhydride 
(Sigma) were distilled prior to use. N-(-maleimidobutyryloxy)sulfosuccinimide-ester (Sulfo-
GMBS) and N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP) were obtained from Pierce. 
Oregon Green 488 (5* isomer, succinimidyl ester) was obtained from Invitrogen. Methanol, 
dicholoromethane, toluene, n-pentane, DMF and diethylether were dried on calciumhydride 
and distilled. Ethylacetate was dried on K2CO3 and distilled. Ultrapure water (type III) was 
obtained through purification on a Synergy UV unit (Millipore).  
Sephadex G-25 pd-10 desalting columns were received from GE. 
Papaine and DNAse I were provided by Sigma.  
2 Instruments 
1H-NMR spectra were recorded on a Bruker Avance 300, 500 or 700 MHz and chemical 
shifts are expressed as ppm () relative to TMS. FTIR measurements were measured by 
means of a Bio-Rad 575C spectrometer in transmission mode (KBr) or in total reflection 
mode (ATR using a diamant crystal). UV/VIS analysis was performed on a Uvikon 810 
spectrometer (Kontron Instruments?). Fluorescence intensity was detected by a Kontron 
SFM25 fluorimeter (Kontron Instruments). Microscopy images were taken with a light 
microscope (Axio – Zeiss). MW determination was achieved on an analytic GPC unit 
(Waters 600 controller) with differential refractometry (Waters R410) detection using an 
eluens composed of 5 % NaH2PO4, 3 % CH3CN at pH 4 (filtered 0.45 µm and degassed with 
He) and separation coloumns (Waters Ultrahydrogel 1000 and Shodex SB803HQ). 
Individual Refractive index was measured on a differential refractometer (DRM-1020, 
Polymer laboratories). Zetapotential values were obtained from a Zetasizer 3000 (Malvern 
Instruments) whereas dynamic light scattering results were derived from a Malvern Autosizer 
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4800 (Malvern Instruments). Agarose gel-electrophoresis was performed on a Gibco BRL 
apparatus (Life Technologies) and a Gibco BRL UV transilluminator TFX-20M (UV-B light). 
3 Synthesis of biodegradable polymers (Chapter 2) 
3.1 preparation of -benzyl-L-glutamate (BG) 
To an ice-cooled suspension of 50 ml H2SO4 (98%) in 500 ml diethylether, 500 ml of 
benzylalcohol is added dropwise. Next, the ether fase is reduced through vacuum 
rotavaporation and 0.5 moles of L-glutamic acid is added to it to let react overnight. 
Subsequently, 900 ml of distilled water is added and the mixture is cooled to 0 °C and the 
pH adjusted to 6-6.5 with concentrated LiOH until the resulting product, -benzyl-L-glutamate 
(BG) precipitates. Following filtration and washing with distilled water, ethanol and 
diethylether, the product is dried in vacuo. A final recrystallisation from water/ethanol (9/1) is 
required. A total yield of around 50% can be achieved via this method.  
1H-NMR (D2O/DCl; 500 MHz): δ = 7.35 ppm (5H, m, Aromatic-H), δ = 5.19 ppm (2H, s, C6H5-
CH2-O-), δ = 4.25 ppm (1H, t, -CH2), δ = 2.60 ppm (2H, t, -CH2); δ = 2.10-2.30 ppm (2H, 
m, -CH2) 
FTIR : 1725 cm-1 (ester) 
 
3.2 Synthesis of -benzyl-L-glutamate-N-carboxyanhydride (BG-NCA) 
In order to synthesise the N-carboxyanhydride (NCA) of L-glutamine the carboxylic group 
located on the side-chain was protected by means of a benzyl ester. In short, 15 g of BG 
was suspended in 250 ml of dry ethylacetate (EtOAc) and heated to 60 °C. A solution of 
diphosgene in EtOAc (15%) is added to the mixture in portions (7x10 ml). With every portion, 
the mixture is let react for 20 min after which N2 is flushed through for 10 min to eliminate 
HCl from the mixture. This procedure is repeated until all BG was converted into BG-NCA 
(solution becomes transparent). Afterwards, the mixture is flushed with N2 (1 hour at 60 °C 
followed by 1 hour at room temperature). In case suspended product remains, the mixture is 
filtered off and the filtrate used accordingly. Following partial solvent removal (to a 100 ml 
total), the product was precipitated in cold pentane and recrystallized from ethylacetate. The 
product is then filtered off again and dried in vacuo. The absence of Cl- was verified via a 
precipitation reaction with AgNO3. Therefore, 10 mg of BG-NCA is dissolved in 1 ml HNO3 
(2M), heated close to boiling temperature in a Bunsen-flame after which 3 drops of AgNO3 
were added. If the product turned out to be less turbid than reference (tap water with 
AgNO3), the BG-NCA was considered sufficiently Cl
- free. The product was confirmed using 
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1H-NMR and FTIR (yield = approximately 80-90%, dependent on amount of recrystallisation 
steps). 
1H-NMR (CDCl3; 500 MHz): δ = 7.35 ppm (5H, m, Aromatic-H), δ = 6.30 ppm (1H, s, CO-
NH), δ = 5.14 ppm (2H, s, C6H5-CH2-O-), δ = 4.39 ppm (1H, t, -CH2), δ = 2.60 ppm (2H, t, 
-CH2); δ = 2.10-2.30 ppm (2H, m, -CH2) 
FTIR : 1780 cm-1 (anhydride peak 1); 1860 cm-1 (anhydride peak 2); 1715 cm-1 (ester) 
 
3.3 Synthesis of -carbobenzyloxy-L-ornithine-N-carboxyanhydride (ZO-NCA) 
Analogue to the synthesis of BG-NCA, the formation of ZO-NCA occurs via a cyclisation 
reaction with diphosgene. Since a protective derivative is commercially available (N-
carbobenzyloxy-L-Ornithine or ZO), there’s no preceding reaction required.  
1H-NMR (CDCl3; 500 MHz): δ = 7.35 ppm (5H, m, Aromatic-H), δ = 7.10 ppm (1H, s, CO-NH, 
side-chain), δ = 5.15 ppm (2H, s, C6H5-CH2-O-), δ = 5.05 ppm (1H, s, CO-NH, ring),  δ = 
4.32 ppm (1H, t, -CH2), δ = 3.25 ppm (2H, t, -CH2);  δ = 1.80-2.10 ppm (2H, m, -CH2); δ = 
1.60-1.75 ppm (2H, m, -CH2) 
FTIR : 1780 cm-1 (anhydride peak 1); 1860 cm-1 (anhydride peak 2); 1690 cm-1 (carbamate) 
 
3.4 Synthesis of poly(-benzyl-L-glutamate) – low MW 
Poly(-benzyl-L-glutamate) (pBG) was synthesised with different initiators, dependent on the  
desired MW. For low MW compounds, BG-NCA (1g, 3.8 mmol) was dissolved in 10 ml 
DCM/EtOAc (6/1 v/v) and n-butylamine (41.2 µl of a 10% solution in DCM for a MW = 
10.000) was added and the reaction was continued for 40h (N2 atmosphere). After 40h, the 
reaction was terminated by adding a 10-fold excess of acetic anhydride and triethylamine 
(30 min). Next, the polymer was purified by precipitating in a cold mixture of 
MeOH/diethylether (1/2). Subsequently, the product was filtered off, washed and vacuum 
dried. The MW could be calculated from the 1H-NMR spectrum (butyl -H) and the reaction 
followed by FTIR. Yield = 80 %. 
1H-NMR (TFA; 500 MHz): δ = 7.35 ppm (5H, m, Aromatic-H), δ = 5.25 ppm (2H, s, C6H5-
CH2-O-), δ = 4.80 ppm (1H, t, -CH2), δ = 2.65 ppm (2H, t, -CH2); δ = 2.10-2.40 ppm (2H, 
m, -CH2); δ = 1.05 ppm (3H, t, butyl -H) 
FTIR : 1730 cm-1 (ester); 1650 cm-1 (amide) 
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3.5 Synthesis of poly(-benzyl-L-glutamate) – high MW 
Similar to the synthesis of low MW pBG, 1g of BG-NCA ( was dissolved in 10 ml 
DCM/EtOAc (6/1 v/v) but now tributylamine (80 µl of a 10% solution in DCM for M/I = 100) 
was added dropwise to start the reaction for 40h. No termination reaction was required and 
purification was carried out subsequently in a mixture of MeOH/diethylether (2/1).  Finally, 
the product was filtered off, washed and dried. The molecular weight (Mv) was determined by 
viscosimetry measurements  in distilled dichloroacetic acid (a = 0.78 & K = 2.78.10-5 g/ml). 
Yield = 80%. 
1H-NMR spectrum and FTIR spectrum analogue to pBG low MW (no initiator signal). 
3.6 Synthesis of poly-(N-CBZ-L-ornithine) 
The polymerisation of ZO-NCA was carried out in the exact same way as for pBG (both low 
& high MW). Only in the case of low MW pZO, the reaction solvent was composed of pure 
DCM. 
Since deprotection was performed, immediately following polymerisation, no confirmation 
was researched.  
3.7 Synthesis of poly-L-ornithine (pORN) 
The final product of the polymerisation, pZO (0.5g – 2.10-3 mol), was dissolved in 5 ml of 
CHCl3 after which 10 ml of a HBr solution (33%) in CH3COOH was carefully added. The 
mixture was stirred for 1h and then precipitated in cold diethylether. The product was filtered 
off, washed and redissolved in 10 ml of a dilute NaHCO3 solution (4%) after which it was 
purified by liquid extraction using 50ml of cold diethylether. The water phase was tapped off 
and collected for dialysis against ultrapure H2O, NaCl (0.1 M) and HCl (0.05 M) to be finally 
dialysed against ultrapure water. The end product was isolated by freeze-drying. Yield = 
70%. 
1H-NMR (D2O/DCl; 500 MHz): δ = 4.25 ppm (1H, t, -CH2), δ = 2.90 ppm (2H, t, -CH2); δ = 
1.60-1.80 ppm (2H, m, -CH2); δ = 1.65 ppm (2H, t, -CH2) 
FTIR : 1650 cm-1 (amide); 3300 cm-1 (primary amine) 
 
3.8 Synthesis of poly-L-arginine (pARG) 
Starting from 0.5g of pORN (3.3.10-3 mol) solubilised in 5 ml of ultrapure water, 9.96g of KI is 
added (to have an end concentration of 6 M). In a separate flask, 16 equivalents of 3,5-
dimethyl-1-guanylpyrrazolenitrate (DMGP) are suspended in 4 ml of water. Using 
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concentrated KOH (4M) the solution is brought to pH 9.5 and added to the pORN solution. 
The total volume is brought to 10ml while maintaining a pH of 9.5 and let react for 24h at 
room temperature. Afterwards the mixture is neutralised using concentrated HCl (1 M) and 
collected in a dialysis membrane (MWCO range 1/5th-1/10th of the MW of pORN) to be 
purified against ultrapure water. After 24h, the dialysis solution is acidified via 1 M HCl and 
again dialysed against ultrapure water, 0.1 M NaCl, 0.05 M HCl and again ultrapure water to 
end. The final product was then obtained by freeze-drying. Yield = 95%. 
1H-NMR (D2O/DCl; 500 MHz): δ = 4.25 ppm (1H, t, -CH2), δ = 3.10 ppm (2H, t, -CH2); δ = 
1.60-1.75 ppm (2H, m, -CH2); δ = 1.50-1.60 ppm (2H, m, -CH2) 
FTIR : 1650 cm-1 (amide); 3300-3400 cm-1 (primary & secondary amine) 
 
3.9 Synthesis of poly(dimethylaminoethyl-L-glutamine) 
pBG (0.5g – 2.28 mmol) is dissolved in 5ml of dry DMF and 1.08g (11.4 mmol) of 2-
hydroxypyridine was added. Next, 4.7 ml (45.6 mmol) of 2-dimethylethylenediamine was 
added after which the mixture was heated tot 50 °C and stirred for 60h (while followed by 
FTIR). For high MW pBG, another 1.175 ml of 2-dimethylethylenediamine was added to let 
react for another 2h.  Poly(dimethylaminoethyl)-L-glutamine (pDMAEG) was obtained by 
precipitation in ice-cooled diethylether, filtered, washed and redissolved in 10 ml of water 
(pH = 5) to be dialysed (MWCO = 1/10th of the MW of pBG) against ultrapure water, 0.05 M 
HCl and finally again ultrapure water. Isolation of the product was achieved by freeze-drying. 
Yield = 75 %  
1H-NMR (D2O; 500 MHz): δ = 4.30 ppm (1H, t, -CH2); δ = 3.60 ppm (2H, t, -CH2-NH-CO-), 
δ = 3.30 ppm (2H, s, -N-CH2-CH2-NH-CO-), δ = 2.90 ppm (6H, s, CH3-N-), δ = 2.35 ppm (2H, 
t, -CH2); δ = 1.90-2.10 ppm (2H, m, -CH2) 
FTIR: 1650 cm-1 (amide); 3250 cm-1 (tertiary amine) 
3.10 Synthesis of poly(dimethylaminoethyl-co-aminoethyl)-L-glutamine 
For a composition of 15% primary amines, pBG (0.5g – 2.28 mmol) is dissolved in 5 ml of 
dry DMF and 1.08g (11.4 mmol) of 2-hydroxypyridine was added. Next, 3.525 ml (34.2 
mmol) of 2-dimethylethylenediamine was added as well as 3.54 g (11.4 mmol) of N-trityl-
ethylenediamine after which the mixture was heated tot 50 °C and stirred for 60h (while 
followed by FTIR). For high MW pBG, another 1.175 ml of 2-dimethylethylenediamine was 
added to let react for another 2h. The product was precipitated using ice-cooled diethylether 
and filtered off. Trityl removal was obtained through acidolysis in pure TFA during 1h which 
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was followed by precipitation in cold diethylether. Subsequently, the polymer was filtered, 
washed and dried to be finally dissolved in water (pH = 5) and collected in a dialysis 
membrane. p(DMAEG-AEG) was obtained by precipitation in ice-cooled diethylether, filtered, 
washed and redissolved in 10 ml water (pH = 5) to be dialysed against ultrapure water, 0.05 
M HCl and finally again ultrapure water. Isolation of the product was achieved by freeze-
drying. Yield = 65%.  
1H-NMR (D2O; 500 MHz): δ = 4.30 ppm (1H, t, -CH2); δ = 3.65 ppm (2H, t, -CH2-NH-CO-, 
% NR2), δ = 3.55 ppm (2H, t, -CH2-NH-CO-, % NH2), δ = 3.30 ppm (2H, s, R2N-CH2-CH2-NH-
CO-), δ = 3.20 ppm (2H, s, H2N-CH2-CH2-NH-CO-), δ = 2.90 ppm (6H, s, CH3-N-), δ = 2.35 
ppm (2H, t, -CH2); δ = 1.90-2.10 ppm (2H, m, -CH2) 
FTIR: 1650 cm-1 (amide); 3200-3300 cm-1 (primary & tertiary amine) 
3.11 Synthesis of poly(dimethylaminoethyl-co-hydroxyethyl)-L-glutamine 
Analogue to the synthesis of p(DMAEG), the reaction of p(DMAEG-HEG) was achieved by 
adding 3.31 ml of 2-dimethylethylenediamine and 1.09 ml of aminoethanol as aminolysis 
reagents for a 40% hydroxyl composition. Yield = 80%. 
1H-NMR (D2O; 500 MHz): δ = 4.30 ppm (1H, t, -CH2); δ = 3.60 ppm (2H, t, -CH2-NH-CO-, 
% OH), δ = 3.55 ppm (2H, t, -CH2-NH-CO-, % NR2), δ = 3.25 ppm (2H, s, R2N-CH2-CH2-NH-
CO-) + (2H, s, HO-CH2-CH2-NH-CO-), δ = 2.90 ppm (6H, s, CH3-N-), δ = 2.35 ppm (2H, t, -
CH2); δ = 1.90-2.10 ppm (2H, m, -CH2) 
FTIR: 1650 cm-1 (amide); 3250 cm-1 (tertiary amine), 3500 (hydroxyl, H-bonded) 
3.12 Synthesis of poly(dimethylaminoethyl-co-aminoyethyl-co-imidazolethyl)-L-
glutamine 
Analogue to the synthesis of p(DMAEG-AEG), the reaction of p(AEG-HEG-ImEG) was 
achieved by adding 2.37 ml of aminoethanol, 0.76 g of histamine and 2.76 g of N-
tritylethylenediamine as aminolysis reagents for a 80% hydroxyl, 10% imidazole and 10% 
amine composition. Yield = 65%. 
1H-NMR (D2O; 500 MHz): δ = 8.40 ppm (1H, s, -N=CH-NH-); δ = 7.15 ppm (1H, s, -C=CH-
NH-); δ = 3.65 ppm (2H, t, -CH2-NH-CO-, % OH), δ = 3.50 ppm (2H, t, -CH2-NH-CO-, % 
NH2) + (2H, s, , -CH2-NH-CO-, % Imidazole), δ = 3.30 ppm (2H, s, HO-CH2-CH2-NH-CO-), δ 
= 3.10 ppm (2H, s, H2N-CH2-CH2-NH-CO-), δ = 2.85 ppm (2H, s, Imid-CH2-CH2-NH-CO-), δ 
= 2.35 ppm (2H, t, -CH2); δ = 1.90-2.10 ppm (2H, m, -CH2) 
FTIR: 1650 cm-1 (amide); 3300 cm-1 (primary amine), 3500 (hydroxyl, H-bonded) 
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3.13 Synthesis of poly(hydroxyethyl-co-guanidylethyl)-L-glutamine 
For a composition of 40 % guanidine functional groups, 0.5 g pBG was dissolved in 5 ml dry 
DMF and 1.08g (11.4 mmol) of 2-hydroxypyridine was added to start the first subreaction. 
Next, 10.55 g of N-tritylethylenediamine was added in two portions (spread over 1h) and 
heated to 50 °C and reacted for 24h followed by the addition of 2.73 ml of aminoethanol. 
After a total reaction time of 60h, another 8.66 ml of aminoethanol was added. Precipitation 
was carried out after 72h of reacting by adding the mixture to cold diethylether. The product 
was filtered off and washed followed by dissolving in pure TFA during 1h. Again the product 
was precipitated, filtered off and dried in vacuo. Subsequently, the dried polymer was 
dissolved in water (pH = 5) and dialysed again in a sequence of ultrapure, 0.05 M HCl and 
again ultrapure water. The intermediate p(HEG-AEG) compound was isolated by freeze-
drying. In a second sub-reaction, 0.4 g (2.15 mmol) of p(HEG-AEG) was dissolved in 4 ml of 
water and 7.97 g of KI was added. 34 mmol of DMGP was dissolved in 3 ml of water and 
adjusted to pH = 9.5 prior to mixing with the dissolved p(HEG-AEG). The total volume of the 
reaction was brought to 8 ml (pH = 9.5) and let react for 24h. Next, the solution was 
neutralised and collected to be dialysed against a sequence of ultrapure, 0.05 M and 
ultrapure water. Product isolation was achieved by freeze-drying. Yield subreation 1 = 65%, 
subreaction 2 = 95%. 
1H-NMR (D2O; 500 MHz): δ = 4.30 ppm (1H, t, -CH2); δ = 3.60 ppm (2H, t, -CH2-NH-CO-, 
% OH), δ = 3.35 ppm (2H, t, -CH2-NH-CO-, % GuAEG), δ = 3.30 ppm (2H, s, Gua-CH2-CH2-
NH-CO-) + (2H, s, HO-CH2-CH2-NH-CO-), δ = 2.35 ppm (2H, t, -CH2); δ = 1.90-2.10 ppm 
(2H, m, -CH2) 
FTIR: 1650 cm-1 (amide); 3300-3400 cm-1 (primary & secondary amine), 3500 (hydroxyl, H-
bonded) 
3.14 Synthesis of graft-copolymers 
The synthesis of graft-copolymers is preceded by the synthesis of amine-containing units 
like aminoethyl-Lglutamine or L-ornithine. For p(HEG87%-AEG13%), 40 mg (0.029 mmol) is 
dissolved in 3 ml DMF. To obtain an M/I of 8, 65 mg of ZO-NCA was added to the mixture 
and the reaction was carried out for 40h. Afterwards, a 10-fold equivalent of TEA & acetic 
anhydride was mixed in and stirred for an additional 30 min. The solution was then 
precipitated in ice-cooled diethylether, filtered off and dried. In a next step, the Z-protecion 
was removed by dissolving the dry product in 5 ml of HBr/CH3COOH for 45 min. The 
resulting p(HEG-AEG)+pORN was purified by precipitating the mixture in ice-cooled 
diethylether. The isolated product was further dissolved in 10 ml NaHCO3 (4%) and purified 
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by liquid extraction in cold diethylether (25 ml). The water phase was separated and acidified 
to pH = 5 after which dialysis was performed against pure water, 0.05 M HCl and finally 
ultrapure water. The resulting p(HEG-AEG)+pORN was isolated by freeze-drying and in a 
subsequent reaction modified with guanidine functional groups, analoge to section 3.8, 
yielding eventually p(HEG-AEG)+pARG. The MW of the grafted copolymers could be 
calculated via 1H- NMR by assuming initiation of all –NH2 units and comparing the -H signal 
of pARG with the -H of the backbone.  
3.15 Synthesis of PEI-Guanidine 
PEI (60 mg – 1.39 mmol) is dissolved in 1 ml of ultrapure water and 2.99 g of KI is added. 
1.12 g of DMGP is dissolved in 1.5 ml of water and adjusted to pH = 9.5 with KOH (4 M) 
after which it is mixed with the PEI solution. The total volume of the mixture is brought to 3 
ml and let react for 24h. Subsequently, the solution is neutralised and dialysed against 
neutral water. Then the dialysed solution was acidified (pH = 4) and further purified against 
ultrapure, 0.05 M HCl and ultrapure water. Isolation of the product was done via freeze-
drying. The yield of this reaction was around 95 %. 
3.16 Synthesis of PEI + p(HEG-co-GuAEG) grafts 
Prior to modification, the commercially available PEI was purified by dissolving 100 mg in 
10ml of acetone and precipitated in ice-cooled pentane, followed by filtration and drying in 
vacuo. To start, 40 mg of PEI was solubilised in 5 ml of DCM (slightly clouded impression) 
and 350 mg of BG-NCA was added to let react for 40h. A 10-fold excess of TEA and acetic 
anhydride was added and stirred for 30 min to acetylate the free primary amines. The 
product was purified by precipitation in a 2/1 mixture of diethylether/methanol and filtered off. 
In a next step, 290 mg of the intermediate compound was dissolved in 5 ml of DMF and 5 
equivalents of 2-hydroxypyridine (560 mg) and 10 equivalents of tritylethylenediamine (3 g) 
were added and reacted overnight at 50 °C after which 10 equivalents of aminoethanol (1.8 
ml) were mixed and continued to be stirred for another 48h. The product was precipitated in 
cold diethylether, filtered off and washed. The remainder was dissolved in 2 ml DCM and 10 
ml of TFA was added and reacted for 1h. Again the product was precipitated in cold 
diethylether, filtered off and washed. The product was dissolved in water and adjusted to pH 
= 5 followed by collection in a dialysis membrane and equilibrated against ultrapure water, 
0.05 M HCl to end finally with ultrapure water. Isolation of the product was achieved by 
freeze-drying. In a final step, 130 mg of PEI+p(HEG-AEG) was dissolved in 3 ml water and 4 
gr of KI was added. DMGP (700 mg), dissolved in 1 ml of water and adjusted to pH = 9.5 
was added to this mixture and reacted for 24h. The final solution was neutralised and 
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dialysed against ultrapure water, followed by acidification of the dialysis solution (pH = 4) 
after which dialysis was continued (ultrapure water, 0.05 M HCl and ultrapure water). 
Isolation of the product was done by freeze-drying. The MW and the composition of the 
grafts was determined by 1H-NMR (-H and -CH2-NH-CO-).      
 
4 Synthesis of polymethacrylates 
4.1 Synthesis of poly(dimethylaminoethyl)methacrylate (pDMAEMA) 
4.1.1 Synthesis via non water-soluble initiators 
4.1.1.1 Synthesis via AIBN 
To start, dimethylaminoethylmethacrylate (DMAEMA) (1,5 ml – 8,9 mmol) was dissolved in 
8.5 ml of distilled toluene. The mixture was degassed (in vacuo) for 5 minutes while 
vigorously stirring and an inert gas (N2) was added afterwards. This step was repeated 3 
times. Subsequently, an amount of initiator (77 µl – 4,67.10-6 mol) from a 10 mg/ml stock in 
toluene, correspondent with an intended MW of 100.000 Da was added. Afterwards, the 
degassing step was repeated and an N2-atmosphere was maintained throughout the total 
reaction process. The temperature was elevated (70 °C) and the mixture was allowed to 
react overnight. The final product was retrieved by precipitation in ice-cooled pentane 
followed by filtration and washing. The product was redissolved in water (brought to pH = 5) 
and dialysed against ultrapure water, 0.05 M HCl and once more with ultrapure water to end 
with. Eventually, the product was obtained by freeze-drying and characterised via 1H-NMR. 
Yield = 30%. 
1H-NMR (D2O, 500 MHz): δ = 4.05 ppm (2H, b, -CH2-O-CO-); δ = 3.25 ppm (2H, b, -N-CH2-), 
δ = 2.65 ppm (6H, s, CH3-N-), δ = 1,70 ppm (2H, b, -CH2-C-); δ = 0.6-0.9 ppm (3H, b, CH3-
C-). 
FTIR: 1730 cm-1 (ester); 3400 cm-1 (tertiary amine)  
4.1.1.2 Synthesis via AIBN & CTA 
DMAEMA (1,5 ml – 8,9 mmol) was dissolved in 8.5 ml of distilled toluene and 31 µl 2-
mercaptoethanol was added (e.g. M/CTA ratio of 20/1 for a MW of 30.000). The mixture was 
degassed following the above mentioned procedure (4.1.1.1) and 77 µl of initiator was 
likewise added. The reaction occurred overnight at elevated temperature and was purified in 
a similar way as above (4.1.1.1). The product was obtained by freeze-drying and 
characterised via 1H-NMR. Yield = 30%. 
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4.1.2 Synthesis via water-soluble initiator 
Distilled DMAEMA (1.5 ml – 8.9 mmol) is dissolved in 8.5 ml ultrapure water and degassed 
according to the previously described method. An amount of APS initiator corresponding 
with the desired MW (1 % for 500.000 kDa or 202.9 µl of a 10 % (w/v) solution) is added and 
the mixture is degassed once more after which the reaction is carried out overnight at 70 °C.  
Post reaction, the product is purified by precipitating in ice-cooled acetone. Following 
filtration and washing, the polymer was dissolved in water (pH = 5) and dialysed against 
ultrapure water,  0.05 M HCl and ultrapure water. Freeze-drying enabled isolation of the 
product. Yield = 40%. 
 
4.2 Synthesis of poly(dimethylaminoethyl-co-aminoethyl)methacrylate 
(pDMAEMA-AEMA) 
For a composition of 50/50, DMAEMA (1.07 ml – 6.8 mmol) and AEMA.HCl (1.13 g – 6.8 
mmol) were dissolved in 6.066 ml of ultrapure water. After thorough degassing, 1.934 ml (2 
%) of APS (10 mg/ml stock) was added to the mixture and the pH of the solution was 
adjusted to pH = 5 (using 1M HCl) followed by a final degassing step while vigorously 
stirring. The total reaction time was set to 24h at 75 °C after which the mixture was diluted to 
50% by ultrapure water. Purification was obtained by precipitation in cooled acetone and 
continued by extensive dialysis (72h in total in a sequence of ultrapure water, 0.05 M HCl 
and finalised by ultrapure water). The final product was obtained by freeze-drying and 
characterised by 1H-NMR. Yield = 50 %).   
1H-NMR (D2O, 500 MHz): δ = 4.10 ppm (2H, b, -CH2-O-CO-, % -NH2); δ = 3.95 ppm (2H, b, -
CH2-O-CO-, % -NR2); δ = 3.25 ppm (2H, b, R2-N-CH2-); δ = 3.05 ppm (2H, b, NH2-CH2-) δ = 
2.70 ppm (6H, s, CH3-N-), δ = 1,70 ppm (2H, b, -CH2-C-); δ = 0.6-0.9 ppm (3H, b, CH3-C-). 
FTIR: 1730 cm-1 (ester); 3200-3400 cm-1 (tertiary + primary amines)  
4.3 Synthesis of poly(dimethylaminoethyl-co-hydroxyethyl)methacrylate 
(pDMAEMA-HEMA) 
To a solution of 1.07 ml DMAEMA (6.8 mmol) and 1.48 ml TMS-HEMA (6.8 mmol) in 7.5 ml 
of toluene, that was thoroughly degassed, 148 µl of AIBN (10 mg/ml stock) was added after 
which it was degassed for a final time to yield a 50/50 % composition and a MW of 100.000 
Da. Optionally, for low MW compounds, 2-mercaptoethanol can be added to the mixture 
before degassing (43 µl  for a M/CTA = 10 or a MW of 10.000 Da). The reaction was stirred 
overnight at elevated temperature (70 °C) and afterwards purified by precipitation in a cold 
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3/2 solution of pentane/diethylether. The intermediate p(DMAEMA-TMS-HEMA) was filtered 
off, washed and dried to be finally redissolved in 10 ml of pure TFA and stirred for 45 
minutes. The product was separated via precipitation in cold pentane and after decanting 
and drying again dissolved in water (pH = 5) to undergo dialysis (against ultrapure water, 
0,05 M HCl and ultrapure water). The final product was received by freeze-drying. Yield = 
25%. 
1H-NMR (D2O; 500 MHz): δ = 4.20 ppm (2H, b, -CH2-O-CO-, % DMAEMA); δ = 3.90 ppm 
(2H, b, -CH2-O-CO-, % HEMA), δ = 3.65 ppm (2H, b, HO-CH2-, % HEMA), δ = 3.40 ppm 
(2H, b, Me2-N-CH2-, % DMAEMA), δ = 2.80 ppm (6H, s, CH3-N-), δ = 1,85 ppm (2H, b, 
backbone CH2); δ = 0.70-0.90 ppm (3H, b, CH3-C-). 
FTIR: 3200-3600 (hydroxyl + tertiary amine); 1721 (ester) 
 
4.4 Synthesis of p(HEMA- GuAEMA) 
4.4.1 Synthesis of N-(tert-butoxycarbonyl)aminoethylmethacrylate (BOC-AEMA) 
To a suspension of 4 g of aminoethylmethacrylate hydrochloride (24.2 mmol) in 70 ml 
anhydrous dichloromethane, which is stirred for 10 min in an ice-water bath, 3.68 ml (1.1 eq) 
of triethylamine is added and stirred for another 20 min. Next a solution of 5.76 g of bis(tert-
butyl)dicarbonate in 10 ml DCM is added and the reaction is allowed to reach room 
temperature and continued for 24h. Afterwards the mixture is washed 2 consecutive times 
with 50 ml of 0.5 M HCl. This is followed by liquid extraction of the organic phase with 0.5 M 
NaHCO3 (50 ml) and 0.1 M NaCl. The organic phase is dried over MgSO4 for 20 min and 
the filtered. Next, the filtrate is concentrated by rotary evaporation until 20 ml remains. This 
solution is allowed to crystallise in a 2/1 solution of pentane/diethylether. After decantation 
the product is dried in vacuo and characterised by 1H-NMR. Yield = 80 %. 
1H-NMR (D2O; 500 MHz): δ = 6.1 & 5.5 ppm (2H, s, CH2=C-); δ = 4.70 ppm (1H, b, -NH-), δ 
= 4.15 ppm (2H, t, -O-CH2-CH2-,) δ = 3.40 ppm (2H, t, -CH2-CH2-NH-), δ = 1.90 ppm (3H, s, 
CH3-C-), δ = 1,40 ppm (9H, s, CH3-C-O-). 
FTIR: 3380 (urethane N-H stretch, sharp); 1710 (urethane) 
 
 
4.4.2 Synthesis of poly(hydroxyethyl-co-guanidylethyl)methacrylate (pHEMA-GuAEMA) 
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Polymerisation of TMS-HEMA and BOC-AEMA is carried out analogue to the synthesis of 
p(DMAEMA-HEMA). After freeze-drying of the p(HEMA-AEMA), the product is guanidylated 
as performed in section 3.8 to yield p(HEMA-GuAEMA). The final composition is obtained by 
1H-NMR and FTIR. Yield = 25 %.  
 
1H-NMR (D2O; 500 MHz): δ = 4.15 ppm (2H, b, -CH2-O-CO-, % GuAEMA); δ = 3.90 ppm 
(2H, b, -CH2-O-CO-, % HEMA), δ = 3.65 ppm (2H, b, HO-CH2-, % HEMA), δ = 3.45 ppm 
(2H, b, Gua-N-CH2-, % GuAEMA), δ = 1,85 ppm (2H, b, backbone CH2); δ = 0.65-0.95 ppm 
(3H, b, CH3-C-). 
FTIR: 3200-3600 (hydroxyl & guanidine); 1715 (ester) 
 
 
5 Phycisochemical characterisation 
5.1 Polyplex formation: protocol 
When a polymer is dissolved in water at physiological pH, the charge ratio (dependent on 
the composition) is calculated based on the mass/charge. This value is derived from the 
structure assuming protonation of the appropriate functional groups and is expressed as 
Da/mol of charges. For every polymer-DNA complex, the charge-ratio (positive to negative 
or polymer to DNA) is defined using the mutual relation of mass/charge between the macro-
ions, expressed in the following equation: 
     
Where X = mass/charge of polycation (Da/mol) 
 Y = mass/charge of polyanion (Da/mol) 
 y = amount of polyanion added (g) 
 x = amount of polycation added (g) 
 z = integer multiple of the excess of polycation over polyanion (where z = 1 for  
        an equal charge ratio, 1/1) 
Polyplexes are obtained in 2 ml solutions via a specific order of mixing: 
16µl of DNA (2,5 mg/ml stock solution) is added to an empty vessel. Next, demineralised 
water is added. Subsequently, an amount of polymer (x), correspondent to the intended 
charge-ratio, is added from a 1 mg/ml stock solution. This solution is vortexed for 5 seconds 
at medium speed (≈ 1500 rpm) and is ready for use afterwards. In this way a polyplex 
xX . y
Y
=( )z .
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solution with 20 µg/ml DNA can be used for in vitro/in vivo experiments. In certain 
experiments, augmented doses of DNA were tested (like 40 or 60 µg/ml), in that case the 
polymer dose for a certain CR is proportionally increased. 
For specific experiments, the use of buffer solution is in order. Since the formation of IPEC’s 
in the presence of ions is highly contested, the polyplexes are first prepared in ultrapure 
water at double concentration and subsequently diluted (1/1) using a double concentration of 
the final required buffer. 
5.2 One-step versus multi-step addition 
For UV detection of multi-step addition, the polyplexes were prepared in triplicate starting 
from a DNA solution (20 µg/ml) in 2 ml ultrapure water. This solution was initially measured 
Subsequently an amount of polymer was repeatedly added, corresponding with a CR 
increase of 0.2 units (e.g. 5.76 µl for p(DMAEG) with a mass/charge of 235 Da/mol), gently 
vortexed (2 s) and measured. This step was repeated until the desired final CR (in the same 
test solution). In single-shot addition, 16 µl of DNA was placed into a cuvette and water was 
added, followed by an amount of polymer solution (1 mg/ml) corresponding with the desired 
CR, gently vortexed and measured (in triplicate). A new solution was prepared for every CR 
tested. Polyplexes for fluorescence measurements were prepared in a similar way but using 
a solution of EtBr (400 ng/ml) in stead of ultrapure water. A solution of 20 µg/ml DNA was 
used to calibrate the device (100 % fluorescence) at 510 nm excitation and 590 nm emission 
wavelength.  
5.3 Polyplex kinetics: stability and formation in time 
Fluorescence measurements were performed on polyplex solutions that were measured 
immediately following preparation (510 nm excitation wavelength and 590 nm for emission). 
To start, the device was calibrated using a DNA solution of 20 µg/ml (in triplicate) and counts 
as zero time point. In a single shot, an amount of polymer corresponding with a 2/1 CR was 
added, immediately vortexed (2 s) and measured at given time intervals (10, 20, 30, 60, 120, 
300, 600, 1200, 1800, 3600 & 7200 s).  
5.4 Polyplex mixing sequence 
These tests were performed by IBMT, Fraunhofer, Skt. Ingbert, Germany. Polyplex solutions 
were prepared in the standard way (2 ml total) or in reversed order, by adding the polymer 
first (conform the desired CR) to an empty vessel, adding water and finalise by adding 16 µl 
of DNA (2.5 mg/ml stock). 
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5.5 EtBr Fluorescence measurements for validation of polyplex formation 
EtBr based exclusion fluorescence was measured by calibrating a DNA solution (20 µg/ml in 
400 µg/ml EtBr solution) using exc = 510 nm and detecting the fluorescence intensity at em 
= 590 nm. This intensity was set to 100 % relative fluorescence. In subsequent steps of 0.2 
CR units (corresponding to an amount of polymer calculated as described in section 5.1), 
polymer was added (from a 1 mg/ml stock) and vortexed (2 s) after which the change in 
fluorescence intensity was measured. Standard measurements were performed up to a total 
CR of 2/1 (at which the volume total reached exactly 2 ml). If no sufficient condensation was 
registered, additional polymer was added, either in similar step or in higher CR’s (e.g. 1/1). 
The tests were performed in triplicate.  
5.6 Agarose gel electrophoresis 
Applied buffers: 10x TBE buffer = 1 M Tris base, 0.9 M anhydrous boric acid, 10 mM 
         Na2EDTA.2H2O & ultrapure water type III 
       10x loading buffer = 50% (v/v) glycerol, 100 mM Na2EDTA.2H2O, 0.1%  
            bromophenol blue & ultrapure water type III 
Gel-preparation: 
1 g of agarose is suspended in 100 ml 1x TBE buffer and is heated using the ‘au bain marie’ 
close to the boiling temperature and maintained until the suspension is completely dissolved. 
The solution is then removed from the hot water bath and cooled down. The gel is then 
poured into a cast (Gibco – Horizon) and allowed to cool down for 45 min (gel thickness ≈ 8 
mm) while preformed wells are created using a plastic well applicator. Next, the gel is 
completely submersed in 1x TBE.  
Polyplex preparation: 
The polyplex solutions are prepared using the section 5.1 for a range of CR (0 to 2/1 in steps 
of 0.2) . For every CR, a separate vessel is made (single-shot addition). 20 µl of every 
solution is mixed with 2 µl of loading buffer and thoroughly mixed (pipetting up and down) in 
an eppendorf tube after which it is injected into a designated well in the submerged gel. 
Gel-retardation assay: 
By applying a voltage of 90 V during 1 hour, the condensed DNA is separated from the free 
DNA. Staining of the gel and visualization is consequently achieved by immersing the gel 
completely in a 0.5 mg/ml solution of EtBr during 1.5 hours after which a digital still image 
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was taken upon irradiation of the gel using an UV transilluminator (UV-B) (processed in 
specific software for EtBr staining).   
5.7 Dynamic light scatteing (photon correlation spectroscopy) 
For DLS measurements, polyplexes were prepared in the standard way with 3 CR’s, 1/1, 2/1 
and 4/1 unless otherwise specified. Following preparation, the solutions were immediately 
measured unless the influence of time was taken into account. All measurements were 
performed at 25 °C or 37 °C and with a scattering angle of 90° in polystyrene cuvettes. One 
measurement consisted of 3 repeat analyses (10 subruns each) and were fitted using the 
CONTIN algorithm. 
5.8 Zeta-potential measurements 
Polyplexes for zeta-potential analysis are prepared using the standard protocol in a 0.5/1, 
1/1, 2/1 and 4/1 CR. Prior to injection into the measuring compartement, the solution are 
diluted (50%). Every value is the result of 10 subruns and all measurements were achieved 
using a celvoltage of 220V and 1000 Hz frequency.  
6 Optimisation and modification of multifunctional polymers 
6.1 Coupling of fluorescent tags 
Succinimidyl-activated fluorescent labels were coupled to primary amine-containing 
polymers in a one step reaction. For a coupling degree of 1-5%, 40 mg polymer was 
dissolved in 4 ml 0.1 M NaHCO3 (pH = 8.3) and shielded from light (using aluminum foil). 
Separately, 2.5 mg of Oregon Green was dissolved in 250 µl of dry DMF and immediately 
added to the polymer solution (dropwise) and the mixture was allowed to react for 1h. The 
reaction was stopped by adding 1 ml of HCl (0.5 M) to lower the pH. The product was 
purified by extensive dialysis (against 0.1 M NaCl, ultrapure water, 0.05 M HCl and finally 
ultrapure water) after which it was freeze-dried. Characterisation of the product was 
achieved by UV/VIS spectroscopy (using the formula in chapter 5 or by preparing a standard 
curve).  
6.2 Polyplex kinetics: UV/VIS absorption tests 
To compare the detection of polyplexes composed of labeled polyplexes and labeled 
polymer as such, 2 solutions (2 ml each) were prepared. One solution was provided with 
DNA (20 µg/ml) and the other plain water. Stepwise, fluorescently labeled polymer was 
added (in steps corresponding with 0.2 CR units) and the solution was measured until a final 
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CR of 2/1. Dependent on the information required, analysis was performed at 488 nm 
(polymer detection) or 280 nm (DNA detection).  
6.3 Coupling of peptides 
6.3.1 Coupling of a heterobifunctional crosslinker (Sulfo-GMBS) 
For this reaction, typically 40 mg (26 µmol –NH2 groups) of polymer was dissolved in 4 ml of 
NaHCO3 (0,1 M  - pH 8,5). Then, a 2-fold molar excess of N-(-maleimidobutyryloxy) 
sulfosuccinimide, dissolved in 1ml of NaHCO3 (0,1 M) was added dropwise and incubated 
for 45 minutes at room temperature. Afterwards, the excess of sulfo-GMBS was removed via 
a pd-10 desalting column (Sephadex G-25, Mr = 5.000 Da) stabilised and eluted with PBS 
(pH = 7.2). The purified polymer-crosslinker solution (7 ml collected fraction) was 
immediately freeze-dried and continued for use in the 2nd reaction. Yield = 80 % 
6.3.2 Coupling of a heterobifunctional crosslinker (SPDP) 
To a solution of 40 mg polymer (26 µmol –NH2 groups) in 4 ml of NaHCO3 (0,1 M  - pH 8,5), 
a solution of 5 mg N-succinimidyl-3-(2-pyridyldithio)propionate (SPDP) in 250 µl of DMSO 
was added dropwise and stirred for 45 minutes at room temperature. Afterwards, the excess 
of SPDP was removed via a pd-10 desalting column (Sephadex G-25, Mr = 5.000 Da) 
stabilised and eluted with PBS (pH = 7.2). The purified polymer-crosslinker solution (7 ml 
collected fraction) was immediately freeze-dried and continued for use in the 2nd reaction.  
6.3.3 Coupling of CPP to a polymer-crosslinker conjugate 
Traditionally, to a 3.5 ml solution of polymer-crosslinker (10 mg/ml in PBS – pH 7,2) , 0,5 ml 
of peptide solution in PBS (5-20 mg/ml) is added an the mixture is reacted for 1,5 hours at 
room temperature. Afterwards, a stop reagent (EtSH – 100 µl) is added. Finally the solution 
is dialysed against 0,1 M NaCl, 0,1 M HCl and ultrapure water using a semi-permeable 
dialysis membrane. The product is isolated by freezedrying and confirmed by 1H-NMR. The 
amount of peptide coupled is determined using NMR or UV/VIS spectroscopy (CPP 
calibration curve). 
1H-NMR: comparison of polymer signal (e.g. backbone -H) to unique signal derived from 
peptide (e.g. Pen = Tryptophan signal (8.1 ppm) or Arg8 = -H) with no polymer signal 
overlap. 
UV/VIS: only for Penetratine, abs = 280 nm 
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6.4 Physical mixing of CPP versus covalently coupled CPP’s 
Polyplexes with covalently coupled CPP’s were prepared using the standard protocol. 
Physical mixing of CPP’s was achieved by mixing the following components (2 ml total): 
 - 16 µl of DNA (2.5 mg/ml stock) 
 - Water is added (2 ml – 16 µl – amountpolymer – amountCPP) 
 - Polymer is added (1 mg/ml stock) corresponding to the desired CR and vortexed 
 - CPP is added (10 mg/ml stock) corresponding to the desired CPP concentration 
 - Vortex the solution (2 s) 
 
7 Biological evaluation 
7.1 Nuclease degradation 
The polymer-DNA complexes for nuclease experiments were prepared in several CR’s 
(0.5/1, 1/1, 2/1 & 4/1) and the preparation is carried out as described in section 5.1 of this 
chapter, but in a total volume of 1 ml of H2O. The prepared polyplex solution is then diluted 
with 1 ml of TRIS buffer (80 mM TRIS.HCl, 20 mM NaCl, 12 mM MgCl2, 20 mM CaCl2, pH = 
7,9). This buffer is previously filtered on a 0,45 µm Millipore filter and degassed for 10 
minutes. The UV-spectrometer is auto-zeroed against a solution containing 1 ml of TRIS 
buffer and 1 ml H2O. After the addition of 40 Kuntzunits of DNase I (Pierce), the different 
solutions were shortly vortexed (1 s) and measured in quartz cuvettes at a wavelength of 
260 nm), at given time-points (0s, 10s, 20s, 30s, 40s, 50s, 60s, 2m, 3m, 4m, 5m, 10m, 15m, 
20m, 25m and 30m) at 37 °C. 
7.2 Haemolysis 
At first, a 2 % RBC suspension was prepared from whole blood samples (Red Cross 
Belgium). Purification was obtained by centrifugation at 3700 rpm for 5 minutes. 
Subsequently, the top layer was removed and the remaining blood cell suspension washed 
with HBS buffer (20 mM HEPES, 150 mM NaCl, pH 7,4). This suspension was again 
centrifuged at 3700 rpm for 5 minutes and the supernatant together with the top layer of cells 
was removed. At last, the suspension was once more washed with HBS buffer and after 
centrifugation both the supernatant as well as the top layer of cells were equally removed. 
The obtained pure RBC’s were then used to prepare a diluted concentration of 2 % RBC’s in 
HBS buffer.   
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Polymer was added to this 2 % RBC suspension in concentrations ranging from 1 till 2000 
μg/ml. The polyplexes were added in a 2/1 charge ratio. The polyplexes are prepared as 
described in section 5.1 but in a total volume of 1 ml of water. The prepared polyplex 
solution was then diluted with 1 ml of a 2 % RBC suspension prepared in a double 
concentrated HBS buffer after which they were incubated for 24 h at 37 °C while shaking at 
100 rpm (horizontally and submerged in water along the shaking-axis). Also a positive and 
negative control was prepared, either by adding 0.2 % Triton X-100 (w/v) (positive control) or 
by appling RBC to a buffer solution (negative control) 
After incubation, the solutions are centrifuged at 3700 rpm and the supernatant is used for 
UV/VIS-measurement. The UV-meter was auto-zeroed against HBS buffer ( = of 545 nm) 
and the different samples were put into cuvettes and measured. The haemolytic activity is 
quantified by comparing the values of the samples with a negative control and a positive 
control, which corresponds to pure HBS buffer (0 % haemolysis) and a Triton-X solution (100 
% haemolysis) respectively.  
 
7.3 Haemo-agglutination 
For these tests, polyplexes were prepared in a 2/1 CR as described in section 5.1 but again 
in a total volume of 1 ml after which the solution was diluted using 1 ml of HBS. In the 
agglutination tests of free polymer, the amount added to a 2 % RBC suspension was 
corresponding to the amount of polymer used in a 2/1 polyplex. The obtained solution 
containing RBCs and polyplexes (or free polymers) was incubated at 37 °C for 1 h (while 
shaking). Hereafter, a few drops of the solution are put on a glass plate and the agglutination 
is visualised by optical microscopy. A 2 % RBC suspension (in HBS buffer) was also 
incubated as a reference. 
7.4 Protease (enzyme) degradation of biodegradable polymers 
Enzyme degradation of biodegradable poly-a-amino acids is performed using 40 µg of 
papaine. Polymer solutions of 10 mg polymer in 1,6 ml phosphate/citrate buffer (0.2 M – pH 
= 6 – containing 0.2 % w/v) were prepared to which  200 µl of EDTA (20 mM in buffer) and 
200 µl dithioerythritol (20 mM in buffer) were added. The solution was incubated at 37 °C 
while shaking (60 rpm) to allow for complete dissolution. Finally, 8 µl of a papaine stock (5 
mg/ml) were added and the solution was continued to be incubated. The MW of the polymer 
was measured as a function of time using GPC (buffer: NaH2PO4 5%, CH3CN 3%, pH =4) at 
given time-points (30m, 1h, 2h, 4h, 8h, 24h and 48h) by injecting 20 µl of the incubated 
solution (without adding new buffer). 
  
Chapter 8: Experimental part            287 
7.5 Transfection 
7.5.1 Transfection protocol 
7.5.1.1 Cell preparation 
Before transfection experiments can occur, cells are treated to be in the proper (confluent) 
state for application of gene vectors. Therefore, a transparent, bottom 96 well plate is treated 
with polyornithine. This protein, facilitates cell attachment, spreading, growth, morphology, 
differentiation, and motility of the HEK (human embryonic kidney) cells on the 96 well plate. 
In many cell cultures normal attachment, growth, and development are dependent on 
attachment factors and extracellular matrix components. In order to speed up this natural 
process 50 µl of polyornithine (1,5 µg/ml) is added in each well. After 1 h the 96 wells plate is 
washed 2 times with distilled sterilized water. Here, HEK 293 cells are used as they are 
extremely easy to bring in culture and to transfect. 
When the HEK cells almost reach confluence, they are washed with PBS without Ca and 
Mg. Subsequently, the cells are trypsinized (trypsin-EDTA 1x in PBS without Ca and Mg) for 
5 minutes at 37 °C. Then, the trypsinization is slowed down by adding 10 % of fetal calf 
serum and hereafter the cell solution is transferred in a centrifugation tube. After 5 min of 
centrifugation at 800 rpm, the supernatant is removed and the cells are re-suspended in 8 ml 
(dependent on the initial cell density) of DMEM medium without serum. Thereafter, the cells 
are counted by means of a counting chamber and diluted in DMEM medium to a final 
concentration of 400 cells/µl. Then, 50 µl of cells are seeded onto the treated 96 wells black 
plate with transparent bottom by using a Gilson Distriman. The plate has to be black in order 
to avoid interfering background during fluorescence measurements. To allow attachment of 
the cells to the plate, they are left in the incubator for 1 h at 37 °C and 5 % CO2. When the 
cells are evenly distributed throughout the bottom of the wells, 50 µl of DMEM medium with 
20 % fetal calf serum is added (to have a final concentration of 10 % serum in each well). At 
last, the cells are left overnight in the incubator to allow growing.  
7.5.1.2 Cell transfection 
After cell conditioning and preparation overnight, the medium in the wells is replaced by 50 
µl of DMEM medium without serum. Then, the pCDNA7RucHA encoding plasmid is diluted 
in H2O in order to have a 90 ng/µl solution. The exact concentration of the stock solution of 
plasmid is determined by a spectrophotometer and subsequently, the polymers are diluted to 
the correct concentration according to the desired polymer/DNA ratios. Therefore, 2/3 
volume (16,7 µl) of 90 ng/µl plasmid is added to 1/3 volume (8,3 µl) of concentrated polymer. 
This mixture is vortexed for 2 seconds and incubated for 1 h at room temperature.  
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After 1 h of incubation, the complex solution is diluted in DMEM medium in order to have 10 
µl complex solution in 40 µl medium. The mixing must be done carefully by pipetting up and 
down for a couple of times. Then, 40 µl of this complex-DMEM solution is distributed in each 
well and incubated at 37 °C and 5 % CO2. After 4 hrs incubation, 10 µl of fetal calf serum 
and doxycycline (1000-fold dilution) is added to each treated well. The latter is necessary to 
allow plasmid expression in HEK cells. After this addition the cells are incubated for 20 hrs at 
37 °C and 5 % CO2. In case of a 3 h incubation approach, the previously described 4 hrs 
incubation is reduced to 3 hrs and followed by a washing step by PBS with Mg and Ca, in 
order to remove those polyplexes which do not adhere to or interact with the membrane after 
3 hrs of incubation. After washing, 10 µl fetal calf serum, 40 µl of DMEM medium and 
doxycycline (1000-fold diluted) is added to the well and incubated for 20 hrs at 37 °C and 5 
% CO2. The 24 hrs incubation is performed twice whereas the 3 hrs incubation approach is 
performed only once. 
After 24 hrs of transfection, 10 % UptiBlue is added into the wells. This mixture is again 
incubated for 2 hrs at 37 °C and 5 % CO2. Hereafter, the fluorescence is measured at an 
excitation and emission wavelength of 540 nm and 600 nm respectively by means of a 
fluorimeter. A negative control (0 % viability) is achieved by adding 2 µl of Triton X-100 to a 
well while 3 wells were left untreated (with no polymer added) and served as the positive 
control (100 % viability).  
After the viability test, the supernatant is removed and 50 µl of passive lysis buffer (PLB) is 
added to each well. Subsequently, the plate is left on a plate shaker at room temperature for 
30 min to ensure complete and even coverage of the cell monolayer with PLB. This 
procedure is performed to lyse the cells hereby releasing the translated enzyme which is 
necessary to allow measurement. To ensure complete lyses, a freezing/thawing approach is 
also performed. Therefore the plate is frozen until -80 °C and rapidly thawed by placing it in 
a water bath of 37 °C. Hereafter, the plate is placed in the luminometer 96 wells plate reader 
and 50 µl of coelenterazine is injected by the apparatus into wells containing cell lysates. 
The luminescence is measured for 10 seconds with a delay of 2 seconds between injection 
and measurement. Since, it has been demonstrated that RLUC is inactivated in the 
presence of substrate, resulting in emission of most of the light as a flash of a few seconds 
after addition. The excitation and emission wavelength used is 540 nm and 600 nm. The 
transfection efficiency is expressed in relative luciferase units (RLU) and was therefore 
compared with a reference (e.g. PEI). In most cases, the background created by the reagent 
in the absence of Renilla luciferase is very small compared to the luciferase signal, thus the 
luciferase activity is normally directly proportional to the total luminescence. However, when 
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measuring very small amounts of luciferase it is important to subtract the background signal 
from the measurement of the total luminescence. Background luminescence is obtained by 
measuring the luminescence produced by lysed untransfected cells. Tests performed and 
worked out by the Homeoprotein & cell-biology lab, école de France, Paris. 
7.5.1.3 Confocal microscopy 
Prior to visualization, 30 µl MSS with a 500-fold dilution of the stock WGA (5 mg of 
lyophilized WGA conjugate dissolved in 5 ml of phosphate-buffered saline) is added to the 
reservoir. After an incubation period of 10 minutes at room temperature the transfected cells 
are visualized by confocal microscopy. In order to visualize the exact location of the polyplex 
and to determine the amount of cell death, 30 µl of 0,4 % trypan blue (TB) is added, to have 
a final concentration of 0,1 % of TB in each channel. Living cells are very selective towards 
membrane passage and because of that cells with intact cell membranes exclude dyes such 
as TB. In dead cells, TB traverses the membrane and colors the cells blue. Due to the 
addition of TB, the ECM is quenched and the polyplexes present in the ECM are colored 
blue. In this way, internalized polyplexes can be differentiated from complexes outside the 
cell. Tests performed and worked out by the Homeoprotein & cell-biology lab, école de 
France, Paris. 
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Nederlandse samenvatting (Dutch summary) 
1 Inleiding  
Op het vlak van biotechnologie en geneeskunde is gentherapie een relatief nieuwe techniek 
die alsmaar meer aandacht trekt. Momenteel is er een breed scala aan aandoeningen, zowel 
erfelijk als besmettelijk, waarvoor geen gepaste behandeling bestaat. Gentherapie werd 
daarom vooropgesteld als een veelbelovende behandeling voor talrijke ernstige ziektes zoals 
taaislijmziekte, kankerbestrijding of macula degeneratie. De techniek is gebaseerd op 
doelgerichte afgifte van DNA aan weefsels waarna het ingebrachte DNA een specifiek, 
therapeutisch proteïne codeert dat wordt vrijgesteld aan de omgeving om op die manier een 
bepaalde functie in het lichaam toe te voegen of te verwijderen. Het toedienen van ‘vrij’ DNA 
(in oplossing) blijkt slechts beperkt efficiënt door de grote van de molecule, de negatieve 
lading (ongewenste interactie) en vooral de aanwezigheid van nucleases in de bloedstroom 
(breken vreemd DNA af). Om deze problemen te vermijden, wordt daarom intens gezocht 
naar het gebruik van bepaalde dragersystemen (vectoren). Virussen worden reeds geruime 
tijd succesvol toegepast als afgiftesystemen omwille van hun natuurlijke eigenschappen om 
gastheercellen te penetreren. Toch bezitten deze systemen een belangrijk beperking, 
voornamelijk op het gebied van toxiciteit. Dit leidde daarom tot de ontwikkeling van een 
breed gamma aan synthetische vectoren die als genafgiftesysteem (vectoren) kunnen 
gebruikt worden. Dankzij de uitstekende controle van het synthese proces kunnen op deze 
manier structuren verkregen worden die zowel de nodig eigenschappen bezitten om als 
efficiente drager te fungeren alsook over de juiste kwaliteiten beschikken om een minimale 
toxiciteit uit te lokken bij gebruik in vitro of in vivo. 
Om tegemoet te komen aan een aantal noden, meer bepaald enkele speciale ziektes zoals 
macula degeneratie (en bijhorende ouderdomsblindheid) of cardio-vacsulaire aandoeningen, 
heeft dit project tot doel om via gentherapie, efficiente strategieën te ontwikkelen die een 
therapeutisch effect kunnen teweegbrengen. Hiervoor wordt een beroep worden gedaan op 
niet-immunogene, biodegradeerbare polymeervectoren gebaseerd op multifunctionele poly-
-aminozuren (lysine, glutamine, arginine) en polymethacrylaten. Deze polymeren zijn o.a. in 
staat om negatief geladen DNA te condenseren in kleine partikels (nm-orde) door middel van 
elektrostatische interactie tussen positief geladen functionele groepen, aanwezig op het 
polymeer en negatief geladen DNA. Deze elektrolytcomplexen kunnen vervolgens door de 
cellen worden opgenomen via o.a. endocytose waarna ze hun DNA cargo kunnen vrijstellen 
zodat deze kan getransloceerd worden naar de celkern voor daaropvolgende protein-
expressie. Zowel cell-penetrerende peptides als fluorescente labels worden covalent 
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gekoppeld aan de polymeren om de cell-opname van deze partikels te stimuleren en te 
bestuderen. Daarnaast zal ook worden gebruikt gemaakt van diverse analyse-technieken 
zoals agarose gel-electroforese (voor de bepaling van de condensatie capaciteit), 
dynamische lichtverstrooing (deeltjesgrootte bepaling), zeta-potentiaal metingen (colloid 
stabiliteit) en fluorescentie metingen om een complete fysico-chemische karakterisatie te 
bekomen. Verder wordt ook de interactie met bloed en bloed componenten onderzocht via 
hemolyse en hemo-agglutinatie experimenten alsook d.m.v. bescherming tegen nuclease 
enzymes. Biodegradeerbare polymeren worden ook getest op hun degradatievermogen via 
protease afbraak. Uiteindelijk kan ook de in vitro transfectie en viabiliteit geregistreerd 
worden via cell testen.  
2 Synthese van multifunctionele polymeren  
2.1 Biodegradeerbare polymeren  
Uitgaande van basis bouwstenen voor het lichaam, meer bepaald L-aminozuren, kan door 
middel van een reeks synthese stappen, een uitermate biocompatibel en biodegradeerbaar 
polymeer bekomen worden. Naast de samenstelling van deze synthetische molecule wordt 
ook het moleculair gewicht (MW) gecontroleerd. Hiervoor wordt gebruikt maakt van 
specifieke initiatoren die in precieze hoeveelheden worden toegevoegd om de polymerisatie 
op maat te laten doorgaan. Polypeptide analogen, zoals poly--aminozuren kunnen het 
eenvoudigst verkregen worden door een ring-openings-polymerisatie (ROP) van hun 
corresponderende N-carboxyanhydride (‘Leuchs’ anhydride). Om dit te verkrijgen, dient het 
basis aminozuur eerst beschermd te worden (R-functionele groep) om vervolgens selectief te 
reageren met difosgeen (met retentie van het stereocenter).  
 
Het MW wordt in deze laatste stap bepaald. Het gebruik van primaire amines als initiatoren 
laat toe om via nucleofiele aanval (carbamaat mechanisme) polymeren met een laag MW te 
bekomen (< 40.000 Da) terwijl tertiary amines via proton abstractie polymerisaties initiëren 
die molecules tot 250.000 Da kunnen genereren (geactiveerd monomeer mechanisme). In 
een volgende stap kunnen daarna specifieke functionele groepen ingevoegd worden door de 
vorming van amides met typische eigenschappen in de zijgroep (aminolyse). Tijdens deze 
reactie wordt ook de beschermgroep verwijdert van de zijketen. Een combinatie van 
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aminolyse reagentia laat dan ook toe om multifunctionele polymeren te bekomen die een 
veelvoud aan eigenschappen hebben (gaande van DNA-interactie over ladingsseparatie tot 
buffering en koppeling van secundaire structuren). Aangezien deze polymeren water-
oplosbaar zijn speelt de pKa van deze functionele groepen een grote rol. Alle 
gesynthetiseerde producten worden gekarakteriseerd via 1H-NMR & FTIR (samenstelling) en 
GPC (MW bepaling).  
In het geval van poly-L-arginine wordt eerst een precursor molecule gesynthetiseerd (poly-L-
ornithine) om daaropvolgend een modificatie reactie uit te voeren die alle primaire amines 
omzet in guanidine functionele groepen.   
 
Bij uitbreiding, worden in dit werk poly--aminozuren uitgaande van een gemengde 
polymeerbackbone geproduceerd (copolymeren). Bovendien worden combinaties van 
intermediaire polymeren als initiator voor het ontwikkelen van polymeerstructuren in de 
zijketen (graft-copolymeren) gevormd, waarbij de invloed van de positionering van 
functionele groepen op de polymeerketen kan nagegaan worden.  
2.2 Niet-biodegradeerbare polymeren  
Polymethacrylaten worden, in tegenstelling tot polypeptides, gekenmerkt door een 
hydrofobe, alifatische hoofdketen die niet biodegradeerbaar is en zich daardoor anders 
gedraagt in waterig milieu (zoals rondom cellen). Deze polymeren komen veelvuldig voor in 
de literatuur als vector omwille van hun beduidende efficiëntie en de relatief eenvoudige 
synthese. De meeste methacrylaten zijn commercieel verkrijgbaar en kunnen via een 1-staps 
procedure reeds kant-en-klare synthetische vectoren opleveren. In dit werk wordt gebruik 
gemaakt van methacrylaten waarbij de R groep verschillende functionele groepen kan 
omvatten: tertiare amines (DMAEMA), primaire amines (AEMA), hydroxyl groepen (HEMA) 
en guanidines, afgeleid van BOC-beschermd AEMA. De polymerisatie van dergelijke 
monomeren verloopt via een vrij-radicalair mechanisme en het gebruik van een initiator 
(thermische of redox). Door dit radicalair proces aan te wenden zonder aanwezigheid van 
radicaal stabilisatoren (zoals gebruikt in ATRP of RAFT) is slechts een beperkte controle van 
het MW mogelijk met relatief grote polydispersiteit als gevolg. De synthese wordt, afhankelijk 
van de geselecteerde monomeren, in tolueen of water uitgevoerd en dient steeds stevig 
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ontgast te worden omdat zuurstof de initiatie inhibeert. Bovendien kan, naargelang het 
gekozen solvent, een onderscheid gemaakt worden in het gewenste MW bereik (met 
bijhorende initiator) dat reikt van 50.000 tot 1.000.000 Da. Indien laag-moleculaire (5.000 – 
50.000 Da) componenten gewenst zijn, dient gebruik gemaakt te worden van transfer 
agentia zoals mercaptoethanol. Door combinatie van verschillende monomeren in eenzelfde 
reactie, kunnen copolymeren gevormd worden met samenstellingen conform de 
monomeerconcentratie. Naargelang de functionele groep reactiviteit bezit, wordt deze initieel 
beschermd (BOC-protectie of protonatie in waterig milieu). Ook deze polymeren worden naar 
samenstelling en MW geverifieerd via 1H-NMR, FTIR en GPC.   
AIBN/APS
C
C
O
R
n
CH2
CH3
O
C
C
O
R
CH2
CH3
O
 
2.3 Modificatie van referentie polymeren  
Om de potentiële eigenschappen van de ontwikkelde vectoren als gen-afgifte systeem  in te 
schatten, worden deze vergeleken met referentie polymeren zoals polyethyleneimine (PEI) 
en poly-L-lysine (PLL) waarvan de transfectie efficiëntie alsook de cell-toxiciteit reeds 
uitvoerig beschreven is in de literatuur. Teneinde deze referentie polymeren, die vaak een 
hoge efficiëntie en toxiciteit bezitten, te optimaliseren worden guanidine modificaties 
doorgevoerd zodat een hogere efficiëntie kan bekomen worden met gelijkaardige toxiciteit of 
een lagere toxiciteit maar met behoud van transfectie potentieel.  
3 Karakterisatie en verificatie van de vector-eigenschappen  
Om te kunnen dienst doen als functioneel dragersysteem in gen-therapie applicaties dient 
een synthetische vector in staat te zijn om het DNA te beschermen en binnen te dringen in 
de cel. Aangezien de interactie met DNA voornamelijk op basis van elektrostatische 
interactie geschiedt is het belangrijk om na te gaan hoe dit gebeurt en als deze inter-
polyelektrolyt complexen (polyplex) in staat zijn om door de cel opgenomen te worden. 
Hiervoor kunnen verschillende analyse technieken aangewend worden.  
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3.1 DNA interactie – Complex vorming  
De eigenschap van een vector om te kunnen interageren met DNA kan nagegaan worden 
met 2 aanvullende technieken. Door middel van agarose gel-elektroforese, kan de ideale 
compositie gevonden worden waarbij polymeer-DNA complexen gevormd worden op basis 
van retentie in een gel bij het aanleggen van een potentiaalverschil. Niet-gecomplexeerd 
DNA zal hierbij migreren doorheen de gel terwijl gecomplexeerd DNA geneutraliseerd wordt 
(door een overmaat aan positief polymeer) en daardoor niet meer aangetrokken wordt tot de 
positieve anode. Een andere techniek, gebaseerd op fluorescentie van geïntercaleerd DNA 
(d.m.v. Ethidiumbromide), laat toe om de daling in fluorescentieopbrengst te meten die 
representatief is voor de vorming van een polyplex waarbij het ethidiumbromide niet langer 
kan intercaleren met DNA. De mate waarin de fluorescentie daalt en het punt waarop de 
intensiteit afname maximaal is kan dan verder gebruikt worden om het polyplex te ontleden.   
Uit deze testen is gebleken dat vooral de samenstelling van het polymeer een grote rol 
speelt in het bekomen van complexen met een minimum aan kationisch polymeer (zodat de 
in-vitro toxiciteit kan beperkt worden) en in beperkte mate het MW. Hoe meer positieve 
ladingen aanwezig zijn op een polymeer hoe sterker de interactie met het DNA. Het 
implementeren van minder geladen structuren zoals imidazole of hydroxyl liet toe om 
vectoren te bekomen die nog steeds voldoende sterk interageren met DNA en dit doen 
zonder substantiële verhoging van de minimum ladingsverhouding nodig voor het induceren 
van complexatie. Niettegenstaande blijft een minimum hoeveelheid aan positieve lading 
nodig om voldoende, welgevormde polyplex formatie te verkrijgen (minimaal 25-30 %). Het 
varieren van het MW blijkt vooral een effect te hebben op de minimale ladingsverhouding 
(LV) waarbij complexatie optreedt. In het geval van poly--aminozuren worden minimale LV’s 
gekenmerkt door polymeren met een zo laag mogelijk MW terwijl voor polymethacrylaten 
een optimum bekomen wordt voor molecules met een gewicht van 100-120 kDa. Voor de 
meest polymeren ligt de LV voor minimale complexatie tussen 0.8 – 1.6 (zie figuren onder). 
- -
-
polyplex
polycation
DNA
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Agarose gel-elektroforese: p(HEG-GuAEG) with descending percentage of guanidine (A  D) 
 
EtBr Fluorescentie grafiek: polyplex vorming in functie van de ladingsverhouding voor p(HEG-GuAEG) 
 
3.2 Deeltjesgrootte van polyplexen (DLS) 
Aan de hand van dynamische lichtverstrooiing is het mogelijk om de gemiddelde grootte van 
een bepaald type polyplex te meten. Bovendien kan ook de distributie hiervan berekend 
worden. Via lichtverstrooiing en correlatie van de signaalintensiteit in functie van de 
uitstervingsfactor (tijdsparameter) wordt de diffusie coëfficiënt afgeleid die op zijn beurt 
gebruikt wordt in de Stokes-Einstein vergelijking om uiteindelijk een waarde op te leveren 
voor de hydrodynamische radius (rh) van een idealiter sferisch voorgesteld partikel. Deze 
waarde heeft belangrijke biologische implicaties, meer bepaald naar opname in de cel toe. Er 
wordt aangenomen dat het belangrijkste mechanisme voor celopname steunt op receptor 
gemedieerde endocytose waarbij uitgegaan wordt van de vereiste dat de partikel diameter 
maximaal 150-200 nm mag zijn. Dit blijkt voor bijna alle polyplexen met een LV van 2/1 of 
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hoger haalbaar te zijn. Aangezien bij lagere LV’en voor sommige vectoren nog geen stabiele, 
welomlijnde complexen mogelijk zijn, situeert de diameter zich vaak in de orde van enkele 
µm (los polymeer en DNA). In het geval van polymeren die condenseren bij lage LV, worden 
de kleinste polyplexen initieel gevormd waarna het toevoegen van additioneel polymeer 
(hogere LV’en) stelselmatig (zij het beperkt) de diameter vergroot. Bij zwakker 
complexerende vectoren, wordt de partikeldiameter alsmaar kleiner met toenemende LV. 
Wat betreft de deeltjesgrootte is slechts in beperkte mate een invloed zichtbaar van de 
hoeveelheid lading aanwezig op de vector. Additioneel kon ook de invloed van de tijd, 
temperatuur en buffermedium gemeten worden. Zo blijkt het overgrote deel van de 
polymeren voldoende stabiliteit te bezitten in functie van de tijd. In buffermedium 
daarentegen vertonen de meeste polyplexen snel aggregatie (zeker bij lage LV’en). 
Verhoogde thermische agitatie (hogere temperatuur) kan dit echter tegengaan. 
 
DLS: deeltjesgrootte en distributie  van p(DMAEMA) complexen (11.9 / 121 / 658 kDa) 
 
3.3 Stabiliteit van geladen complexen (Zeta-potentiaal) 
Wanneer geladen structuren zoals polyplexen in oplossing gebracht worden, kunnen deze 
op termijn aggregaten beginnen vormen. Om na te gaan in welke mate complexen hiertegen 
bestand zijn worden zeta-potentiaal metingen uitgevoerd. Via deze methode, die eveneens 
steunt op een meting van lichtverstrooiing kan de electroforetische mobiliteit gemeten 
worden die gerelateerd wordt aan de zeta-potentiaal. Deze laatste geeft een idee van de 
mogelijkheid van geladen deeltjes om in oplossing te blijven zonder te aggregeren. Hoe 
hoger de zeta-potentiaal, des te meer zullen equipolaire structuren elkaar afstoten en in 
oplossing blijven. De algemene trend die wordt waargenomen voor de betreffende vectoren 
vertoont een correlatie met de ladingsverhouding. Hoe hoger deze laatste, hoe hoger de 
zeta-potentiaal. Wanneer polyplexen nog niet gevormd zijn, overheerst de negatieve lading 
van het DNA. Tijdens deze testen is wel gebleken dat de hoeveelheid lading op het polymeer 
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een rol speelt, met name hoe hoger ladingsdensiteit, hoe hoger de zeta-potentiaal bij 
eenzelfde LV. Bij een hoge LV (4/1) bedraagt de zeta-potentiaal tussen de 30-60 mV wat 
overeenkomt met goed tot uitstekende stabiliteit. Dit werd ook bevestigd door metingen met 
de voorgaande analysetechnieken in functie van de tijd (zie figuur onder: pDMAEMA). 
 
4 Optimisatie van vector: koppeling van fluorescente groepen en peptides  
4.1 Koppelen van fluorescente labels  
Een essentieel deel van de karakterisatie van synthetische vectoren bestaat erin om de 
internalisatie methode van polyplexen te bestuderen. Via confocale microscopie kan een 
polymeer of polyplex gevolgd worden binnen in de cel om zo de opname van DNA te 
bevestigen. Hiervoor dient een polyplex visueel waarneembaar te zijn en dit wordt bereikt 
door een fluorescente molecule toe te voegen. Omdat deze kleine molecules vaak water-
onoplosbaar zijn en gemakkelijk uit het complex zouden kunnen diffunderen dienen deze 
covalent verankerd te worden. Teneinde de werking van het therapeutisch DNA niet te 
verstoren wordt dit meestal gekoppeld aan het polymeer. In dit werk wordt Oregon Green 
488, een fluoresceïne afgeleide gebruikt als model molecule. Via een geactiveerd 
succinimide derivaat kan koppeling met primaire amines worden bewerkstelligd in een 
bicarbonaat buffer met typsiche koppelingsgraden van 2-5%. Om na te gaan als de 
incorporatie van hydrofobe groepen geen impact heeft op de DNA-interactie, worden de 
hiervan afgeleidde polyplexen aan elektroforese en fluorescentie metingen onderworpen. 
Hieruit kan worden geconcludeerd dat de koppeling van fluorescente molecules wel degelijk 
een invloed kan hebben op de minimale LV voor polyplex formatie alsook op de sterkte van 
de interactie (bv. voor gekoppeld PEI) waardoor minder hechte complexen worden gevormd. 
Dit blijkt veel minder het geval voor volledige geladen vectoren en heeft te maken met de 
graad van afscherming die een dergelijke molecule teweegbrengt. Daarom dient de 
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concentratie aan fluorescente groep zoveel mogelijk beperkt te worden (en toch nog 
visualisatie toe te laten). 
4.2 Koppeling van cell-penetrerende peptides  
Zoals in de inleiding reeds werd aangehaald, vormt de beperkte transfectie efficiëntie van 
synthetische vectoren nog steeds een hekelpunt in vergelijking met de potentere virale 
vectoren. Om dit probleem te counteren wordt recentelijk vaak gebruik gemaakt van peptides 
die in staat zijn om de cell-internalisatie (één van de prominente barrières in het totale 
transfectie proces) te vergemakkelijken, vaak door specifieke interactie met receptoren op 
het celmembraan. Het koppelen van deze structuren kan bovendien een sterkere interactie 
met DNA uitlokken gezien de overwegend positief geladen structuren waarover de meeste 
peptides (CPP’s) beschikken. Bovendien worden door het koppelen van deze functionele 
groepen een aantal extra analyse technieken mogelijk die meer informatie kunnen opleveren 
over polymeer-DNA complexen. Zo kan bv. FRET/FCS analyse toelaten om de LV te 
bepalen waarop complexatie optreedt en bevestigen UV/VIS analyses dat de fluorescente 
groepen zich oriënteren naar het midden van het complex toe (zo ver mogelijk verwijderd 
van het omringende water netwerk).  In dit werk, wordt voornamelijk penetratine en arginine8 
gekoppeld, 2 CPP’s die in de literatuur frequent beschreven worden als internalisatie 
promotors. Het is mogelijk om deze peptides zowel fysisch in te mengen met de polyplexen 
als via het covalent verankeren van het peptide op de polymeer backbone. Daarvoor wordt 
een beroep gedaan op cysteine-gemodificeerde peptides die door middel van een hetero-
bifunctionele crosslinker zoals GMBS of SPDP kunnen gelinkt worden aan het polymeer 
waarbij gemiddeld 1-5 % aan koppeling bereikt wordt. Bovendien wordt ook de invloed van 
een aantal spacer-bevattende peptides geëvalueerd (met diverse lengte en rigiditeit).  
 
Via elektroforese en EtBr fluorescentie testen is gebleken dat de koppeling van CPP’s een 
wisselende invloed heeft op de complexatie eigenschappen. Voor vectoren die beperkt 
geladen zijn kan het invoeren van geladen CPP’s een gevoelig verbetering opleveren in  
complexatie gedrag (lagere LV). Indien het basispolymeer reeds voldoende kationische 
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lading bezit, zorgt de koppeling van CPP’s veelal voor een minimale verhoging van de LV 
waarbij complexatie optreedt maar met behoud van complex sterkte. Wanneer nog eens 
spacers worden geïncorporeerd, vergroot de toename in minimale LV alsook de DNA 
interactie capaciteit van het polymeer. Deze trend vertaalt zich ook naar de deeltjesgrootte 
waar een lichte verhoging in diameter merkbaar is (10-20 nm) maar zonder gevaar voor de 
cellulair opname. Ook zeta-potentiaal bevindingen bevestigen de verminderde kationische 
ladingsdichtheid van het polyplex(oppervlak). Door middel van impedantie metingen op 
alleenstaande cellen wordt de interactie van CPP’s met het cellulaire membraan 
aangetoond. Uit initiele testen met fysisch gemengde complexen wordt verwacht dat CPP’s 
kunnen geïncorporeerd worden zonder de physico-chemische eigenschappen te veranderen. 
5 Biologische evaluatie van synthetische vectoren 
Omdat het uiteindelijke doel van gen therapie gericht is op de toediening van therapeutisch 
DNA aan levende cellen (systemisch of in vitro), is het van vitaal belang dat het gebruik van 
dragersystemen (vectoren) geen inflammatoire of toxische respons genereert. Om de 
effecten van polykationen en polyplexen op cellullair niveau na te gaan, kunnen biologisch 
relevante experimenten (zoals hematologische of transfectie testen) worden uitgevoerd om 
een initieel idee te krijgen van de bio-compatibiliteit en functionaliteit. Ook de mogelijkheid 
om via het lichaam gemetaboliseerd te worden behoort tot deze experimenten. Analyses die 
gebruik maken van cel structuren laten ook toe om het internalisatie proces te onderzoeken, 
bv. door middel van confocale microscopie.  
5.1 DNA degradatie bescherming  
Wanneer DNA via systemische weg zou worden binnengebracht in het lichaam, kunnen de 
polyplexen aan heel wat gevaren worden blootgesteld. Een van de meest significante 
aspecten tijdens dit toedieningsproces is de mogelijkheid van vectoren om DNA af te 
schermen van nuclease enzymes die abundant teruggevonden worden doorheen het 
lichaam. Om deze invloed te simuleren worden geselecteerde polyplexen blootgesteld aan 
DNAse enzymes (type I – 40 Kuntzunits) in een TRIS buffer die Ca en Mg ionen bevat voor 
de activatie van het enzyme. Op een ideale temperatuur van 37 °C waarbij de fosfodiester 
binding (zowel endo als exo) wordt verbroken, kan via UV meting (260 nm) de 
intensiteitstoename van het afgebroken DNA in functie van de tijd gedetecteerd worden. 
Daarbij is geconstateerd dat de bescherming optimaal is bij LV’en die voldoende boven het 
punt van complexatie liggen. Wanneer de LV lager dan het complexatie punt ligt is de 
afscherming vrijwel onbestaande. Ook rond de LV corresponderend met de initiatie van 
complex vorming, is de bescherming niet afdoend. Indien de graad van bescherming 
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vergeleken wordt bij een gemiddelde LV (2/1) kan duidelijk de invloed van 
polymeersamenstelling waargenomen worden. Met name, een toegenomen UV waarde was 
te zien bij zwak geladen polymeren terwijl exclusief geladen polymeren een nagenoeg vlak 
verloop vertoonden.  
5.2 Degradatie van polymeren  
Biodegradeerbare poly--aminozuren werden aan het begin van dit doctoraatswerk o.a. 
geselecteerd op basis van hun analogie met lichaamseigen peptides die opgebouwd zijn uit 
amide-bindingen. Aangezien deze vlot door het lichaam kunnen worden gemetaboliseerd, 
werd dit ook vooropgesteld voor de polymere dragers. Door het lysosomale milieu binnen in 
het lichaam na te bootsen (papaine enzym 20 µg/ml citraat/fosfaat buffer, pH =6), kan het 
degradatievermogen van deze polymeren ingeschat worden. Initiële testen hebben 
uitgewezen dat bij de toegepaste concentratie, zeer vlotte degradatie mogelijk is (t.e.m 
oligomeren). Tot op zekere hoogte wordt een trend waargenomen in degradatiesnelheid 
gerelateerd aan de samenstelling (meer positieve lading veroorzaakt tragere degradatie).  
5.3 Bloed compatibiliteit  
Bij in vivo applicaties vormt de compatibiliteit met bloed of componenten van het bloed een 
zeer belangrijke factor voor o.a. systemisch gebruik. Aangezien erythrocyten, het 
hoofdaandeel van de bloedcomponenten uitmaken, geven hemolyse en hemoagglutinatie 
experimenten een goeie indruk van de mogelijke interactie met polyplexen. Hemolyse is een 
verschijnsel waarbij het celmembraan lyseert onder invloed van cel interactie met externe 
structuren. Gezien de negatieve oppervlaktelading van membranen en het exces aan 
positieve lading waarover polymeer-DNA complexen beschikken, vormen deze laatste een 
gevaar voor de inductie van hemolytische effecten. Daarom worden zowel polyplexen als 
polymeren op zich geïncubeerd in een HBS buffer met rode bloedcellen (2 %) die vooraf 
gezuiverd en gefilterd is. Voor alle polymeren is gebleken dat reeds vanaf een kleine 
concentratie, hemolyse valt waar te nemen en deze blijkt het meest intens voor hoger 
geladen structuren. Imidazole bevattende polymeren vertonen dan weer de het minste effect. 
Ook bij polyplexen met een LV van 2/1 hemolyse gedetecteerd worden, al is er een 
duidelijke verlaging merkbaar door de aanwezigheid van DNA. Bovendien blijkt een stijgend 
MW een groter hemolytisch effect te veroorzaken.Een ander aspect van het gebruik van 
polyplexen is de interactie met geladen structuren die leidt tot coagulatie (gevolgd door 
precipitatie). Hemoagglutinatie (het samenklitten van rode bloedcellen) kan een gevolg zijn 
hiervan en is makkelijk te verifieren via optische microscopie. Hiervoor worden polyplexen en 
polymeren geïncubeerd een RBC oplossing gedurende 1uur waarna de agglutinatie voor en 
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na vergeleken wordt. Opnieuw kan hier het verschil tussen polyplexen en polymeren 
opgemerkt worden, waarbij de invloed van DNA een gunstig effect veroorzaakt op de 
agglutinatie. Ook hier blijkt de samenstelling een invloed te hebben met verminderde 
agglutinatie indien minder geladen groepen aanwezig zijn (zie figuur onder).  
 
5.4 Cel experimenten  
De ultieme eigenschap van een afgifte systeem voor gen therapie bestaat erin om DNA tot 
expressie te laten brengen. Daarom is de meest relevante test voor bepaling van de mate 
waarin een vector efficiënt kan zijn, het uitvoeren van transfectie experimenten. Zowel de 
activiteit alsook de toxiciteit kan bepaald worden en vergeleken worden met het referentie 
polymeer PEI. Cell viabiliteit in functie van de LV wordt voor een selectie aan polyplexen 
uitgevoerd met behulp van een uptiblue assay die verkleurt in de aanwezigheid van levende, 
metaboliserende cellen. Voor de transfectie efficiëntie wordt gebruikt gemaakt van een 
plasmide model (RucHA) dat codeert voor GFP en makkelijk detecteerbaar is via absorptie 
of fluorescentie spectroscopie. Hiervoor wordt beroep gedaan op specifieke cellijnen 
(ARPE19, HEK 293 en COS-7) die via een speciaal ontwikkeld protocol uitgetest worden. 
De toxiciteit van alle poly--aminozuren was, afhankelijk van de gebruikte LV, vrij beperkt 
(tenzij voor LV > 4/1 en voor p(ARG) afgeleides) in vergelijking met PEI dat op zijn beurt 
substantiële celsterfte induceert, reeds vanaf een 2/1 LV. Modificatie van dit polymeer met 
o.a. guanidine conversie of fluorescente groepen kon deze toxiciteit wel voor een deel 
beperken. Polymethacrylaten vertonen een iets lagere viabiliteit, zeker wanneer hoog MW 
componenten gebruikt worden. Als er neutrale groepen ingebouwd worden, zorgt dit in 
tegenstelling tot de biodegradeerbare tegenhangers niet tot een verbetering van de viabiliteit. 
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Meestal vertoont de toxiciteit een stijgend verloop met toenemende LV, al blijken een aantal 
polyglutamines met o.a. imidazol functionele groepen geen tekenen van afgenomen viabiliteit 
te vertonen (voor de courant toegepaste LV’en t.e.m. 8-1).  
Omdat de graad van efficiente, grotendeels afhankelijk is van de gebruikte cellijn en het 
aangewende protocol wordt in de meest experimenten gerefereerd naar standaard vectoren. 
Aangezien in de literatuur PEI als zeer efficiente vector wordt beschreven, is ook in deze 
testen gebruik gemaakt van dit polymeer. Een heleboel polymeren die zijn getest op hun 
transfectie efficiëntie vertonen geen significante activiteit. Voor een aantal andere is dit wel 
het geval, waarbij sommige een betere efficiëntie dan PEI vertoonden (zie figuur onder). Zo 
blijken polyglutamines met 35% guainidine groepen die partieel geladen zijn (met 
hydroxyl/imidazole zijgroepen) een vergelijkbare efficiëntie te bezitten bij hogere LV. Enkele 
polymethacrylaten beschikken zelfs over een dubbele efficiëntie t.o.v. PEI maar dan wel bij 
hogere LV. Opnieuw corresponderen copolymeren met de hogere waardes in vergelijking 
met homopolymeren. Ook PEI gemodificeerd met guandine groepen bekomt hogere 
waardes in transfectie efficiëntie, eveneens bij hogeren LV. Omdat de grootste activiteit is 
gedetecteerd bij hogere LV dient wel rekening gehouden te worden met de viabiliteit. 
Hierdoor kunnen polymeren met lager MW beschouwd worden als de meest optimale, vooral 
bij polyglutamines waar de laagste toxiciteit wordt teruggevonden.  
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Code Polymeer Code Polymeer 
A p(DMAEG)+Arg8 242 kDa F p(HEG32%-GuAEG11%-ImEG57%) 9.6 
kDa 
B p(HEG63%-GuAEG37%) 9.6 kDa G p(DMAEMA) 121 kDa 
C p(ARG82%-ORN18%) 71.1 kDa H p(DMAEMA82%-AEMA18%) 135 kDa 
D p(ARG82%-ORN18%)+PEN 71.1 kDa I p(DMAEMA56%-HEMA44%) 218 kDa 
kDa 
E p(GuAEG35%-ImEG65%) 13 kDa J PEI-Guanidine20% 
 
5.5 Confocale microscopie 
Aan de hand van confocale microscopie kan het internalisatie process beter begrepen 
worden. Deze techniek stelt ook in staat om de morfologie van de polyplexen tot op zekere 
hoogte te visualiseren. Daardoor kunnen de verschillen in efficiëntie deels verklaard worden. 
Zo vertonen PEI complexen een heel wat diffusere morfologie in vergelijking met p(DMAEG) 
complexen die vrijwel geen activiteit vertonen. Door gebruik te maken van bepaalde 
componenten (Tryphan blue) kunnen de geïnternaliseerde complexen onderscheiden wordt 
van deze die op het oppervlak blijven. Dit gebrek aan opname zou al een eerste belangrijke 
oorzaak kunnen zijn voor veel polymeren die niet goed scoren inzake transfectie efficiëntie. 
Daarnaast moet ook rekening gehouden worden met de sterkte van de complexen, zo blijkt 
dat een aantal types polymeren wel kunnen geïnternaliseerd worden maar zonder 
daaropvolgende expressie, een gevolg van enerzijds de samenstelling en anderzijds de 
vertraging in opname. Wanneer DNA succesvol tot in de celkern kan gebracht worden, is 
proteïne expressie mogelijk (visualiseerbaar als rode fluorescentie). Voor p(DMAEMA) (zie 
figuur onder) kan zo een onderscheid gemaakt worden tussen de het geproduceerde 
proteine, niet-gedissocieerd polyplex alsook overblijfselen van niet-geinternaliseerd polyplex. 
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6 Conclusie  
Tijdens dit doctoraatsonderzoek werden een breed gamma aan polykationische vectoren 
succesvol gesynthetiseerd met diverse moleculaire gewichten. Naast de vereiste kationische 
functionele groepen werden ook zijgroepen met neutrale of bufferende eigenschappen 
geproduceerd, zowel voor poly--aminozuren als polymethacrylaten. De mogelijkheid om als 
vector gebruikt te worden werd in bijna alle gevallen positief geëvalueerd door middel van 
physico-chemische karakterisatie. Wanneer ook biologisch relevante analyses in rekening 
werden gebracht verkleinde de selectie potentiële vectoren drastisch. Niettegenstaande 
werden zowel voor polymethacrylaten als polyamides, gunstige kandidaten gevonden die 
een hogere transfectie efficientie bekwamen terwijl de viabiliteit, hemo-compatibiliteit en 
nuclease afscherming gelijk of zelfs beter presteerden. Ook de modificatie van referentie 
polymeren leidde tot verbeterde resultaten op het gebied van biologische evaluatie. 
Daarenboven kon ook het internalisatie proces met behulp van fluorescente derivaten verder 
opgehelderd worden om zo tot een optimale polymeersamenstelling te kunnen komen. 
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